Additional Information
Book Details
Abstract
No dental office should be without this quick-reference drug guide! Mosby's Dental Drug Reference, 12th Edition profiles the most commonly used drugs in dentistry, with emphasis on dental-specific considerations. More than 800 drug monographs make it easy to find information such as dosages, indications, contraindications, interactions, precautions, side effects, and serious reactions. Online resources include over 100 additional drug monographs, photos of common oral complications, patient education guides, and more. From lead editor Arthur Jeske, a well-known researcher and author in dental pharmacology, this pocket-sized reference provides the current, concise drug information you need at the point of care.
- More than 800 drug monographs include each drug’s generic name, pronunciation, brand names, drug class, controlled substances schedule, mechanism of action, uses or indications, doses and routes of administration, side effects/adverse reactions, contraindications, precautions, pharmacokinetics, drug interactions of concern to dentistry, and more.
- Detailed dental considerations at the end of each monograph include an easy-to-use, bulleted list of specific dental-related information as well as general drug information.
- Durable, pocket-sized format provides essential drug information at a glance, and makes this guide ideal for chairside use.
- Emphasis on oral health, prevention, and treatment from the dental hygienist’s perspective makes it easier to use drug information for patient and family education.
- Coverage of oral contraceptives provides dental information on these commonly used drugs, often known only by their brand names.
- Primers in the front of the guide include information on biologic agents, medication-related osteonecrosis of the jaw, and a list of online resources for the management of medically compromised patients along with management of common oral lesions.
- Evolve companion website includes more than 100 additional monographs, photos of common oral complications, patient education guides, information on herbs and alternative medicine, and more.
- NEW! More than 50 new monographs include newly released, FDA-approved drugs and up-to-date content on the latest drug therapies.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | cover | ||
| IFC_Evolve page | IFC1 | ||
| Additional Monographs on Evolve | IFC2 | ||
| Mosby's Dental Drug Reference | i | ||
| Copyright Page | iv | ||
| Drug Monograph Content Contributors and Reviewers | v | ||
| Preface | vii | ||
| A Detailed Guide to Mosby’s Dental Drug Reference, Twelfth Edition | vii | ||
| Table Of Contents | ix | ||
| Internet References for Additional Drug Information and Professional Guidelines | xi | ||
| Medication-Related Osteonecrosis of the Jaw | xiii | ||
| Monoclonal Antibodies and Other Biologic Drugs | xv | ||
| Summary: | xv | ||
| Classification: | xv | ||
| Dental Considerations for Monoclonal Antibodies/Biologically Targeted Agents | xv | ||
| General: | xv | ||
| Consultations: | xvi | ||
| Teach Patient/Family to: | xvi | ||
| Reference: | xvi | ||
| abacavir | 1 | ||
| Category and Schedule | 1 | ||
| Drug Class: | 1 | ||
| Mechanism of Action | 1 | ||
| Uses | 1 | ||
| Pharmacokinetics | 1 | ||
| Indications and Dosages | 1 | ||
| ► HIV Infection (in combination with other antiretrovirals) | 1 | ||
| PO | 1 | ||
| Adults. | 1 | ||
| Children (3 mo–16 yr). | 1 | ||
| ► Dosage in Hepatic Impairment | 1 | ||
| Mild Impairment. | 1 | ||
| Moderate to Severe Impairment. | 1 | ||
| Side Effects/Adverse Reactions | 1 | ||
| Adults | 1 | ||
| abarelix | 2 | ||
| Category and Schedule | 2 | ||
| Drug Class: | 2 | ||
| Mechanism of Action | 2 | ||
| Uses | 2 | ||
| Pharmacokinetics | 2 | ||
| Indications and Dosages | 2 | ||
| ► Prostate Cancer | 2 | ||
| IM | 2 | ||
| Adults, Elderly. | 2 | ||
| Side Effects/Adverse Reactions | 2 | ||
| Frequent | 2 | ||
| Occasional | 2 | ||
| Rare | 2 | ||
| Precautions and Contraindications | 3 | ||
| Drug Interactions of Concern to Dentistry | 3 | ||
| Serious Reactions | 3 | ||
| Dental Considerations | 3 | ||
| General: | 3 | ||
| Consultations: | 3 | ||
| Teach Patient/Family to: | 3 | ||
| abatacept | 3 | ||
| Category and Schedule | 3 | ||
| Drug Class: | 3 | ||
| Mechanism of Action | 3 | ||
| Uses | 3 | ||
| Pharmacokinetics | 3 | ||
| Indications and Dosages | 3 | ||
| ► Rheumatoid Arthritis (moderate to severe) in patients who have had an inadequate response to one or more disease-modifying antirheumatic drugs | 3 | ||
| IV | 4 | ||
| Adults. | 4 | ||
| Children. | 4 | ||
| abciximab | 5 | ||
| Category and Schedule | 5 | ||
| Drug Class: | 5 | ||
| Mechanism of Action | 5 | ||
| Uses | 5 | ||
| Pharmacokinetics | 5 | ||
| Indications and Dosages | 5 | ||
| ► Percutaneous Coronary Intervention (PCI) | 5 | ||
| absorbable gelatin sponge | 6 | ||
| Category and Schedule | 6 | ||
| Drug Class: | 6 | ||
| Mechanism of Action | 6 | ||
| Uses | 6 | ||
| Pharmacokinetics | 6 | ||
| Indications and Dosages | 6 | ||
| ► Dental Use | 6 | ||
| Adult. | 6 | ||
| Side Effects/Adverse Reactions | 6 | ||
| acamprosate calcium | 7 | ||
| Category and Schedule | 7 | ||
| Drug Class: | 7 | ||
| Mechanism of Actions | 7 | ||
| Uses | 7 | ||
| Pharmacokinetics | 7 | ||
| Indications and Dosages | 7 | ||
| ► Maintenance of Alcohol Abstinence | 7 | ||
| PO | 7 | ||
| Adult. | 7 | ||
| Side Effects/Adverse Reactions | 7 | ||
| Precautions and Contraindications | 7 | ||
| Caution: | 7 | ||
| Drug Interactions of Concern to Dentistry | 7 | ||
| Dental Considerations | 7 | ||
| Teach Patient/Family to: | 7 | ||
| General: | 7 | ||
| Consultations: | 8 | ||
| Teach Patient/Family to: | 8 | ||
| acarbose | 8 | ||
| Category and Schedule | 8 | ||
| Drug Class: | 8 | ||
| Mechanism of Action | 8 | ||
| Uses | 8 | ||
| Pharmacokinetics | 8 | ||
| acebutolol | 9 | ||
| Category and Schedule | 9 | ||
| Drug Class: | 9 | ||
| Mechanism of Action | 9 | ||
| Uses | 9 | ||
| Pharmacokinetics | 9 | ||
| Indications and Dosages | 10 | ||
| ► Mild-to-Moderate Hypertension | 10 | ||
| acetaminophen | 11 | ||
| Category and Schedule | 11 | ||
| Drug Class: | 11 | ||
| Mechanism of Action | 11 | ||
| Uses | 11 | ||
| Pharmacokinetics | 11 | ||
| Indications and Dosages | 12 | ||
| ► Analgesia and Antipyresis | 12 | ||
| PO | 12 | ||
| Adults, Elderly. | 12 | ||
| acetazolamide | 13 | ||
| Category and Schedule | 13 | ||
| Drug Class: | 13 | ||
| Mechanism of Action | 13 | ||
| Uses | 13 | ||
| Pharmacokinetics | 13 | ||
| Indications and Dosages | 14 | ||
| ► Glaucoma | 14 | ||
| acetohexamide | 15 | ||
| Category and Schedule | 15 | ||
| Drug Class: | 15 | ||
| Mechanism of Action | 15 | ||
| Uses | 15 | ||
| Pharmacokinetics | 15 | ||
| Indications and Dosages | 15 | ||
| ► Diabetes Mellitus | 15 | ||
| PO | 15 | ||
| Adults, Elderly. | 15 | ||
| Side Effects/Adverse Reactions | 16 | ||
| Frequent | 16 | ||
| Occasional | 16 | ||
| Precautions and Contraindications | 16 | ||
| Caution: | 16 | ||
| Drug Interactions of Concern to Dentistry | 16 | ||
| Serious Reactions | 16 | ||
| Dental Considerations | 16 | ||
| General: | 16 | ||
| Consultations: | 16 | ||
| Teach Patient/Family to: | 16 | ||
| acetylcholine chloride | 17 | ||
| Category and Schedule | 17 | ||
| Drug Class: | 17 | ||
| Mechanism of Action | 17 | ||
| Uses | 17 | ||
| Pharmacokinetics | 17 | ||
| Indications and Dosages | 17 | ||
| ► Production of Miosis | 17 | ||
| Intraocular | 17 | ||
| Adults, Elderly. | 17 | ||
| Side Effects/Adverse Reactions | 17 | ||
| Rare | 17 | ||
| Precautions and Contraindications | 17 | ||
| Drug Interactions of Concern to Dentistry | 17 | ||
| Serious Reactions | 17 | ||
| Dental Considerations | 17 | ||
| General: | 17 | ||
| Uses | 18 | ||
| Pharmacokinetics | 18 | ||
| Indications and Dosages | 18 | ||
| ► Adjunctive Treatment of Viscid Mucus Secretions from Chronic Bronchopulmonary Disease and for Pulmonary Complications of Cystic Fibrosis | 18 | ||
| Nebulization | 18 | ||
| acetylcysteine | 17 | ||
| acitretin | 19 | ||
| Category and Schedule | 19 | ||
| Drug Class: | 19 | ||
| Mechanism of Action | 19 | ||
| Uses | 19 | ||
| Pharmacokinetics | 19 | ||
| Indications and Dosages | 19 | ||
| ► Psoriasis | 19 | ||
| PO | 19 | ||
| Adults, Elderly. | 19 | ||
| Side Effects/Adverse Reactions | 20 | ||
| Frequent | 20 | ||
| Occasional | 20 | ||
| Precautions and Contraindications | 20 | ||
| Caution: | 20 | ||
| Drug Interactions of Concern to Dentistry | 20 | ||
| Serious Reactions | 20 | ||
| Dental Considerations | 20 | ||
| General: | 20 | ||
| Consultations: | 20 | ||
| Teach Patient/Family to: | 20 | ||
| acyclovir | 21 | ||
| Category and Schedule | 21 | ||
| Drug Class: | 21 | ||
| Mechanism of Action | 21 | ||
| Uses | 21 | ||
| Pharmacokinetics | 21 | ||
| Indications and Dosages | 21 | ||
| ► Genital Herpes (initial episode) | 21 | ||
| adalimumab | 23 | ||
| Category and Schedule | 23 | ||
| Drug Class: | 23 | ||
| Mechanism of Action | 23 | ||
| Uses | 23 | ||
| Pharmacokinetics | 23 | ||
| Indications and Dosages | 23 | ||
| ► Rheumatoid Arthritis | 23 | ||
| Subcutaneous | 23 | ||
| Adults, Elderly. | 23 | ||
| Side Effects/Adverse Reactions | 23 | ||
| Frequent | 23 | ||
| Occasional | 23 | ||
| Rare | 23 | ||
| Precautions and Contraindications | 23 | ||
| Caution: | 23 | ||
| Drug Interactions of Concern to Dentistry | 23 | ||
| Serious Reactions | 23 | ||
| Dental Considerations | 23 | ||
| General: | 23 | ||
| Consultations: | 24 | ||
| Teach Patient/Family to: | 24 | ||
| adapalene | 24 | ||
| Category and Schedule | 24 | ||
| Drug Class: | 24 | ||
| Mechanism of Action | 24 | ||
| Uses | 24 | ||
| Pharmacokinetics | 24 | ||
| Indications and Dosages | 24 | ||
| ► Acne Vulgaris | 24 | ||
| Topical | 24 | ||
| Adults, Elderly, Children older than 12 yr. | 24 | ||
| Side Effects/Adverse Reactions | 24 | ||
| Frequent | 24 | ||
| Occasional | 24 | ||
| Precautions and Contraindications | 24 | ||
| Drug Interactions of Concern to Dentistry | 24 | ||
| Serious Reactions | 24 | ||
| Dental Considerations | 24 | ||
| General: | 24 | ||
| Teach Patient/Family to: | 25 | ||
| adefovir | 25 | ||
| Category and Schedule | 25 | ||
| Drug Class: | 25 | ||
| Mechanism of Action | 25 | ||
| Uses | 25 | ||
| Pharmacokinetics | 25 | ||
| Indications and Dosages | 25 | ||
| ► Chronic Hepatitis B in Patients with Normal Renal Function | 25 | ||
| aflibercept | 26 | ||
| Category and Schedule | 26 | ||
| Drug Class: | 26 | ||
| Mechanism of Action | 26 | ||
| Uses | 26 | ||
| Pharmacokinetics | 26 | ||
| Indications and Dosages | 26 | ||
| ► Age-Related Macular Degeneration (AMD) | 26 | ||
| albendazole | 27 | ||
| Category and Schedule | 27 | ||
| Drug Class: | 27 | ||
| Mechanism of Action | 27 | ||
| Uses | 27 | ||
| Pharmacokinetics | 27 | ||
| Indications and Dosages | 27 | ||
| ► Neurocysticercosis | 27 | ||
| PO | 27 | ||
| Adults, Elderly weighing more than 60 kg. | 27 | ||
| Adults, Elderly weighing less than 60 kg. | 27 | ||
| ► Cystic Hydatid | 28 | ||
| PO | 28 | ||
| Adults, Elderly weighing more than 60 kg. | 28 | ||
| Side Effects/Adverse Reactions | 28 | ||
| Frequent | 28 | ||
| Occasional | 28 | ||
| Precautions and Contraindications | 28 | ||
| Drug Interactions of Concern to Dentistry | 28 | ||
| Serious Reactions | 28 | ||
| Dental Considerations | 28 | ||
| General: | 28 | ||
| Consultations: | 28 | ||
| albiglutide | 28 | ||
| Category and Schedule | 28 | ||
| Drug Class: | 28 | ||
| Mechanism of Action | 28 | ||
| Uses | 28 | ||
| Pharmacokinetics | 28 | ||
| Indications and Dosages | 29 | ||
| ► Type 2 Diabetes Mellitus | 29 | ||
| Adults. | 29 | ||
| Side Effects/Adverse Reactions | 29 | ||
| Frequent | 29 | ||
| Occasional | 29 | ||
| Precautions and Contraindications | 29 | ||
| Drug Interactions of Concern to Dentistry | 29 | ||
| Serious Reactions | 29 | ||
| Dental Considerations | 29 | ||
| General: | 29 | ||
| Consultations: | 29 | ||
| Teach Patient/Family to: | 30 | ||
| albuterol | 30 | ||
| Category and Schedule | 30 | ||
| Drug Class: | 30 | ||
| Mechanism of Action | 30 | ||
| Uses | 30 | ||
| Pharmacokinetics | 30 | ||
| Indications and Dosages | 30 | ||
| ► Bronchospasm | 30 | ||
| PO | 30 | ||
| alclometasone | 31 | ||
| Category and Schedule | 31 | ||
| Drug Class: | 31 | ||
| Mechanism of Action | 32 | ||
| Uses | 32 | ||
| Pharmacokinetics | 32 | ||
| Indications and Dosages | 32 | ||
| ► Atopic Dermatitis, Contact Dermatitis, Dermatitis, Discoid Lupus Erythematosus, Eczema, Exfoliative Dermatitis, Granuloma Annulare, Lichen Planus, Lichen Simplex, Polymorphous Light Eruption, Pruritus, Psoriasis, Rhus Dermatitis, Seborrheic Dermatitis, Xerosis | 32 | ||
| Topical | 32 | ||
| Adults, Adolescents, Children 1 yr and older. | 32 | ||
| Side Effects/Adverse Reactions | 32 | ||
| Frequent | 32 | ||
| Occasional | 32 | ||
| Rare | 32 | ||
| Precautions and Contraindications | 32 | ||
| Drug Interactions of Concern to Dentistry | 32 | ||
| Serious Reactions | 32 | ||
| Dental Considerations | 32 | ||
| General: | 32 | ||
| Teach Patient/Family to: | 32 | ||
| interleukin-2 (aldesleukin) | 32 | ||
| Category and Schedule | 32 | ||
| Drug Class: | 32 | ||
| Mechanism of Action | 33 | ||
| Uses | 33 | ||
| Pharmacokinetics | 33 | ||
| Indications and Dosages | 33 | ||
| ► Metastatic Melanoma, Metastatic Renal Cell Carcinoma | 33 | ||
| IV | 33 | ||
| Adults 18 yr and older. | 33 | ||
| Side Effects/Adverse Reactions | 33 | ||
| Frequent | 33 | ||
| Occasional | 33 | ||
| Rare | 33 | ||
| Precautions and Contraindications | 33 | ||
| Drug Interactions of Concern to Dentistry | 33 | ||
| Serious Reactions | 33 | ||
| Dental Considerations | 34 | ||
| General: | 34 | ||
| Consultations: | 34 | ||
| Teach Patient/Family to: | 34 | ||
| alefacept | 34 | ||
| Category and Schedule | 34 | ||
| Drug Class: | 34 | ||
| alemtuzumab | 35 | ||
| Category and Schedule | 35 | ||
| Drug Class: | 35 | ||
| Mechanism of Action | 35 | ||
| Uses | 35 | ||
| Pharmacokinetics | 35 | ||
| Indications and Dosages | 35 | ||
| ► Plaque Psoriasis | 35 | ||
| IV | 35 | ||
| Uses | 36 | ||
| Pharmacokinetics | 36 | ||
| Indications and Dosages | 36 | ||
| ► Chronic Lymphocytic Leukemia | 36 | ||
| IV | 36 | ||
| Adults, Elderly. | 36 | ||
| Side Effects/Adverse Reactions | 36 | ||
| Frequent | 36 | ||
| Occasional | 36 | ||
| Precautions and Contraindications | 36 | ||
| Drug Interactions of Concern to Dentistry | 36 | ||
| Serious Reactions | 36 | ||
| Dental Considerations | 36 | ||
| General: | 36 | ||
| Consultations: | 37 | ||
| Teach Patient/Family to: | 37 | ||
| alendronate sodium | 37 | ||
| Category and Schedule | 37 | ||
| Drug Class: | 37 | ||
| Mechanism of Action | 37 | ||
| Uses | 37 | ||
| Pharmacokinetics | 37 | ||
| Indications and Dosages | 37 | ||
| ► Osteoporosis (in Men) | 37 | ||
| PO | 37 | ||
| Adults, Elderly. | 37 | ||
| ► Glucocorticoid-Induced Osteoporosis | 38 | ||
| alfuzosin | 39 | ||
| Category and Schedule | 39 | ||
| Drug Class: | 39 | ||
| Mechanism of Action | 39 | ||
| Uses | 39 | ||
| Pharmacokinetics | 39 | ||
| Indications and Dosages | 39 | ||
| ► Bph | 39 | ||
| PO | 39 | ||
| Adults. | 39 | ||
| Side Effects/Adverse Reactions | 39 | ||
| Frequent | 39 | ||
| Occasional | 39 | ||
| Rare | 39 | ||
| Precautions and Contraindications | 39 | ||
| Caution: | 39 | ||
| Drug Interactions of Concern to Dentistry | 39 | ||
| Serious Reactions | 40 | ||
| Dental Considerations | 40 | ||
| General: | 40 | ||
| Consultations: | 40 | ||
| Teach Patient/Family to: | 40 | ||
| alglucosidase alfa | 40 | ||
| Category and Schedule | 40 | ||
| Drug Class: | 40 | ||
| Mechanism of Action | 40 | ||
| Uses | 40 | ||
| Pharmacokinetics | 40 | ||
| Indications and Dosages | 40 | ||
| ► Replacement Therapy for Pompe Disease | 40 | ||
| IV Infusion | 40 | ||
| Adults. | 40 | ||
| Children (1 mo–3.5 yr. at first infusion). | 40 | ||
| Side Effects/Adverse Reactions | 40 | ||
| Frequent | 40 | ||
| Precautions and Contraindications | 41 | ||
| Caution: | 41 | ||
| Drug Interactions of Concern to Dentistry | 41 | ||
| Serious Reactions | 41 | ||
| Dental Considerations | 41 | ||
| General: | 41 | ||
| Teach Patient/Family to: | 41 | ||
| aliskiren | 41 | ||
| Category and Schedule | 41 | ||
| Drug Class: | 41 | ||
| Mechanism of Action | 41 | ||
| Uses | 41 | ||
| Pharmacokinetics | 41 | ||
| Indications and Dosages | 42 | ||
| ► Hypertension (Monotherapy) | 42 | ||
| Adults. | 42 | ||
| Side Effects/Adverse Reactions | 42 | ||
| Frequent | 42 | ||
| Occasional | 42 | ||
| Rare | 42 | ||
| Precautions and Contraindications | 42 | ||
| Drug Interactions of Concern to Dentistry | 42 | ||
| Serious Reactions | 42 | ||
| Dental Considerations | 42 | ||
| General: | 42 | ||
| Consultations: | 42 | ||
| Teach patient/family to: | 42 | ||
| alitretinoin | 42 | ||
| Category and Schedule | 42 | ||
| Drug Class: | 42 | ||
| Mechanism of Action | 42 | ||
| allopurinol | 43 | ||
| Category and Schedule | 43 | ||
| Drug Class: | 43 | ||
| Mechanism of Action | 43 | ||
| Uses | 43 | ||
| Pharmacokinetics | 43 | ||
| Indications and Dosages | 43 | ||
| ► KS Skin Lesions | 43 | ||
| Topical | 43 | ||
| Adults. | 43 | ||
| Side Effects/Adverse Reactions | 43 | ||
| Frequent | 43 | ||
| Precautions and Contraindications | 43 | ||
| Caution: | 43 | ||
| Drug Interactions of Concern to Dentistry | 43 | ||
| Serious Reactions | 43 | ||
| Dental Considerations | 43 | ||
| General: | 43 | ||
| Pharmacokinetics | 44 | ||
| Indications and Dosages | 44 | ||
| ► Chronic Gouty Arthritis | 44 | ||
| almotriptan malate | 45 | ||
| Category and Schedule | 45 | ||
| Drug Class: | 45 | ||
| Mechanism of Action | 45 | ||
| Uses | 45 | ||
| Pharmacokinetics | 45 | ||
| Indications and Dosages | 45 | ||
| ► Migraine Headache | 45 | ||
| PO | 45 | ||
| Adults, Elderly. | 45 | ||
| ► Dosage in Renal Impairment | 45 | ||
| Side Effects/Adverse Reactions | 45 | ||
| Frequent | 45 | ||
| Occasional | 45 | ||
| Precautions and Contraindications | 45 | ||
| Caution: | 45 | ||
| Drug Interactions of Concern to Dentistry | 46 | ||
| Serious Reactions | 46 | ||
| Dental Considerations | 46 | ||
| General: | 46 | ||
| Consultations: | 46 | ||
| Teach Patient/Family to: | 46 | ||
| alogliptin | 46 | ||
| Category and Schedule | 46 | ||
| Drug Class: | 46 | ||
| Mechanism of Action | 46 | ||
| Uses | 46 | ||
| Pharmacokinetics | 46 | ||
| Indications and Dosages | 46 | ||
| ► Type 2 Diabetes Mellitus | 46 | ||
| PO | 46 | ||
| Adults. | 46 | ||
| Side Effects/Adverse Reactions | 47 | ||
| Frequent | 47 | ||
| Occasional | 47 | ||
| Precautions and Contraindications | 47 | ||
| Drug Interactions of Concern to Dentistry | 47 | ||
| Serious Reactions | 47 | ||
| Dental Considerations | 47 | ||
| General: | 47 | ||
| Consultations: | 47 | ||
| Teach Patient/Family to: | 48 | ||
| alprazolam | 48 | ||
| Category and Schedule | 48 | ||
| Drug Class: | 48 | ||
| Mechanism of Action | 48 | ||
| Uses | 48 | ||
| Pharmacokinetics | 48 | ||
| Indications and Dosages | 48 | ||
| ► Anxiety Disorders | 48 | ||
| alprostadil (prostaglandin e1, pge1) | 50 | ||
| Category and Schedule | 50 | ||
| Mechanism of Action | 50 | ||
| Uses | 50 | ||
| Pharmacokinetics | 50 | ||
| Indications and Dosages | 50 | ||
| ► Maintain Patency of Ductus Arteriosus | 50 | ||
| IV Infusion | 50 | ||
| Neonates. | 50 | ||
| ► Impotence | 50 | ||
| Pellet, Intracavernosal | 50 | ||
| Adults. | 50 | ||
| Side Effects/Adverse Reactions | 50 | ||
| Frequent | 50 | ||
| Occasional | 50 | ||
| Precautions and Contraindications | 50 | ||
| Caution: | 50 | ||
| Drug Interactions of Concern to Dentistry | 50 | ||
| alvimopan | 51 | ||
| Category and Schedule | 51 | ||
| Drug Class: | 51 | ||
| Mechanism of Action | 51 | ||
| Uses | 51 | ||
| Pharmacokinetics | 51 | ||
| Indications and Dosages | 51 | ||
| ► Postoperative Control of Ileus | 51 | ||
| Adult. | 51 | ||
| Side Effects/Adverse Reactions | 51 | ||
| Frequent | 51 | ||
| Occasional | 51 | ||
| Precautions and Contraindications | 51 | ||
| Drug Interactions of Concern to Dentistry | 51 | ||
| Serious Reactions | 51 | ||
| Dental Considerations | 51 | ||
| General: | 51 | ||
| Consultations: | 51 | ||
| Teach patient/family to: | 51 | ||
| amantadine hydrochloride | 52 | ||
| Category and Schedule | 52 | ||
| Drug Class: | 52 | ||
| Mechanism of Action | 52 | ||
| Uses | 52 | ||
| Pharmacokinetics | 52 | ||
| Indications and Dosages | 52 | ||
| ► Prevention and Symptomatic Treatment of Respiratory Illness Caused by Influenza A Virus | 52 | ||
| ambenonium | 53 | ||
| Category and Schedule | 53 | ||
| Drug Class: | 53 | ||
| Mechanism of Action | 53 | ||
| Uses | 53 | ||
| Pharmacokinetics | 53 | ||
| Indications and Dosages | 53 | ||
| ► Myasthenia Gravis | 53 | ||
| PO | 53 | ||
| Adults. | 53 | ||
| Side Effects/Adverse Reactions | 53 | ||
| Frequent | 53 | ||
| Occasional | 53 | ||
| Rare | 54 | ||
| Precautions and Contraindications | 54 | ||
| Caution: | 54 | ||
| Drug Interactions of Concern to Dentistry | 54 | ||
| Serious Reactions | 54 | ||
| Dental Considerations | 54 | ||
| General: | 54 | ||
| Consultations: | 54 | ||
| Teach Patient/Family to: | 54 | ||
| ambrisentan | 54 | ||
| Category and Schedule | 54 | ||
| Drug Class: | 54 | ||
| amcinonide | 55 | ||
| Category and Schedule | 55 | ||
| Drug Class: | 55 | ||
| Mechanism of Action | 55 | ||
| Uses | 55 | ||
| Pharmacokinetics | 55 | ||
| Indications and Dosages | 55 | ||
| ► Pulmonary Arterial Hypertension | 55 | ||
| Adult. | 55 | ||
| Side Effects/Adverse Reactions | 55 | ||
| Frequent | 55 | ||
| Occasional | 55 | ||
| Precautions and Contraindications | 55 | ||
| Drug Interactions of Concern to Dentistry | 55 | ||
| Serious Reactions | 55 | ||
| Dental Considerations | 55 | ||
| General: | 55 | ||
| Consultations: | 55 | ||
| Teach patient/family to: | 55 | ||
| Uses | 56 | ||
| Pharmacokinetics | 56 | ||
| Indications and Dosages | 56 | ||
| ► Dermatoses | 56 | ||
| Topical | 56 | ||
| Adults, Elderly. | 56 | ||
| Side Effects/Adverse Reactions | 56 | ||
| Frequent | 56 | ||
| Occasional | 56 | ||
| Rare | 56 | ||
| Precautions and Contraindications | 56 | ||
| Drug Interactions of Concern to Dentistry | 56 | ||
| Serious Reactions | 56 | ||
| Dental Considerations | 56 | ||
| General: | 56 | ||
| Teach Patient/Family to: | 56 | ||
| amifostine | 56 | ||
| Category and Schedule | 56 | ||
| Drug Class: | 56 | ||
| Mechanism of Action | 56 | ||
| Uses | 57 | ||
| Pharmacokinetics | 57 | ||
| Indications and Dosages | 57 | ||
| ► To Reduce Cumulative Renal Toxicity from Repeated Administration of Cisplatin in Patients with Advanced Ovarian Cancer | 57 | ||
| amiloride hydrochloride | 58 | ||
| Category and Schedule | 58 | ||
| Drug Class: | 58 | ||
| Mechanism of Action | 58 | ||
| Uses | 59 | ||
| Pharmacokinetics | 59 | ||
| Indications and Dosages | 59 | ||
| ► To Counteract Potassium Loss Induced by Other Diuretics | 59 | ||
| PO | 59 | ||
| Adults, Children weighing more than 20 kg. | 59 | ||
| Elderly. | 59 | ||
| Children weighing 6–20 kg. | 59 | ||
| ► Dosage in Renal Impairment | 59 | ||
| Side Effects/Adverse Reactions | 59 | ||
| Frequent | 59 | ||
| Occasional | 59 | ||
| Rare | 59 | ||
| Precautions and Contraindications | 59 | ||
| Caution: | 59 | ||
| Drug Interactions of Concern to Dentistry | 59 | ||
| Serious Reactions | 59 | ||
| Dental Considerations | 59 | ||
| General: | 59 | ||
| Consultations: | 60 | ||
| Teach Patient/Family to: | 60 | ||
| aminoglutethimide | 60 | ||
| Category and Schedule | 60 | ||
| Drug Class: | 60 | ||
| Mechanism of Action | 60 | ||
| Uses | 60 | ||
| Pharmacokinetics | 60 | ||
| Indications and Dosages | 60 | ||
| ► Cushing’s Syndrome | 60 | ||
| PO | 60 | ||
| Adults. | 60 | ||
| Side Effects/Adverse Reactions | 60 | ||
| Frequent | 60 | ||
| Occasional | 60 | ||
| Rare | 60 | ||
| Precautions and Contraindications | 60 | ||
| Drug Interactions of Concern to Dentistry | 60 | ||
| Serious Reactions | 60 | ||
| Dental Considerations | 61 | ||
| General: | 61 | ||
| Consultations: | 61 | ||
| Teach Patient/Family to: | 61 | ||
| aminophylline/theophylline | 61 | ||
| Category and Schedule | 61 | ||
| Drug Class: | 61 | ||
| Mechanism of Action | 62 | ||
| Uses | 62 | ||
| Pharmacokinetics | 62 | ||
| Indications and Dosages | 62 | ||
| ► Chronic Bronchospasm | 62 | ||
| aminosalicylic acid | 63 | ||
| Category and Schedule | 63 | ||
| Drug Class: | 63 | ||
| Mechanism of Action | 63 | ||
| Uses | 63 | ||
| Pharmacokinetics | 63 | ||
| Indications and Dosages | 64 | ||
| ► Tuberculosis | 64 | ||
| PO | 64 | ||
| Adults, Elderly. | 64 | ||
| Children. | 64 | ||
| Side Effects/Adverse Reactions | 64 | ||
| Occasional | 64 | ||
| Rare | 64 | ||
| Precautions and Contraindications | 64 | ||
| Caution: | 64 | ||
| Drug Interactions of Concern to Dentistry | 64 | ||
| Serious Reactions | 64 | ||
| Dental Considerations | 64 | ||
| General: | 64 | ||
| Consultations: | 64 | ||
| Teach Patient/Family to: | 64 | ||
| amiodarone hydrochloride | 65 | ||
| Category and Schedule | 65 | ||
| Drug Class: | 65 | ||
| Mechanism of Action | 65 | ||
| Uses | 65 | ||
| Pharmacokinetics | 65 | ||
| Indications and Dosages | 65 | ||
| ► Life-Threatening Recurrent Ventricular Fibrillation or Hemodynamically Unstable Ventricular Tachycardia | 65 | ||
| PO | 65 | ||
| Adults, Elderly. | 65 | ||
| Children. | 65 | ||
| IV Infusion | 65 | ||
| Adults. | 65 | ||
| Side Effects/Adverse Reactions | 65 | ||
| Expected | 65 | ||
| Frequent | 65 | ||
| Occasional | 65 | ||
| Rare | 66 | ||
| Precautions and Contraindications | 66 | ||
| Caution: | 66 | ||
| Drug Interactions of Concern to Dentistry | 66 | ||
| Serious Reactions | 66 | ||
| Dental Considerations | 66 | ||
| General: | 66 | ||
| Consultations: | 66 | ||
| Teach Patient/Family to: | 66 | ||
| amitriptyline hydrochloride | 67 | ||
| Category and Schedule | 67 | ||
| Drug Class: | 67 | ||
| Mechanism of Action | 67 | ||
| Uses | 67 | ||
| Pharmacokinetics | 67 | ||
| Indications and Dosages | 67 | ||
| ► Depression | 67 | ||
| amlexanox | 69 | ||
| Category and Schedule | 69 | ||
| Drug Class: | 69 | ||
| Mechanism of Action | 69 | ||
| Uses | 69 | ||
| Pharmacokinetics | 69 | ||
| Indications and Dosages | 69 | ||
| ► Aphthous Ulcers | 69 | ||
| Topical | 69 | ||
| Adults, Elderly. | 69 | ||
| Side Effects/Adverse Reactions | 69 | ||
| Rare | 69 | ||
| Precautions and Contraindications | 69 | ||
| Caution: | 69 | ||
| Drug Interactions of Concern to Dentistry | 69 | ||
| Serious Reactions | 69 | ||
| Dental Considerations | 69 | ||
| General: | 69 | ||
| Teach Patient/Family to: | 69 | ||
| Uses | 70 | ||
| Pharmacokinetics | 70 | ||
| Indications and Dosages | 70 | ||
| ► Essential Hypertension, Stable Angina and Vasospastic Angina | 70 | ||
| Adult. | 70 | ||
| Child (6–17 yr). | 70 | ||
| Side effects/adverse reactions | 70 | ||
| Frequent | 70 | ||
| Occasional | 70 | ||
| Rare | 70 | ||
| Precautions and Contraindications | 70 | ||
| Drug Interactions of Concern to Dentistry | 70 | ||
| Serious Reactions | 70 | ||
| Dental Considerations | 70 | ||
| General: | 70 | ||
| Consultations: | 71 | ||
| Teach Patient/Family to: | 71 | ||
| amlodipine | 69 | ||
| amoxapine | 71 | ||
| Category and Schedule | 71 | ||
| Drug Class: | 71 | ||
| Mechanism of Action | 71 | ||
| Uses | 71 | ||
| Pharmacokinetics | 71 | ||
| Indications and Dosages | 71 | ||
| ► Depression | 71 | ||
| PO | 71 | ||
| Adults. | 71 | ||
| Adolescents. | 71 | ||
| Elderly. | 71 | ||
| Side Effects/Adverse Reactions | 71 | ||
| Frequent | 71 | ||
| Occasional | 71 | ||
| Rare | 71 | ||
| Precautions and Contraindications | 72 | ||
| Caution: | 72 | ||
| Drug Interactions of Concern to Dentistry | 72 | ||
| Serious Reactions | 72 | ||
| Dental Considerations | 72 | ||
| General: | 72 | ||
| Consultations: | 72 | ||
| Teach Patient/Family to: | 72 | ||
| amoxicillin | 73 | ||
| Category and Schedule | 73 | ||
| Drug Class: | 73 | ||
| Mechanism of Action | 73 | ||
| Uses | 73 | ||
| Pharmacokinetics | 73 | ||
| Indications and Dosages | 73 | ||
| ► Ear, Nose, and Throat Infections | 73 | ||
| amoxicillin/clavulanate potassium | 74 | ||
| Category and Schedule | 74 | ||
| Drug Class: | 74 | ||
| Mechanism of Action | 75 | ||
| Uses | 75 | ||
| Pharmacokinetics | 75 | ||
| Indications and Dosages | 75 | ||
| ► Mild-to-Moderate Infections | 75 | ||
| amphetamine | 76 | ||
| Category and Schedule | 76 | ||
| Drug Class: | 76 | ||
| Mechanism of Action | 76 | ||
| Uses | 76 | ||
| Pharmacokinetics | 76 | ||
| Indications and Dosages | 76 | ||
| ► Adhd | 76 | ||
| PO | 76 | ||
| Adults. | 76 | ||
| Adults, Children older than 12 yr. | 76 | ||
| Children 6–12 yr. | 76 | ||
| Children 3–6 yr. | 77 | ||
| ► Narcolepsy | 77 | ||
| PO | 77 | ||
| Adults. | 77 | ||
| Adults, Children older than 12 yr. | 77 | ||
| Children 6–12 yr. | 77 | ||
| Side Effects/Adverse Reactions | 77 | ||
| Frequent | 77 | ||
| Occasional | 77 | ||
| Precautions and Contraindications | 77 | ||
| Caution: | 77 | ||
| Drug Interactions of Concern to Dentistry | 77 | ||
| Serious Reactions | 77 | ||
| Dental Considerations | 77 | ||
| General: | 77 | ||
| Consultations: | 77 | ||
| Teach Patient/Family to: | 77 | ||
| amphotericin b | 78 | ||
| Category and Schedule | 78 | ||
| Drug Class: | 78 | ||
| Mechanism of Action | 78 | ||
| Uses | 78 | ||
| Pharmacokinetics | 78 | ||
| Indications and Dosages | 78 | ||
| ► Cryptococcosis; Blastomycosis; Systemic Candidiasis; Disseminated Forms of Moniliasis, Coccidioidomycosis, and Histoplasmosis; Zygomycosis; Sporotrichosis; Aspergillosis | 78 | ||
| IV Infusion (Fungizone) | 78 | ||
| Adults, Elderly. | 78 | ||
| Children. | 78 | ||
| ► Invasive Fungal Infections Unresponsive to or Intolerant of Fungizone | 78 | ||
| IV Infusion (Abelcet) | 78 | ||
| Adults, Children. | 78 | ||
| ► Empiric Treatment of Fungal Infections in Patients with Febrile Neutropenia; Aspergillosis, Candidiasis, or Cryptococcosis in Patients with Renal Impairment and Those Who Have Experienced Toxicity or Treatment Failure with Fungizone | 78 | ||
| IV Infusion (Ambisome) | 78 | ||
| amphotericin b, lipid-based | 79 | ||
| Category and Schedule | 79 | ||
| Drug Class: | 79 | ||
| Mechanism of Action | 80 | ||
| Uses | 80 | ||
| Pharmacokinetics | 80 | ||
| Indications and Dosages | 80 | ||
| ► Invasive Fungal Infections Unresponsive to, or Intolerant of, Fungizone. | 80 | ||
| IV Infusion | 80 | ||
| Adults, Children. | 80 | ||
| Side Effects/Adverse Reactions | 80 | ||
| Frequent | 80 | ||
| Occasional | 80 | ||
| Precautions and Contraindications | 80 | ||
| Drug Interactions of Concern to Dentistry | 80 | ||
| Serious Reactions | 80 | ||
| Dental Considerations | 80 | ||
| General: | 80 | ||
| Consultations: | 80 | ||
| Teach Patient/Family to: | 81 | ||
| ampicillin | 81 | ||
| Category and Schedule | 81 | ||
| Drug Class: | 81 | ||
| Mechanism of Action | 81 | ||
| Uses | 81 | ||
| Pharmacokinetics | 81 | ||
| Indications and Dosages | 81 | ||
| ► Respiratory Tract, Skin/Skin-Structure Infections | 81 | ||
| ampicillin sodium | 82 | ||
| Category and Schedule | 82 | ||
| Drug Class: | 82 | ||
| Mechanism of Action | 83 | ||
| Uses | 83 | ||
| Pharmacokinetics | 83 | ||
| Indications and Dosages | 83 | ||
| ► Respiratory Tract, Skin and Skin-Structure Infections | 83 | ||
| ampicillin/sulbactam sodium | 84 | ||
| Category and Schedule | 84 | ||
| Drug Class: | 84 | ||
| Mechanism of Action | 84 | ||
| Uses | 84 | ||
| Pharmacokinetics | 84 | ||
| Indications and Dosages | 84 | ||
| ► Skin and Skin-Structure, Intraabdominal, and Gynecologic Infections | 84 | ||
| IV, IM | 84 | ||
| Adults, Elderly. | 84 | ||
| ► Dosage in Renal Impairment | 84 | ||
| Side Effects/Adverse Reactions | 84 | ||
| Frequent | 84 | ||
| Occasional | 85 | ||
| Precautions and Contraindications | 85 | ||
| Drug Interactions of Concern to Dentistry | 85 | ||
| Serious Reactions | 85 | ||
| Dental Considerations | 85 | ||
| General: | 85 | ||
| Consultations: | 85 | ||
| Teach Patient/Family to: | 85 | ||
| amprenavir | 85 | ||
| Category and Schedule | 85 | ||
| Drug Class: | 85 | ||
| Mechanism of Action | 85 | ||
| Uses | 86 | ||
| Pharmacokinetics | 86 | ||
| Indications and Dosages | 86 | ||
| ► HIV-1 Infection (in combination with other antiretrovirals) | 86 | ||
| PO | 86 | ||
| Adults, Children 13–16 yr. | 86 | ||
| amyl nitrite | 87 | ||
| Category and Schedule | 87 | ||
| Drug Class: | 87 | ||
| Mechanism of Action | 87 | ||
| Uses | 87 | ||
| Pharmacokinetics | 87 | ||
| Indications and Dosages | 87 | ||
| ► Acute Relief of Angina Pectoris | 87 | ||
| Nasal Inhalation | 87 | ||
| Adults, Elderly. | 87 | ||
| Side Effects/Adverse Reactions | 87 | ||
| Frequent | 87 | ||
| Occasional | 88 | ||
| Rare | 88 | ||
| Precautions and Contraindications | 88 | ||
| Drug Interactions of Concern to Dentistry | 88 | ||
| Serious Reactions | 88 | ||
| Dental Considerations | 88 | ||
| General: | 88 | ||
| Consultations: | 88 | ||
| Teach Patient/Family to: | 88 | ||
| anagrelide | 88 | ||
| Category and Schedule | 88 | ||
| Drug Class: | 88 | ||
| Mechanism of Action | 88 | ||
| Uses | 89 | ||
| Pharmacokinetics | 89 | ||
| Indications and Dosages | 89 | ||
| ► Thrombocythemia | 89 | ||
| PO | 89 | ||
| Adults, Elderly. | 89 | ||
| Side Effects/Adverse Reactions | 89 | ||
| Frequent | 89 | ||
| Occasional | 89 | ||
| Rare | 89 | ||
| Precautions and Contraindications | 89 | ||
| Caution: | 89 | ||
| Drug Interactions of Concern to Dentistry | 89 | ||
| Serious Reactions | 89 | ||
| Dental Considerations | 89 | ||
| General: | 89 | ||
| Consultations: | 89 | ||
| Teach Patient/Family to: | 89 | ||
| anakinra | 90 | ||
| Category and Schedule | 90 | ||
| Drug Class: | 90 | ||
| Mechanism of Action | 90 | ||
| Uses | 90 | ||
| Pharmacokinetics | 90 | ||
| Indications and Dosages | 90 | ||
| ► Rheumatoid Arthritis | 90 | ||
| Subcutaneous | 90 | ||
| Adults, Children older than 18 yr, Elderly. | 90 | ||
| Side Effects/Adverse Reactions | 90 | ||
| Occasional | 90 | ||
| Rare | 90 | ||
| Precautions and Contraindications | 90 | ||
| Drug Interactions of Concern to Dentistry | 90 | ||
| Serious Reactions | 90 | ||
| Dental Considerations | 90 | ||
| General: | 90 | ||
| Consultations: | 90 | ||
| Teach Patient/Family to: | 91 | ||
| anastrozole | 91 | ||
| Category and Schedule | 91 | ||
| Drug Class: | 91 | ||
| Mechanism of Action | 91 | ||
| Uses | 91 | ||
| Pharmacokinetics | 91 | ||
| Indications and Dosages | 91 | ||
| ► Breast Cancer | 91 | ||
| PO | 91 | ||
| Adults, Elderly. | 91 | ||
| Side Effects/Adverse Reactions | 91 | ||
| Frequent | 91 | ||
| Occasional | 91 | ||
| Rare | 91 | ||
| Precautions and Contraindications | 91 | ||
| Drug Interactions of Concern to Dentistry | 91 | ||
| Serious Reactions | 91 | ||
| Dental Considerations | 91 | ||
| General: | 91 | ||
| Consultations: | 92 | ||
| Teach Patient/Family to: | 92 | ||
| anidulafungin | 92 | ||
| Category and Schedule | 92 | ||
| Drug Class: | 92 | ||
| Mechanism of Action | 92 | ||
| Uses | 92 | ||
| Pharmacokinetics | 92 | ||
| Indications and Dosages | 92 | ||
| ► Candidemia | 92 | ||
| IV | 92 | ||
| Adults. | 92 | ||
| ► Esophageal Candidiasis | 93 | ||
| IV | 93 | ||
| Adult. | 93 | ||
| Children. | 93 | ||
| Side Effects/Adverse Reactions | 93 | ||
| Rare | 93 | ||
| Precautions and Contraindications | 93 | ||
| Caution: | 93 | ||
| Drug Interactions of Concern to Dentistry | 93 | ||
| Serious Reactions | 93 | ||
| Dental Considerations | 93 | ||
| General: | 93 | ||
| Teach Patient/Family to: | 93 | ||
| apomorphine | 93 | ||
| Category and Schedule | 93 | ||
| Drug Class: | 93 | ||
| Mechanism of Action | 93 | ||
| Uses | 93 | ||
| Pharmacokinetics | 93 | ||
| Indications and Dosages | 94 | ||
| ► Acute, Intermittent Treatment of Hypomobility (“Off Episodes”) Associated with Advanced Parkinson’s Disease | 94 | ||
| Injection Pen for Subcutaneous Administration | 94 | ||
| Adult, Elderly. | 94 | ||
| Side Effects/Adverse Reactions | 94 | ||
| Precautions and Contraindications | 94 | ||
| Drug Interactions of Concern to Dentistry | 94 | ||
| Dental Considerations | 94 | ||
| General: | 94 | ||
| Consultations: | 94 | ||
| Teach Patient/Family to: | 94 | ||
| apraclonidine hydrochloride | 95 | ||
| Category and Schedule | 95 | ||
| Drug Class: | 95 | ||
| Mechanism of Action | 95 | ||
| Uses | 95 | ||
| Pharmacokinetics | 95 | ||
| Indications and Dosages | 95 | ||
| ► Glaucoma | 95 | ||
| apremilast | 96 | ||
| Category and Schedule | 96 | ||
| Drug Class: | 96 | ||
| Mechanism of Action | 96 | ||
| Uses | 96 | ||
| Pharmacokinetics | 96 | ||
| Indications and Dosages | 96 | ||
| ► Active Psoriatic Arthritis or Plaque Psoriasis (Moderate to Severe) | 96 | ||
| PO | 96 | ||
| Adults. | 96 | ||
| Side Effects/Adverse Reactions | 96 | ||
| Frequent | 96 | ||
| Occasional | 96 | ||
| Precautions and Contraindications | 96 | ||
| Drug Interactions of Concern to Dentistry | 97 | ||
| Serious Reactions | 97 | ||
| Dental Considerations | 97 | ||
| General: | 97 | ||
| Teach Patient/Family to: | 97 | ||
| aprepitant | 97 | ||
| Category and Schedule | 97 | ||
| Drug Class: | 97 | ||
| Mechanism of Action | 97 | ||
| Uses | 97 | ||
| Pharmacokinetics | 97 | ||
| Indications and Dosages | 97 | ||
| ► Prevention of Chemotherapy-Induced Nausea and Vomiting | 97 | ||
| PO | 97 | ||
| Adults, Elderly. | 97 | ||
| Side Effects/Adverse Reactions | 97 | ||
| Frequent | 97 | ||
| Occasional | 97 | ||
| Rare | 97 | ||
| Precautions and Contraindications | 98 | ||
| Caution: | 98 | ||
| Drug Interactions of Concern to Dentistry | 98 | ||
| Serious Reactions | 98 | ||
| Dental Considerations | 98 | ||
| General: | 98 | ||
| Consultations: | 98 | ||
| Teach Patient/Family to: | 98 | ||
| arformoterol tartrate | 99 | ||
| Category and Schedule | 99 | ||
| Drug Class: | 99 | ||
| Mechanism of Action | 99 | ||
| Uses | 99 | ||
| Pharmacokinetics | 99 | ||
| Indications and Dosages | 99 | ||
| ► COPD | 99 | ||
| Oral Inhalation | 99 | ||
| Adults. | 99 | ||
| Children. | 99 | ||
| Side Effects/Adverse Reactions | 99 | ||
| Occasional | 99 | ||
| Rare | 99 | ||
| Precautions and Contraindications | 99 | ||
| Caution: | 99 | ||
| Drug Interactions of Concern to Dentistry | 99 | ||
| Serious Reactions | 99 | ||
| Dental Considerations | 99 | ||
| General: | 99 | ||
| Consultations: | 100 | ||
| Teach Patient/Family to: | 100 | ||
| aripiprazole | 100 | ||
| Category and Schedule | 100 | ||
| Drug Class: | 100 | ||
| Mechanism of Action | 100 | ||
| Uses | 100 | ||
| Pharmacokinetics | 100 | ||
| Indications and Dosages | 100 | ||
| ► Schizophrenia, Bipolar Disorder | 100 | ||
| PO | 100 | ||
| Adults, Elderly. | 100 | ||
| Side Effects/Adverse Reactions | 100 | ||
| Frequent | 100 | ||
| Occasional | 100 | ||
| Rare | 100 | ||
| Precautions and Contraindications | 100 | ||
| Caution: | 100 | ||
| Drug Interactions of Concern to Dentistry | 100 | ||
| Serious Reactions | 101 | ||
| Dental Considerations | 101 | ||
| General: | 101 | ||
| Consultations: | 101 | ||
| Teach Patient/Family to: | 101 | ||
| armodafinil | 101 | ||
| Category and Schedule | 101 | ||
| Drug Class: | 101 | ||
| Mechanism of Action | 101 | ||
| Uses | 101 | ||
| Pharmacokinetics | 101 | ||
| Indications and Dosages | 101 | ||
| ► Narcolepsy, Improve Wakefulness in Patients with Excessive Sleepiness; Obstructive Sleep Apnea | 101 | ||
| artemether/lumefantrine | 102 | ||
| Category and Schedule | 102 | ||
| Drug Class: | 102 | ||
| Mechanism of Action | 102 | ||
| Uses | 103 | ||
| Pharmacokinetics | 103 | ||
| Indications and Dosages | 103 | ||
| ► Malaria due to Plasmodium falciparum | 103 | ||
| PO | 103 | ||
| Adults, 16 yr and older (who weigh 35 kg or greater). | 103 | ||
| Children younger than 16 yr old who weigh 25 to less than 35 kg. | 103 | ||
| Children younger than 16 yr old who weigh 15 to less than 25 kg. | 103 | ||
| Children younger than 16 yr old who weigh 5 to less than 15 kg. | 103 | ||
| Side Effects/Adverse Reactions | 103 | ||
| Frequent | 103 | ||
| Occasional | 103 | ||
| Rare | 103 | ||
| Precautions and Contraindications | 103 | ||
| Caution: | 103 | ||
| Drug Interactions of Concern to Dentistry | 104 | ||
| Serious Reactions | 104 | ||
| Dental Considerations | 104 | ||
| General: | 104 | ||
| Consultations: | 104 | ||
| Teach Patient/Family to: | 104 | ||
| articaine hydrochloride | 105 | ||
| Category and Schedule | 105 | ||
| Drug Class: | 105 | ||
| Mechanism of Action | 105 | ||
| Uses | 105 | ||
| Pharmacokinetics | 105 | ||
| Indications and Dosages | 105 | ||
| ► Local, Infiltrative, or Conductive Anesthesia in Both Simple and Complex Dental or Periodontal Procedures | 105 | ||
| Infiltration | 105 | ||
| Adults, Elderly, Children older than 4 yr. | 105 | ||
| Side Effects/Adverse Reactions | 105 | ||
| Rare | 105 | ||
| Precautions and Contraindications | 105 | ||
| Caution: | 105 | ||
| Drug Interactions of Concern to Dentistry | 105 | ||
| Serious Reactions | 106 | ||
| Dental Considerations | 106 | ||
| General: | 106 | ||
| Teach Patient/Family to: | 106 | ||
| asenapine | 106 | ||
| Category and Schedule | 106 | ||
| Drug Class: | 106 | ||
| Mechanism of Action | 106 | ||
| Uses | 106 | ||
| Pharmacokinetics | 106 | ||
| Indications and Dosages | 107 | ||
| ► Schizophrenia | 107 | ||
| aspirin/acetylsalicylic acid | 108 | ||
| Category and Schedule | 108 | ||
| Drug Class: | 108 | ||
| Mechanism of Action | 108 | ||
| Uses | 108 | ||
| Pharmacokinetics | 108 | ||
| Indications and Dosages | 108 | ||
| ► Analgesia, Fever | 108 | ||
| PO, Rectal | 108 | ||
| atazanavir + cobicistat | 110 | ||
| Category and Schedule | 110 | ||
| Drug Class: | 110 | ||
| Mechanism of Action | 110 | ||
| Uses | 110 | ||
| Pharmacokinetics | 110 | ||
| Indications and Dosages | 111 | ||
| ► HIV-1 Infection (treatment-naive or treatment-experienced) | 111 | ||
| PO | 111 | ||
| Adults. | 111 | ||
| Side Effects/Adverse Reactions | 111 | ||
| Frequent | 111 | ||
| Occasional | 111 | ||
| Precautions and Contraindications | 111 | ||
| Drug Interactions of Concern to Dentistry | 111 | ||
| Serious Reactions | 111 | ||
| Dental Considerations | 112 | ||
| General: | 112 | ||
| Consultations: | 112 | ||
| Teach Patient/Family to: | 112 | ||
| atazanavir sulfate | 112 | ||
| Category and Schedule | 112 | ||
| Drug Class: | 112 | ||
| Mechanism of Action | 112 | ||
| Uses | 112 | ||
| Pharmacokinetics | 112 | ||
| Indications and Dosages | 112 | ||
| ► HIV-1 Infection | 112 | ||
| atenolol | 114 | ||
| Category and Schedule | 114 | ||
| Drug Class: | 114 | ||
| Mechanism of Action | 114 | ||
| Uses | 114 | ||
| Pharmacokinetics | 114 | ||
| Indications and Dosages | 114 | ||
| ► Hypertension | 114 | ||
| atomoxetine | 116 | ||
| Category and Schedule | 116 | ||
| Drug Class: | 116 | ||
| Mechanism of Action | 116 | ||
| Uses | 116 | ||
| Pharmacokinetics | 116 | ||
| Indications and Dosages | 116 | ||
| ► ADHD | 116 | ||
| PO | 116 | ||
| Adults, Children weighing 70 kg and more. | 116 | ||
| Children weighing less than 70 kg. | 116 | ||
| ► Dosage in Hepatic Impairment | 116 | ||
| Side Effects/Adverse Reactions | 116 | ||
| Frequent | 116 | ||
| Occasional | 116 | ||
| Rare | 117 | ||
| Precautions and Contraindications | 117 | ||
| Caution: | 117 | ||
| Drug Interactions of Concern to Dentistry | 117 | ||
| Serious Reactions | 117 | ||
| Dental Considerations | 117 | ||
| General: | 117 | ||
| Consultations: | 117 | ||
| Teach Patient/Family to: | 117 | ||
| atorvastatin | 117 | ||
| Category and Schedule | 117 | ||
| Drug Class: | 117 | ||
| Mechanism of Action | 117 | ||
| Uses | 118 | ||
| Pharmacokinetics | 118 | ||
| Indications and Dosages | 118 | ||
| ► Hyperlipidemia, Reduction of Risk of MI, Angina Revascularization Procedures | 118 | ||
| atropine sulfate | 118 | ||
| Category and Schedule | 118 | ||
| Drug Class: | 118 | ||
| Mechanism of Action | 119 | ||
| Uses | 119 | ||
| Pharmacokinetics | 119 | ||
| Indications and Dosages | 119 | ||
| ► Asystole, Slow, Pulseless Electrical Activity | 119 | ||
| aurothioglucose/gold sodium thiomalate | 120 | ||
| Category and Schedule | 120 | ||
| Drug Class: | 120 | ||
| Mechanism of Action | 120 | ||
| Uses | 120 | ||
| Pharmacokinetics | 120 | ||
| Indications and Dosages | 121 | ||
| ► Rheumatoid Arthritis (Aurothioglucose) | 121 | ||
| avanafil | 122 | ||
| Category and Schedule | 122 | ||
| Drug Class: | 122 | ||
| Mechanism of Action | 122 | ||
| Uses | 122 | ||
| Pharmacokinetics | 122 | ||
| Indications and Dosages | 122 | ||
| ► Erectile Dysfunction | 122 | ||
| PO | 122 | ||
| Adults. | 122 | ||
| Side Effects/Adverse Reactions | 123 | ||
| Frequent | 123 | ||
| Occasional | 123 | ||
| Precautions and Contraindications | 123 | ||
| Drug Interactions of Concern to Dentistry | 123 | ||
| Serious Reactions | 123 | ||
| Dental Considerations | 123 | ||
| General: | 123 | ||
| Teach Patient/Family to: | 123 | ||
| axitinib | 123 | ||
| Category and Schedule | 123 | ||
| Drug Class: | 123 | ||
| Mechanism of Action | 123 | ||
| Uses | 123 | ||
| Pharmacokinetics | 123 | ||
| Indications and Dosages | 124 | ||
| ► Renal Cell Cancer, Advanced | 124 | ||
| PO | 124 | ||
| Adults. | 124 | ||
| Side Effects/Adverse Reactions | 124 | ||
| Frequent | 124 | ||
| Occasional | 124 | ||
| Precautions and Contraindications | 124 | ||
| Drug Interactions of Concern to Dentistry | 124 | ||
| Serious Reactions | 124 | ||
| Dental Considerations | 124 | ||
| General: | 124 | ||
| Consultations: | 124 | ||
| Teach Patient/Family to: | 125 | ||
| azatadine maleate | 125 | ||
| Category and Schedule | 125 | ||
| Drug Class: | 125 | ||
| Mechanism of Action | 125 | ||
| Uses | 125 | ||
| Pharmacokinetics | 125 | ||
| Indications and Dosages | 125 | ||
| ► Allergic Rhinitis | 125 | ||
| PO | 125 | ||
| Adults, Elderly, Children 12 yr or older. | 125 | ||
| Side Effects/Adverse Reactions | 125 | ||
| Frequent | 125 | ||
| Rare | 125 | ||
| Precautions and Contraindications | 125 | ||
| Drug Interactions of Concern to Dentistry | 125 | ||
| Serious Reactions | 125 | ||
| Dental Considerations | 125 | ||
| General: | 125 | ||
| Consultations: | 126 | ||
| Teach Patient/Family to: | 126 | ||
| azathioprine | 126 | ||
| Category and Schedule | 126 | ||
| Drug Class: | 126 | ||
| Mechanism of Action | 126 | ||
| Uses | 126 | ||
| Pharmacokinetics | 126 | ||
| Indications and Dosages | 126 | ||
| ► Adjunct in Prevention of Renal Allograft Rejection | 126 | ||
| PO, IV | 126 | ||
| Adults, Elderly, Children. | 126 | ||
| ► Rheumatoid Arthritis | 126 | ||
| PO | 126 | ||
| Adults. | 126 | ||
| Elderly. | 127 | ||
| ► Dosage in Renal Impairment | 127 | ||
| Side Effects/Adverse Reactions | 127 | ||
| Frequent | 127 | ||
| Occasional | 127 | ||
| Rare | 127 | ||
| Precautions and Contraindications | 127 | ||
| Drug Interactions of Concern to Dentistry | 127 | ||
| Serious Reactions | 127 | ||
| Dental Considerations | 127 | ||
| General: | 127 | ||
| Consultations: | 127 | ||
| Teach Patient/Family to: | 127 | ||
| azelastine | 127 | ||
| Category and Schedule | 127 | ||
| Drug Class: | 127 | ||
| Mechanism of Action | 128 | ||
| Uses | 128 | ||
| Pharmacokinetics | 128 | ||
| Indications and Dosages | 128 | ||
| ► Allergic Rhinitis | 128 | ||
| Nasal | 128 | ||
| Adults, Elderly, Children 12 yr and older. | 128 | ||
| Children 5–11 yr. | 128 | ||
| ► Allergic Conjunctivitis | 128 | ||
| Ophthalmic | 128 | ||
| Adults, Elderly, Children 3 yr or older. | 128 | ||
| Side Effects/Adverse Reactions | 128 | ||
| Frequent | 128 | ||
| Rare | 128 | ||
| Precautions and Contraindications | 128 | ||
| Drug Interactions of Concern to Dentistry | 128 | ||
| Serious Reactions | 128 | ||
| Dental Considerations | 128 | ||
| General: | 128 | ||
| Teach Patient/Family: | 128 | ||
| azilsartan medoxomil | 129 | ||
| Category and Schedule | 129 | ||
| Drug Class: | 129 | ||
| Mechanism of Action | 129 | ||
| Uses | 129 | ||
| Pharmacokinetics | 129 | ||
| Indications and Dosages | 129 | ||
| ► Hypertension | 129 | ||
| PO | 129 | ||
| Adults. | 129 | ||
| Side Effects/Adverse Reactions | 129 | ||
| Frequent | 129 | ||
| Occasional | 129 | ||
| Precautions and Contraindications | 129 | ||
| Drug Interactions of Concern to Dentistry | 129 | ||
| Serious Reactions | 129 | ||
| Dental Considerations | 130 | ||
| General: | 130 | ||
| Consultations: | 130 | ||
| Teach Patient/Family to: | 130 | ||
| azithromycin | 130 | ||
| Category and Schedule | 130 | ||
| Drug Class: | 130 | ||
| Mechanism of Action | 130 | ||
| Uses | 130 | ||
| Pharmacokinetics | 130 | ||
| Indications and Dosages | 131 | ||
| ► Respiratory Tract, Skin, and Skin-Structure Infections | 131 | ||
| aztreonam | 132 | ||
| Category and Schedule | 132 | ||
| Drug Class: | 132 | ||
| Mechanism of Action | 132 | ||
| Uses | 132 | ||
| Pharmacokinetics | 132 | ||
| Indications and Dosages | 132 | ||
| ► UTIs | 132 | ||
| bacitracin | 134 | ||
| Category and Schedule | 134 | ||
| Drug Class: | 134 | ||
| Mechanism of Action | 134 | ||
| Uses | 134 | ||
| Indications and Dosages | 134 | ||
| ► Superficial Ocular Infections | 134 | ||
| Ophthalmic | 134 | ||
| Adults. | 134 | ||
| ► Skin Abrasions, Superficial Skin Infections | 134 | ||
| Topical | 134 | ||
| Adults, Children. | 134 | ||
| ► Surgical Treatment and Prophylaxis | 134 | ||
| Irrigation | 134 | ||
| Adults, Elderly. | 134 | ||
| Side Effects/Adverse Reactions | 134 | ||
| Rare | 134 | ||
| Precautions and Contraindications | 134 | ||
| Drug Interactions of Concern to Dentistry | 134 | ||
| Serious Reactions | 134 | ||
| Dental Considerations | 134 | ||
| General: | 134 | ||
| Teach Patient/Family to: | 134 | ||
| Mechanism of Action | 135 | ||
| Uses | 135 | ||
| Pharmacokinetics | 135 | ||
| Indications and Dosages | 135 | ||
| ► Spasticity | 135 | ||
| PO | 135 | ||
| Adults. | 135 | ||
| Elderly. | 135 | ||
| Children. | 135 | ||
| Usual Intrathecal Dosage | 135 | ||
| Adults, Elderly, Children older than 12 yr. | 135 | ||
| Children 12 yr and younger. | 135 | ||
| Side Effects/Adverse Reactions | 135 | ||
| Frequent | 135 | ||
| Occasional | 135 | ||
| Rare | 135 | ||
| Precautions and Contraindications | 135 | ||
| Drug Interactions of Concern To Dentistry | 135 | ||
| Serious Reactions | 135 | ||
| Dental Considerations | 135 | ||
| General: | 135 | ||
| Teach Patient/Family: | 136 | ||
| baclofen | 134 | ||
| balsalazide | 136 | ||
| Category and Schedule | 136 | ||
| Drug Class: | 136 | ||
| Mechanism of Action | 136 | ||
| Uses | 136 | ||
| Pharmacokinetics | 136 | ||
| Indications and Dosages | 136 | ||
| ► Ulcerative Colitis | 136 | ||
| PO | 136 | ||
| Adults, Elderly. | 136 | ||
| Side Effects/Adverse Reactions | 136 | ||
| Frequent | 136 | ||
| Occasional | 136 | ||
| Precautions and Contraindications | 136 | ||
| Drug Interactions of Concern to Dentistry | 136 | ||
| Serious Reactions | 136 | ||
| Dental Considerations | 136 | ||
| General: | 136 | ||
| Consultations: | 136 | ||
| becaplermin | 137 | ||
| Category and Schedule | 137 | ||
| Drug Class: | 137 | ||
| Mechanism of Action | 137 | ||
| Uses | 137 | ||
| Pharmacokinetics | 137 | ||
| Indications and Dosages | 137 | ||
| ► Ulcers | 137 | ||
| Topical | 137 | ||
| Adults, Elderly. | 137 | ||
| Side Effects/Adverse Reactions | 137 | ||
| Occasional | 137 | ||
| Precautions and Contraindications | 137 | ||
| Caution: | 137 | ||
| Drug Interactions of Concern to Dentistry | 137 | ||
| Serious Reactions | 137 | ||
| Dental Considerations | 137 | ||
| General: | 137 | ||
| Consultations: | 137 | ||
| Teach Patient/Family to: | 137 | ||
| beclomethasone dipropionate/beclomethasone dipropionate hfa | 138 | ||
| Category and Schedule | 138 | ||
| Drug Class: | 138 | ||
| Mechanism of Action | 138 | ||
| Uses | 138 | ||
| Pharmacokinetics | 138 | ||
| Indications and Dosages | 138 | ||
| Oral Inhalation (QVAR only) | 138 | ||
| Adults, Adolescents. | 138 | ||
| Children 5–11 yr. | 138 | ||
| Nasal Inhalation | 138 | ||
| benazepril | 139 | ||
| Category and Schedule | 139 | ||
| Drug Class: | 139 | ||
| Mechanism of Action | 139 | ||
| Uses | 139 | ||
| Pharmacokinetics | 139 | ||
| Indications and Dosages | 139 | ||
| ► Hypertension (monotherapy) | 139 | ||
| PO | 139 | ||
| Adults. | 139 | ||
| Elderly. | 140 | ||
| ► Hypertension (combination therapy) | 140 | ||
| PO | 140 | ||
| Adults. | 140 | ||
| ► Dosage in Renal Impairment | 140 | ||
| Side Effects/Adverse Reactions | 140 | ||
| Frequent | 140 | ||
| Occasional | 140 | ||
| Rare | 140 | ||
| Precautions and Contraindications | 140 | ||
| Caution: | 140 | ||
| Drug Interactions of Concern to Dentistry | 140 | ||
| Serious Reactions | 140 | ||
| Dental Considerations | 140 | ||
| General: | 140 | ||
| Consultations: | 141 | ||
| Teach Patient/Family to: | 141 | ||
| bendamustine | 141 | ||
| Category and Schedule | 141 | ||
| Drug Class: | 141 | ||
| Mechanism of Action | 141 | ||
| Uses | 141 | ||
| Pharmacokinetics | 141 | ||
| Indications and Dosages | 141 | ||
| IV | 141 | ||
| Adult. | 141 | ||
| Pediatric Dosing. | 141 | ||
| Dose Adjustments. | 141 | ||
| Side Effects/Adverse Reactions | 142 | ||
| Frequent | 142 | ||
| Occasional | 142 | ||
| Precautions and Contraindications | 142 | ||
| Drug Interactions of Concern to Dentistry | 142 | ||
| Serious Reactions | 142 | ||
| Dental Considerations | 142 | ||
| General: | 142 | ||
| Consultations: | 142 | ||
| Teach Patient/Family to: | 142 | ||
| bendroflumethiazide | 143 | ||
| Category and Schedule | 143 | ||
| Drug Class: | 143 | ||
| Mechanism of Action | 143 | ||
| Uses | 143 | ||
| Pharmacokinetics | 143 | ||
| Indications and Dosages | 143 | ||
| ► Edema | 143 | ||
| benzocaine | 144 | ||
| Category and Schedule | 144 | ||
| Drug Class: | 144 | ||
| Mechanism of Action | 145 | ||
| Uses | 145 | ||
| Pharmacokinetics | 145 | ||
| Indications and Dosages | 145 | ||
| ► Canker Sores | 145 | ||
| benzonatate | 146 | ||
| Category and Schedule | 146 | ||
| Drug Class: | 146 | ||
| Mechanism of Action | 146 | ||
| Uses | 146 | ||
| Pharmacokinetics | 146 | ||
| Indications and Dosages | 146 | ||
| ► Antitussive | 146 | ||
| PO | 146 | ||
| Adults, Elderly, Children older than 10 yr. | 146 | ||
| Side Effects/Adverse Reactions | 146 | ||
| Occasional | 146 | ||
| Precautions and Contraindications | 146 | ||
| Caution: | 146 | ||
| Drug Interactions of Concern to Dentistry | 146 | ||
| Serious Reactions | 146 | ||
| Dental Considerations | 146 | ||
| General: | 146 | ||
| Uses | 147 | ||
| Pharmacokinetics | 147 | ||
| Indications and Dosages | 147 | ||
| ► Edema | 147 | ||
| benzthiazide | 146 | ||
| benztropine mesylate | 148 | ||
| Category and Schedule | 148 | ||
| Drug Class: | 148 | ||
| Mechanism of Action | 148 | ||
| Uses | 148 | ||
| Pharmacokinetics | 148 | ||
| Indications and Dosages | 148 | ||
| ► Parkinsonism | 148 | ||
| PO | 148 | ||
| bepridil | 149 | ||
| Category and Schedule | 149 | ||
| Drug Class: | 149 | ||
| Mechanism of Action | 150 | ||
| Uses | 150 | ||
| Pharmacokinetics | 150 | ||
| Indications and Dosages | 150 | ||
| ► Chronic Stable Angina | 150 | ||
| PO | 150 | ||
| Adults, Elderly. | 150 | ||
| Side Effects/Adverse Reactions | 150 | ||
| Frequent | 150 | ||
| Occasional | 150 | ||
| Rare | 150 | ||
| Precautions and Contraindications | 150 | ||
| Caution: | 150 | ||
| Drug Interactions of Concern to Dentistry | 150 | ||
| Serious Reactions | 150 | ||
| Dental Considerations | 150 | ||
| General: | 150 | ||
| Consultations: | 151 | ||
| Teach Patient/Family to: | 151 | ||
| besifloxacin | 151 | ||
| Category and Schedule | 151 | ||
| Drug Class: | 151 | ||
| Mechanism of Action | 151 | ||
| Uses | 151 | ||
| Pharmacokinetics | 151 | ||
| Indications and Dosages | 151 | ||
| ► Conjunctivitis | 151 | ||
| Adults, Children over 1 yr. | 151 | ||
| Side Effects/Adverse Reactions | 151 | ||
| Frequent | 151 | ||
| Occasional | 151 | ||
| Precautions and Contraindications | 151 | ||
| Drug Interactions of Concern to Dentistry | 151 | ||
| Serious Reactions | 151 | ||
| Dental Considerations | 151 | ||
| General: | 151 | ||
| betamethasone | 152 | ||
| Category and Schedule | 152 | ||
| Drug Class: | 152 | ||
| Mechanism of Action | 152 | ||
| Uses | 152 | ||
| Pharmacokinetics | 152 | ||
| Indications and Dosages | 152 | ||
| ► Antiinflammation, Immunosuppression, Corticosteroid Replacement Therapy | 152 | ||
| PO | 152 | ||
| betaxolol | 153 | ||
| Category and Schedule | 153 | ||
| Drug Class: | 153 | ||
| Mechanism of Action | 153 | ||
| Uses | 153 | ||
| Pharmacokinetics | 153 | ||
| Indications and Dosages | 153 | ||
| ► Hypertension | 153 | ||
| PO | 153 | ||
| Adults. | 153 | ||
| Elderly. | 153 | ||
| ► Chronic Open-Angle Glaucoma and Ocular Hypertension | 153 | ||
| Ophthalmic (Eye Drops) | 153 | ||
| Adults, Elderly. | 153 | ||
| ► Dosage in Renal Impairment | 154 | ||
| Side Effects/Adverse Reactions | 154 | ||
| Frequent | 154 | ||
| Occasional | 154 | ||
| Rare | 154 | ||
| Precautions and Contraindications | 154 | ||
| Caution: | 154 | ||
| Drug Interactions of Concern to Dentistry | 154 | ||
| Serious Reactions | 154 | ||
| Dental Considerations | 154 | ||
| General: | 154 | ||
| Consultations: | 155 | ||
| Teach Patient/Family to: | 155 | ||
| bethanechol chloride | 155 | ||
| Category and Schedule | 155 | ||
| Drug Class: | 155 | ||
| Mechanism of Action | 155 | ||
| Uses | 155 | ||
| Pharmacokinetics | 155 | ||
| Indications and Dosages | 155 | ||
| ► Postoperative and Postpartum Urine Retention, Atony of Bladder | 155 | ||
| PO | 155 | ||
| Adults, Elderly. | 155 | ||
| Children. | 155 | ||
| Side Effects/Adverse Reactions | 155 | ||
| Occasional | 155 | ||
| Precautions and Contraindications | 155 | ||
| Caution: | 156 | ||
| Drug Interactions of Concern to Dentistry | 156 | ||
| Serious Reactions | 156 | ||
| Dental Considerations | 156 | ||
| General: | 156 | ||
| Consultations: | 156 | ||
| bevacizumab | 156 | ||
| Category and Schedule | 156 | ||
| Drug Class: | 156 | ||
| Mechanism of Action | 156 | ||
| Uses | 156 | ||
| Pharmacokinetics | 156 | ||
| Indications and Dosages | 156 | ||
| ► First-Line Treatment of Metastatic Carcinoma of the Colon or Rectum in Combination with 5-Fluorouracil (5-FU) | 156 | ||
| IV | 156 | ||
| Adults, Elderly. | 156 | ||
| Side Effects/Adverse Reactions | 156 | ||
| Frequent | 156 | ||
| Occasional | 156 | ||
| Rare | 156 | ||
| Precautions and Contraindications | 156 | ||
| Drug Interactions of Concern to Dentistry | 157 | ||
| Serious Reactions | 157 | ||
| Dental Considerations | 157 | ||
| General: | 157 | ||
| Consultations: | 157 | ||
| Teach Patient/Family to: | 157 | ||
| bexarotene | 158 | ||
| Category and Schedule | 158 | ||
| Drug Class: | 158 | ||
| Mechanism of Action | 158 | ||
| Uses | 158 | ||
| Pharmacokinetics | 158 | ||
| Indications and Dosages | 158 | ||
| ► Cutaneous T-Cell Lymphoma Refractory to at Least One Prior Systemic Therapy | 158 | ||
| PO | 158 | ||
| bicalutamide | 159 | ||
| Category and Schedule | 159 | ||
| Drug Class: | 159 | ||
| Mechanism of Action | 159 | ||
| Uses | 159 | ||
| Pharmacokinetics | 159 | ||
| Indications and Dosages | 159 | ||
| ► Prostatic Carcinoma | 159 | ||
| PO | 159 | ||
| Adults, Elderly. | 159 | ||
| Side Effects/Adverse Reactions | 159 | ||
| Frequent | 159 | ||
| Occasional | 159 | ||
| Rare | 159 | ||
| Precautions and Contraindications | 159 | ||
| Caution: | 159 | ||
| Drug Interactions of Concern to Dentistry | 159 | ||
| Serious Reactions | 159 | ||
| Dental Considerations | 159 | ||
| General: | 159 | ||
| Consultations: | 160 | ||
| Teach Patient/Family to: | 160 | ||
| bimatoprost | 160 | ||
| Category and Schedule | 160 | ||
| Drug Class: | 160 | ||
| Mechanism of Action | 160 | ||
| Uses | 160 | ||
| Pharmacokinetics | 160 | ||
| Indications and Dosages | 160 | ||
| ► Glaucoma, Ocular Hypertension | 160 | ||
| Ophthalmic | 160 | ||
| Adults, Elderly. | 160 | ||
| Side Effects/Adverse Reactions | 160 | ||
| Frequent | 160 | ||
| Occasional | 160 | ||
| Rare | 160 | ||
| Precautions and Contraindications | 161 | ||
| Caution: | 161 | ||
| Drug Interactions of Concern to Dentistry | 161 | ||
| Serious Reactions | 161 | ||
| Dental Considerations | 161 | ||
| General: | 161 | ||
| Consultations: | 161 | ||
| Teach Patient/Family to: | 161 | ||
| biperiden | 161 | ||
| Category and Schedule | 161 | ||
| Drug Class: | 161 | ||
| Mechanism of Action | 161 | ||
| Uses | 161 | ||
| Pharmacokinetics | 161 | ||
| Indications and Dosages | 161 | ||
| ► Extrapyramidal Symptoms | 161 | ||
| bismuth subsalicylate | 162 | ||
| Category and Schedule | 162 | ||
| Drug Class: | 162 | ||
| Mechanism of Action | 162 | ||
| Uses | 163 | ||
| Pharmacokinetics | 163 | ||
| Indications and Dosages | 163 | ||
| ► Diarrhea, Gastric Distress | 163 | ||
| bisoprolol fumarate | 163 | ||
| Category and Schedule | 163 | ||
| Drug Class: | 163 | ||
| Mechanism of Action | 163 | ||
| Uses | 164 | ||
| Pharmacokinetics | 164 | ||
| Indications and Dosages | 164 | ||
| ► Hypertension | 164 | ||
| PO | 164 | ||
| Adults. | 164 | ||
| Elderly. | 164 | ||
| ► Dosage in Hepatic Impairment | 164 | ||
| Side Effects/Adverse Reactions | 164 | ||
| Frequent | 164 | ||
| Occasional | 164 | ||
| Rare | 164 | ||
| Precautions and Contraindications | 164 | ||
| Caution: | 164 | ||
| Drug Interactions of Concern to Dentistry | 164 | ||
| Serious Reactions | 164 | ||
| Dental Considerations | 164 | ||
| General: | 164 | ||
| Consultations: | 165 | ||
| Teach Patient/Family to: | 165 | ||
| bivalirudin | 165 | ||
| Category and Schedule | 165 | ||
| Drug Class: | 165 | ||
| Mechanism of Action | 165 | ||
| Uses | 165 | ||
| Pharmacokinetics | 165 | ||
| Indications and Dosages | 165 | ||
| ► Anticoagulant in Patients with Unstable Angina Who Are Undergoing Percutaneous Transluminal Coronary Angioplasty (PTCA) in Conjunction with Aspirin | 165 | ||
| IV | 165 | ||
| Adults, Elderly. | 165 | ||
| Dosage in Renal Impairment | 166 | ||
| Side Effects/Adverse Reactions | 166 | ||
| Frequent | 166 | ||
| Occasional | 166 | ||
| Rare | 166 | ||
| Precautions and Contraindications | 166 | ||
| Drug Interactions of Concern To Dentistry | 166 | ||
| Serious Reactions | 166 | ||
| Dental Considerations | 166 | ||
| General: | 166 | ||
| Consultations: | 166 | ||
| Teach Patient/Family to: | 166 | ||
| bleomycin sulfate | 166 | ||
| Category and Schedule | 166 | ||
| Drug Class: | 166 | ||
| Mechanism of Action | 166 | ||
| Uses | 167 | ||
| Pharmacokinetics | 167 | ||
| Indications and Dosages | 167 | ||
| ► As Monotherapy to Treat Testicular Carcinoma; Lymphomas (Including Hodgkin’s Disease, Choriocarcinoma, Reticulum Cell Sarcoma, and Lymphosarcoma); and Squamous Cell Carcinomas of the Head and Neck (Including Mouth, Tongue, Tonsil, Nasopharynx, Oropharynx, Sinus, Palate, Lip, Buccal Mucosa, Gingiva, Epiglottis, and Larynx) | 167 | ||
| IV, IM, Subcutaneous | 167 | ||
| boceprevir | 168 | ||
| Category and Schedule | 168 | ||
| Drug Class: | 168 | ||
| Mechanism of Action | 168 | ||
| Uses | 168 | ||
| Pharmacokinetics | 168 | ||
| Indications and Dosages | 169 | ||
| ► Treatment of Chronic Hepatitis C (CHC) | 169 | ||
| PO | 169 | ||
| Adults. | 169 | ||
| Side Effects/Adverse Reactions | 169 | ||
| Frequent | 169 | ||
| Occasional | 169 | ||
| Precautions and Contraindications | 169 | ||
| Drug Interactions of Concern to Dentistry | 169 | ||
| Serious Reactions | 169 | ||
| Dental Considerations | 169 | ||
| General: | 169 | ||
| Consultations: | 169 | ||
| Teach Patient/Family to: | 169 | ||
| bosentan | 169 | ||
| Category and Schedule | 169 | ||
| Drug Class: | 169 | ||
| Mechanism of Action | 170 | ||
| Uses | 170 | ||
| Pharmacokinetics | 170 | ||
| Indications and Dosages | 170 | ||
| ► PAH in Those with WHO Class III or IV Symptoms | 170 | ||
| PO | 170 | ||
| Adults, Elderly. | 170 | ||
| Children weighing less than 40 kg. | 170 | ||
| Side Effects/Adverse Reactions | 170 | ||
| Occasional | 170 | ||
| Rare | 170 | ||
| Precautions and Contraindications | 170 | ||
| Caution: | 170 | ||
| Drug Interactions of Concern to Dentistry | 170 | ||
| Serious Reactions | 170 | ||
| Dental Considerations | 170 | ||
| General: | 170 | ||
| Teach Patient/Family to: | 170 | ||
| brexpiprazole | 171 | ||
| Category and Schedule | 171 | ||
| Drug Class: | 171 | ||
| Mechanism of Action | 171 | ||
| Uses | 171 | ||
| Pharmacokinetics | 171 | ||
| Indications and Dosages | 171 | ||
| ► Major Depressive Disorder (Adjunct to Antidepressants) | 171 | ||
| brimonidine | 172 | ||
| Category and Schedule | 172 | ||
| Drug Class: | 172 | ||
| Mechanism of Action | 172 | ||
| Uses | 172 | ||
| Pharmacokinetics | 172 | ||
| Indications and Dosages | 172 | ||
| ► Glaucoma, Ocular Hypertension | 172 | ||
| Ophthalmic | 172 | ||
| Adults, Elderly, Children 2 yr and older. | 172 | ||
| Side Effects/Adverse Reactions | 173 | ||
| Occasional | 173 | ||
| Precautions and Contraindications | 173 | ||
| Caution: | 173 | ||
| Drug Interactions of Concern to Dentistry | 173 | ||
| Serious Reactions | 173 | ||
| Dental Considerations | 173 | ||
| General: | 173 | ||
| Consultations: | 173 | ||
| Teach Patient/Family to: | 173 | ||
| brinzolamide | 173 | ||
| Category and Schedule | 173 | ||
| Drug Class: | 173 | ||
| bromocriptine mesylate | 174 | ||
| Category and Schedule | 174 | ||
| Drug Class: | 174 | ||
| Mechanism of Action | 174 | ||
| Uses | 174 | ||
| Pharmacokinetics | 174 | ||
| Indications and Dosages | 174 | ||
| ► Glaucoma, Ocular Hypertension | 174 | ||
| Ophthalmic | 174 | ||
| Adults, Elderly. | 174 | ||
| Side Effects/Adverse Reactions | 174 | ||
| Occasional | 174 | ||
| Rare | 174 | ||
| Precautions and Contraindications | 174 | ||
| Caution: | 174 | ||
| Drug Interactions of Concern to Dentistry | 174 | ||
| Serious Reactions | 174 | ||
| Dental Considerations | 174 | ||
| General: | 174 | ||
| Consultations: | 174 | ||
| Uses | 175 | ||
| Pharmacokinetics | 175 | ||
| Indications and Dosages | 175 | ||
| ► Hyperprolactinemia | 175 | ||
| brompheniramine | 176 | ||
| Category and Schedule | 176 | ||
| Drug Class: | 176 | ||
| Mechanism of Action | 176 | ||
| Uses | 176 | ||
| Pharmacokinetics | 176 | ||
| Indications and Dosages | 176 | ||
| ► Allergic Rhinitis, Anaphylaxis, Urticarial Transfusion Reactions, Urticaria | 176 | ||
| PO | 176 | ||
| bucindolol | 177 | ||
| Drug Class: | 177 | ||
| Mechanism of Action | 177 | ||
| Uses | 177 | ||
| Pharmacokinetics | 177 | ||
| Indications and Dosages | 177 | ||
| ► Hypertension | 177 | ||
| PO | 177 | ||
| Adults. | 177 | ||
| ► Congestive Heart Failure | 178 | ||
| PO | 178 | ||
| Adults. | 178 | ||
| Side Effects/Adverse Reactions | 178 | ||
| Frequent | 178 | ||
| Occasional | 178 | ||
| Rare | 178 | ||
| Precautions and Contraindications | 178 | ||
| Caution: | 178 | ||
| Drug Interactions of Concern to Dentistry | 178 | ||
| Serious Reactions | 178 | ||
| Dental Considerations | 178 | ||
| General: | 178 | ||
| Consultations: | 179 | ||
| Teach Patient/Family to: | 179 | ||
| buclizine hydrochloride | 179 | ||
| Category and Schedule | 179 | ||
| Drug Class: | 179 | ||
| Mechanism of Action | 179 | ||
| Uses | 179 | ||
| Pharmacokinetics | 179 | ||
| Indications and Dosages | 179 | ||
| ► Motion Sickness | 179 | ||
| PO | 179 | ||
| Adults, Elderly, Children 12 yr and older. | 179 | ||
| Side Effects/Adverse Reactions | 179 | ||
| Frequent | 179 | ||
| Occasional | 179 | ||
| Precautions and Contraindications | 179 | ||
| Drug Interactions of Concern to Dentistry | 179 | ||
| Serious Reactions | 179 | ||
| Dental Considerations | 180 | ||
| General: | 180 | ||
| Teach Patient/Family to: | 180 | ||
| budesonide | 180 | ||
| Category and Schedule | 180 | ||
| Drug Class: | 180 | ||
| Mechanism of Action | 180 | ||
| Uses | 180 | ||
| Pharmacokinetics | 180 | ||
| Indications and Dosages | 180 | ||
| ► Rhinitis | 180 | ||
| Intranasal (Rhinocort Aqua) | 180 | ||
| bumetanide | 181 | ||
| Category and Schedule | 181 | ||
| Drug Class: | 181 | ||
| Mechanism of Action | 181 | ||
| Uses | 181 | ||
| Pharmacokinetics | 182 | ||
| Indications and Dosages | 182 | ||
| ► Edema | 182 | ||
| bupivacaine | 183 | ||
| Category and Schedule | 183 | ||
| Drug Class: | 183 | ||
| Mechanism of Action | 183 | ||
| Uses | 183 | ||
| Pharmacokinetics | 183 | ||
| Indications and Dosages | 183 | ||
| ► Analgesic, Epidural (partial to moderate motor blockade) | 183 | ||
| IV | 183 | ||
| Adults, Elderly. | 183 | ||
| Children weighing more than 10 kg. | 183 | ||
| Children weighing less than 10 kg. | 183 | ||
| ► Analgesic, Epidural (moderate to complete motor blockade) | 184 | ||
| buprenorphine hydrochloride | 186 | ||
| Category and Schedule | 186 | ||
| Drug Class: | 186 | ||
| Mechanism of Action | 186 | ||
| Uses | 186 | ||
| Pharmacokinetics: | 186 | ||
| Indications and Dosages | 187 | ||
| ► Analgesia | 187 | ||
| IV, IM | 187 | ||
| Adults, Children older than 12 yr. | 187 | ||
| Children 2–12 yr. | 187 | ||
| Elderly. | 187 | ||
| ► Opioid Dependence | 187 | ||
| Sublingual | 187 | ||
| Adults, Elderly, Children older than 16 yr. | 187 | ||
| Side Effects/Adverse Reactions | 187 | ||
| Frequent | 187 | ||
| Occasional | 187 | ||
| Precautions and Contraindications | 187 | ||
| Caution: | 187 | ||
| Drug Interactions of Concern to Dentistry | 187 | ||
| Serious Reactions | 187 | ||
| Dental Considerations | 187 | ||
| General: | 187 | ||
| Consultations: | 188 | ||
| Teach Patient/Family to: | 188 | ||
| buprenorphine + naloxone | 188 | ||
| Category and Schedule | 188 | ||
| Drug Class: | 188 | ||
| Mechanism of Action | 188 | ||
| Uses | 188 | ||
| Pharmacokinetics | 188 | ||
| Indications and Dosages | 188 | ||
| ► Opioid Dependence | 188 | ||
| Adults. | 188 | ||
| Side Effects/Adverse Reactions | 188 | ||
| Frequent | 188 | ||
| Occasional | 188 | ||
| Precautions and Contraindications | 188 | ||
| Drug Interactions of Concern to Dentistry | 189 | ||
| Serious Reactions | 189 | ||
| Dental Considerations | 189 | ||
| General: | 189 | ||
| Consultations: | 189 | ||
| Teach Patient/Family to: | 189 | ||
| bupropion | 190 | ||
| Category and Schedule | 190 | ||
| Drug Class: | 190 | ||
| Mechanism of Action | 190 | ||
| Uses | 190 | ||
| Pharmacokinetics | 190 | ||
| Indications and Dosages | 190 | ||
| ► Depression | 190 | ||
| PO (Immediate-Release) | 190 | ||
| buspirone hydrochloride | 191 | ||
| Category and Schedule | 191 | ||
| Drug Class: | 191 | ||
| Mechanism of Action | 191 | ||
| Uses | 191 | ||
| Pharmacokinetics | 191 | ||
| Indications and Dosages | 192 | ||
| ► Short-Term Management (up to 4 wk) of Anxiety Disorders | 192 | ||
| PO | 192 | ||
| Adults. | 192 | ||
| Elderly. | 192 | ||
| Children. | 192 | ||
| Side Effects/Adverse Reactions | 192 | ||
| Frequent | 192 | ||
| Occasional | 192 | ||
| Rare | 192 | ||
| Precautions and Contraindications | 192 | ||
| Caution: | 192 | ||
| Drug Interactions of Concern to Dentistry | 192 | ||
| Serious Reactions | 192 | ||
| Dental Considerations | 192 | ||
| General: | 192 | ||
| Consultations: | 192 | ||
| Teach Patient/Family: | 192 | ||
| busulfan | 193 | ||
| Category and Schedule | 193 | ||
| Drug Class: | 193 | ||
| Mechanism of Action | 193 | ||
| Uses | 193 | ||
| Pharmacokinetics | 193 | ||
| Indications and Dosages | 193 | ||
| ► Remission Induction in Chronic Myelogenous Leukemia (CML) | 193 | ||
| butabarbital sodium | 195 | ||
| Category and Schedule | 195 | ||
| Drug Class: | 195 | ||
| Mechanism of Action | 195 | ||
| Uses | 195 | ||
| Pharmacokinetics | 195 | ||
| Indications and Dosages | 195 | ||
| ► Insomnia, Short-Term | 195 | ||
| butenafine | 196 | ||
| Category and Schedule | 196 | ||
| Drug Class: | 196 | ||
| Mechanism of Action | 196 | ||
| Uses | 196 | ||
| Pharmacokinetics | 196 | ||
| Indications and Dosages | 196 | ||
| ► Tinea Pedis, Tinea Corporis, Tinea Cruris, Tinea Versicolor | 196 | ||
| Topical | 196 | ||
| Adults, Elderly, Children 12 yr and older. | 196 | ||
| Side Effects/Adverse Reactions | 196 | ||
| Occasional | 196 | ||
| Rare | 196 | ||
| Precautions and Contraindications | 196 | ||
| Caution: | 196 | ||
| Drug Interactions of Concern to Dentistry | 196 | ||
| Serious Reactions | 196 | ||
| butoconazole | 197 | ||
| Category and Schedule | 197 | ||
| Drug Class: | 197 | ||
| Mechanism of Action | 197 | ||
| Uses | 197 | ||
| Pharmacokinetics | 197 | ||
| Indications and Dosages | 197 | ||
| ► Treatment of Candidiasis | 197 | ||
| Topical | 197 | ||
| Adults, Elderly. | 197 | ||
| Side Effects/Adverse Reactions | 197 | ||
| Occasional | 197 | ||
| Precautions and Contraindications | 197 | ||
| Caution: | 197 | ||
| Serious Reactions | 197 | ||
| Dental Considerations | 197 | ||
| General: | 197 | ||
| Indications and Dosages | 198 | ||
| ► Analgesia | 198 | ||
| IV | 198 | ||
| butorphanol tartrate | 197 | ||
| cabergoline | 200 | ||
| Category and Schedule | 200 | ||
| Drug Class: | 200 | ||
| Mechanism of Action | 200 | ||
| Uses | 200 | ||
| Pharmacokinetics | 200 | ||
| Indications and Dosages | 200 | ||
| ► Hyperprolactinemia (Idiopathic or Primary Pituitary Adenomas) | 200 | ||
| calcifediol | 201 | ||
| Category and Schedule | 201 | ||
| Drug Class: | 201 | ||
| Mechanism of Action | 201 | ||
| Uses | 201 | ||
| Pharmacokinetics | 201 | ||
| Indications and Dosages | 201 | ||
| ► Secondary Hyperparathyroidism | 201 | ||
| PO | 201 | ||
| Adults. | 201 | ||
| Side Effects/Adverse Reactions | 202 | ||
| Frequent | 202 | ||
| Occasional | 202 | ||
| Precautions and Contraindications | 202 | ||
| Drug Interactions of Concern to Dentistry | 202 | ||
| Serious Reactions | 202 | ||
| Dental Considerations | 202 | ||
| General: | 202 | ||
| Consultations: | 202 | ||
| Teach Patient/Family to: | 202 | ||
| calcitonin | 202 | ||
| Category and Schedule | 202 | ||
| Drug Class: | 202 | ||
| Mechanism of Action | 202 | ||
| Uses | 202 | ||
| Pharmacokinetics | 202 | ||
| Indications and Dosages | 203 | ||
| ► Skin Testing Before Treatment in Patients with Suspected Sensitivity to Calcitonin-Salmon | 203 | ||
| Intracutaneous | 203 | ||
| canagliflozin | 204 | ||
| Category and Schedule | 204 | ||
| Drug Class: | 204 | ||
| Mechanism of Action | 204 | ||
| Uses | 204 | ||
| Pharmacokinetics | 204 | ||
| Indications and Dosages | 204 | ||
| ► Type 2 Diabetes Mellitus | 204 | ||
| PO | 204 | ||
| Adults. | 204 | ||
| Side Effects/Adverse Reactions | 204 | ||
| Frequent | 204 | ||
| Occasional | 204 | ||
| Precautions and Contraindications | 204 | ||
| Drug Interactions of Concern to Dentistry | 205 | ||
| Serious Reactions | 205 | ||
| Dental Considerations | 205 | ||
| General: | 205 | ||
| Consultations: | 205 | ||
| Teach Patient/Family to: | 205 | ||
| canakinumab | 205 | ||
| Category and Schedule | 205 | ||
| Drug Class: | 205 | ||
| Mechanism of Action | 205 | ||
| Uses | 205 | ||
| Pharmacokinetics | 205 | ||
| Indications and Dosages | 206 | ||
| ► Cryopyrin-Associated Periodic Syndrome (CAPS) | 206 | ||
| Children ≥4 yr and adolescents. | 206 | ||
| Children ≥4 yr and adolescents >40 kg. | 206 | ||
| ► Systemic Juvenile Idiopathic Arthritis (SJIA) | 206 | ||
| Children ≥2 yr and ≥7.5 kg and adolescents. | 206 | ||
| Side Effects/Adverse Reactions | 206 | ||
| Frequent | 206 | ||
| Occasional | 206 | ||
| Precautions and Contraindications | 206 | ||
| Drug Interactions of Concern to Dentistry | 206 | ||
| Serious Reactions | 206 | ||
| Dental Considerations | 206 | ||
| General: | 206 | ||
| Teach Patient/Family to: | 206 | ||
| candesartan cilexetil | 207 | ||
| Category and Schedule | 207 | ||
| Drug Class: | 207 | ||
| Mechanism of Action | 207 | ||
| Uses | 207 | ||
| Pharmacokinetics | 207 | ||
| Indications and Dosages | 207 | ||
| ► Hypertension Alone or in Combination with Other Antihypertensives | 207 | ||
| PO | 207 | ||
| Adults, Elderly, Patients with mildly impaired liver or renal function. | 207 | ||
| Side Effects/Adverse Reactions | 207 | ||
| Occasional | 207 | ||
| Rare | 207 | ||
| Precautions and Contraindications | 207 | ||
| Caution: | 207 | ||
| Drug Interactions of Concern to Dentistry | 207 | ||
| Serious Reactions | 207 | ||
| Dental Considerations | 207 | ||
| General: | 207 | ||
| Consultations: | 208 | ||
| Teach Patient/Family to: | 208 | ||
| capecitabine | 208 | ||
| Category and Schedule | 208 | ||
| Drug Class: | 208 | ||
| Mechanism of Action | 208 | ||
| Uses | 208 | ||
| Pharmacokinetics | 208 | ||
| Indications and Dosages | 208 | ||
| ► Metastatic Breast Cancer, Colon Cancer | 208 | ||
| PO | 208 | ||
| Adults, Elderly. | 208 | ||
| Side Effects/Adverse Reactions | 208 | ||
| Frequent | 208 | ||
| Occasional | 208 | ||
| Precautions and Contraindications | 208 | ||
| Caution: | 209 | ||
| Drug Interactions of Concern to Dentistry | 209 | ||
| Serious Reactions | 209 | ||
| Dental Considerations | 209 | ||
| General: | 209 | ||
| Consultations: | 209 | ||
| Teach Patient/Family to: | 209 | ||
| caprylidene | 210 | ||
| Category and Schedule | 210 | ||
| Drug Class: | 210 | ||
| Mechanism of Action | 210 | ||
| Uses | 210 | ||
| Pharmacokinetics | 210 | ||
| Indications and Dosages | 210 | ||
| ► Dietary Management of Metabolic Processes Associated with Mild-to-Moderate Alzheimer’s Disease | 210 | ||
| PO | 210 | ||
| Adults. | 210 | ||
| Side Effects/Adverse Reactions | 210 | ||
| Frequent | 210 | ||
| Occasional | 210 | ||
| Precautions and Contraindications | 210 | ||
| Drug Interactions of Concern to Dentistry | 210 | ||
| Serious Reactions | 210 | ||
| Dental Considerations | 210 | ||
| General: | 210 | ||
| Consultations: | 211 | ||
| capsaicin | 211 | ||
| Category and Schedule | 211 | ||
| Drug Class: | 211 | ||
| Mechanism of Action | 211 | ||
| Uses | 211 | ||
| Pharmacokinetics | 211 | ||
| Indications and Dosages | 211 | ||
| ► Treatment of Neuralgia, Osteoarthritis, Rheumatoid Arthritis | 211 | ||
| Topical | 211 | ||
| Adults, Elderly, Children older than 2 yr. | 211 | ||
| Side Effects/Adverse Reactions | 211 | ||
| Frequent | 211 | ||
| Precautions and Contraindications | 211 | ||
| Caution: | 211 | ||
| Drug Interactions of Concern to Dentistry | 211 | ||
| Serious Reactions | 211 | ||
| Dental Considerations | 211 | ||
| General: | 211 | ||
| Teach Patient/Family to: | 211 | ||
| captopril | 212 | ||
| Category and Schedule | 212 | ||
| Drug Class: | 212 | ||
| Mechanism of Action | 212 | ||
| Uses | 212 | ||
| Pharmacokinetics | 212 | ||
| Indications and Dosages | 212 | ||
| ► Hypertension | 212 | ||
| carbachol | 214 | ||
| Category and Schedule | 214 | ||
| Drug Class: | 214 | ||
| Mechanism of Action | 214 | ||
| Uses | 214 | ||
| Pharmacokinetics | 214 | ||
| Indications and Dosages | 214 | ||
| ► Glaucoma | 214 | ||
| carbamazepine | 215 | ||
| Category and Schedule | 215 | ||
| Drug Class: | 215 | ||
| Mechanism of Action | 215 | ||
| Uses | 215 | ||
| Pharmacokinetics | 215 | ||
| Indications and Dosages | 215 | ||
| ► Seizure Control | 215 | ||
| carbamide peroxide | 217 | ||
| Category and Schedule | 217 | ||
| Drug Class: | 217 | ||
| Mechanism of Action | 217 | ||
| Uses | 217 | ||
| Pharmacokinetics | 217 | ||
| Indications and Dosages | 217 | ||
| ► Earwax Removal | 217 | ||
| carbidopa | 218 | ||
| Category and Schedule | 218 | ||
| Drug Class: | 218 | ||
| Mechanism of Action | 218 | ||
| Uses | 218 | ||
| Pharmacokinetics | 218 | ||
| Indications and Dosages | 218 | ||
| ► Parkinson’s Disease | 218 | ||
| PO | 218 | ||
| Adults, Patients receiving carbidopa-levodopa 10/100. | 218 | ||
| Patients receiving carbidopa-levodopa 25/250 or carbidopa-levodopa 25/100. | 218 | ||
| Side Effects/Adverse Reactions | 218 | ||
| Frequent | 218 | ||
| Occasional | 219 | ||
| Precautions and Contraindications | 219 | ||
| Drug Interactions of Concern to Dentistry | 219 | ||
| Serious Reactions | 219 | ||
| Dental Considerations | 219 | ||
| General: | 219 | ||
| Teach Patient/Family to: | 219 | ||
| carbidopa + levodopa | 219 | ||
| Category and Schedule | 219 | ||
| Drug Class: | 219 | ||
| Mechanism of Action | 219 | ||
| Uses | 219 | ||
| Pharmacokinetics | 220 | ||
| Indications and Dosages | 220 | ||
| ► Treatment of Motor Fluctuations in Patients With Advanced Parkinson’s Disease | 220 | ||
| Adults. | 220 | ||
| Side Effects/Adverse Reactions | 220 | ||
| Frequent | 220 | ||
| Occasional | 220 | ||
| Precautions and Contraindications | 220 | ||
| Drug Interactions of Concern to Dentistry | 220 | ||
| Serious Reactions | 220 | ||
| Dental Considerations | 220 | ||
| General: | 220 | ||
| Consultations: | 221 | ||
| Teach Patient/Family to: | 221 | ||
| carbinoxamine maleate | 221 | ||
| Category and Schedule | 221 | ||
| Drug Class: | 221 | ||
| Mechanism of Action | 221 | ||
| Uses | 221 | ||
| Pharmacokinetics | 221 | ||
| Indications and Dosages | 221 | ||
| ► Allergic Rhinitis | 221 | ||
| PO | 221 | ||
| Adults, Children 6 yr and older. | 221 | ||
| Children 18 mo–6 yr. | 221 | ||
| Children 9–18 mo. | 221 | ||
| Side Effects/Adverse Reactions | 221 | ||
| Frequent | 221 | ||
| Occasional | 222 | ||
| Rare | 222 | ||
| Precautions and Contraindications | 222 | ||
| Drug Interactions of Concern to Dentistry | 222 | ||
| Serious Reactions | 222 | ||
| Dental Considerations | 222 | ||
| General: | 222 | ||
| Teach Patient/Family to: | 222 | ||
| carboplatin | 222 | ||
| Category and Schedule | 222 | ||
| Drug Class: | 222 | ||
| Mechanism of Action | 222 | ||
| Uses | 222 | ||
| Pharmacokinetics | 222 | ||
| Indications and Dosages | 222 | ||
| ► Ovarian Carcinoma (Monotherapy) | 222 | ||
| IV | 222 | ||
| Adults. | 222 | ||
| ► Ovarian Carcinoma (Combination Therapy) | 223 | ||
| Adults. | 223 | ||
| Children. | 223 | ||
| ► Dosage in Renal Impairment | 223 | ||
| Side Effects/Adverse Reactions | 223 | ||
| Frequent | 223 | ||
| Occasional | 223 | ||
| Rare | 223 | ||
| Precautions and Contraindications | 223 | ||
| Drug Interactions of Concern to Dentistry | 223 | ||
| Serious Reactions | 223 | ||
| Dental Considerations | 223 | ||
| General: | 223 | ||
| Consultations: | 223 | ||
| Teach Patient/Family to: | 224 | ||
| carglumic acid | 224 | ||
| Category and Schedule | 224 | ||
| Drug Class: | 224 | ||
| Mechanism of Action | 224 | ||
| Uses | 224 | ||
| Pharmacokinetics | 224 | ||
| Indications and Dosages | 224 | ||
| ► Acute Hyperammonemia | 224 | ||
| PO | 224 | ||
| Adults, Children. | 224 | ||
| ► Chronic Hyperammonemia | 225 | ||
| PO | 225 | ||
| Adults, Children. | 225 | ||
| Side Effects/Adverse Reactions | 225 | ||
| Frequent | 225 | ||
| Occasional | 225 | ||
| Precautions and Contraindications | 225 | ||
| Drug Interactions of Concern to Dentistry | 225 | ||
| Serious Reactions | 225 | ||
| Dental Considerations | 225 | ||
| General: | 225 | ||
| Consultations: | 225 | ||
| Teach Patient/Family to: | 225 | ||
| carisoprodol | 225 | ||
| Category and Schedule | 225 | ||
| Drug Class: | 225 | ||
| Mechanism of Action | 225 | ||
| Uses | 225 | ||
| Pharmacokinetics | 225 | ||
| carmustine | 226 | ||
| Category and Schedule | 226 | ||
| Drug Class: | 226 | ||
| Mechanism of Action | 226 | ||
| Uses | 226 | ||
| Pharmacokinetics | 226 | ||
| Indications and Dosages | 226 | ||
| ► Adjunct to Rest, Physical Therapy, Analgesics, and Other Measures for Relief of Discomfort from Acute, Painful Musculoskeletal Conditions | 226 | ||
| PO | 226 | ||
| ► Disseminated Hodgkin’s Disease, Non-Hodgkin’s Lymphoma, Multiple Myeloma, and Primary and Metastatic Brain Tumors in Previously Untreated Patients (Monotherapy) | 226 | ||
| IV (BiCNu) | 226 | ||
| Adults, Elderly. | 226 | ||
| Side Effects/Adverse Reactions | 226 | ||
| Frequent | 226 | ||
| Occasional | 226 | ||
| Precautions and Contraindications | 226 | ||
| Caution: | 226 | ||
| Drug Interactions of Concern to Dentistry | 226 | ||
| Serious Reactions | 226 | ||
| Dental Considerations | 226 | ||
| General: | 226 | ||
| Teach Patient/Family to: | 226 | ||
| Children. | 226 | ||
| ► Implantation (Gliadel) | 226 | ||
| Adults, Elderly, Children. | 226 | ||
| Side Effects/Adverse Reactions | 227 | ||
| Frequent | 227 | ||
| Occasional | 227 | ||
| Rare | 227 | ||
| Precautions and Contraindications | 227 | ||
| Drug Interactions of Concern to Dentistry | 227 | ||
| Serious Reactions | 227 | ||
| Dental Considerations | 227 | ||
| General: | 227 | ||
| Consultations: | 227 | ||
| Teach Patient/Family to: | 227 | ||
| carteolol | 228 | ||
| Category and Schedule | 228 | ||
| Drug Class: | 228 | ||
| Mechanism of Action | 228 | ||
| Uses | 228 | ||
| Pharmacokinetics | 228 | ||
| Indications and Dosages | 228 | ||
| ► Ocular Hypertension | 228 | ||
| PO | 228 | ||
| carvedilol | 230 | ||
| Category and Schedule | 230 | ||
| Drug Class: | 230 | ||
| Mechanism of Action | 230 | ||
| Uses | 230 | ||
| Pharmacokinetics | 230 | ||
| Indications and Dosages | 230 | ||
| ► Hypertension | 230 | ||
| cefaclor | 232 | ||
| Category and Schedule | 232 | ||
| Drug Class: | 232 | ||
| Mechanism of Action | 232 | ||
| Uses | 232 | ||
| Pharmacokinetics | 232 | ||
| Indications and Dosages | 232 | ||
| ► Bronchitis | 232 | ||
| cefadroxil | 233 | ||
| Category and Schedule | 233 | ||
| Drug Class: | 233 | ||
| Mechanism of Action | 233 | ||
| Uses | 234 | ||
| Pharmacokinetics | 234 | ||
| Indications and Dosages | 234 | ||
| ► UTIs | 234 | ||
| cefazolin sodium | 235 | ||
| Category and Schedule | 235 | ||
| Drug Class: | 235 | ||
| Mechanism of Action | 235 | ||
| Uses | 235 | ||
| Pharmacokinetics | 235 | ||
| Indications and Dosages | 235 | ||
| ► Uncomplicated UTIs | 235 | ||
| cefdinir | 237 | ||
| Category and Schedule | 237 | ||
| Drug Class: | 237 | ||
| Mechanism of Action | 237 | ||
| Uses | 237 | ||
| Pharmacokinetics | 237 | ||
| Indications and Dosages | 237 | ||
| ► Community-Acquired Pneumonia | 237 | ||
| cefditoren pivoxil | 238 | ||
| Category and Schedule | 238 | ||
| Drug Class: | 238 | ||
| Mechanism of Action | 238 | ||
| Uses | 239 | ||
| Pharmacokinetics | 239 | ||
| Indications and Dosages | 239 | ||
| ► Pharyngitis, Tonsillitis, Skin Infections | 239 | ||
| cefepime | 240 | ||
| Category and Schedule | 240 | ||
| Drug Class: | 240 | ||
| Mechanism of Action | 240 | ||
| Uses | 240 | ||
| Pharmacokinetics | 240 | ||
| Indications and Dosages | 240 | ||
| ► Pneumonia | 240 | ||
| IV | 240 | ||
| Adults, Elderly. | 240 | ||
| Children 2 mo and older. | 240 | ||
| ► Intraabdominal Infections | 241 | ||
| cefixime | 242 | ||
| Category and Schedule | 242 | ||
| Drug Class: | 242 | ||
| Mechanism of Action | 242 | ||
| Uses | 242 | ||
| Pharmacokinetics | 242 | ||
| Indications and Dosages | 242 | ||
| ► Otitis Media, Acute Bronchitis, Acute Exacerbations of Chronic Bronchitis, Pharyngitis, Tonsillitis, and Uncomplicated UTIs | 242 | ||
| cefonicid sodium | 243 | ||
| Category and Schedule | 243 | ||
| Drug Class: | 243 | ||
| Mechanism of Action | 243 | ||
| Uses | 243 | ||
| Pharmacokinetics | 243 | ||
| Indications and Dosages | 243 | ||
| ► UTIs | 243 | ||
| cefoperazone | 245 | ||
| Category and Schedule | 245 | ||
| Drug Class: | 245 | ||
| Mechanism of Action | 245 | ||
| Uses | 245 | ||
| Pharmacokinetics | 245 | ||
| Indications and Dosages | 245 | ||
| ► Mild to Moderate Infections | 245 | ||
| cefotaxime sodium | 246 | ||
| Category and Schedule | 246 | ||
| Drug Class: | 246 | ||
| Mechanism of Action | 246 | ||
| Uses | 246 | ||
| Pharmacokinetics | 246 | ||
| Indications and Dosages | 246 | ||
| ► Uncomplicated Infections | 246 | ||
| cefotetan disodium | 248 | ||
| Category and Schedule | 248 | ||
| Drug Class: | 248 | ||
| Mechanism of Action | 248 | ||
| Uses | 248 | ||
| Pharmacokinetics | 248 | ||
| Indications and Dosages | 248 | ||
| ► UTIs | 248 | ||
| cefoxitin sodium | 249 | ||
| Category and Schedule | 249 | ||
| Drug Class: | 249 | ||
| Mechanism of Action | 249 | ||
| Uses | 249 | ||
| Pharmacokinetics | 249 | ||
| Indications and Dosages | 250 | ||
| ► Mild to Moderate Infections | 250 | ||
| cefpodoxime proxetil | 251 | ||
| Category and Schedule | 251 | ||
| Drug Class: | 251 | ||
| Mechanism of Action | 251 | ||
| Uses | 251 | ||
| Pharmacokinetics | 251 | ||
| Indications and Dosages | 251 | ||
| ► Chronic Bronchitis, Pneumonia | 251 | ||
| cefprozil | 253 | ||
| Category and Schedule | 253 | ||
| Drug Class: | 253 | ||
| Mechanism of Action | 253 | ||
| Uses | 253 | ||
| Pharmacokinetics | 253 | ||
| Indications and Dosages | 253 | ||
| ► Pharyngitis, Tonsillitis | 253 | ||
| ceftaroline fosamil | 254 | ||
| Category and Schedule | 254 | ||
| Drug Class: | 254 | ||
| Mechanism of Action | 254 | ||
| Uses | 254 | ||
| Pharmacokinetics | 254 | ||
| Indications and Dosages | 254 | ||
| ► Pneumonia, Community-Acquired | 254 | ||
| ceftazidime | 255 | ||
| Category and Schedule | 255 | ||
| Drug Class: | 255 | ||
| Mechanism of Action | 255 | ||
| Uses | 256 | ||
| Pharmacokinetics | 256 | ||
| Indications and Dosages | 256 | ||
| ► UTIs | 256 | ||
| ceftibuten | 257 | ||
| Category and Schedule | 257 | ||
| Drug Class: | 257 | ||
| Mechanism of Action | 257 | ||
| Uses | 257 | ||
| Pharmacokinetics | 257 | ||
| Indications and Dosages | 257 | ||
| ► Chronic Bronchitis | 257 | ||
| ceftizoxime sodium | 259 | ||
| Category and Schedule | 259 | ||
| Drug Class: | 259 | ||
| Mechanism of Action | 259 | ||
| Uses | 259 | ||
| Pharmacokinetics | 259 | ||
| Indications and Dosages | 259 | ||
| ► Uncomplicated UTIs | 259 | ||
| ceftriaxone sodium | 260 | ||
| Category and Schedule | 260 | ||
| Drug Class: | 260 | ||
| Mechanism of Action | 260 | ||
| Uses | 260 | ||
| Pharmacokinetics | 260 | ||
| Indications and Dosages | 260 | ||
| ► Mild to Moderate Infections | 260 | ||
| IV, IM | 260 | ||
| Adults, Elderly. | 260 | ||
| ► Serious Infections | 261 | ||
| cefuroxime axetil/cefuroxime sodium | 262 | ||
| Category and Schedule | 262 | ||
| Drug Class: | 262 | ||
| Mechanism of Action | 262 | ||
| Uses | 262 | ||
| Pharmacokinetics | 262 | ||
| Indications and Dosages | 262 | ||
| ► Ampicillin-Resistant Influenza; Bacterial Meningitis; Early Lyme Disease; GU Tract, Gynecologic, Skin and Bone Infections; Septicemia; Gonorrhea and Other Gonococcal Infections | 262 | ||
| IV, IM | 262 | ||
| celecoxib | 264 | ||
| Category and Schedule | 264 | ||
| Drug Class: | 264 | ||
| Mechanism of Action | 264 | ||
| Uses | 264 | ||
| Pharmacokinetics | 264 | ||
| Indications and Dosages | 264 | ||
| ► Osteoarthritis | 264 | ||
| cephalexin | 265 | ||
| Category and Schedule | 265 | ||
| Drug Class: | 265 | ||
| Mechanism of Action | 265 | ||
| Uses | 266 | ||
| Pharmacokinetics | 266 | ||
| Indications and Dosages | 266 | ||
| ► Bone Infections, Prophylaxis of Rheumatic Fever, Follow-up to Parenteral Therapy | 266 | ||
| cephradine | 267 | ||
| Category and Schedule | 267 | ||
| Drug Class: | 267 | ||
| Mechanism of Action | 267 | ||
| Uses | 267 | ||
| Pharmacokinetics | 267 | ||
| Indications and Dosages | 267 | ||
| ► Mild, Moderate or Severe Infections of the Respiratory and GU Tracts; Bone, Joint and Skin Infections; Prostatitis; Otitis Media | 267 | ||
| PO | 267 | ||
| Adults, Elderly. | 267 | ||
| Children older than 9 mo. | 267 | ||
| ► Dosage in Renal Impairment | 267 | ||
| Side Effects/Adverse Reactions | 268 | ||
| Frequent | 268 | ||
| Occasional | 268 | ||
| Rare | 268 | ||
| Precautions and Contraindications | 268 | ||
| Caution: | 268 | ||
| Drug Interactions of Concern to Dentistry | 268 | ||
| Serious Reactions | 268 | ||
| Dental Considerations | 268 | ||
| General: | 268 | ||
| Consultations: | 268 | ||
| Teach Patient/Family to: | 268 | ||
| certolizumab | 268 | ||
| Category and Schedule | 268 | ||
| Drug Class: | 268 | ||
| Mechanism of Action | 268 | ||
| Uses | 269 | ||
| Pharmacokinetics | 269 | ||
| Indications and Dosages | 269 | ||
| Adult. | 269 | ||
| Pediatric. | 269 | ||
| Side Effects/Adverse Reactions | 269 | ||
| Frequent | 269 | ||
| Occasional | 269 | ||
| Rare | 269 | ||
| Precautions and Contraindications | 269 | ||
| Caution: | 269 | ||
| Drug Interactions of Concern to Dentistry | 269 | ||
| Serious Reactions | 269 | ||
| Dental Considerations | 269 | ||
| General: | 269 | ||
| Consultations: | 269 | ||
| Teach Patient/Family to: | 270 | ||
| cetirizine | 270 | ||
| Category and Schedule | 270 | ||
| Drug Class: | 270 | ||
| Mechanism of Action | 270 | ||
| Uses | 270 | ||
| Pharmacokinetics | 270 | ||
| Indications and Dosages | 270 | ||
| ► Allergic Rhinitis, Urticaria | 270 | ||
| PO | 270 | ||
| Adults, Elderly, Children older than 5 yr. | 270 | ||
| Children 2–5 yr. | 270 | ||
| Children 12–23 mo. | 270 | ||
| Children 6–11 mo. | 270 | ||
| ► Dosage in Renal or Hepatic Impairment | 270 | ||
| Side Effects/Adverse Reactions | 270 | ||
| Occasional | 270 | ||
| Precautions and Contraindications | 270 | ||
| Caution: | 270 | ||
| Drug Interactions of Concern to Dentistry | 270 | ||
| Serious Reactions | 271 | ||
| Dental Considerations | 271 | ||
| General: | 271 | ||
| Teach Patient/Family: | 271 | ||
| cetuximab | 271 | ||
| Category and Schedule | 271 | ||
| Drug Class: | 271 | ||
| Mechanism of Action | 271 | ||
| Uses | 271 | ||
| Pharmacokinetics | 271 | ||
| Indications and Dosages | 271 | ||
| ► Metastatic Colorectal Carcinoma | 271 | ||
| IV | 271 | ||
| Adults, Elderly. | 271 | ||
| Side Effects/Adverse Reactions | 271 | ||
| Frequent | 271 | ||
| Occasional | 271 | ||
| Rare | 271 | ||
| Precautions and Contraindications | 271 | ||
| Drug Interactions of Concern to Dentistry | 271 | ||
| Serious Reactions | 272 | ||
| Dental Considerations | 272 | ||
| General: | 272 | ||
| Consultations: | 272 | ||
| Teach Patient/Family to: | 272 | ||
| cevimeline | 272 | ||
| Category and Schedule | 272 | ||
| Drug Class: | 272 | ||
| Mechanism of Action | 272 | ||
| Uses | 273 | ||
| Pharmacokinetics | 273 | ||
| Indications and Dosages | 273 | ||
| ► Dry Mouth | 273 | ||
| PO | 273 | ||
| Adults. | 273 | ||
| Side Effects/Adverse Reactions | 273 | ||
| Frequent | 273 | ||
| Occasional | 273 | ||
| Rare | 273 | ||
| Precautions and Contraindications | 273 | ||
| Caution: | 273 | ||
| Drug Interactions of Concern to Dentistry | 273 | ||
| Serious Reactions | 273 | ||
| Dental Considerations | 273 | ||
| General: | 273 | ||
| Consultations: | 273 | ||
| Teach Patient/Family to: | 273 | ||
| chloral hydrate | 274 | ||
| Category and Schedule | 274 | ||
| Drug Class: | 274 | ||
| Mechanism of Action | 274 | ||
| Uses | 274 | ||
| Pharmacokinetics | 274 | ||
| Indications and Dosages | 274 | ||
| ► Premedication for Dental or Medical Procedures | 274 | ||
| chlordiazepoxide | 275 | ||
| Category and Schedule | 275 | ||
| Drug Class: | 275 | ||
| Mechanism of Action | 275 | ||
| Uses | 275 | ||
| Pharmacokinetics | 275 | ||
| Indications and Dosages | 275 | ||
| ► Alcohol Withdrawal Symptoms | 275 | ||
| chlorhexidine gluconate | 276 | ||
| Category and Schedule | 276 | ||
| Drug Class: | 276 | ||
| Mechanism of Action | 276 | ||
| Uses | 277 | ||
| Pharmacokinetics | 277 | ||
| Indications and Dosages | 277 | ||
| ► Gingivitis | 277 | ||
| Oral Rinse | 277 | ||
| chloroquine/chloroquine phosphate | 277 | ||
| Category and Schedule | 277 | ||
| Drug Class: | 277 | ||
| Mechanism of Action | 278 | ||
| Uses | 278 | ||
| Pharmacokinetics | 278 | ||
| Indications and Dosages | 278 | ||
| Chloroquine Phosphate | 278 | ||
| ► Treatment of Malaria (Acute Attack): Dose (mg Base) | 278 | ||
| ► Suppression of Malaria | 278 | ||
| chlorothiazide | 279 | ||
| Category and Schedule | 279 | ||
| Drug Class: | 279 | ||
| Mechanism of Action | 279 | ||
| Uses | 279 | ||
| Pharmacokinetics | 279 | ||
| Indications and Dosages | 279 | ||
| ► Edema, Hypertension | 279 | ||
| PO | 279 | ||
| Adults. | 279 | ||
| Children 12 yr and older. | 279 | ||
| Children 2–12 yr. | 279 | ||
| Children 6 mo–2 yr. | 279 | ||
| Children younger than 6 mo. | 280 | ||
| ► Hypertension | 280 | ||
| IV | 280 | ||
| Side Effects/Adverse Reactions | 280 | ||
| Expected | 280 | ||
| Frequent | 280 | ||
| Occasional | 280 | ||
| Precautions and Contraindications | 280 | ||
| Caution: | 280 | ||
| Drug Interactions of Concern to Dentistry | 280 | ||
| Serious Reactions | 280 | ||
| Dental Considerations | 280 | ||
| General: | 280 | ||
| Consultations: | 280 | ||
| Teach Patient/Family to: | 281 | ||
| chlorpheniramine | 281 | ||
| Category and Schedule | 281 | ||
| Drug Class: | 281 | ||
| Mechanism of Action | 281 | ||
| Uses | 281 | ||
| Pharmacokinetics | 281 | ||
| Indications and Dosages | 281 | ||
| ► Allergic Rhinitis, Common Cold | 281 | ||
| PO | 281 | ||
| chlorpromazine | 282 | ||
| Category and Schedule | 282 | ||
| Drug Class: | 282 | ||
| Mechanism of Action | 282 | ||
| Uses | 283 | ||
| Pharmacokinetics | 283 | ||
| Indications and Dosages | 283 | ||
| ► Severe Nausea or Vomiting | 283 | ||
| chlorpropamide | 285 | ||
| Category and Schedule | 285 | ||
| Drug Class: | 285 | ||
| Mechanism of Action | 285 | ||
| Uses | 285 | ||
| Pharmacokinetics | 285 | ||
| Indications and Dosages | 285 | ||
| ► Diabetes Mellitus, Combination Therapy | 285 | ||
| PO | 285 | ||
| Adults. | 285 | ||
| Elderly. | 285 | ||
| ► Renal Function Impairment | 285 | ||
| Side Effects/Adverse Reactions | 285 | ||
| Frequent | 285 | ||
| Occasional | 285 | ||
| Precautions and Contraindications | 285 | ||
| Caution: | 285 | ||
| Drug Interactions of Concern to Dentistry | 285 | ||
| Serious Reactions | 285 | ||
| Dental Considerations | 285 | ||
| General: | 285 | ||
| Consultations: | 286 | ||
| Teach Patient/Family to: | 286 | ||
| chlorthalidone | 286 | ||
| Category and Schedule | 286 | ||
| Drug Class: | 286 | ||
| Mechanism of Action | 286 | ||
| Uses | 286 | ||
| Pharmacokinetics | 286 | ||
| Indications and Dosages | 286 | ||
| ► Hypertension, Edema | 286 | ||
| PO | 286 | ||
| Adults. | 286 | ||
| Elderly. | 286 | ||
| Side Effects/Adverse Reactions | 286 | ||
| Expected | 286 | ||
| Frequent | 286 | ||
| Occasional | 286 | ||
| Rare | 286 | ||
| Precautions and Contraindications | 286 | ||
| Caution: | 287 | ||
| Drug Interactions of Concern to Dentistry | 287 | ||
| Serious Reactions | 287 | ||
| Dental Considerations | 287 | ||
| General: | 287 | ||
| Consultations: | 287 | ||
| Teach Patient/Family to: | 287 | ||
| chlorzoxazone | 287 | ||
| Category and Schedule | 287 | ||
| Drug Class: | 287 | ||
| cholestyramine resin | 288 | ||
| Category and Schedule | 288 | ||
| Drug Class: | 288 | ||
| Mechanism of Action | 288 | ||
| Uses | 288 | ||
| Pharmacokinetics | 288 | ||
| Indications and Dosages | 288 | ||
| ► Musculoskeletal Pain | 288 | ||
| PO | 288 | ||
| Adults, Elderly. | 288 | ||
| Children. | 288 | ||
| Side Effects/Adverse Reactions | 288 | ||
| Frequent | 288 | ||
| Occasional | 288 | ||
| Precautions and Contraindications | 288 | ||
| Caution: | 288 | ||
| Drug Interactions of Concern to Dentistry | 288 | ||
| Serious Reactions | 288 | ||
| Dental Considerations | 288 | ||
| General: | 288 | ||
| Indications and Dosages | 289 | ||
| ► Primary Hypercholesterolemia | 289 | ||
| cholic acid | 289 | ||
| Category and Schedule | 289 | ||
| Drug Class: | 289 | ||
| Mechanism of Action | 289 | ||
| Uses | 289 | ||
| Pharmacokinetics | 289 | ||
| Indications and Dosages | 290 | ||
| ► Bile Acid Synthesis Disorders, Peroxisomal Disorders | 290 | ||
| PO | 290 | ||
| Adults. | 290 | ||
| Side Effects/Adverse Reactions | 290 | ||
| Frequent | 290 | ||
| Occasional | 290 | ||
| Precautions and Contraindications | 290 | ||
| Drug Interactions of Concern to Dentistry | 290 | ||
| Serious Reactions | 290 | ||
| Dental Considerations | 290 | ||
| General: | 290 | ||
| Consultations: | 290 | ||
| Teach Patient/Family to: | 290 | ||
| ciclesonide | 290 | ||
| Category and Schedule | 290 | ||
| Drug Class: | 290 | ||
| Mechanism of Action | 290 | ||
| Pharmacokinetics | 291 | ||
| Indications and Dosages | 291 | ||
| ► Asthma | 291 | ||
| Oral Inhalation (Alvesco) | 291 | ||
| Adults, Children 12 yr and older. | 291 | ||
| ► Allergic Rhinitis | 291 | ||
| Nasal (Omnaris) | 291 | ||
| Adults, Children 6 yr and older. | 291 | ||
| Side Effects/Adverse Reactions | 291 | ||
| Frequent | 291 | ||
| Occasional | 291 | ||
| Rare | 291 | ||
| Precautions and Contraindications | 291 | ||
| Drug Interactions of Concern to Dentistry | 291 | ||
| Serious Reactions | 291 | ||
| Dental Considerations | 291 | ||
| General: | 291 | ||
| Consultations: | 292 | ||
| Teach Patient/Family to: | 292 | ||
| ciclopirox | 292 | ||
| Category and Schedule | 292 | ||
| Drug Class: | 292 | ||
| Mechanism of Action | 292 | ||
| Uses | 292 | ||
| Pharmacokinetics | 292 | ||
| Indications and Dosages | 292 | ||
| ► Tinea Pedis | 292 | ||
| cimetidine | 293 | ||
| Category and Schedule | 293 | ||
| Drug Class: | 293 | ||
| Mechanism of Action | 293 | ||
| Uses | 293 | ||
| Pharmacokinetics | 293 | ||
| Indications and Dosages | 293 | ||
| ► Active Ulcer | 293 | ||
| ciprofloxacin hydrochloride | 295 | ||
| Category and Schedule | 295 | ||
| Drug Class: | 295 | ||
| Mechanism of Action | 295 | ||
| Uses | 295 | ||
| Pharmacokinetics | 295 | ||
| Indications and Dosages | 295 | ||
| ► Mild to Moderate UTIs | 295 | ||
| cisplatin | 297 | ||
| Category and Schedule | 297 | ||
| Drug Class: | 297 | ||
| Mechanism of Action | 297 | ||
| Uses | 297 | ||
| Pharmacokinetics | 297 | ||
| Indications and Dosages | 297 | ||
| ► Advanced Bladder Carcinoma, Metastatic Ovarian Tumors, Metastatic Testicular Tumors | 297 | ||
| IV | 297 | ||
| Adults, Elderly, Children. | 297 | ||
| ► Dosage in Renal Impairment | 297 | ||
| Side Effects/Adverse Reactions | 298 | ||
| Frequent | 298 | ||
| Occasional | 298 | ||
| Rare | 298 | ||
| Precautions and Contraindications | 298 | ||
| Drug Interactions of Concern to Dentistry | 298 | ||
| Serious Reactions | 298 | ||
| Dental Considerations | 298 | ||
| General: | 298 | ||
| Consultations: | 298 | ||
| Teach Patient/Family to: | 299 | ||
| clarithromycin | 299 | ||
| Category and Schedule | 299 | ||
| Drug Class: | 299 | ||
| Mechanism of Action | 299 | ||
| Uses | 299 | ||
| Pharmacokinetics | 299 | ||
| Indications and Dosages | 299 | ||
| ► Bronchitis | 299 | ||
| clemastine fumarate | 301 | ||
| Category and Schedule | 301 | ||
| Drug Class: | 301 | ||
| Mechanism of Action | 301 | ||
| Uses | 301 | ||
| Pharmacokinetics | 301 | ||
| Indications and Dosages | 301 | ||
| ► Allergic Rhinitis, Urticaria | 301 | ||
| PO | 301 | ||
| Adults, Children older than 11 yr. | 301 | ||
| Children 6–11 yr. | 301 | ||
| Children younger than 6 yr. | 301 | ||
| Elderly. | 301 | ||
| Side Effects/Adverse Reactions | 301 | ||
| Frequent | 301 | ||
| Occasional | 301 | ||
| Precautions and Contraindications | 301 | ||
| Caution: | 301 | ||
| Drug Interactions of Concern to Dentistry | 301 | ||
| Serious Reactions | 302 | ||
| Dental Considerations | 302 | ||
| General: | 302 | ||
| Teach Patient/Family to: | 302 | ||
| clevidipine | 302 | ||
| Category and Schedule | 302 | ||
| Drug Class: | 302 | ||
| Mechanism of Action | 302 | ||
| Uses | 302 | ||
| Pharmacokinetics | 302 | ||
| Indications and Dosages | 303 | ||
| ► Hypertension when Oral Therapy Is Not Feasible or Desired, Perioperative Hypertension, Hypertensive Urgency, and Hypertensive Emergency | 303 | ||
| IV | 303 | ||
| Adults. | 303 | ||
| Side Effects/Adverse Reactions | 303 | ||
| Frequent | 303 | ||
| Occasional | 303 | ||
| Precautions and Contraindications | 303 | ||
| Caution: | 303 | ||
| Drug Interactions of Concern to Dentistry | 303 | ||
| Serious Reactions | 303 | ||
| Dental Considerations | 303 | ||
| General: | 303 | ||
| Consultations: | 303 | ||
| Teach Patient/Family to: | 303 | ||
| clindamycin | 304 | ||
| Category and Schedule | 304 | ||
| Drug Class: | 304 | ||
| Mechanism of Action | 304 | ||
| Uses | 304 | ||
| Pharmacokinetics | 304 | ||
| Indications and Dosages | 304 | ||
| ► Chronic Bone and Joint, Respiratory Tract, Skin and Soft Tissue, Intraabdominal, and Female GU Infections; Endocarditis; Septicemia | 304 | ||
| clindamycin + tretinoin | 305 | ||
| Category and Schedule | 305 | ||
| Drug Class: | 305 | ||
| Mechanism of Action | 305 | ||
| Uses | 305 | ||
| clobazam | 306 | ||
| Category and Schedule | 306 | ||
| Drug Class: | 306 | ||
| Mechanism of Action | 306 | ||
| Uses | 306 | ||
| Pharmacokinetics | 306 | ||
| Indications and Dosages | 306 | ||
| ► Acne Vulgaris | 306 | ||
| Topical | 306 | ||
| Adults, Children 12 yr and older. | 306 | ||
| Side Effects/Adverse Reactions | 306 | ||
| Frequent | 306 | ||
| Occasional | 306 | ||
| Precautions and Contraindications | 306 | ||
| Drug Interactions of Concern to Dentistry | 306 | ||
| Serious Reactions | 306 | ||
| Dental Considerations | 306 | ||
| General: | 306 | ||
| Teach Patient/Family to: | 306 | ||
| Indications and Dosages | 307 | ||
| ► Lennox-Gastaut (adjunctive) | 307 | ||
| PO | 307 | ||
| Adults, Children 2 yr or older weighing less than 30 kg. | 307 | ||
| Children weighing more than 30 kg. | 307 | ||
| Elderly weighing less than 30 kg. | 307 | ||
| Elderly weighing more than 30 kg. | 307 | ||
| Side Effects/Adverse Reactions | 307 | ||
| Frequent | 307 | ||
| Occasional | 307 | ||
| Precautions and Contraindications | 307 | ||
| Drug Interactions of Concern to Dentistry | 307 | ||
| Serious Reactions | 307 | ||
| Dental Considerations | 307 | ||
| General: | 307 | ||
| Consultations: | 307 | ||
| Teach Patient/Family to: | 308 | ||
| clobetasol | 308 | ||
| Category and Schedule | 308 | ||
| Drug Class: | 308 | ||
| Mechanism of Action | 308 | ||
| Uses | 308 | ||
| Pharmacokinetics | 308 | ||
| Indications and Dosages | 308 | ||
| ► Antiinflammatory, Corticosteroid Replacement Therapy | 308 | ||
| Topical | 308 | ||
| clocortolone | 309 | ||
| Category and Schedule | 309 | ||
| Drug Class: | 309 | ||
| Mechanism of Action | 309 | ||
| Uses | 309 | ||
| Pharmacokinetics | 309 | ||
| Indications and Dosages | 309 | ||
| ► Dermatoses | 309 | ||
| Topical | 309 | ||
| Adults, Elderly, Children 12 yr and older. | 309 | ||
| Side Effects/Adverse Reactions | 309 | ||
| Occasional | 309 | ||
| Rare | 309 | ||
| Precautions and Contraindications | 309 | ||
| Caution: | 309 | ||
| Drug Interactions of Concern to Dentistry | 309 | ||
| Serious Reactions | 309 | ||
| Dental Considerations | 310 | ||
| General: | 310 | ||
| clofarabine | 310 | ||
| Category and Schedule | 310 | ||
| Drug Class: | 310 | ||
| Mechanism of Action | 310 | ||
| Uses | 310 | ||
| Pharmacokenetics | 310 | ||
| Indications and Dosages | 310 | ||
| ► ALL | 310 | ||
| IV | 310 | ||
| Adults. | 310 | ||
| Children. | 310 | ||
| Side Effects/Adverse Reactions: | 310 | ||
| Frequent | 310 | ||
| Occasional | 310 | ||
| Precautions and Contraindications | 311 | ||
| Caution: | 311 | ||
| Drug Interactions of Concern to Dentistry | 311 | ||
| Serious Reactions | 311 | ||
| Dental Considerations | 311 | ||
| General: | 311 | ||
| Consultations: | 311 | ||
| Teach Family/Patient to: | 311 | ||
| clofazimine | 311 | ||
| Category and Schedule | 311 | ||
| Drug Class: | 311 | ||
| Mechanism of Action | 311 | ||
| clofibrate | 312 | ||
| Category and Schedule | 312 | ||
| Drug Class: | 312 | ||
| Mechanism of Action | 312 | ||
| Uses | 312 | ||
| Pharmacokinetics | 312 | ||
| Indications and Dosages | 312 | ||
| ► Leprosy | 312 | ||
| Indications and Dosages | 313 | ||
| ► Hypercholesterolemia | 313 | ||
| PO | 313 | ||
| Adults, Elderly. | 313 | ||
| Side Effects/Adverse Reactions | 313 | ||
| Frequent | 313 | ||
| Occasional | 313 | ||
| Rare | 313 | ||
| Precautions and Contraindications | 313 | ||
| Caution: | 313 | ||
| Drug Interactions of Concern to Dentistry | 313 | ||
| Serious Reactions | 313 | ||
| Dental Considerations | 313 | ||
| General: | 313 | ||
| Consultations: | 313 | ||
| Teach Patient/Family to: | 313 | ||
| clomiphene | 313 | ||
| Category and Schedule | 313 | ||
| Drug Class: | 313 | ||
| Mechanism of Action | 313 | ||
| Uses | 313 | ||
| Pharmacokinetics | 313 | ||
| Indications and Dosages | 314 | ||
| ► Ovulatory Failure, Females | 314 | ||
| PO | 314 | ||
| Adults. | 314 | ||
| Side Effects/Adverse Reactions | 314 | ||
| Frequent | 314 | ||
| Occasional | 314 | ||
| Rare | 314 | ||
| Precautions and Contraindications | 314 | ||
| Caution: | 314 | ||
| Drug Interactions of Concern to Dentistry | 314 | ||
| Serious Reactions | 314 | ||
| Dental Considerations | 314 | ||
| General: | 314 | ||
| clomipramine hydrochloride | 314 | ||
| Category and Schedule | 314 | ||
| Drug Class: | 314 | ||
| Mechanism of Action | 314 | ||
| Uses | 314 | ||
| Pharmacokinetics | 315 | ||
| Indications and Dosages | 315 | ||
| ► Obsessive-Compulsive Disorder | 315 | ||
| PO | 315 | ||
| Adults, Elderly. | 315 | ||
| Children 10 yr and older. | 315 | ||
| Side Effects/Adverse Reactions | 315 | ||
| Frequent | 315 | ||
| Occasional | 315 | ||
| Rare | 315 | ||
| Precautions and Contraindications | 315 | ||
| Caution: | 315 | ||
| Drug Interactions of Concern to Dentistry | 315 | ||
| Serious Reactions | 315 | ||
| Dental Considerations | 315 | ||
| General: | 315 | ||
| Consultations: | 316 | ||
| Teach Patient/Family to: | 316 | ||
| clonazepam | 316 | ||
| Category and Schedule | 316 | ||
| Drug Class: | 316 | ||
| Mechanism of Action | 316 | ||
| Uses | 316 | ||
| Pharmacokinetics | 316 | ||
| Indications and Dosages | 316 | ||
| ► Adjunctive Treatment of Lennox-Gastaut Syndrome (Petit Mal Variant) and Akinetic, Myoclonic, and Absence (Petit Mal) Seizures | 316 | ||
| PO | 316 | ||
| Adults, Elderly, Children 10 yr and older. | 316 | ||
| Infants, Children younger than 10 yr or weighing less than 30 kg. | 317 | ||
| ► Panic Disorder | 317 | ||
| PO | 317 | ||
| Adults, Elderly. | 317 | ||
| Side Effects/Adverse Reactions | 317 | ||
| Frequent | 317 | ||
| Occasional | 317 | ||
| Rare | 317 | ||
| Precautions and Contraindications | 317 | ||
| Caution: | 317 | ||
| Drug Interactions of Concern to Dentistry | 317 | ||
| Serious Reactions | 317 | ||
| Dental Considerations | 317 | ||
| General: | 317 | ||
| Consultations: | 317 | ||
| Teach Patient/Family to: | 318 | ||
| clonidine | 318 | ||
| Category and Schedule | 318 | ||
| Drug Class: | 318 | ||
| Mechanism of Action | 318 | ||
| Uses | 318 | ||
| Pharmacokinetics | 318 | ||
| Indications and Dosages | 318 | ||
| ► Hypertension | 318 | ||
| clopidogrel | 320 | ||
| Category and Schedule | 320 | ||
| Drug Class: | 320 | ||
| Mechanism of Action | 320 | ||
| Uses | 320 | ||
| Pharmacokinetics | 320 | ||
| Indications and Dosages | 320 | ||
| ► MI, Stroke Reduction | 320 | ||
| clorazepate dipotassium | 321 | ||
| Category and Schedule | 321 | ||
| Drug Class: | 321 | ||
| Mechanism of Action | 321 | ||
| Uses | 321 | ||
| Pharmacokinetics | 321 | ||
| Indications and Dosages | 321 | ||
| ► Anxiety | 321 | ||
| PO (Regular-Release) | 321 | ||
| clotrimazole | 323 | ||
| Category and Schedule | 323 | ||
| Drug Class: | 323 | ||
| Mechanism of Action | 323 | ||
| Uses | 323 | ||
| Pharmacokinetics | 323 | ||
| Indications and Dosages | 323 | ||
| ► Oropharyngeal Candidiasis Treatment | 323 | ||
| clozapine | 324 | ||
| Category and Schedule | 324 | ||
| Drug Class: | 324 | ||
| Mechanism of Action | 324 | ||
| Uses | 324 | ||
| Pharmacokinetics | 324 | ||
| Indications and Dosages | 324 | ||
| ► Schizophrenic Disorders, Reduce Suicidal Behavior | 324 | ||
| PO | 324 | ||
| Adults. | 324 | ||
| Elderly. | 324 | ||
| Side Effects/Adverse Reactions | 324 | ||
| Frequent | 324 | ||
| Occasional | 324 | ||
| Rare | 324 | ||
| Precautions and Contraindications | 324 | ||
| Caution: | 325 | ||
| Drug Interactions of Concern to Dentistry | 325 | ||
| Serious Reactions | 325 | ||
| Dental Considerations | 325 | ||
| General: | 325 | ||
| Consultations: | 325 | ||
| Teach Patient/Family to: | 325 | ||
| cocaine hydrochloride | 326 | ||
| Category and Schedule | 326 | ||
| Drug Class: | 326 | ||
| Mechanism of Action | 326 | ||
| Uses | 326 | ||
| Pharmacokinetics | 326 | ||
| Indications and Dosages | 326 | ||
| ► Anesthesia | 326 | ||
| Topical | 326 | ||
| Adults, Elderly, Children. | 326 | ||
| Side Effects/Adverse Reactions | 326 | ||
| Frequent | 326 | ||
| Occasional | 326 | ||
| Precautions and Contraindications | 326 | ||
| Drug Interactions of Concern to Dentistry | 326 | ||
| Serious Reactions | 326 | ||
| Dental Considerations | 326 | ||
| General: | 326 | ||
| Consultations: | 327 | ||
| Teach Patient/Family: | 327 | ||
| codeine phosphate/codeine sulfate | 327 | ||
| Category and Schedule | 327 | ||
| Drug Class: | 327 | ||
| Mechanism of Action | 327 | ||
| Uses | 327 | ||
| Pharmacokinetics | 327 | ||
| Indications and Dosages | 328 | ||
| ► Analgesia | 328 | ||
| PO, IM, subcutaneous | 328 | ||
| Adults, Elderly. | 328 | ||
| Children. | 328 | ||
| ► Cough | 328 | ||
| PO | 328 | ||
| Adults, Elderly, Children 12 yr and older. | 328 | ||
| Children 6–11 yr. | 328 | ||
| Children 2–5 yr. | 328 | ||
| ► Dosage in Renal Impairment | 328 | ||
| Side Effects/Adverse Reactions | 328 | ||
| Frequent | 328 | ||
| Occasional | 328 | ||
| Rare | 328 | ||
| Precautions and Contraindications | 328 | ||
| Caution: | 328 | ||
| Drug Interactions of Concern to Dentistry | 328 | ||
| Serious Reactions | 328 | ||
| Dental Considerations | 328 | ||
| General: | 328 | ||
| Teach Patient/Family: | 328 | ||
| colchicine | 329 | ||
| Category and Schedule | 329 | ||
| Drug Class: | 329 | ||
| Mechanism of Action | 329 | ||
| Uses | 329 | ||
| Pharmacokinetics | 329 | ||
| Indications and Dosages | 329 | ||
| ► Acute Gouty Arthritis | 329 | ||
| colesevelam | 330 | ||
| Category and Schedule | 330 | ||
| Drug Class: | 330 | ||
| Mechanism of Action | 330 | ||
| Uses | 330 | ||
| Pharmacokinetics | 330 | ||
| Indications and Dosages | 330 | ||
| ► Primary Hyperlipidemia (Used as Monotherapy or in Combinations with an HMG COA Reductase Inhibitor, or “Statin”) | 330 | ||
| colestipol | 331 | ||
| Category and Schedule | 331 | ||
| Drug Class: | 331 | ||
| Mechanism of Action | 331 | ||
| Uses | 331 | ||
| Pharmacokinetics | 331 | ||
| Indications and Dosages | 331 | ||
| ► Primary Hypercholesterolemia | 331 | ||
| PO, Granules | 331 | ||
| conivaptan | 332 | ||
| Category and Schedule | 332 | ||
| Drug Class: | 332 | ||
| Mechanism of Action | 332 | ||
| Uses | 332 | ||
| Pharmacokinetics | 332 | ||
| Indications and Dosages | 332 | ||
| ► Hyponatremia | 332 | ||
| IV | 332 | ||
| Adults. | 332 | ||
| Side Effects/Adverse Reactions | 333 | ||
| Frequent | 333 | ||
| Occasional | 333 | ||
| Precautions and Contraindications | 333 | ||
| Caution: | 333 | ||
| Drug Interactions of Concern to Dentistry | 333 | ||
| Serious Reactions | 333 | ||
| Dental Considerations | 333 | ||
| Consultations: | 333 | ||
| Teach Patient/Family to: | 333 | ||
| cortisone acetate | 333 | ||
| Category and Schedule | 333 | ||
| Drug Class: | 333 | ||
| Mechanism of Action | 333 | ||
| Uses | 333 | ||
| Pharmacokinetics | 334 | ||
| Indications and Dosages | 334 | ||
| ► Antiinflammation, Immunosuppression | 334 | ||
| cromolyn sodium | 335 | ||
| Category and Schedule | 335 | ||
| Drug Class: | 335 | ||
| Mechanism of Action | 335 | ||
| Uses | 335 | ||
| Pharmacokinetics | 335 | ||
| Indications and Dosages | 335 | ||
| ► Asthma | 335 | ||
| Inhalation (Nebulization) | 335 | ||
| Adults, Elderly, Children older than 2 yr. | 335 | ||
| Aerosol spray | 335 | ||
| Adults, Elderly, Children 12 yr and older. | 336 | ||
| Children 5–11 yr. | 336 | ||
| ► Prevention of Bronchospasm | 336 | ||
| Inhalation (Nebulization) | 336 | ||
| Adults, Elderly, Children older than 2 yr. | 336 | ||
| Aerosol spray | 336 | ||
| Adults, Elderly, Children older than 5 yr. | 336 | ||
| ► Food Allergy, Inflammatory Bowel Disease | 336 | ||
| cyclobenzaprine hydrochloride | 337 | ||
| Category and Schedule | 337 | ||
| Drug Class: | 337 | ||
| Mechanism of Action | 337 | ||
| Uses | 337 | ||
| Pharmacokinetics | 337 | ||
| Indications and Dosages | 337 | ||
| ► Acute, Painful Musculoskeletal Conditions | 337 | ||
| PO | 337 | ||
| Adults. | 337 | ||
| Elderly. | 337 | ||
| ► Dosage in Hepatic Impairment | 338 | ||
| Mild. | 338 | ||
| Moderate and severe. | 338 | ||
| cyclopentolate hydrochloride | 339 | ||
| Category and Schedule | 339 | ||
| Drug Class: | 339 | ||
| Mechanism of Action | 339 | ||
| Uses | 339 | ||
| Pharmacokinetics | 339 | ||
| Indications and Dosages | 339 | ||
| ► Cycloplegia Induction, Mydriasis Induction | 339 | ||
| Ophthalmic | 339 | ||
| Adults, Elderly, Children. | 339 | ||
| Neonates, infants. | 339 | ||
| Side Effects/Adverse Reactions | 339 | ||
| Occasional | 339 | ||
| Rare | 339 | ||
| Precautions and Contraindications | 339 | ||
| Drug Interactions of Concern to Dentistry | 339 | ||
| Serious Reactions | 339 | ||
| Dental Considerations | 339 | ||
| General: | 339 | ||
| cyclophosphamide | 340 | ||
| Category and Schedule | 340 | ||
| Drug Class: | 340 | ||
| Mechanism of Action | 340 | ||
| Uses | 340 | ||
| Pharmacokinetics | 340 | ||
| Indications and Dosages | 340 | ||
| ► Ovarian Adenocarcinoma, Breast Carcinoma, Hodgkin’s Disease, Non-Hodgkin’s Lymphoma, Multiple Myeloma, Leukemia (Acute Lymphoblastic, Acute Myelogenous, Acute Monocytic, Chronic Granulocytic, Chronic Lymphocytic), Mycosis Fungoides, Disseminated Neuroblastoma, Retinoblastoma | 340 | ||
| cycloserine | 341 | ||
| Category and Schedule | 341 | ||
| Drug Class: | 341 | ||
| Mechanism of Action | 341 | ||
| Uses | 341 | ||
| Pharmacokinetics | 341 | ||
| Indications and Dosages | 342 | ||
| ► TB | 342 | ||
| Adults, Elderly. | 342 | ||
| Children. | 342 | ||
| ► Dosage in Renal Impairment | 342 | ||
| Side Effects/Adverse Reactions | 342 | ||
| Occasional | 342 | ||
| Precautions and Contraindications | 342 | ||
| Drug Interactions of Concern to Dentistry | 342 | ||
| Serious Reactions/Adverse Reactions | 342 | ||
| Dental Considerations | 342 | ||
| General: | 342 | ||
| Consultation: | 342 | ||
| Teach Patient/Family to: | 342 | ||
| cyclosporine | 343 | ||
| Category and Schedule | 343 | ||
| Drug Class: | 343 | ||
| Mechanism of Action | 343 | ||
| Uses | 343 | ||
| Pharmacokinetics | 343 | ||
| Indications and Dosages | 343 | ||
| ► Transplantation, Prevention of Organ Rejection | 343 | ||
| cyproheptadine | 345 | ||
| Category and Schedule | 345 | ||
| Drug Class: | 345 | ||
| Mechanism of Action | 345 | ||
| Uses | 345 | ||
| Pharmacokinetics | 345 | ||
| Indications and Dosages | 345 | ||
| ► Allergic Condition | 345 | ||
| cysteamine bitartrate | 346 | ||
| Category and Schedule | 346 | ||
| Drug Class: | 346 | ||
| Mechanism of Action | 346 | ||
| Uses | 346 | ||
| Pharmacokinetics | 346 | ||
| Indications and Dosages | 346 | ||
| ► Cystinosis | 346 | ||
| PO | 346 | ||
| Adults. | 346 | ||
| Children older than 12 yr and weighing more than 110 lb. | 346 | ||
| Children 6–12 yr. | 346 | ||
| Side Effects/Adverse Reactions | 346 | ||
| Frequent | 346 | ||
| Occasional | 346 | ||
| Precautions and Contraindications | 346 | ||
| Drug Interactions of Concern to Dentistry | 346 | ||
| Serious Reactions | 347 | ||
| Dental Considerations | 347 | ||
| General: | 347 | ||
| Consultations: | 347 | ||
| Teach Patient/Family to: | 347 | ||
| cytarabine | 347 | ||
| Category and Schedule | 347 | ||
| Drug Class: | 347 | ||
| Mechanism of Action | 347 | ||
| Uses | 347 | ||
| Pharmacokinetics | 347 | ||
| Indications and Dosages | 347 | ||
| ► To Induce Remission in Acute Lymphocytic Leukemia, Acute and Chronic Myelocytic Leukemia, Meningeal Leukemia, or Non-Hodgkin’s Lymphoma in Children | 347 | ||
| dabigatran | 350 | ||
| Category and Schedule | 350 | ||
| Drug Class: | 350 | ||
| Mechanism of Action | 350 | ||
| Uses | 350 | ||
| Pharmacokinetics | 350 | ||
| Indications and Dosages | 350 | ||
| ► Nonvalvular Atrial Fibrillation | 350 | ||
| daclizumab | 351 | ||
| Category and Schedule | 351 | ||
| Drug Class: | 351 | ||
| Mechanism of Action | 351 | ||
| Uses | 351 | ||
| Pharmacokinetics | 351 | ||
| Indications and Dosages | 351 | ||
| ► Prevention of Acute Renal Transplant Rejection (in combination with an immunosuppressive) | 351 | ||
| IV | 351 | ||
| Adults, Children. | 351 | ||
| Side Effects/Adverse Reactions | 351 | ||
| Occasional | 351 | ||
| Precautions and Contraindications | 352 | ||
| Caution: | 352 | ||
| Drug Interactions of Concern to Dentistry | 352 | ||
| Serious Reactions | 352 | ||
| Dental Considerations | 352 | ||
| General: | 352 | ||
| Consultations: | 352 | ||
| Teach Patient/Family to: | 352 | ||
| dalfampridine | 352 | ||
| Category and Schedule | 352 | ||
| Drug Class: | 352 | ||
| Mechanism of Action | 352 | ||
| Uses | 352 | ||
| Pharmacokinetics | 352 | ||
| Indications and Dosages | 352 | ||
| ► Multiple Sclerosis | 352 | ||
| PO | 352 | ||
| Adults. | 352 | ||
| Side Effects/Adverse Reactions | 352 | ||
| Frequent | 352 | ||
| Occasional | 352 | ||
| Rare | 353 | ||
| Precautions and Contraindications | 353 | ||
| Caution: | 353 | ||
| Drug Interactions of Concern to Dentistry | 353 | ||
| Serious Reactions | 353 | ||
| Dental Considerations | 353 | ||
| General: | 353 | ||
| Consultations: | 353 | ||
| Teach Patient/Family to: | 353 | ||
| dalteparin sodium | 353 | ||
| Category and Schedule | 353 | ||
| Drug Class: | 353 | ||
| Mechanism of Action | 353 | ||
| Uses | 353 | ||
| Pharmacokinetics | 353 | ||
| Indications and Dosages | 353 | ||
| ► Low- to Moderate-Risk Abdominal Surgery | 353 | ||
| Subcutaneous | 353 | ||
| Adults, Elderly. | 353 | ||
| ► High-Risk Abdominal Surgery | 354 | ||
| danaparoid | 354 | ||
| Category and Schedule | 354 | ||
| Drug Class: | 354 | ||
| Mechanism of Action | 355 | ||
| Uses | 355 | ||
| Pharmacokinetics | 355 | ||
| Indications and Dosages | 355 | ||
| ► Prevention of DVT | 355 | ||
| Subcutaneous | 355 | ||
| Adults, Elderly. | 355 | ||
| Side Effects/Adverse Reactions | 355 | ||
| Frequent | 355 | ||
| Occasional | 355 | ||
| Rare | 355 | ||
| Precautions and Contraindications | 355 | ||
| Caution: | 355 | ||
| Drug Interactions of Concern to Dentistry | 355 | ||
| Serious Reactions | 355 | ||
| Dental Considerations | 355 | ||
| General: | 355 | ||
| Consultations: | 356 | ||
| Teach Patient/Family to: | 356 | ||
| danazol | 356 | ||
| Category and Schedule | 356 | ||
| Drug Class: | 356 | ||
| Mechanism of Action | 356 | ||
| Uses | 356 | ||
| Pharmacokinetics | 356 | ||
| Indications and Dosages | 356 | ||
| ► Endometriosis | 356 | ||
| dantrolene sodium | 357 | ||
| Category and Schedule | 357 | ||
| Drug Class: | 357 | ||
| Mechanism of Action | 357 | ||
| Uses | 357 | ||
| Pharmacokinetics | 357 | ||
| Indications and Dosages | 357 | ||
| ► Spasticity | 357 | ||
| PO | 357 | ||
| Adults, Elderly. | 357 | ||
| Children. | 358 | ||
| ► Prevention of Malignant Hyperthermic Crisis | 358 | ||
| PO | 358 | ||
| dapagliflozin + metformin | 359 | ||
| Category and Schedule | 359 | ||
| Drug Class: | 359 | ||
| Mechanism of Action | 359 | ||
| Uses | 359 | ||
| Pharmacokinetics | 359 | ||
| Indications and Dosages | 359 | ||
| ► Type 2 Diabetes Mellitus | 359 | ||
| PO | 359 | ||
| Adults. | 359 | ||
| Side Effects/Adverse Reactions | 359 | ||
| Frequent | 359 | ||
| Occasional | 359 | ||
| Precautions and Contraindications | 359 | ||
| Drug Interactions of Concern to Dentistry | 360 | ||
| Serious Reactions | 360 | ||
| Dental Considerations | 360 | ||
| General: | 360 | ||
| Consultations: | 360 | ||
| Teach Patient/Family to: | 360 | ||
| dapiprazole hydrochloride | 360 | ||
| Category and Schedule | 360 | ||
| Drug Class: | 360 | ||
| Mechanism of Action | 360 | ||
| Uses | 360 | ||
| Pharmacokinetics | 360 | ||
| Indications and Dosages | 360 | ||
| ► Drug-Induced Mydriasis | 360 | ||
| Ophthalmic | 360 | ||
| Adults, Elderly, Children. | 360 | ||
| dapsone | 361 | ||
| Category and Schedule | 361 | ||
| Drug Class: | 361 | ||
| Mechanism of Action | 361 | ||
| Uses | 361 | ||
| Pharmacokinetics | 361 | ||
| Indications and Dosages | 361 | ||
| ► Leprosy | 361 | ||
| daptomycin | 362 | ||
| Category and Schedule | 362 | ||
| Drug Class: | 362 | ||
| Mechanism of Action | 362 | ||
| Uses | 362 | ||
| Pharmacokinetics | 362 | ||
| Indications and Dosages | 362 | ||
| ► Complicated Skin and Skin-Structure Infections | 362 | ||
| IV | 362 | ||
| Adults, Elderly. | 362 | ||
| ► Dosage in Renal Impairment | 362 | ||
| Side Effects/Adverse Reactions | 362 | ||
| Frequent | 362 | ||
| Occasional | 362 | ||
| Rare | 362 | ||
| Precautions and Contraindications | 363 | ||
| Caution: | 363 | ||
| Drug Interactions of Concern to Dentistry | 363 | ||
| Serious Reactions | 363 | ||
| Dental Considerations | 363 | ||
| General: | 363 | ||
| Consultations: | 363 | ||
| darbepoetin alfa | 363 | ||
| Category and Schedule | 363 | ||
| Drug Class: | 363 | ||
| Mechanism of Action | 363 | ||
| Uses | 363 | ||
| Pharmacokinetics | 363 | ||
| Indications and Dosages | 363 | ||
| ► Anemia in Chronic Renal Failure | 363 | ||
| IV Bolus, Subcutaneous | 363 | ||
| darifenacin | 364 | ||
| Category and Schedule | 364 | ||
| Drug Class: | 364 | ||
| Mechanism of Action | 364 | ||
| Uses | 364 | ||
| Pharmacokinetics | 364 | ||
| Indications and Dosages | 365 | ||
| ► Symptoms of Bladder Overactivity | 365 | ||
| PO | 365 | ||
| Adults. | 365 | ||
| Side Effects/Adverse Reactions | 365 | ||
| Frequent | 365 | ||
| Occasional | 365 | ||
| Precautions and Contraindications | 365 | ||
| Drug Interactions of Concern to Dentistry | 365 | ||
| Serious Reactions | 365 | ||
| Dental Considerations | 365 | ||
| General: | 365 | ||
| Teach Patient/Family: | 365 | ||
| darunavir | 365 | ||
| Category and Schedule | 365 | ||
| Drug Class: | 365 | ||
| Mechanism of Action | 365 | ||
| Uses | 366 | ||
| Pharmacokenetics | 366 | ||
| Indications and Dosages | 366 | ||
| ► HIV Infection (in combination with ritonavir) | 366 | ||
| PO | 366 | ||
| Adults. | 366 | ||
| Side Effects/Adverse Reactions | 366 | ||
| Frequent | 366 | ||
| Occasional | 366 | ||
| Rare | 366 | ||
| Precautions and Contraindications | 366 | ||
| Drug Interactions of Concern to Dentistry | 366 | ||
| Serious Reactions | 366 | ||
| Dental Considerations | 367 | ||
| General: | 367 | ||
| Consultations: | 367 | ||
| Teach Patient/Family to: | 367 | ||
| darunavir + cobicistat | 367 | ||
| Category and Schedule | 367 | ||
| Drug Class: | 367 | ||
| Mechanism of Action | 367 | ||
| Uses | 367 | ||
| Pharmacokinetics | 367 | ||
| Indications and Dosages | 367 | ||
| ► HIV-1 Infection (treatment-naive or treatment-experienced patients without darunavir resistance–associated substitutions) | 367 | ||
| PO | 367 | ||
| Adults. | 367 | ||
| Side Effects/Adverse Reactions | 368 | ||
| Frequent | 368 | ||
| Occasional | 368 | ||
| Precautions and Contraindications | 368 | ||
| Drug Interactions of Concern to Dentistry | 368 | ||
| Serious Reactions | 368 | ||
| Dental Considerations | 368 | ||
| General: | 368 | ||
| Consultations: | 369 | ||
| Teach Patient/Family to: | 369 | ||
| dasatinib | 369 | ||
| Category and Schedule | 369 | ||
| Drug Class: | 369 | ||
| Mechanism of Action | 369 | ||
| Uses | 369 | ||
| Pharmacokenetics | 369 | ||
| Indications and Dosages | 369 | ||
| ► ALL, Philadelphia Chromosome-Positive, Resistant or Intolerant to Prior Therapy | 369 | ||
| PO | 369 | ||
| daunorubicin citrate liposome | 371 | ||
| Category and Schedule | 371 | ||
| Drug Class: | 371 | ||
| Mechanism of Action | 371 | ||
| Uses | 371 | ||
| Pharmacokinetics | 371 | ||
| Indications and Dosages | 371 | ||
| ► KS | 371 | ||
| IV | 371 | ||
| Adults. | 371 | ||
| Side Effects/Adverse Reactions | 371 | ||
| Frequent | 371 | ||
| Occasional | 371 | ||
| Rare | 371 | ||
| Precautions and Contraindications | 371 | ||
| Drug Interactions of Concern to Dentistry | 371 | ||
| Serious Reactions | 371 | ||
| Dental Considerations | 371 | ||
| General: | 371 | ||
| Consultations: | 372 | ||
| Teach Patient/Family to: | 372 | ||
| decitabine | 372 | ||
| Category and Schedule | 372 | ||
| Drug Class: | 372 | ||
| Mechanism of Action | 372 | ||
| Uses | 372 | ||
| Pharmacokinetics | 372 | ||
| Indications and Dosages | 372 | ||
| ► MDS | 372 | ||
| IV | 372 | ||
| Adults. | 372 | ||
| Side Effects/Adverse Reactions | 372 | ||
| Frequent | 372 | ||
| Occasional | 373 | ||
| Rare | 373 | ||
| Precautions and Contraindications | 373 | ||
| Drug Interactions of Concern to Dentistry | 373 | ||
| Serious Reactions | 373 | ||
| Dental Considerations | 373 | ||
| General: | 373 | ||
| Consultations: | 373 | ||
| Teach Patient/Family to: | 373 | ||
| deferiprone | 374 | ||
| Category and Schedule | 374 | ||
| Drug Class: | 374 | ||
| Mechanism of Action | 374 | ||
| Uses | 374 | ||
| Pharmacokinetics | 374 | ||
| Indications and Dosages | 374 | ||
| ► Transfusional Iron Overload | 374 | ||
| PO | 374 | ||
| Adults. | 374 | ||
| Side Effects/Adverse Reactions | 374 | ||
| Frequent | 374 | ||
| Occasional | 374 | ||
| Precautions and Contraindications | 374 | ||
| delavirdine mesylate | 375 | ||
| Category and Schedule | 375 | ||
| Drug Class: | 375 | ||
| Mechanism of Action | 375 | ||
| Uses | 375 | ||
| Pharmacokinetics | 375 | ||
| Indications and Dosages | 375 | ||
| ► HIV Infection (in combination with other antiretrovirals) | 375 | ||
| PO | 375 | ||
| Adults. | 375 | ||
| Side Effects/Adverse Reactions | 375 | ||
| Frequent | 375 | ||
| Occasional | 375 | ||
| Precautions and Contraindications | 375 | ||
| Caution: | 375 | ||
| Drug Interactions of Concern to Dentistry | 375 | ||
| Serious Reactions | 375 | ||
| Dental Considerations | 375 | ||
| General: | 375 | ||
| Dental Considerations | 376 | ||
| General: | 376 | ||
| Consultations: | 376 | ||
| Teach Patient/Family to: | 376 | ||
| demecarium bromide | 376 | ||
| Category and Schedule | 376 | ||
| Drug Class: | 376 | ||
| Mechanism of Action | 376 | ||
| Uses | 376 | ||
| Pharmacokinetics | 376 | ||
| Indications and Dosages | 376 | ||
| ► Glaucoma | 376 | ||
| demeclocycline hydrochloride | 377 | ||
| Category and Schedule | 377 | ||
| Drug Class: | 377 | ||
| Mechanism of Action | 377 | ||
| Uses | 378 | ||
| Pharmacokinetics | 378 | ||
| Indications and Dosages | 378 | ||
| ► Mild-to-Moderate Infections, Including Acne, Pertussis, Chronic Bronchitis, and UTIs | 378 | ||
| deoxycholic acid | 379 | ||
| Category and Schedule | 379 | ||
| Drug Class: | 379 | ||
| Mechanism of Action | 379 | ||
| Uses | 379 | ||
| Pharmacokinetics | 379 | ||
| Indications and Dosages | 379 | ||
| ► Submental Convexity/Fullness | 379 | ||
| Adults. | 379 | ||
| Side Effects/Adverse Reactions | 379 | ||
| Frequent | 379 | ||
| Occasional | 379 | ||
| Precautions and Contraindications | 379 | ||
| Drug Interactions of Concern to Dentistry | 379 | ||
| Serious Reactions | 380 | ||
| Dental Considerations | 380 | ||
| General: | 380 | ||
| Consultations: | 380 | ||
| Teach Patient/Family to: | 380 | ||
| desipramine hydrochloride | 380 | ||
| Category and Schedule | 380 | ||
| Drug Class: | 380 | ||
| Mechanism of Action | 380 | ||
| Uses | 380 | ||
| Pharmacokinetics | 380 | ||
| Indications and Dosages | 380 | ||
| ► Depression | 380 | ||
| PO | 380 | ||
| Adults. | 380 | ||
| Elderly. | 380 | ||
| Children older than 12 yr. | 380 | ||
| Children 6–12 yr. | 380 | ||
| Side Effects/Adverse Reactions | 380 | ||
| Frequent | 380 | ||
| Occasional | 381 | ||
| Rare | 381 | ||
| Precautions and Contraindications | 381 | ||
| Caution: | 381 | ||
| Drug Interactions of Concern to Dentistry | 381 | ||
| Serious Reactions | 381 | ||
| Dental Considerations | 381 | ||
| General: | 381 | ||
| Consultations: | 381 | ||
| Teach Patient/Family to: | 381 | ||
| desirudin | 382 | ||
| Category and Schedule | 382 | ||
| Drug Class: | 382 | ||
| Mechanism of Action | 382 | ||
| Uses | 382 | ||
| Pharmacokinetics | 382 | ||
| Indications and Dosages | 382 | ||
| ► Prevention of DVT in Patients Undergoing Hip Replacement Surgery | 382 | ||
| desloratadine | 383 | ||
| Category and Schedule | 383 | ||
| Drug Class: | 383 | ||
| Mechanism of Action | 383 | ||
| Uses | 383 | ||
| Pharmacokinetics | 383 | ||
| Indications and Dosages | 383 | ||
| ► Allergic Rhinitis, Urticaria | 383 | ||
| PO | 383 | ||
| Adults, Elderly, Children older than 12 yr. | 383 | ||
| ► Dosage in Hepatic or Renal Impairment | 383 | ||
| Side Effects/Adverse Reactions | 383 | ||
| Frequent | 383 | ||
| Occasional | 383 | ||
| Rare | 383 | ||
| Precautions and Contraindications | 383 | ||
| Caution: | 383 | ||
| Drug Interactions of Concern to Dentistry | 384 | ||
| Serious Reactions | 384 | ||
| Dental Considerations | 384 | ||
| General: | 384 | ||
| Teach Patient/Family to: | 384 | ||
| desmopressin | 384 | ||
| Category and Schedule | 384 | ||
| Drug Class: | 384 | ||
| Mechanism of Action | 384 | ||
| Uses | 384 | ||
| Pharmacokinetics | 384 | ||
| Indications and Dosages | 384 | ||
| ► Primary Nocturnal Enuresis | 384 | ||
| desonide | 386 | ||
| Category and Schedule | 386 | ||
| Drug Class: | 386 | ||
| Mechanism of Action | 386 | ||
| Uses | 386 | ||
| Pharmacokinetics | 386 | ||
| Indications and Dosages | 386 | ||
| ► Dermatoses | 386 | ||
| Topical | 386 | ||
| Adults, Elderly. | 386 | ||
| ► Otitis Externa | 386 | ||
| Aural | 386 | ||
| Adults, Elderly, Children. | 386 | ||
| Side Effects/Adverse Reactions | 386 | ||
| Occasional | 386 | ||
| Precautions and Contraindications | 386 | ||
| Caution: | 386 | ||
| Drug Interactions of Concern to Dentistry | 386 | ||
| Serious Reactions | 386 | ||
| Dental Considerations | 386 | ||
| General: | 386 | ||
| desoximetasone | 387 | ||
| Category and Schedule | 387 | ||
| Drug Class: | 387 | ||
| Mechanism of Action | 387 | ||
| Uses | 387 | ||
| Pharmacokinetics | 387 | ||
| Indications and Dosages | 387 | ||
| ► Dermatoses | 387 | ||
| Topical | 387 | ||
| Adults, Elderly. | 387 | ||
| Children. | 387 | ||
| Side Effects/Adverse Reactions | 387 | ||
| Frequent | 387 | ||
| Occasional | 387 | ||
| Rare | 387 | ||
| Precautions and Contraindications | 387 | ||
| Caution: | 387 | ||
| Serious Reactions | 387 | ||
| Dental Considerations | 387 | ||
| General: | 387 | ||
| Teach Patient/Family to: | 387 | ||
| desvenlafaxine | 388 | ||
| Category and Schedule | 388 | ||
| Drug Class: | 388 | ||
| Mechanism of Action | 388 | ||
| Uses | 388 | ||
| Pharmacokinetics | 388 | ||
| Indications and Dosages | 388 | ||
| ► Major Depressive Disorder | 388 | ||
| PO | 388 | ||
| dexamethasone | 389 | ||
| Category and Schedule | 389 | ||
| Drug Class: | 389 | ||
| Mechanism of Action | 389 | ||
| Uses | 390 | ||
| Pharmacokinetics | 390 | ||
| Indications and Dosages | 390 | ||
| ► Antiinflammatory | 390 | ||
| dexamethasone sodium phosphate | 391 | ||
| Category and Schedule | 391 | ||
| Drug Class: | 391 | ||
| Mechanism of Action | 392 | ||
| Uses | 392 | ||
| Pharmacokinetics | 392 | ||
| Indications and Dosages | 392 | ||
| ► Ocular Inflammatory Conditions | 392 | ||
| Ophthalmic, Ointment | 392 | ||
| dexchlorpheniramine | 393 | ||
| Category and Schedule | 393 | ||
| Drug Class: | 393 | ||
| Mechanism of Action | 393 | ||
| Uses | 393 | ||
| Pharmacokinetics | 393 | ||
| Indications and Dosages | 393 | ||
| ► Allergic Rhinitis, Common Cold | 393 | ||
| PO | 393 | ||
| Adults, Elderly, Children 12 yr or older. | 393 | ||
| Children 6–11 yr. | 393 | ||
| Children 2–5 yr. | 393 | ||
| Side Effects/Adverse Reactions | 393 | ||
| Frequent | 393 | ||
| Occasional | 393 | ||
| Precautions and Contraindications | 393 | ||
| Caution: | 393 | ||
| Drug Interactions of Concern to Dentistry | 393 | ||
| Serious Reactions | 394 | ||
| Dental Considerations | 394 | ||
| General: | 394 | ||
| Teach Patient/Family: | 394 | ||
| dexlansoprazole | 394 | ||
| Category and Schedule | 394 | ||
| Drug Class: | 394 | ||
| Mechanisn of Action | 394 | ||
| Uses | 394 | ||
| Pharmacokinetics | 394 | ||
| Indications and Dosages | 394 | ||
| ► Erosive Esophagitis | 394 | ||
| dexmethylphenidate hydrochloride | 395 | ||
| Category and Schedule | 395 | ||
| Drug Class: | 395 | ||
| Mechanism of Action | 395 | ||
| Uses | 395 | ||
| Pharmacokinetics | 395 | ||
| Indications and Dosages | 395 | ||
| ► ADHD | 395 | ||
| PO | 395 | ||
| Patients new to dexmethylphenidate or methylphenidate. | 395 | ||
| Patients currently taking methylphenidate. | 396 | ||
| Side Effects/Adverse Reactions | 396 | ||
| Frequent | 396 | ||
| Occasional | 396 | ||
| Rare | 396 | ||
| Precautions and Contraindications | 396 | ||
| Caution: | 396 | ||
| Drug Interactions of Concern to Dentistry | 396 | ||
| Serious Reactions | 396 | ||
| Dental Considerations | 396 | ||
| General: | 396 | ||
| Consultations: | 396 | ||
| Teach Patient/Family to: | 396 | ||
| dextroamphetamine sulfate | 397 | ||
| Category and Schedule | 397 | ||
| Drug Class: | 397 | ||
| Mechanism of Action | 397 | ||
| Uses | 397 | ||
| Pharmacokinetics | 397 | ||
| Indications and Dosages | 397 | ||
| ► Narcolepsy | 397 | ||
| dextromethorphan | 398 | ||
| Category and Schedule | 398 | ||
| Drug Class: | 398 | ||
| Mechanism of Action | 398 | ||
| dextromethorphan + quinidine | 399 | ||
| Category and Schedule | 399 | ||
| Drug Class: | 399 | ||
| Mechanism of Action | 399 | ||
| Uses | 399 | ||
| Pharmacokinetics | 399 | ||
| Indications and Dosages | 399 | ||
| ► Cough | 399 | ||
| PO | 399 | ||
| Adults, Elderly, Children 12 yr and older. | 399 | ||
| Children 6–12 yr. | 399 | ||
| Children 2–5 yr. | 399 | ||
| Side Effects/Adverse Reactions | 399 | ||
| Rare | 399 | ||
| Precautions and Contraindications | 399 | ||
| Caution: | 399 | ||
| Drug Interactions of Concern to Dentistry | 399 | ||
| Serious Reactions | 399 | ||
| Dental Considerations | 399 | ||
| General: | 399 | ||
| Indications and Dosages | 400 | ||
| ► Pseudobulbar Affect (PBA) | 400 | ||
| PO | 400 | ||
| Adults. | 400 | ||
| Side Effects/Adverse Reactions | 400 | ||
| Frequent | 400 | ||
| Occasional | 400 | ||
| Precautions and Contraindications | 400 | ||
| Drug Interactions of Concern to Dentistry | 400 | ||
| Serious Reactions | 400 | ||
| Dental Considerations | 400 | ||
| General: | 400 | ||
| Teach Patient/Family to: | 400 | ||
| diazepam | 401 | ||
| Category and Schedule | 401 | ||
| Drug Class: | 401 | ||
| Mechanism of Action | 401 | ||
| Uses | 401 | ||
| Pharmacokinetics | 401 | ||
| Indications and Dosages | 401 | ||
| ► Anxiety, Skeletal Muscle Relaxation | 401 | ||
| diclofenac | 403 | ||
| Category and Schedule | 403 | ||
| Drug Class: | 403 | ||
| Mechanism of Action | 403 | ||
| Uses | 403 | ||
| Pharmacokinetics | 403 | ||
| Indications and Dosages | 403 | ||
| ► Osteoarthritis | 403 | ||
| dicloxacillin sodium | 405 | ||
| Category and Schedule | 405 | ||
| Drug Class: | 405 | ||
| Mechanism of Action | 405 | ||
| Uses | 405 | ||
| Pharmacokinetics | 405 | ||
| Indications and Dosage | 405 | ||
| ► Respiratory Tract Infection, Staphylococcal and Streptococcal Infections | 405 | ||
| PO | 405 | ||
| Adults, Elderly, Children weighing more than 40 kg. | 405 | ||
| Children weighing less than 40 kg. | 405 | ||
| Side Effects/Adverse Reactions | 405 | ||
| Frequent | 405 | ||
| Occasional | 406 | ||
| Precautions and Contraindications | 406 | ||
| Caution: | 406 | ||
| Drug Interactions of Concern to Dentistry | 406 | ||
| Serious Reactions | 406 | ||
| Dental Considerations | 406 | ||
| General: | 406 | ||
| Consultations: | 406 | ||
| Teach Patient/Family to: | 406 | ||
| dicyclomine hydrochloride | 406 | ||
| Category and Schedule | 406 | ||
| Drug Class: | 406 | ||
| Mechanism of Action | 406 | ||
| Uses | 406 | ||
| Pharmacokinetics | 406 | ||
| Indications and Dosages | 406 | ||
| ► Functional Disturbances of GI Motility | 406 | ||
| PO | 406 | ||
| Adults. | 406 | ||
| Children older than 2 yr. | 407 | ||
| Children 6 mo–2 yr. | 407 | ||
| Elderly. | 407 | ||
| IM | 407 | ||
| Side Effects/Adverse Reactions | 407 | ||
| Frequent | 407 | ||
| Occasional | 407 | ||
| Rare | 407 | ||
| Precautions and Contraindications | 407 | ||
| Caution: | 407 | ||
| Drug Interactions of Concern to Dentistry | 407 | ||
| Serious Reactions | 407 | ||
| Dental Considerations | 407 | ||
| General: | 407 | ||
| Consultation: | 407 | ||
| Teach Patient/Family to: | 407 | ||
| didanosine | 408 | ||
| Category and Schedule | 408 | ||
| Drug Class: | 408 | ||
| Mechanism of Action | 408 | ||
| Uses | 408 | ||
| Pharmacokinetics | 408 | ||
| Indications and Dosages | 408 | ||
| ► HIV Infection (in combination with other antiretrovirals) | 408 | ||
| PO (Chewable Tablets) | 408 | ||
| diethylpropion | 410 | ||
| Category and Schedule | 410 | ||
| Drug Class: | 410 | ||
| Mechanism of Action | 410 | ||
| Uses | 410 | ||
| Pharmacokinetics | 410 | ||
| Indications and Dosages | 410 | ||
| ► Obesity | 410 | ||
| PO | 410 | ||
| Adults. | 410 | ||
| Side Effects/Adverse Reactions | 410 | ||
| Frequent | 410 | ||
| Occasional | 410 | ||
| Rare | 410 | ||
| Precautions and Contraindications | 410 | ||
| Caution: | 410 | ||
| Drug Interactions of Concern to Dentistry | 410 | ||
| Serious Reactions | 410 | ||
| Dental Considerations | 410 | ||
| General: | 410 | ||
| Consultations: | 411 | ||
| Teach Patient/Family to: | 411 | ||
| diflorasone | 411 | ||
| Category and Schedule | 411 | ||
| Drug Class: | 411 | ||
| Mechanism of Action | 411 | ||
| Uses | 411 | ||
| Pharmacokinetics | 411 | ||
| Indications and Dosages | 411 | ||
| ► Dermatoses | 411 | ||
| Topical | 411 | ||
| Adults, Elderly. | 411 | ||
| Side Effects/Adverse Reactions | 411 | ||
| Rare | 411 | ||
| Precautions and Contraindications | 411 | ||
| Caution: | 411 | ||
| Serious Reactions | 412 | ||
| Dental Considerations | 412 | ||
| General: | 412 | ||
| diflunisal | 412 | ||
| Category and Schedule | 412 | ||
| Drug Class: | 412 | ||
| Mechanism of Action | 412 | ||
| Uses | 412 | ||
| Pharmacokinetics | 412 | ||
| Indications and Dosages | 412 | ||
| ► Mild-to-Moderate Pain | 412 | ||
| digoxin | 414 | ||
| Category and Schedule | 414 | ||
| Drug Class: | 414 | ||
| Mechanism of Action | 414 | ||
| Uses | 414 | ||
| Pharmacokinetics | 414 | ||
| Indications and Dosages | 414 | ||
| ► Rapid Loading Dose for the Management and Treatment of CHF; Control of Ventricular Rate in Patients with Atrial Fibrillation; Treatment and Prevention of Recurrent Paroxysmal Atrial Tachycardia | 414 | ||
| PO | 414 | ||
| dihydrotachysterol | 415 | ||
| Category and Schedule | 415 | ||
| Drug Class: | 415 | ||
| Mechanism of Action | 415 | ||
| Uses | 416 | ||
| Pharmacokinetics | 416 | ||
| Indications and Dosages | 416 | ||
| ► Hypoparathyroidism | 416 | ||
| diltiazem hydrochloride | 417 | ||
| Category and Schedule | 417 | ||
| Drug Class: | 417 | ||
| Mechanism of Action | 417 | ||
| Uses | 417 | ||
| Pharmacokinetics | 417 | ||
| Indications and Dosages | 417 | ||
| ► Angina Related to Coronary Artery Spasm (Prinzmetal’s Variant), Chronic Stable Angina (Effort-Associated) | 417 | ||
| PO | 417 | ||
| dimenhydrinate | 419 | ||
| Category and Schedule | 419 | ||
| Drug Class: | 419 | ||
| Mechanism of Action | 419 | ||
| Uses | 419 | ||
| Pharmacokinetics | 419 | ||
| Indications and Dosages | 419 | ||
| ► Motion Sickness | 419 | ||
| PO | 419 | ||
| Adults, Elderly, Children older than 12 yr. | 419 | ||
| Children 6–12 yr. | 419 | ||
| Children 2–5 yr. | 419 | ||
| Side Effects/Adverse Reactions | 419 | ||
| Frequent | 419 | ||
| Occasional | 419 | ||
| Rare | 419 | ||
| Precautions and Contraindications | 419 | ||
| Caution: | 419 | ||
| Drug Interactions of Concern to Dentistry | 420 | ||
| Serious Reactions | 420 | ||
| Dental Considerations | 420 | ||
| General: | 420 | ||
| Teach Patient/Family to: | 420 | ||
| dimethyl fumarate | 420 | ||
| Category and Schedule | 420 | ||
| Drug Class: | 420 | ||
| Mechanism of Action | 420 | ||
| Uses | 420 | ||
| Pharmacokinetics | 420 | ||
| Indications and Dosages | 420 | ||
| ► Multiple Sclerosis | 420 | ||
| PO | 420 | ||
| Adults. | 420 | ||
| Side Effects/Adverse Reactions | 420 | ||
| Frequent | 420 | ||
| Occasional | 420 | ||
| Precautions and Contraindications | 421 | ||
| Drug Interactions of Concern to Dentistry | 421 | ||
| Serious Reactions | 421 | ||
| Dental Considerations | 421 | ||
| General: | 421 | ||
| Consultations: | 421 | ||
| Teach Patient/Family to: | 421 | ||
| diphenhydramine | 421 | ||
| Category and Schedule | 421 | ||
| Drug Class: | 421 | ||
| Mechanism of Action | 421 | ||
| Uses | 422 | ||
| Pharmacokinetics | 422 | ||
| Indications and Dosages | 422 | ||
| ► Moderate to Severe Allergic Reaction, Dystonic Reaction | 422 | ||
| dipivefrin hydrochloride | 423 | ||
| Category and Schedule | 423 | ||
| Drug Class: | 423 | ||
| Mechanism of Action | 423 | ||
| Uses | 423 | ||
| Pharmacokinetics | 423 | ||
| Indications and Dosages | 423 | ||
| ► Glaucoma, Open-Angle | 423 | ||
| Ophthalmic, Topical | 423 | ||
| Adults, Elderly. | 423 | ||
| Side Effects/Adverse Reactions | 423 | ||
| Occasional | 423 | ||
| dipyridamole | 424 | ||
| Category and Schedule | 424 | ||
| Drug Class: | 424 | ||
| Mechanism of Action | 424 | ||
| Uses | 424 | ||
| Pharmacokinetics | 424 | ||
| Indications and Dosages | 424 | ||
| ► Prevention of Thromboembolic Disorders | 424 | ||
| PO | 424 | ||
| Adults, Elderly. | 424 | ||
| Children. | 424 | ||
| ► Diagnostic Aid | 424 | ||
| IV | 424 | ||
| Adults, Elderly (based on weight). | 424 | ||
| Side Effects/Adverse Reactions | 424 | ||
| Frequent | 424 | ||
| Occasional | 424 | ||
| Rare | 424 | ||
| Precautions and Contraindications | 424 | ||
| Caution: | 424 | ||
| Drug Interactions of Concern to Dentistry | 424 | ||
| Serious Reactions | 424 | ||
| Dental Considerations | 424 | ||
| General: | 424 | ||
| Precautions and Contraindications | 425 | ||
| Caution: | 425 | ||
| Drug Interactions of Concern to Dentistry | 425 | ||
| Serious Reactions | 425 | ||
| Dental Considerations | 425 | ||
| General: | 425 | ||
| Consultations: | 425 | ||
| Teach Patient/Family to: | 425 | ||
| dirithromycin | 425 | ||
| Category and Schedule | 425 | ||
| Drug Class: | 425 | ||
| Mechanism of Action | 425 | ||
| Uses | 425 | ||
| Pharmacokinetics | 425 | ||
| Indications and Dosages | 425 | ||
| ► Pharyngitis, Tonsillitis | 425 | ||
| disopyramide phosphate | 426 | ||
| Category and Schedule | 426 | ||
| Drug Class: | 426 | ||
| Mechanism of Action | 426 | ||
| Uses | 426 | ||
| Pharmacokinetics | 427 | ||
| Indications and Dosages | 427 | ||
| ► Suppression and Prevention of Ventricular Ectopy, Unifocal or Multifocal Premature Ventricular Contractions, Paired Ventricular Contractions (Couplets), and Episodes of Ventricular Tachycardia | 427 | ||
| disulfiram | 428 | ||
| Category and Schedule | 428 | ||
| Drug Class: | 428 | ||
| Mechanism of Action | 428 | ||
| Uses | 428 | ||
| Pharmacokinetics | 428 | ||
| Indications and Dosages | 429 | ||
| ► Adjunct in Management of Selected Chronic Alcoholic Patients Who Want to Remain in State of Enforced Sobriety | 429 | ||
| PO | 429 | ||
| Adults, Elderly. | 429 | ||
| Side Effects/Adverse Reactions | 429 | ||
| Frequent | 429 | ||
| Occasional | 429 | ||
| Precautions and Contraindications | 429 | ||
| Caution: | 429 | ||
| Drug Interactions of Concern to Dentistry | 429 | ||
| Serious Reactions | 429 | ||
| Dental Considerations | 429 | ||
| General: | 429 | ||
| Consultations: | 429 | ||
| Teach Patient/Family to: | 429 | ||
| dobutamine hydrochloride | 429 | ||
| Category and Schedule | 429 | ||
| Drug Class: | 429 | ||
| Mechanism of Action | 429 | ||
| docetaxel | 430 | ||
| Category and Schedule | 430 | ||
| Drug Class: | 430 | ||
| Mechanism of Action | 430 | ||
| Uses | 430 | ||
| Pharmacokinetics | 430 | ||
| Indications and Dosages | 430 | ||
| ► Short-Term Management of Cardiac Decompensation | 430 | ||
| IV Infusion | 430 | ||
| Adults, Elderly, Children. | 430 | ||
| Neonates. | 430 | ||
| Side Effects/Adverse Reactions | 430 | ||
| Frequent | 430 | ||
| Occasional | 430 | ||
| Rare | 430 | ||
| Precautions and Contraindications | 430 | ||
| Drug Interactions of Concern to Dentistry | 430 | ||
| Serious Reactions | 430 | ||
| Dental Considerations | 430 | ||
| General: | 430 | ||
| Indications and Dosages | 431 | ||
| ► Breast Carcinoma | 431 | ||
| docosanol | 432 | ||
| Category and Schedule | 432 | ||
| Drug Class: | 432 | ||
| Mechanism of Action | 432 | ||
| Uses | 432 | ||
| Pharmacokinetics | 432 | ||
| Indications and Dosages | 432 | ||
| ► Recurrent Herpes Labialis | 432 | ||
| Topical | 432 | ||
| Adult, Children older than 12 yr. | 432 | ||
| Side Effects/Adverse Reactions | 432 | ||
| docusate | 433 | ||
| Category and Schedule | 433 | ||
| Drug Class: | 433 | ||
| Mechanism of Action | 433 | ||
| Uses | 433 | ||
| Pharmacokinetics | 433 | ||
| Indications and Dosages | 433 | ||
| ► Stool Softener | 433 | ||
| PO | 433 | ||
| Adults, Elderly, Children 12 yr and older. | 433 | ||
| Children 6–11 yr. | 433 | ||
| Children 3–5 yr. | 433 | ||
| Children younger than 3 yr. | 433 | ||
| Side Effects/Adverse Reactions | 433 | ||
| Occasional | 433 | ||
| Rare | 433 | ||
| Precautions and Contraindications | 433 | ||
| Caution: | 433 | ||
| Drug Interactions of Concern to Dentistry | 433 | ||
| Dental Considerations | 433 | ||
| Teach Patient/Family to: | 433 | ||
| Serious Reactions | 434 | ||
| Dental Considerations | 434 | ||
| General: | 434 | ||
| dofetilide | 434 | ||
| Category and Schedule | 434 | ||
| Drug Class: | 434 | ||
| Mechanism of Action | 434 | ||
| Uses | 434 | ||
| Pharmacokinetics | 434 | ||
| Indications and Dosages | 434 | ||
| ► Maintain Normal Sinus Rhythm after Conversion from Atrial Fibrillation or Flutter | 434 | ||
| PO | 434 | ||
| Adults, Elderly. | 434 | ||
| Side Effects/Adverse Reactions | 434 | ||
| Occasional | 434 | ||
| Precautions and Contraindications | 434 | ||
| Caution: | 434 | ||
| Drug Interactions of Concern to Dentistry | 434 | ||
| Serious Reactions | 435 | ||
| Dental Considerations | 435 | ||
| General: | 435 | ||
| Consultations: | 435 | ||
| Teach Patient/Family to: | 435 | ||
| dolasetron | 435 | ||
| Category and Schedule | 435 | ||
| Drug Class: | 435 | ||
| Mechanism of Action | 435 | ||
| Uses | 435 | ||
| Pharmacokinetics | 435 | ||
| Indications and Dosages | 435 | ||
| ► Prevention of Chemotherapy-Induced Nausea and Vomiting | 435 | ||
| PO | 435 | ||
| Adults. | 435 | ||
| Children 2–16 yr. | 435 | ||
| IV | 435 | ||
| Adults, Children 1–16 yr. | 435 | ||
| ► Treatment or Prevention of Postoperative Nausea or Vomiting | 436 | ||
| PO | 436 | ||
| donepezil hydrochloride | 436 | ||
| Category and Schedule | 436 | ||
| Drug Class: | 436 | ||
| Mechanism of Action | 436 | ||
| Uses | 436 | ||
| Pharmacokinetics | 437 | ||
| Indications and Dosages | 437 | ||
| ► Alzheimer’s Disease | 437 | ||
| PO | 437 | ||
| Adults, Elderly. | 437 | ||
| Side Effects/Adverse Reactions | 437 | ||
| Frequent | 437 | ||
| Occasional | 437 | ||
| Rare | 437 | ||
| Precautions and Contraindications | 437 | ||
| Caution: | 437 | ||
| Drug Interactions of Concern to Dentistry | 437 | ||
| Serious Reactions | 437 | ||
| Dental Considerations | 437 | ||
| General: | 437 | ||
| Consultations: | 438 | ||
| Teach Patient/Family to: | 438 | ||
| doripenem | 438 | ||
| Category and Schedule | 438 | ||
| Drug Class: | 438 | ||
| Mechanism of Action | 438 | ||
| Uses | 438 | ||
| Pharmacokinetics | 438 | ||
| Indications and Dosages | 438 | ||
| ► Complicated Intraabdominal Infection | 438 | ||
| dornase alfa | 439 | ||
| Category and Schedule | 439 | ||
| Drug Class: | 439 | ||
| Mechanism of Action | 439 | ||
| Uses | 439 | ||
| Pharmacokinetics | 439 | ||
| Indications and Dosages | 439 | ||
| ► To Improve Management of Pulmonary Function in Patients with Cystic Fibrosis | 439 | ||
| Nebulization | 439 | ||
| Adults, Children older than 5 yr. | 439 | ||
| Side Effects/Adverse Reactions | 439 | ||
| Frequent | 439 | ||
| Occasional | 439 | ||
| Precautions and Contraindications | 439 | ||
| Caution: | 439 | ||
| Drug Interactions of Concern to Dentistry | 439 | ||
| Serious Reactions | 439 | ||
| Dental Considerations | 439 | ||
| General: | 439 | ||
| Consultations: | 439 | ||
| Teach Patient/Family to: | 439 | ||
| dorzolamide hydrochloride | 440 | ||
| Category and Schedule | 440 | ||
| Drug Class: | 440 | ||
| Mechanism of Action | 440 | ||
| Uses | 440 | ||
| Pharmacokinetics | 440 | ||
| Indications and Dosages | 440 | ||
| ► Glaucoma, Ocular Hypertension | 440 | ||
| Ophthalmic | 440 | ||
| Adults, Elderly. | 440 | ||
| Side Effects/Adverse Reactions | 440 | ||
| Frequent | 440 | ||
| Occasional | 440 | ||
| Precautions and Contraindications | 440 | ||
| Caution: | 440 | ||
| Drug Interactions of Concern to Dentistry | 440 | ||
| Serious Reactions | 440 | ||
| Dental Considerations | 440 | ||
| General: | 440 | ||
| Consultations: | 440 | ||
| Teach Patient/Family to: | 440 | ||
| Consultations: | 441 | ||
| doxazosin mesylate | 441 | ||
| Category and Schedule | 441 | ||
| Drug Class: | 441 | ||
| Mechanism of Action | 441 | ||
| Uses | 441 | ||
| Pharmacokinetics | 441 | ||
| Indications and Dosages | 441 | ||
| ► Mild-to-Moderate Hypertension | 441 | ||
| doxepin hydrochloride | 442 | ||
| Category and Schedule | 442 | ||
| Drug Class: | 442 | ||
| Mechanism of Action | 442 | ||
| Uses | 442 | ||
| Pharmacokinetics | 442 | ||
| Indications and Dosages | 443 | ||
| ► Depression, Anxiety | 443 | ||
| PO | 443 | ||
| Adults. | 443 | ||
| Elderly. | 443 | ||
| Adolescents. | 443 | ||
| Children 12 yr and younger. | 443 | ||
| ► Pruritus Associated with Eczema | 443 | ||
| Topical | 443 | ||
| Adults, Elderly. | 443 | ||
| Side Effects/Adverse Reactions | 443 | ||
| Frequent | 443 | ||
| Occasional | 443 | ||
| Rare | 443 | ||
| Precautions and Contraindications | 443 | ||
| Caution: | 443 | ||
| Drug Interactions of Concern to Dentistry FOR TOPICAL FORM | 443 | ||
| Drug Interactions of Concern to Dentistry FOR SYSTEMIC-DOSE FORM | 443 | ||
| Serious Reactions | 443 | ||
| Dental Considerations | 444 | ||
| ► Topical Form | 444 | ||
| doxorubicin | 445 | ||
| Category and Schedule | 445 | ||
| Drug Class: | 445 | ||
| Mechanism of Action | 445 | ||
| Uses | 445 | ||
| Pharmacokinetics | 445 | ||
| Indications and Dosages | 445 | ||
| ► AIDS-Related Kaposi’s Sarcoma | 445 | ||
| doxycycline | 446 | ||
| Category and Schedule | 446 | ||
| Drug Class: | 446 | ||
| Mechanism of Action | 446 | ||
| Uses | 446 | ||
| Pharmacokinetics | 446 | ||
| Indications and Dosages | 447 | ||
| ► Respiratory, Skin, and Soft-Tissue Infections; UTIs; Pelvic Inflammatory Disease (PID); Brucellosis; Trachoma; Rocky Mountain Spotted Fever; Typhus; Q Fever; Rickettsia; Severe Acne (Adoxa); Smallpox; Psittacosis; Ornithosis; Granuloma Inguinale; Lymphogranuloma Venereum; Intestinal Amebiasis (Adjunctive Treatment); Prevention of Rheumatic Fever | 447 | ||
| doxycycline hyclate (dental-systemic) | 448 | ||
| Category and Schedule | 448 | ||
| Drug Class: | 448 | ||
| Mechanism of Action | 448 | ||
| Uses | 448 | ||
| Pharmacokinetics | 448 | ||
| Indications and Dosages | 448 | ||
| PO | 448 | ||
| Adult. | 448 | ||
| doxycycline hyclate gel | 449 | ||
| Category and Schedule | 449 | ||
| Drug Class: | 449 | ||
| Mechanism of Action | 449 | ||
| Uses | 449 | ||
| Pharmacokinetics | 449 | ||
| Indications and Dosages | 449 | ||
| Topical | 449 | ||
| Adult. | 449 | ||
| Side Effects/Adverse Reactions | 449 | ||
| Precautions and Contraindications | 449 | ||
| Caution: | 449 | ||
| Drug Interactions of Concern to Dentistry | 449 | ||
| Serious Reactions | 449 | ||
| Dental Considerations | 449 | ||
| General: | 449 | ||
| Teach Patient/Family to: | 449 | ||
| Precautions and Contraindications | 450 | ||
| Caution: | 450 | ||
| Drug Interactions of Concern to Dentistry | 450 | ||
| Serious Reactions | 450 | ||
| Dental Consideratons | 450 | ||
| General: | 450 | ||
| Teach Patient/Family to: | 450 | ||
| dronabinol | 450 | ||
| Category and Schedule | 450 | ||
| Drug Class: | 450 | ||
| Mechanism of Action | 450 | ||
| Uses | 450 | ||
| Pharmacokinetics | 450 | ||
| Indications and Dosages | 450 | ||
| ► Prevention of Chemotherapy-Induced Nausea and Vomiting | 450 | ||
| PO | 450 | ||
| Adults, Children. | 450 | ||
| ► Appetite Stimulant | 451 | ||
| PO | 451 | ||
| Adults. | 451 | ||
| Side Effects/Adverse Reactions | 451 | ||
| Frequent | 451 | ||
| Occasional | 451 | ||
| Rare | 451 | ||
| Precautions and Contraindications | 451 | ||
| Caution: | 451 | ||
| Drug Interactions of Concern to Dentistry | 451 | ||
| Serious Reactions | 451 | ||
| Dental Considerations | 451 | ||
| General: | 451 | ||
| Teach Patient/Family to: | 451 | ||
| dronedarone | 452 | ||
| Category and Schedule | 452 | ||
| Drug Class: | 452 | ||
| Mechanism of Action | 452 | ||
| Uses | 452 | ||
| Pharmacokinetics | 452 | ||
| Indications and Dosages | 452 | ||
| ► Atrial Fibrillation | 452 | ||
| droperidol | 453 | ||
| Category and Schedule | 453 | ||
| Drug Class: | 453 | ||
| Mechanism of Action | 453 | ||
| Uses | 454 | ||
| Pharmacokinetics | 454 | ||
| Indications and Dosages | 454 | ||
| ► Preoperative | 454 | ||
| IM/IV | 454 | ||
| dulaglutide | 455 | ||
| Category and Schedule | 455 | ||
| Drug Class: | 455 | ||
| Mechanism of Action | 455 | ||
| Uses | 455 | ||
| Pharmacokinetics | 455 | ||
| Indications and Dosages | 455 | ||
| ► Type 2 Diabetes Mellitus | 455 | ||
| Adults. | 455 | ||
| Side Effects/Adverse Reactions | 455 | ||
| Frequent | 455 | ||
| Occasional | 455 | ||
| Precautions and Contraindications | 455 | ||
| Drug Interactions of Concern to Dentistry | 455 | ||
| Serious Reactions | 456 | ||
| Dental Considerations | 456 | ||
| General: | 456 | ||
| Consultations: | 456 | ||
| Teach Patient/Family to: | 456 | ||
| duloxetine | 456 | ||
| Category and Schedule | 456 | ||
| Drug Class: | 456 | ||
| Mechanism of Action | 456 | ||
| Uses | 456 | ||
| Pharmacokinetics | 456 | ||
| Indications and Dosages | 456 | ||
| ► Depression | 456 | ||
| PO | 456 | ||
| Adult. | 456 | ||
| ► Diabetic Peripheral Neuropathic Pain | 457 | ||
| PO | 457 | ||
| Adult. | 457 | ||
| Side Effects/Adverse Reactions | 457 | ||
| Precautions and Contraindications | 457 | ||
| Drug Interactions of Concern to Dentistry | 457 | ||
| Serious Reactions | 457 | ||
| Dental Considerations | 457 | ||
| General: | 457 | ||
| Consultations: | 457 | ||
| Teach Patient/Family to: | 457 | ||
| dutasteride | 458 | ||
| Category and Schedule | 458 | ||
| Drug Class: | 458 | ||
| Mechanism of Action | 458 | ||
| Uses | 458 | ||
| Pharmacokinetics | 458 | ||
| Indications and Dosages | 458 | ||
| ► BPH | 458 | ||
| PO | 458 | ||
| Adults, Elderly. | 458 | ||
| Side Effects/Adverse Reactions | 458 | ||
| Occasional | 458 | ||
| Precautions and Contraindications | 458 | ||
| Caution: | 458 | ||
| Drug Interactions of Concern to Dentistry | 458 | ||
| Serious Reactions | 458 | ||
| Dental Considerations | 458 | ||
| General: | 458 | ||
| Consultations: | 458 | ||
| Teach Patient/Family to: | 458 | ||
| dutasteride + tamsulosin | 459 | ||
| Category and Schedule | 459 | ||
| Drug Class: | 459 | ||
| Mechanism of Action | 459 | ||
| Uses | 459 | ||
| Pharmacokinetics | 459 | ||
| Indications and Dosages | 459 | ||
| ► Benign Prostatic Hyperplasia (BPH) | 459 | ||
| PO | 459 | ||
| Adults. | 459 | ||
| Side Effects/Adverse Reactions | 459 | ||
| Frequent | 459 | ||
| Occasional | 459 | ||
| Precautions and Contraindications | 459 | ||
| Drug Interactions of Concern to Dentistry | 459 | ||
| Serious Reactions | 460 | ||
| Dental Considerations | 460 | ||
| General: | 460 | ||
| dyphylline | 460 | ||
| Category and Schedule | 460 | ||
| Drug Class: | 460 | ||
| Mechanism of Action | 460 | ||
| Uses | 460 | ||
| Pharmacokinetics | 460 | ||
| Indications and Dosages | 460 | ||
| ► Chronic Bronchospasm, Asthma | 460 | ||
| PO | 460 | ||
| echothiophate iodide | 462 | ||
| Category and Schedule | 462 | ||
| Drug Class: | 462 | ||
| Mechanism of Action | 462 | ||
| Uses | 462 | ||
| Pharmacokinetics | 462 | ||
| Indications and Dosages | 462 | ||
| ► Glaucoma | 462 | ||
| edoxaban | 463 | ||
| Category and Schedule | 463 | ||
| Drug Class: | 463 | ||
| Mechanism of Action | 463 | ||
| Uses | 463 | ||
| Pharmacokinetics | 463 | ||
| Indications and Dosages | 463 | ||
| ► Deep Vein Thrombosis and Pulmonary Embolism | 463 | ||
| efavirenz | 464 | ||
| Category and Schedule | 464 | ||
| Drug Class: | 464 | ||
| Mechanism of Action | 464 | ||
| Uses | 464 | ||
| Pharmacokinetics | 464 | ||
| Indications and Dosages | 464 | ||
| ► HIV Infection (in Combination with Other Antiretrovirals) | 464 | ||
| PO | 464 | ||
| Adults, Elderly, Children 3 yr and older weighing 40 kg or more. | 464 | ||
| Children 3 yr and older weighing 32.5 kg to less than 40 kg. | 464 | ||
| Children 3 yr and older weighing 25 kg to less than 32.5 kg. | 465 | ||
| Children 3 yr and older weighing 20 kg to less than 25 kg. | 465 | ||
| Children 3 yr and older weighing 15 kg to less than 20 kg. | 465 | ||
| Children 3 yr and older weighing 10 kg to less than 15 kg. | 465 | ||
| Side Effects/Adverse Reactions | 465 | ||
| Frequent | 465 | ||
| Occasional | 465 | ||
| Precautions and Contraindications | 465 | ||
| Caution: | 465 | ||
| Drug Interactions of Concern to Dentistry | 465 | ||
| Serious Reactions | 465 | ||
| Dental Considerations | 465 | ||
| General: | 465 | ||
| Consultations: | 465 | ||
| Teach Patient/Family to: | 465 | ||
| efinaconazole | 466 | ||
| Category and Schedule | 466 | ||
| Drug Class: | 466 | ||
| Mechanism of Action | 466 | ||
| Uses | 466 | ||
| Pharmacokinetics | 466 | ||
| Indications and Dosages | 466 | ||
| ► Onychomycosis | 466 | ||
| Adults. | 466 | ||
| Side Effects/Adverse Reactions | 466 | ||
| Frequent | 466 | ||
| Occasional | 466 | ||
| Precautions and Contraindications | 466 | ||
| Drug Interactions of Concern to Dentistry | 466 | ||
| Serious Reactions | 466 | ||
| Dental Considerations | 466 | ||
| General: | 466 | ||
| Teach Patient/Family to: | 466 | ||
| Uses | 467 | ||
| Pharmacokinetics | 467 | ||
| Indications and Dosages | 467 | ||
| ► Acute Migraine Headache | 467 | ||
| PO | 467 | ||
| Adults, Elderly. | 467 | ||
| Side Effects/Adverse Reactions | 467 | ||
| Occasional | 467 | ||
| Rare | 467 | ||
| Precautions and Contraindications | 467 | ||
| Caution: | 467 | ||
| Drug Interactions of Concern to Dentistry | 467 | ||
| Serious Reactions | 467 | ||
| Dental Considerations | 467 | ||
| General: | 467 | ||
| Consultations: | 467 | ||
| Teach Patient/Family to: | 467 | ||
| eletriptan | 466 | ||
| eliglustat | 468 | ||
| Category and Schedule | 468 | ||
| Drug Class: | 468 | ||
| Mechanism of Action | 468 | ||
| Uses | 468 | ||
| Pharmacokinetics | 468 | ||
| Indications and Dosages | 468 | ||
| ► Gaucher’S Disease, Type 1 | 468 | ||
| PO | 468 | ||
| Adults. | 468 | ||
| Side Effects/Adverse Reactions | 468 | ||
| Frequent | 468 | ||
| Occasional | 468 | ||
| Precautions and Contraindications | 468 | ||
| Drug Interactions of Concern to Dentistry | 468 | ||
| Serious Reactions | 469 | ||
| Dental Considerations | 469 | ||
| General: | 469 | ||
| Consultations: | 469 | ||
| Teach Patient/Family to: | 469 | ||
| eluxadoline | 469 | ||
| Category and Schedule | 469 | ||
| Drug Class: | 469 | ||
| Mechanism of Action | 469 | ||
| Uses | 469 | ||
| Pharmacokinetics | 469 | ||
| Indications and Dosages | 469 | ||
| ► Irritable Bowel Syndrome With Diarrhea | 469 | ||
| PO | 469 | ||
| Adults. | 469 | ||
| Side Effects/Adverse Reactions | 469 | ||
| Frequent | 469 | ||
| Occasional | 469 | ||
| Precautions and Contraindications | 469 | ||
| Drug Interactions of Concern to Dentistry | 470 | ||
| Serious Reactions | 470 | ||
| Dental Considerations | 470 | ||
| General: | 470 | ||
| Consultations: | 470 | ||
| Teach Patient/Family to: | 470 | ||
| emedastine | 470 | ||
| Category and Schedule | 470 | ||
| Drug Class: | 470 | ||
| Mechanism of Action | 470 | ||
| Uses | 470 | ||
| Pharmacokinetics | 470 | ||
| Indications and Dosages | 470 | ||
| ► Allergic Conjunctivitis | 470 | ||
| Ophthalmic | 470 | ||
| Adults, Elderly, Children 3 yr and older. | 470 | ||
| Side Effects/Adverse Reactions | 470 | ||
| Frequent | 470 | ||
| Occasional | 470 | ||
| empagliflozin | 471 | ||
| Category and Schedule | 471 | ||
| Drug Class: | 471 | ||
| Mechanism of Action | 471 | ||
| Uses | 471 | ||
| Pharmacokinetics | 471 | ||
| Indications and Dosages | 471 | ||
| ► Type 2 Diabetes Mellitus | 471 | ||
| PO | 471 | ||
| Adults. | 471 | ||
| Side Effects/Adverse Reactions | 471 | ||
| Frequent | 471 | ||
| Occasional | 471 | ||
| Precautions and Contraindications | 471 | ||
| Caution: | 471 | ||
| Drug Interactions of Concern to Dentistry | 471 | ||
| Serious Reactions | 471 | ||
| Serious Reactions | 472 | ||
| Dental Considerations | 472 | ||
| General: | 472 | ||
| Consultations: | 472 | ||
| Teach Patient/Family to: | 472 | ||
| emtricitabine | 472 | ||
| Category and Schedule | 472 | ||
| Drug Class: | 472 | ||
| Mechanism of Action | 472 | ||
| Uses | 472 | ||
| Pharmacokinetics | 472 | ||
| Indications and Dosages | 472 | ||
| ► HIV Infection (in Combination with Other Antiretrovirals) | 472 | ||
| PO | 472 | ||
| Adults, Elderly. | 472 | ||
| ► Dosage in Renal Impairment | 472 | ||
| Side Effects/Adverse Reactions | 473 | ||
| Frequent | 473 | ||
| Occasional | 473 | ||
| Rare | 473 | ||
| Precautions and Contraindications | 473 | ||
| Caution: | 473 | ||
| Drug Interactions of Concern to Dentistry | 473 | ||
| Serious Reactions | 473 | ||
| Dental Considerations | 473 | ||
| General: | 473 | ||
| Consultations: | 473 | ||
| Teach Patient/Family to: | 473 | ||
| emtricitabine + rilpivirine + tenofovir disoproxil | 473 | ||
| Category and Schedule | 473 | ||
| Drug Class: | 473 | ||
| Mechanism of Action | 473 | ||
| Uses | 474 | ||
| Pharmacokinetics | 474 | ||
| Indications and Dosages | 474 | ||
| ▸ HIV | 474 | ||
| PO | 474 | ||
| Adults. | 474 | ||
| Side Effects/Adverse Reactions | 474 | ||
| Frequent | 474 | ||
| Occasional | 474 | ||
| Precautions and Contraindications | 474 | ||
| Drug Interactions of Concern to Dentistry | 474 | ||
| Serious Reactions | 474 | ||
| Dental Considerations | 474 | ||
| General: | 474 | ||
| Teach Patient/Family to: | 475 | ||
| enalapril maleate | 475 | ||
| Category and Schedule | 475 | ||
| Drug Class: | 475 | ||
| Mechanism of Action | 475 | ||
| Uses | 475 | ||
| Pharmacokinetics | 475 | ||
| Indications and Dosages | 475 | ||
| ► Hypertension Alone or in Combination with Other Antihypertensives | 475 | ||
| enfuvirtide | 477 | ||
| Category and Schedule | 477 | ||
| Drug Class: | 477 | ||
| Mechanism of Action | 477 | ||
| Uses | 477 | ||
| Pharmacokinetics | 477 | ||
| Indications and Dosages | 477 | ||
| ► HIV Infection (in combination with other antiretrovirals) | 477 | ||
| Subcutaneous | 477 | ||
| Adults, Elderly. | 477 | ||
| Children 6–16 yr. | 477 | ||
| Pediatric dosing guidelines | 477 | ||
| Side Effects/Adverse Reactions | 477 | ||
| Expected | 477 | ||
| Frequent | 477 | ||
| Occasional | 477 | ||
| Rare | 477 | ||
| Precautions and Contraindications | 477 | ||
| Drug Interactions of Concern to Dentistry | 478 | ||
| Serious Reactions | 478 | ||
| Dental Considerations | 478 | ||
| General: | 478 | ||
| Consultations: | 478 | ||
| Teach Patient/Family to: | 478 | ||
| enoxaparin sodium | 478 | ||
| Category and Schedule | 478 | ||
| Drug Class: | 478 | ||
| Mechanism of Action | 478 | ||
| Uses | 478 | ||
| Pharmacokinetics | 478 | ||
| Indications and Dosages | 479 | ||
| ► Prevention of DVT after Hip and Knee Surgery | 479 | ||
| entacapone | 480 | ||
| Category and Schedule | 480 | ||
| Drug Class: | 480 | ||
| Mechanism of Action | 480 | ||
| Uses | 480 | ||
| Pharmacokinetics | 480 | ||
| Indications and Dosages | 480 | ||
| ► Adjunctive Treatment of Parkinson’s Disease | 480 | ||
| PO | 480 | ||
| Adults, Elderly. | 480 | ||
| Side Effects/Adverse Reactions | 480 | ||
| Frequent | 480 | ||
| Occasional | 480 | ||
| Rare | 480 | ||
| Precautions and Contraindications | 480 | ||
| Caution: | 480 | ||
| Drug Interactions of Concern to Dentistry | 480 | ||
| Serious Reactions | 481 | ||
| Dental Considerations | 481 | ||
| General: | 481 | ||
| Consultations: | 481 | ||
| Teach Patient/Family to: | 481 | ||
| ephedrine | 481 | ||
| Category and Schedule | 481 | ||
| Drug Class: | 481 | ||
| Mechanism of Action | 481 | ||
| Uses | 481 | ||
| Pharmacokinetics | 481 | ||
| Indications and Dosages | 482 | ||
| ► Asthma | 482 | ||
| epinastine | 483 | ||
| Category and Schedule | 483 | ||
| Drug Class: | 483 | ||
| Mechanism of Action | 483 | ||
| Uses | 483 | ||
| Pharmacokinetics | 483 | ||
| Indications and Dosages | 483 | ||
| ► Allergic Conjunctivitis | 483 | ||
| Ophthalmic | 483 | ||
| Adults, Elderly, Children 3 yr and older. | 483 | ||
| Side Effects/Adverse Reactions | 483 | ||
| Occasional | 483 | ||
| Rare | 483 | ||
| Precautions and Contraindications | 483 | ||
| Caution: | 483 | ||
| Drug Interactions of Concern to Dentistry | 483 | ||
| Serious Reactions | 483 | ||
| Dental Considerations | 484 | ||
| General: | 484 | ||
| epinephrine | 484 | ||
| Category and Schedule | 484 | ||
| Drug Class: | 484 | ||
| Mechanism of Action | 484 | ||
| Uses | 484 | ||
| Pharmacokinetics | 484 | ||
| Indications and Dosages | 484 | ||
| ► Asystole | 484 | ||
| epinephryl borate | 486 | ||
| Category and Schedule | 486 | ||
| Drug Class: | 486 | ||
| Mechanism of Action | 486 | ||
| Uses | 486 | ||
| Pharmacokinetics | 486 | ||
| Indications and Dosages | 486 | ||
| ► Glaucoma | 486 | ||
| Ophthalmic | 486 | ||
| Adults, Elderly. | 486 | ||
| Side Effects/Adverse Reactions | 486 | ||
| Frequent | 486 | ||
| Occasional | 486 | ||
| Precautions and Contraindications | 486 | ||
| Drug Interactions of Concern to Dentistry | 486 | ||
| Serious Reactions | 486 | ||
| Dental Considerations | 486 | ||
| General: | 486 | ||
| Consultations: | 487 | ||
| Teach Patient/Family to: | 487 | ||
| epirubicin | 487 | ||
| Category and Schedule | 487 | ||
| Drug Class: | 487 | ||
| Mechanism of Action | 487 | ||
| Uses | 487 | ||
| Pharmacokinetics | 487 | ||
| Indications and Dosages | 487 | ||
| ► Breast Cancer | 487 | ||
| IV | 487 | ||
| Adults. | 487 | ||
| Side Effects/Adverse Reactions | 487 | ||
| Frequent | 487 | ||
| Occasional | 487 | ||
| Rare | 487 | ||
| Precautions and Contraindications | 487 | ||
| Drug Interactions of Concern to Dentistry | 487 | ||
| Serious Reactions | 487 | ||
| Dental Considerations | 488 | ||
| General: | 488 | ||
| Consultations: | 488 | ||
| Teach Patient/Family to: | 488 | ||
| eplerenone | 488 | ||
| Category and Schedule | 488 | ||
| Drug Class: | 488 | ||
| Mechanism of Action | 488 | ||
| Uses | 489 | ||
| Pharmacokinetics | 489 | ||
| Indications and Dosages | 489 | ||
| ► Hypertension | 489 | ||
| epoetin alfa | 490 | ||
| Category and Schedule | 490 | ||
| Drug Class: | 490 | ||
| Mechanism of Action | 490 | ||
| Uses | 490 | ||
| Pharmacokinetics | 490 | ||
| Indications and Dosages | 490 | ||
| ► Treatment of Anemia in Chemotherapy Patients | 490 | ||
| epoprostenol sodium, prostacyclin | 492 | ||
| Category and Schedule | 492 | ||
| Drug Class: | 492 | ||
| Mechanism of Action | 492 | ||
| Uses | 492 | ||
| Indications and Dosages | 492 | ||
| ► Long-Term Treatment of New York Heart Association Class III and IV Primary Pulmonary Hypertension | 492 | ||
| IV Infusion | 492 | ||
| Adults, Elderly. | 492 | ||
| Side Effects/Adverse Reactions | 492 | ||
| Frequent | 492 | ||
| Occasional | 492 | ||
| Rare | 492 | ||
| Precautions and Contraindications | 492 | ||
| Drug Interactions of Concern to Dentistry | 492 | ||
| Serious Reactions | 493 | ||
| Dental Considerations | 493 | ||
| General: | 493 | ||
| Consultations: | 493 | ||
| Teach Patient/Family to: | 493 | ||
| eprosartan | 493 | ||
| Category and Schedule | 493 | ||
| Drug Class: | 493 | ||
| Mechanism of Action | 493 | ||
| Uses | 493 | ||
| Pharmacokinetics | 493 | ||
| Indications and Dosages | 494 | ||
| ► Hypertension | 494 | ||
| PO | 494 | ||
| Adults, Elderly. | 494 | ||
| Side Effects/Adverse Reactions | 494 | ||
| Occasional | 494 | ||
| Rare | 494 | ||
| Precautions and Contraindications | 494 | ||
| Caution: | 494 | ||
| Drug Interactions of Concern to Dentistry | 494 | ||
| Serious Reactions | 494 | ||
| Dental Considerations | 494 | ||
| General: | 494 | ||
| Consultations: | 494 | ||
| Teach Patient/Family to: | 494 | ||
| eptifibatide | 494 | ||
| Category and Schedule | 494 | ||
| Drug Class: | 494 | ||
| Mechanism of Action | 495 | ||
| Uses | 495 | ||
| Pharmacokinetics | 495 | ||
| Indications and Dosages | 495 | ||
| 4Adjunct to Percutaneous Coronary Intervention | 495 | ||
| ergoloid mesylates | 496 | ||
| Category and Schedule | 496 | ||
| Drug Class: | 496 | ||
| Mechanism of Action | 496 | ||
| Uses | 496 | ||
| Pharmacokinetics | 496 | ||
| Indications and Dosages | 496 | ||
| ► Age-Related Decline in Mental Capacity | 496 | ||
| PO | 496 | ||
| Adults, Elderly. | 496 | ||
| Side Effects/Adverse Reactions | 496 | ||
| Occasional | 496 | ||
| Precautions and Contraindications | 496 | ||
| Caution: | 496 | ||
| Serious Reactions | 496 | ||
| Dental Considerations | 497 | ||
| General: | 497 | ||
| Teach Patient/Family to: | 497 | ||
| ergotamine tartrate/dihydroergotamine | 497 | ||
| Category and Schedule | 497 | ||
| Drug Class: | 497 | ||
| Mechanism of Action | 497 | ||
| Uses | 497 | ||
| Pharmacokinetics | 497 | ||
| Indications and Dosages | 497 | ||
| ► Vascular Headaches | 497 | ||
| PO (Cafergot [Fixed-Combination of Ergotamine and Caffeine]) | 497 | ||
| erlotinib | 498 | ||
| Category and Schedule | 498 | ||
| Drug Class: | 498 | ||
| Mechanism of Action | 498 | ||
| Uses | 498 | ||
| Pharmacokinetics | 499 | ||
| Indications and Dosages | 499 | ||
| ► Non–Small-Cell Lung Pancreatic Cancer | 499 | ||
| PO | 499 | ||
| Adults, Elderly. | 499 | ||
| Side Effects/Adverse Reactions | 499 | ||
| Frequent | 499 | ||
| Occasional | 499 | ||
| Rare | 499 | ||
| Precautions and Contraindications | 499 | ||
| Drug Interactions of Concern to Dentistry | 499 | ||
| Serious Reactions | 499 | ||
| Dental Considerations | 499 | ||
| General: | 499 | ||
| Consultations: | 499 | ||
| Teach Patient/Family to: | 499 | ||
| ertapenem | 500 | ||
| Category and Schedule | 500 | ||
| Drug Class: | 500 | ||
| Mechanism of Action | 500 | ||
| Uses | 500 | ||
| Pharmacokinetics | 500 | ||
| Indications and Dosages | 500 | ||
| ► Intraabdominal Infection | 500 | ||
| erythromycin | 501 | ||
| Category and Schedule | 501 | ||
| Drug Class: | 501 | ||
| Mechanism of Action | 501 | ||
| Uses | 501 | ||
| Pharmacokinetics | 501 | ||
| Indications and Dosages | 501 | ||
| ► Mild-to-Moderate Infections of the Upper and Lower Respiratory Tract, Pharyngitis, Skin Infections | 501 | ||
| escitalopram | 503 | ||
| Category and Schedule | 503 | ||
| Drug Class: | 503 | ||
| Mechanism of Action | 503 | ||
| Uses | 503 | ||
| Pharmacokinetics | 503 | ||
| Indications and Dosages | 503 | ||
| ► Depression, General Anxiety Disorder (GAD) | 503 | ||
| PO | 503 | ||
| Adults. | 503 | ||
| Elderly. | 503 | ||
| Side Effects/Adverse Reactions | 503 | ||
| Frequent | 503 | ||
| Occasional | 503 | ||
| Rare | 503 | ||
| Precautions and Contraindications | 503 | ||
| Caution: | 503 | ||
| Drug Interactions of Concern to Dentistry | 503 | ||
| Serious Reactions | 504 | ||
| Dental Considerations | 504 | ||
| General: | 504 | ||
| Consultations: | 504 | ||
| Teach Patient/Family to: | 504 | ||
| esomeprazole | 504 | ||
| Category and Schedule | 504 | ||
| Drug Class: | 504 | ||
| Mechanism of Action | 504 | ||
| Uses | 504 | ||
| Pharmacokinetics | 504 | ||
| Indications and Dosages | 505 | ||
| ► Erosive Esophagitis | 505 | ||
| estazolam | 506 | ||
| Category and Schedule | 506 | ||
| Drug Class: | 506 | ||
| Mechanism of Action | 506 | ||
| Uses | 506 | ||
| Pharmacokinetics | 506 | ||
| Indications and Dosages | 506 | ||
| ► Insomnia | 506 | ||
| PO | 506 | ||
| Adults (older than 18 yr). | 506 | ||
| Elderly, debilitated, liver disease, low serum albumin. | 506 | ||
| Side Effects/Adverse Reactions | 506 | ||
| Frequent | 506 | ||
| Occasional | 506 | ||
| Rare | 506 | ||
| Precautions and Contraindications | 506 | ||
| Caution: | 506 | ||
| Drug Interactions of Concern to Dentistry | 506 | ||
| Serious Reactions | 506 | ||
| Dental Considerations | 507 | ||
| General: | 507 | ||
| Teach Patient/Family to: | 507 | ||
| estradiol | 507 | ||
| Category and Schedule | 507 | ||
| Drug Class: | 507 | ||
| Mechanism of Action | 507 | ||
| Uses | 507 | ||
| Pharmacokinetics | 507 | ||
| Indications and Dosages | 507 | ||
| ► Prostate Cancer | 507 | ||
| IM (Estradiol Valerate) | 507 | ||
| estradiol valerate + dienogest | 509 | ||
| Category and Schedule | 509 | ||
| Drug Class: | 509 | ||
| Mechanism of Action | 509 | ||
| Uses | 509 | ||
| Pharmacokinetics | 509 | ||
| Indications and Dosages | 509 | ||
| ▸ Contraception or Treatment of Heavy Menstrual Bleeding | 509 | ||
| PO | 509 | ||
| Adults (Females). | 509 | ||
| Side Effects/Adverse Reactions | 509 | ||
| Frequent | 509 | ||
| Occasional | 509 | ||
| Precautions and Contraindications | 509 | ||
| Drug Interactions of Concern to Dentistry | 510 | ||
| Serious Reactions | 510 | ||
| Dental Considerations | 510 | ||
| General: | 510 | ||
| estramustine phosphate sodium | 510 | ||
| Category and Schedule | 510 | ||
| Drug Class: | 510 | ||
| Mechanism of Action | 510 | ||
| Uses | 510 | ||
| Pharmacokinetics | 510 | ||
| Indications and Dosages | 510 | ||
| ► Prostatic Carcinoma | 510 | ||
| PO | 510 | ||
| Adults, Elderly. | 510 | ||
| Side Effects/Adverse Reactions | 510 | ||
| Frequent | 510 | ||
| Occasional | 511 | ||
| Rare | 511 | ||
| Precautions and Contraindications | 511 | ||
| Drug Interactions of Concern to Dentistry | 511 | ||
| Serious Reactions | 511 | ||
| Dental Considerations | 511 | ||
| General: | 511 | ||
| Consultations: | 511 | ||
| Teach Patient/Family to: | 511 | ||
| estrogens, conjugated; medroxyprogesterone acetate | 511 | ||
| Category and Schedule | 511 | ||
| Drug Class: | 511 | ||
| Mechanism of Action | 511 | ||
| Uses | 512 | ||
| Pharmacokinetics | 512 | ||
| Indications and Dosages | 512 | ||
| estropipate | 513 | ||
| Category and Schedule | 513 | ||
| Drug Class: | 513 | ||
| Mechanism of Action | 513 | ||
| Uses | 513 | ||
| Pharmacokinetics | 513 | ||
| Indications and Dosages | 513 | ||
| ► Vasomotor Symptoms, Atrophic Vaginitis, Kraurosis Vulvae | 513 | ||
| eszopiclone | 514 | ||
| Category and Schedule | 514 | ||
| Drug Class: | 514 | ||
| Mechanism of Action | 514 | ||
| Uses | 514 | ||
| Pharmacokinetics | 514 | ||
| Indications and Dosages | 515 | ||
| ► Insomnia | 515 | ||
| PO | 515 | ||
| Adult. | 515 | ||
| Side Effects/Adverse Reactions | 515 | ||
| Precautions and Contraindications | 515 | ||
| Drug Interactions of Concern to Dentistry | 515 | ||
| Dental Considerations | 515 | ||
| General: | 515 | ||
| Consultations: | 515 | ||
| Teach Patient/Family: | 515 | ||
| etanercept | 515 | ||
| Category and Schedule | 515 | ||
| Drug Class: | 515 | ||
| Mechanism of Action | 515 | ||
| Uses | 516 | ||
| Pharmacokinetics | 516 | ||
| Indications and Dosages | 516 | ||
| ► Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis | 516 | ||
| ethambutol | 517 | ||
| Category and Schedule | 517 | ||
| Drug Class: | 517 | ||
| Mechanism of Action | 517 | ||
| Uses | 517 | ||
| Pharmacokinetics | 517 | ||
| Indications and Dosages | 517 | ||
| ► TB | 517 | ||
| ethionamide | 518 | ||
| Category and Schedule | 518 | ||
| Drug Class: | 518 | ||
| Mechanism of Action | 518 | ||
| Uses | 518 | ||
| Pharmacokinetics | 518 | ||
| Indications and Dosages | 518 | ||
| ► TB | 518 | ||
| PO | 518 | ||
| Adults, Elderly. | 518 | ||
| Children. | 518 | ||
| ► Dosage in Renal Impairment | 518 | ||
| Side Effects/Adverse Reactions | 518 | ||
| Occasional | 518 | ||
| Rare | 518 | ||
| Precautions and Contraindications | 518 | ||
| Caution: | 519 | ||
| Drug Interactions of Concern to Dentistry | 519 | ||
| Serious Reactions | 519 | ||
| Dental Considerations | 519 | ||
| General: | 519 | ||
| Consultations: | 519 | ||
| Teach Patient/Family to: | 519 | ||
| ethosuximide | 519 | ||
| Category and Schedule | 519 | ||
| Drug Class: | 519 | ||
| Mechanism of Action | 519 | ||
| Uses | 519 | ||
| Pharmacokinetics | 519 | ||
| Indications and Dosages | 519 | ||
| ► Absence Seizures | 519 | ||
| PO | 519 | ||
| Adults, Elderly, Children older than 6 yr. | 519 | ||
| Children 3–6 yr. | 520 | ||
| Side Effects/Adverse Reactions | 520 | ||
| Occasional | 520 | ||
| Rare | 520 | ||
| Precautions and Contraindications | 520 | ||
| Caution: | 520 | ||
| Drug Interactions of Concern to Dentistry | 520 | ||
| Serious Reactions | 520 | ||
| Dental Considerations | 520 | ||
| General: | 520 | ||
| Consultations: | 520 | ||
| Teach Patient/Family to: | 520 | ||
| etidronate disodium | 520 | ||
| Category and Schedule | 520 | ||
| Drug Class: | 520 | ||
| Mechanism of Action | 520 | ||
| Uses | 520 | ||
| Pharmacokinetics | 521 | ||
| Indications and Dosages | 521 | ||
| ► Paget’s Disease | 521 | ||
| etodolac | 521 | ||
| Category and Schedule | 521 | ||
| Drug Class: | 521 | ||
| Mechanism of Action | 522 | ||
| Uses | 522 | ||
| Pharmacokinetics | 522 | ||
| Indications and Dosages | 522 | ||
| ► Osteoarthritis, Rheumatoid Arthritis | 522 | ||
| PO (Immediate-Release) | 522 | ||
| etoposide, VP-16 | 523 | ||
| Category and Schedule | 523 | ||
| Drug Class: | 523 | ||
| Mechanism of Action | 523 | ||
| Uses | 523 | ||
| Pharmacokinetics | 523 | ||
| Indications and Dosages | 524 | ||
| ► Refractory Testicular Tumors | 524 | ||
| etravirine | 525 | ||
| Category and Schedule | 525 | ||
| Drug Class: | 525 | ||
| Mechanism of Action | 525 | ||
| Uses | 525 | ||
| Pharmacokinetics | 525 | ||
| Indications and Dosages | 525 | ||
| PO | 525 | ||
| Adult. | 525 | ||
| Side Effects/Adverse Reactions | 526 | ||
| Frequent | 526 | ||
| Occasional | 526 | ||
| Precautions and Contraindications | 526 | ||
| Drug Interactions of Concern to Dentistry | 526 | ||
| Serious Reactions | 526 | ||
| Dental Considerations | 526 | ||
| General: | 526 | ||
| Consultations: | 526 | ||
| Teach Patient/Family to: | 526 | ||
| everolimus | 527 | ||
| Category and Schedule | 527 | ||
| Drug Class: | 527 | ||
| Mechanism of Action | 527 | ||
| Uses | 527 | ||
| Pharmacokinetics | 527 | ||
| Indications and Dosages | 527 | ||
| ► Breast Cancer, Advanced, Hormone Receptor-Positive, HER2-Negative | 527 | ||
| exemestane | 529 | ||
| Category and Schedule | 529 | ||
| Drug Class: | 529 | ||
| Mechanism of Action | 529 | ||
| Uses | 529 | ||
| Pharmacokinetics | 529 | ||
| Indications and Dosages | 529 | ||
| ► Breast Cancer | 529 | ||
| PO | 529 | ||
| Adults, Elderly. | 529 | ||
| Side Effects/Adverse Reactions | 529 | ||
| Frequent | 529 | ||
| Occasional | 530 | ||
| Rare | 530 | ||
| Precautions and Contraindications | 530 | ||
| Drug Interactions of Concern to Dentistry | 530 | ||
| Serious Reactions | 530 | ||
| Dental Considerations | 530 | ||
| General: | 530 | ||
| Consultations: | 530 | ||
| Teach Patient/Family to: | 530 | ||
| exenatide | 530 | ||
| Category and Schedule | 530 | ||
| Drug Class: | 530 | ||
| Mechanism of Action | 530 | ||
| Uses | 530 | ||
| Pharmacokinetics | 530 | ||
| Indications and Dosages | 530 | ||
| ► Treatment of Type 2 Diabetes Mellitus (NIDDM), Adjunct or Monotherapy | 530 | ||
| SC | 530 | ||
| Adults. | 530 | ||
| Side Effects/Adverse Reactions | 531 | ||
| Frequent | 531 | ||
| Occasional | 531 | ||
| Precautions and Contraindications | 531 | ||
| Caution: | 531 | ||
| Drug Interactions of Concern to Dentistry | 531 | ||
| Serious Reactions | 531 | ||
| Dental Considerations | 531 | ||
| General: | 531 | ||
| Consultations: | 531 | ||
| Teach Patient/Family to: | 531 | ||
| ezetimibe | 531 | ||
| Category and Schedule | 531 | ||
| Drug Class: | 531 | ||
| Mechanism of Action | 532 | ||
| Uses | 532 | ||
| Pharmacokinetics | 532 | ||
| Indications and Dosages | 532 | ||
| ► Hypercholesterolemia | 532 | ||
| PO | 532 | ||
| Adults, Elderly. | 532 | ||
| Side Effects/Adverse Reactions | 532 | ||
| Occasional | 532 | ||
| Precautions and Contraindications | 532 | ||
| Caution: | 532 | ||
| Drug Interactions of Concern to Dentistry | 532 | ||
| Serious Reactions | 532 | ||
| Dental Considerations | 532 | ||
| General: | 532 | ||
| Consultations: | 532 | ||
| Teach Patient/Family to: | 532 | ||
| ezogabine | 533 | ||
| Category and Schedule | 533 | ||
| Drug Class: | 533 | ||
| Mechanism of Action | 533 | ||
| Uses | 533 | ||
| Pharmacokinetics | 533 | ||
| Indications and Dosages | 533 | ||
| ► Partial-Onset Seizures, Adjunct | 533 | ||
| PO | 533 | ||
| Adults. | 533 | ||
| Elderly. | 533 | ||
| ► Renal Impairment | 533 | ||
| ► Hepatic Impairment | 533 | ||
| Side Effects/Adverse Reactions | 533 | ||
| Frequent | 533 | ||
| Occasional | 533 | ||
| Precautions and Contraindications | 533 | ||
| Drug Interactions of Concern to Dentistry | 533 | ||
| Serious Reactions | 534 | ||
| Dental Considerations | 534 | ||
| General: | 534 | ||
| Consultations: | 534 | ||
| Teach Patient/Family to: | 534 | ||
| famciclovir | 535 | ||
| Category and Schedule | 535 | ||
| Drug Class: | 535 | ||
| Mechanism of Action | 535 | ||
| Uses | 535 | ||
| Pharmacokinetics | 535 | ||
| Indications and Dosages | 535 | ||
| ► Herpes Zoster | 535 | ||
| famotidine | 536 | ||
| Category and Schedule | 536 | ||
| Drug Class: | 536 | ||
| Mechanism of Action | 536 | ||
| Uses | 536 | ||
| Pharmacokinetics | 536 | ||
| Indications and Dosages | 536 | ||
| ► Acute Treatment of Duodenal and Gastric Ulcers | 536 | ||
| febuxostat | 537 | ||
| Category and Schedule | 537 | ||
| Drug Class: | 537 | ||
| Mechanism of Action | 538 | ||
| Uses | 538 | ||
| Pharmacokinetics | 538 | ||
| Indications and Dosages | 538 | ||
| ► Hyperuricemia in Patients with Gout | 538 | ||
| PO | 538 | ||
| Adults. | 538 | ||
| Side Effects/Adverse Reactions | 538 | ||
| Rare (≤1%) | 538 | ||
| Precautions and Contraindications | 538 | ||
| Caution: | 538 | ||
| Drug Interactions of Concern to Dentistry | 538 | ||
| Serious Reactions | 538 | ||
| Dental Considerations | 538 | ||
| General: | 538 | ||
| Consultations: | 538 | ||
| Teach Patient/Family to: | 538 | ||
| felbamate | 539 | ||
| Category and Schedule | 539 | ||
| Drug Class: | 539 | ||
| Mechanism of Action | 539 | ||
| Uses | 539 | ||
| Pharmacokinetics | 539 | ||
| Indications and Dosages | 539 | ||
| ► Monotherapy or Adjunctive Therapy in the Treatment of Partial Seizures, with and without Generalization | 539 | ||
| felodipine | 540 | ||
| Category and Schedule | 540 | ||
| Drug Class: | 540 | ||
| Mechanism of Action | 540 | ||
| Uses | 541 | ||
| Pharmacokinetics | 541 | ||
| Indications and Dosages | 541 | ||
| ► Hypertension | 541 | ||
| PO | 541 | ||
| Adults. | 541 | ||
| Elderly, Patients with impaired hepatic function. | 541 | ||
| Side Effects/Adverse Reactions | 541 | ||
| Frequent | 541 | ||
| Occasional | 541 | ||
| Rare | 541 | ||
| Precautions and Contraindications | 541 | ||
| Caution: | 541 | ||
| Drug Interactions of Concern to Dentistry | 541 | ||
| Serious Reactions | 541 | ||
| Dental Considerations | 541 | ||
| General: | 541 | ||
| Consultations: | 542 | ||
| Teach Patient/Family to: | 542 | ||
| fenofibrate | 542 | ||
| Category and Schedule | 542 | ||
| Drug Class: | 542 | ||
| Mechanism of Action | 542 | ||
| Uses | 542 | ||
| Pharmacokinetics | 542 | ||
| Indications and Dosages | 542 | ||
| ► Reduction of Very High Serum Triglyceride Levels in Patients at Risk for Pancreatitis | 542 | ||
| fenoprofen calcium | 543 | ||
| Category and Schedule | 543 | ||
| Drug Class: | 543 | ||
| Mechanism of Action | 543 | ||
| Uses | 543 | ||
| Pharmacokinetics | 543 | ||
| Indications and Dosages | 544 | ||
| ► Mild-to-Moderate Pain | 544 | ||
| fentanyl, buccal | 545 | ||
| Category and Schedule | 545 | ||
| Drug Class: | 545 | ||
| Mechanism of Action | 545 | ||
| Uses | 545 | ||
| Pharmacokinetics | 545 | ||
| Indications and Dosages | 545 | ||
| ► Chronic Pain | 545 | ||
| Transmucosal form | 545 | ||
| Adults. | 545 | ||
| Side Effects/Adverse Reactions | 545 | ||
| Frequent | 545 | ||
| Occasional | 545 | ||
| Precautions and Contraindications | 545 | ||
| Drug Interactions of Concern to Dentistry | 545 | ||
| Serious Reactions | 545 | ||
| Dental Considerations | 546 | ||
| General: | 546 | ||
| Teach Patient/Family to: | 546 | ||
| fentanyl transdermal system | 546 | ||
| Category and Schedule | 546 | ||
| Drug Class: | 546 | ||
| Mechanism of Action | 546 | ||
| Uses | 546 | ||
| Pharmacokinetics | 546 | ||
| Indications and Dosages | 546 | ||
| ► Chronic Pain | 546 | ||
| Topical | 546 | ||
| ferric citrate | 547 | ||
| Category and Schedule | 547 | ||
| Drug Class: | 547 | ||
| Mechanism of Action | 547 | ||
| Uses | 547 | ||
| Pharmacokinetics | 547 | ||
| Indications and Dosages | 548 | ||
| ► Hyperphosphatemia | 548 | ||
| PO | 548 | ||
| Adults. | 548 | ||
| Side Effects/Adverse Reactions | 548 | ||
| Frequent | 548 | ||
| Occasional | 548 | ||
| Precautions and Contraindications | 548 | ||
| Drug Interactions of Concern to Dentistry | 548 | ||
| Serious Reactions | 548 | ||
| Dental Considerations | 548 | ||
| General: | 548 | ||
| Consultations: | 548 | ||
| Teach Patient/Family to: | 548 | ||
| fesoterodine | 548 | ||
| Category and Schedule | 548 | ||
| Drug Class: | 548 | ||
| Mechanism of Action | 548 | ||
| Uses | 548 | ||
| Pharmacokinetics | 548 | ||
| Indications and Dosages | 549 | ||
| ► Overactive Bladder | 549 | ||
| PO | 549 | ||
| Adults. | 549 | ||
| Side Effects/Adverse Reactions | 549 | ||
| Frequent | 549 | ||
| Occasional | 549 | ||
| Precautions and Contraindications | 549 | ||
| Caution: | 549 | ||
| Drug Interactions of Concern to Dentistry | 549 | ||
| Serious Reactions | 549 | ||
| Dental Considerations | 549 | ||
| General: | 549 | ||
| Consultations: | 549 | ||
| Teach Patient/Family to: | 549 | ||
| fexofenadine hydrochloride | 550 | ||
| fidaxomicin | 550 | ||
| Category and Schedule | 550 | ||
| Drug Class: | 550 | ||
| Mechanism of Action | 550 | ||
| Uses | 550 | ||
| Pharmacokinetics | 550 | ||
| Indications and Dosages | 550 | ||
| ► Allergic Rhinitis, Urticaria | 550 | ||
| PO | 550 | ||
| Adults, Elderly, Children 12 yr and older. | 550 | ||
| filgrastim | 551 | ||
| Category and Schedule | 551 | ||
| Drug Class: | 551 | ||
| Mechanism of Action | 551 | ||
| Uses | 551 | ||
| Pharmacokinetics | 551 | ||
| Indications and Dosages | 551 | ||
| ► Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) | 551 | ||
| PO | 551 | ||
| Adults. | 551 | ||
| Side Effects/Adverse Reactions | 551 | ||
| Frequent | 551 | ||
| Occasional | 551 | ||
| Precautions and Contraindications | 551 | ||
| Drug Interactions of Concern to Dentistry | 551 | ||
| Serious Reactions | 551 | ||
| Dental Considerations | 551 | ||
| General: | 551 | ||
| Teach Patient/Family to: | 551 | ||
| Indications and Dosages | 552 | ||
| ► Myelosuppression | 552 | ||
| IV or Subcutaneous Infusion, Subcutaneous Injection | 552 | ||
| finafloxacin | 553 | ||
| Category and Schedule | 553 | ||
| Drug Class: | 553 | ||
| Mechanism of Action | 553 | ||
| Uses | 553 | ||
| Pharmacokinetics | 553 | ||
| Indications and Dosages | 553 | ||
| ► Acute Otitis Externa | 553 | ||
| Children 1 yr and older and adults. | 553 | ||
| Side Effects/Adverse Reactions | 553 | ||
| Frequent | 553 | ||
| Occasional | 553 | ||
| Precautions and Contraindications | 553 | ||
| Drug Interactions of Concern to Dentistry | 553 | ||
| Serious Reactions | 553 | ||
| finasteride | 554 | ||
| Category and Schedule | 554 | ||
| Drug Class: | 554 | ||
| Mechanism of Action | 554 | ||
| Uses | 554 | ||
| Pharmacokinetics | 554 | ||
| Indications and Dosages | 554 | ||
| ► BPH | 554 | ||
| fingolimod | 555 | ||
| Category and Schedule | 555 | ||
| Drug Class: | 555 | ||
| Mechanism of Action | 555 | ||
| Uses | 555 | ||
| Pharmacokinetics | 555 | ||
| Indications and Dosages | 555 | ||
| ► Multiple Sclerosis | 555 | ||
| PO | 555 | ||
| Adults. | 555 | ||
| Side Effects/Adverse Reactions | 555 | ||
| Frequent | 555 | ||
| Occasional | 555 | ||
| Precautions and Contraindications | 555 | ||
| Drug Interactions of Concern to Dentistry | 555 | ||
| Serious Reactions | 555 | ||
| Dental Considerations | 555 | ||
| General: | 555 | ||
| Consultations: | 556 | ||
| Teach Patient/Family to: | 556 | ||
| flavoxate | 556 | ||
| Category and Schedule | 556 | ||
| Drug Class: | 556 | ||
| Mechanism of Action | 556 | ||
| Uses | 556 | ||
| Pharmacokinetics | 556 | ||
| Indications and Dosages | 556 | ||
| ► To Relieve Symptoms of Cystitis, Prostatitis, Urethritis, Urethrocystitis, or Urethrotrigonitis | 556 | ||
| PO | 556 | ||
| Adults, Elderly, Adolescents. | 556 | ||
| Side Effects/Adverse Reactions | 556 | ||
| Frequent | 556 | ||
| Occasional | 556 | ||
| Rare | 556 | ||
| Precautions and Contraindications | 556 | ||
| Caution: | 556 | ||
| Drug Interactions of Concern to Dentistry | 556 | ||
| Serious Reactions | 556 | ||
| Dental Considerations | 557 | ||
| General: | 557 | ||
| Teach Patient/Family to: | 557 | ||
| flecainide | 557 | ||
| Category and Schedule | 557 | ||
| Drug Class: | 557 | ||
| Mechanism of Action | 557 | ||
| Uses | 557 | ||
| Pharmacokinetics | 557 | ||
| Indications and Dosages | 557 | ||
| ► Life-Threatening Ventricular Arrhythmias, Sustained Ventricular Tachycardia | 557 | ||
| flibanserin | 558 | ||
| Category and Schedule | 558 | ||
| Drug Class: | 558 | ||
| Mechanism of Action | 558 | ||
| Uses | 558 | ||
| Pharmacokinetics | 558 | ||
| Indications and Dosages | 558 | ||
| ► Hypoactive Sexual Desire Disorder (Females—Premenopausal) | 558 | ||
| PO | 558 | ||
| Adults. | 558 | ||
| Side Effects/Adverse Reactions | 559 | ||
| Frequent | 559 | ||
| Occasional | 559 | ||
| Precautions and Contraindications | 559 | ||
| Drug Interactions of Concern to Dentistry | 559 | ||
| Serious Reactions | 559 | ||
| Dental Considerations | 559 | ||
| General: | 559 | ||
| Consultations: | 559 | ||
| Teach Patient/Family to: | 559 | ||
| fluconazole | 559 | ||
| Category and Schedule | 559 | ||
| Drug Class: | 559 | ||
| Mechanism of Action | 560 | ||
| Uses | 560 | ||
| Pharmacokinetics | 560 | ||
| Indications and Dosages | 560 | ||
| ► Oropharyngeal Candidiasis | 560 | ||
| flucytosine | 561 | ||
| Category and Schedule | 561 | ||
| Drug Class: | 561 | ||
| Mechanism of Action | 561 | ||
| Uses | 561 | ||
| Pharmacokinetics | 562 | ||
| Indications and Dosages | 562 | ||
| ► Fungal Infections, Candidiasis, Cryptococcosis | 562 | ||
| PO | 562 | ||
| Adults, Elderly, Children. | 562 | ||
| ► Dosage in Renal Function Impairment | 562 | ||
| Side Effects/Adverse Reactions | 562 | ||
| Occasional | 562 | ||
| Precautions and Contraindications | 562 | ||
| Caution: | 562 | ||
| Drug Interactions of Concern to Dentistry | 562 | ||
| Serious Reactions | 562 | ||
| Dental Considerations | 562 | ||
| General: | 562 | ||
| Consultations: | 562 | ||
| Teach Patient/Family to: | 562 | ||
| fludarabine phosphate | 562 | ||
| Category and Schedule | 562 | ||
| Drug Class: | 562 | ||
| Mechanism of Action | 563 | ||
| Uses | 563 | ||
| Pharmacokinetics | 563 | ||
| Indications and Dosages | 563 | ||
| ► Chronic Lymphocytic Leukemia | 563 | ||
| fludrocortisone | 564 | ||
| Category and Schedule | 564 | ||
| Drug Class: | 564 | ||
| Mechanism of Action | 564 | ||
| Uses | 564 | ||
| Pharmacokinetics | 564 | ||
| Indications and Dosages | 564 | ||
| ► Addison’s Disease | 564 | ||
| PO | 564 | ||
| Adults, Elderly. | 564 | ||
| ► Salt-Losing Adrenogenital Syndrome | 565 | ||
| PO | 565 | ||
| Adults, Elderly. | 565 | ||
| Usual Pediatric Dosage | 565 | ||
| Children. | 565 | ||
| Side Effects/Adverse Reactions | 565 | ||
| Frequent | 565 | ||
| Occasional | 565 | ||
| Rare | 565 | ||
| Precautions and Contraindications | 565 | ||
| Caution: | 565 | ||
| Drug Interactions of Concern to Dentistry | 565 | ||
| Serious Reactions | 565 | ||
| Dental Considerations | 565 | ||
| General: | 565 | ||
| Consultations: | 566 | ||
| Teach Patient/Family to: | 566 | ||
| flumazenil | 566 | ||
| Category and Schedule | 566 | ||
| Drug Class: | 566 | ||
| Mechanism of Action | 566 | ||
| Uses | 566 | ||
| Pharmacokinetics | 566 | ||
| Indications and Dosages | 566 | ||
| ► Reversal of Conscious Sedation or General Anesthesia | 566 | ||
| flunisolide | 567 | ||
| Category and Schedule | 567 | ||
| Drug Class: | 567 | ||
| Mechanism of Action | 567 | ||
| Uses | 567 | ||
| Pharmacokinetics | 567 | ||
| Indications and Dosages | 567 | ||
| ► Long-Term Control of Bronchial Asthma, Assists in Reducing or Discontinuing Oral Corticosteroid Therapy | 567 | ||
| Inhalation | 567 | ||
| Adults, Elderly. | 567 | ||
| Children 6–15 yr. | 567 | ||
| ► Relief of Symptoms of Perennial and Seasonal Rhinitis | 568 | ||
| Intranasal | 568 | ||
| Adults, Elderly. | 568 | ||
| Children 6–14 yr. | 568 | ||
| Side Effects/Adverse Reactions | 568 | ||
| Frequent | 568 | ||
| Occasional | 568 | ||
| Precautions and Contraindications | 568 | ||
| Caution: | 568 | ||
| Serious Reactions | 568 | ||
| Dental Considerations | 568 | ||
| General: | 568 | ||
| Consultations: | 568 | ||
| Teach Patient/Family to: | 568 | ||
| fluocinolone acetonide | 569 | ||
| Category and Schedule | 569 | ||
| Drug Class: | 569 | ||
| Mechanism of Action | 569 | ||
| Uses | 569 | ||
| Pharmacokinetics | 569 | ||
| Indications and Dosages | 569 | ||
| ► Atopic Dermatitis | 569 | ||
| fluocinonide | 570 | ||
| Category and Schedule | 570 | ||
| Drug Class: | 570 | ||
| Mechanism of Action | 570 | ||
| Uses | 570 | ||
| Pharmacokinetics | 570 | ||
| Indications and Dosages | 570 | ||
| ► Dermatoses | 570 | ||
| Topical | 570 | ||
| Adults, Elderly. | 570 | ||
| Side Effects/Adverse Reactions | 570 | ||
| Occasional | 570 | ||
| Rare | 570 | ||
| Precautions and Contraindications | 570 | ||
| Caution: | 570 | ||
| Drug Interactions of Concern to Dentistry | 570 | ||
| Serious Reactions | 570 | ||
| Dental Considerations | 570 | ||
| General: | 570 | ||
| Teach Patient/Family to: | 570 | ||
| fluorouracil, 5FU | 571 | ||
| Category and Schedule | 571 | ||
| Drug Class: | 571 | ||
| Mechanism of Action | 571 | ||
| Uses | 571 | ||
| Pharmacokinetics | 571 | ||
| Indications and Dosages | 571 | ||
| ► Carcinoma of Breast, Colon, Pancreas, Rectum, and Stomach; in Combination with Levamisole after Surgical Resection in Patients with Duke’s Stage C Colon Cancer | 571 | ||
| IV | 571 | ||
| Adults, Elderly, Children. | 571 | ||
| ► Multiple Actinic or Solar Keratoses | 571 | ||
| Topical (Carac) | 571 | ||
| fluoxetine hydrochloride | 572 | ||
| Category and Schedule | 572 | ||
| Drug Class: | 572 | ||
| Mechanism of Action | 572 | ||
| Uses | 572 | ||
| Pharmacokinetics | 572 | ||
| Indications and Dosages | 572 | ||
| ► Depression, Obsessive-Compulsive Disorder | 572 | ||
| PO | 572 | ||
| Adults. | 572 | ||
| Elderly. | 572 | ||
| Children 7–17 yr. | 572 | ||
| ► Panic Disorder | 573 | ||
| fluoxymesterone | 574 | ||
| Category and Schedule | 574 | ||
| Drug Class: | 574 | ||
| Mechanism of Action | 574 | ||
| Uses | 574 | ||
| Pharmacokinetics | 574 | ||
| Indications and Dosages | 574 | ||
| ► Males (Hypogonadism) | 574 | ||
| fluphenazine decanoate | 575 | ||
| Category and Schedule | 575 | ||
| Drug Class: | 575 | ||
| Mechanism of Action | 575 | ||
| Uses | 575 | ||
| Pharmacokinetics | 575 | ||
| Indications and Dosages | 575 | ||
| ► Psychotic Disorders | 575 | ||
| flurandrenolide | 577 | ||
| Category and Schedule | 577 | ||
| Drug Class: | 577 | ||
| Mechanism of Action | 577 | ||
| Uses | 577 | ||
| Pharmacokinetics | 577 | ||
| Indications and Dosages | 577 | ||
| ► Antiinflammatory, Immunosuppressant, Corticosteroid Replacement Therapy | 577 | ||
| Topical | 577 | ||
| Adults, Elderly. | 577 | ||
| Children. | 577 | ||
| Side Effects/Adverse Reactions | 577 | ||
| Occasional | 577 | ||
| Rare | 577 | ||
| Precautions and Contraindications | 577 | ||
| Caution: | 578 | ||
| Drug Interactions of Concern to Dentistry | 578 | ||
| Serious Reactions | 578 | ||
| Dental Considerations | 578 | ||
| General: | 578 | ||
| flurazepam hydrochloride | 578 | ||
| Category and Schedule | 578 | ||
| Drug Class: | 578 | ||
| Mechanism of Action | 578 | ||
| Uses | 578 | ||
| Pharmacokinetics | 578 | ||
| Indications and Dosages | 578 | ||
| ► Insomnia | 578 | ||
| PO | 578 | ||
| Adults. | 578 | ||
| Elderly, debilitated, liver disease, low serum albumin, Children 15 yr and older. | 578 | ||
| Side Effects/Adverse Reactions | 578 | ||
| Frequent | 578 | ||
| Occasional | 578 | ||
| Rare | 578 | ||
| Precautions and Contraindications | 578 | ||
| Caution: | 579 | ||
| Drug Interactions of Concern to Dentistry | 579 | ||
| Serious Reactions | 579 | ||
| Dental Considerations | 579 | ||
| General: | 579 | ||
| Consultations: | 579 | ||
| Teach Patient/Family to: | 579 | ||
| flurbiprofen | 579 | ||
| Category and Schedule | 579 | ||
| Drug Class: | 579 | ||
| Mechanism of Action | 579 | ||
| Uses | 579 | ||
| Pharmacokinetics | 579 | ||
| Indications and Dosages | 579 | ||
| ► Rheumatoid Arthritis, Osteoarthritis | 579 | ||
| PO | 579 | ||
| Adults, Elderly. | 579 | ||
| ► Dysmenorrhea, Pain | 580 | ||
| PO | 580 | ||
| Adults. | 580 | ||
| ► Usual Ophthalmic Dosage | 580 | ||
| Adults, Elderly, Children. | 580 | ||
| Side Effects/Adverse Reactions | 580 | ||
| Occasional | 580 | ||
| Rare | 580 | ||
| Precautions and Contraindications | 580 | ||
| Caution: | 580 | ||
| Drug Interactions of Concern to Dentistry | 580 | ||
| Serious Reactions | 580 | ||
| Dental Considerations | 580 | ||
| General: | 580 | ||
| Consultations: | 580 | ||
| Teach Patient/Family to: | 581 | ||
| flutamide | 581 | ||
| Category and Schedule | 581 | ||
| Drug Class: | 581 | ||
| Mechanism of Action | 581 | ||
| Uses | 581 | ||
| Pharmacokinetics | 581 | ||
| Indications and Dosages | 581 | ||
| ► Prostatic Carcinoma (in Combination with Leuprolide) | 581 | ||
| PO | 581 | ||
| Adults, Elderly. | 581 | ||
| Side Effects/Adverse Reactions | 581 | ||
| Frequent | 581 | ||
| Occasional | 581 | ||
| Rare | 581 | ||
| Precautions and Contraindications | 581 | ||
| Caution: | 581 | ||
| Serious Reactions | 582 | ||
| Dental Considerations | 582 | ||
| General: | 582 | ||
| fluticasone propionate | 582 | ||
| Category and Schedule | 582 | ||
| Drug Class: | 582 | ||
| Mechanism of Action | 582 | ||
| Uses | 582 | ||
| Pharmacokinetics | 582 | ||
| Indications and Dosages | 582 | ||
| ► Allergic Rhinitis | 582 | ||
| Intranasal | 582 | ||
| Adults, Elderly. | 582 | ||
| Children 4 yr and older. | 582 | ||
| ► Relief of Inflammation and Pruritus associated with Steroid-Responsive Disorders, such as Contact Dermatitis and Eczema | 582 | ||
| Topical | 582 | ||
| Adults, Elderly, Children 3 mo and older. | 582 | ||
| ► Maintenance Treatment for Asthma for Those Previously Treated with Bronchodilators | 582 | ||
| Inhalation Powder (Flovent Diskus) | 582 | ||
| fluticasone + vilanterol | 584 | ||
| Category and Schedule | 584 | ||
| Drug Class: | 584 | ||
| Mechanism of Action | 584 | ||
| Uses | 584 | ||
| Pharmacokinetics | 584 | ||
| Indications and Dosages | 584 | ||
| ► Asthma | 584 | ||
| fluvastatin | 586 | ||
| Category and Schedule | 586 | ||
| Drug Class: | 586 | ||
| Mechanism of Action | 586 | ||
| Uses | 586 | ||
| Pharmacokinetics | 586 | ||
| Indications and Dosages | 586 | ||
| ► Hyperlipoproteinemia | 586 | ||
| PO | 586 | ||
| Adults, Elderly. | 586 | ||
| Patients requiring more than a 25% decrease in LDL cholesterol. | 586 | ||
| Side Effects/Adverse Reactions | 586 | ||
| Frequent | 586 | ||
| Occasional | 586 | ||
| Precautions and Contraindications | 586 | ||
| Caution: | 586 | ||
| Drug Interactions of Concern to Dentistry | 586 | ||
| Serious Reactions | 586 | ||
| fluvoxamine maleate | 587 | ||
| Category and Schedule | 587 | ||
| Drug Class: | 587 | ||
| Mechanism of Action | 587 | ||
| Uses | 587 | ||
| Pharmacokinetics | 587 | ||
| Indications and Dosages | 587 | ||
| ► Obsessive-Compulsive Disorder | 587 | ||
| PO | 587 | ||
| Adults. | 587 | ||
| Children 8–17 yr. | 587 | ||
| Side Effects/Adverse Reactions | 587 | ||
| Frequent | 587 | ||
| Occasional | 587 | ||
| Rare | 587 | ||
| Precautions and Contraindications | 587 | ||
| Caution: | 587 | ||
| Drug Interactions of Concern to Dentistry | 587 | ||
| Serious Reactions | 587 | ||
| Dental Considerations | 587 | ||
| General: | 587 | ||
| Consultations: | 588 | ||
| Teach Patient/Family: | 588 | ||
| folic acid/sodium folate (vitamin B9) | 588 | ||
| Category and Schedule | 588 | ||
| Drug Class: | 588 | ||
| Mechanism of Action | 588 | ||
| Uses | 588 | ||
| Pharmacokinetics | 588 | ||
| Indications and Dosages | 588 | ||
| ► Vitamin B9 Deficiency | 588 | ||
| formoterol fumarate | 589 | ||
| Category and Schedule | 589 | ||
| Drug Class: | 589 | ||
| Mechanism of Action | 589 | ||
| Uses | 589 | ||
| Pharmacokinetics | 589 | ||
| Indications and Dosages | 589 | ||
| ► Asthma, COPD | 589 | ||
| fosamprenavir | 590 | ||
| Category and Schedule | 590 | ||
| Drug Class: | 590 | ||
| Mechanism of Action | 590 | ||
| Uses | 590 | ||
| Pharmacokinetics | 591 | ||
| Indications and Dosages | 591 | ||
| ► HIV Infection in Patients Who Have Not Had Previous Protease Inhibitor Therapy | 591 | ||
| foscarnet sodium | 592 | ||
| Category and Schedule | 592 | ||
| Drug Class: | 592 | ||
| Mechanism of Action | 592 | ||
| Uses | 592 | ||
| Pharmacokinetics | 592 | ||
| Indications and Dosages | 592 | ||
| ► CMV Retinitis | 592 | ||
| fosfomycin tromethamine | 593 | ||
| Category and Schedule | 593 | ||
| Drug Class: | 593 | ||
| Mechanism of Action | 593 | ||
| Uses | 593 | ||
| Pharmacokinetics | 593 | ||
| Indications and Dosages | 594 | ||
| ► Uncomplicated UTIs | 594 | ||
| PO | 594 | ||
| Females. | 594 | ||
| Males. | 594 | ||
| Side Effects/Adverse Reactions | 594 | ||
| Occasional | 594 | ||
| Rare | 594 | ||
| Precautions and Contraindications | 594 | ||
| Caution: | 594 | ||
| Drug Interactions of Concern to Dentistry | 594 | ||
| Serious Reactions | 594 | ||
| Dental Considerations | 594 | ||
| General: | 594 | ||
| Teach Patient/Family: | 594 | ||
| fosinopril | 594 | ||
| Category and Schedule | 594 | ||
| Drug Class: | 594 | ||
| Mechanism of Action | 594 | ||
| Uses | 594 | ||
| Pharmacokinetics | 594 | ||
| Indications and Dosages | 595 | ||
| ► Hypertension (Monotherapy) | 595 | ||
| fosphenytoin | 596 | ||
| Category and Schedule | 596 | ||
| Drug Class: | 596 | ||
| Mechanism of Action | 596 | ||
| Uses | 596 | ||
| Pharmacokinetics | 596 | ||
| Indications and Dosages | 596 | ||
| ► Status Epilepticus | 596 | ||
| IV | 596 | ||
| frovatriptan | 597 | ||
| Category and Schedule | 597 | ||
| Drug Class: | 597 | ||
| Mechanism of Action | 597 | ||
| Uses | 597 | ||
| Pharmacokinetics | 597 | ||
| Indications and Dosages | 598 | ||
| ► Acute Migraine Attack | 598 | ||
| PO | 598 | ||
| Adults, Elderly. | 598 | ||
| Side Effects/Adverse Reactions | 598 | ||
| Occasional | 598 | ||
| Rare | 598 | ||
| Precautions and Contraindications | 598 | ||
| Drug Interactions of Concern to Dentistry | 598 | ||
| Serious Reactions | 598 | ||
| Dental Considerations | 598 | ||
| General: | 598 | ||
| Consultations: | 598 | ||
| Teach Patient/Family to: | 598 | ||
| furosemide | 598 | ||
| Category and Schedule | 598 | ||
| Drug Class: | 598 | ||
| Mechanism of Action | 599 | ||
| Uses | 599 | ||
| Pharmacokinetics | 599 | ||
| Indications and Dosages | 599 | ||
| ► Edema, Hypertension | 599 | ||
| PO | 599 | ||
| gabapentin | 601 | ||
| Category and Schedule | 601 | ||
| Drug Class: | 601 | ||
| Mechanism of Action | 601 | ||
| Uses | 601 | ||
| Pharmacokinetics | 601 | ||
| Indications and Dosages | 601 | ||
| ► Adjunctive Therapy for Seizure Control | 601 | ||
| galantamine | 602 | ||
| Category and Schedule | 602 | ||
| Drug Class: | 602 | ||
| Mechanism of Action | 602 | ||
| Uses | 602 | ||
| Pharmacokinetics | 603 | ||
| Indications and Dosages | 603 | ||
| ► Alzheimer’s Disease | 603 | ||
| PO | 603 | ||
| Adults, Elderly. | 603 | ||
| ► Dosage in Renal Impairment | 603 | ||
| Side Effects/Adverse Reactions | 603 | ||
| Frequent | 603 | ||
| Occasional | 603 | ||
| Rare | 603 | ||
| Precautions and Contraindications | 603 | ||
| Caution: | 603 | ||
| Drug Interactions of Concern to Dentistry | 603 | ||
| Serious Reactions | 603 | ||
| Dental Considerations | 603 | ||
| General: | 603 | ||
| Consultations: | 603 | ||
| Teach Patient/Family to: | 604 | ||
| galsulfase | 604 | ||
| Category and Schedule | 604 | ||
| Drug Class: | 604 | ||
| Mechanism of Action | 604 | ||
| Uses | 604 | ||
| Pharmacokinetics | 604 | ||
| Indications and Dosages | 604 | ||
| ► Maroteaux-Lamy Syndrome | 604 | ||
| IV | 604 | ||
| Adults. | 604 | ||
| Children (5 yr and older). | 604 | ||
| Side Effects/Adverse Reactions | 604 | ||
| Frequent | 604 | ||
| Precautions and Contraindications | 604 | ||
| Caution: | 604 | ||
| Drug Interactions of Concern to Dentistry | 604 | ||
| Serious Reactions | 604 | ||
| Dental Considerations | 604 | ||
| General | 604 | ||
| Consultations: | 605 | ||
| Teach Patient/Family to: | 605 | ||
| ganciclovir sodium | 605 | ||
| Category and Schedule | 605 | ||
| Drug Class: | 605 | ||
| Mechanism of Action | 605 | ||
| Uses | 605 | ||
| Pharmacokinetics | 605 | ||
| Indications and Dosages | 605 | ||
| ► CMV Retinitis | 605 | ||
| gefitinib | 607 | ||
| Category and Schedule | 607 | ||
| Drug Class: | 607 | ||
| Mechanism of Action | 607 | ||
| Uses | 607 | ||
| Pharmacokinetics | 607 | ||
| Indications and Dosages | 607 | ||
| ► Non–Small-Cell Lung Cancer | 607 | ||
| PO | 607 | ||
| Adults, Elderly. | 607 | ||
| Side Effects/Adverse Reactions | 607 | ||
| Frequent | 607 | ||
| Occasional | 607 | ||
| Rare | 607 | ||
| Precautions and Contraindications | 607 | ||
| Drug Interactions of Concern to Dentistry | 607 | ||
| Serious Reactions | 607 | ||
| Dental Considerations | 607 | ||
| General: | 607 | ||
| Consultations: | 608 | ||
| Teach Patient/Family to: | 608 | ||
| gemcitabine hydrochloride | 608 | ||
| Category and Schedule | 608 | ||
| Drug Class: | 608 | ||
| Mechanism of Action | 608 | ||
| Uses | 608 | ||
| Pharmacokinetics | 608 | ||
| Indications and Dosages | 608 | ||
| ► Non–Small-Cell Lung Cancer (in Combination with Cisplatin) | 608 | ||
| gemfibrozil | 610 | ||
| Category and Schedule | 610 | ||
| Drug Class: | 610 | ||
| Mechanism of Action | 610 | ||
| Uses | 610 | ||
| Pharmacokinetics | 610 | ||
| Indications and Dosages | 610 | ||
| ► Hyperlipidemia | 610 | ||
| PO | 610 | ||
| Adults, Elderly. | 610 | ||
| Side Effects/Adverse Reactions | 610 | ||
| Frequent | 610 | ||
| Occasional | 610 | ||
| Rare | 610 | ||
| Precautions and Contraindications | 610 | ||
| Caution: | 610 | ||
| Drug Interactions of Concern to Dentistry | 610 | ||
| Serious Reactions | 610 | ||
| Dental Considerations | 610 | ||
| General: | 610 | ||
| Consultations: | 611 | ||
| gemifloxacin mesylate | 611 | ||
| Category and Schedule | 611 | ||
| Drug Class: | 611 | ||
| Mechanism of Action | 611 | ||
| Uses | 611 | ||
| Pharmacokinetics | 611 | ||
| Indications and Dosages | 611 | ||
| ► Acute Bacterial Exacerbation of Chronic Bronchitis | 611 | ||
| gentamicin sulfate | 612 | ||
| Category and Schedule | 612 | ||
| Drug Class: | 612 | ||
| Mechanism of Action | 612 | ||
| Uses | 612 | ||
| Pharmacokinetics | 612 | ||
| Indications and Dosages | 613 | ||
| ► Acute Pelvic, Bone, Intraabdominal, Joint, Respiratory Tract, Burn Wound, Postoperative and Skin or Skin-Structure Infections; Complicated UTIs; Septicemia; Meningitis | 613 | ||
| gentamicin sulfate; prednisolone acetate | 614 | ||
| Category and Schedule | 614 | ||
| Drug Class: | 614 | ||
| Mechanism of Action | 614 | ||
| Uses | 614 | ||
| Pharmacokinetics | 614 | ||
| Indications and Dosages | 614 | ||
| ► Treatment of Steroid Responsive Inflammatory Conditions, Superficial Ocular Infections | 614 | ||
| Ophthalmic Ointment | 614 | ||
| glatiramer | 615 | ||
| Category and Schedule | 615 | ||
| Drug Class: | 615 | ||
| Mechanism of Action | 615 | ||
| Uses | 615 | ||
| Pharmacokinetics | 615 | ||
| Indications and Dosages | 615 | ||
| ► Multiple Sclerosis | 615 | ||
| Subcutaneous | 615 | ||
| Adults, Elderly. | 615 | ||
| Side Effects/Adverse Reactions | 615 | ||
| Expected | 615 | ||
| Frequent | 615 | ||
| Occasional | 615 | ||
| Rare | 615 | ||
| Precautions and Contraindications | 615 | ||
| Drug Interactions of Concern to Dentistry | 615 | ||
| Serious Reactions | 615 | ||
| Dental Considerations | 615 | ||
| General: | 615 | ||
| Dental Considerations | 616 | ||
| General: | 616 | ||
| Consultations: | 616 | ||
| Teach Patient/Family to: | 616 | ||
| glimepiride | 616 | ||
| Category and Schedule | 616 | ||
| Drug Class: | 616 | ||
| Mechanism of Action | 616 | ||
| Uses | 616 | ||
| Pharmacokinetics | 616 | ||
| Indications and Dosages | 616 | ||
| ► Diabetes Mellitus | 616 | ||
| PO | 616 | ||
| Adults, Elderly. | 616 | ||
| ► Dosage in Renal Impairment | 617 | ||
| PO | 617 | ||
| Adults. | 617 | ||
| Side Effects/Adverse Reactions | 617 | ||
| Frequent | 617 | ||
| Occasional | 617 | ||
| Precautions and Contraindications | 617 | ||
| Caution: | 617 | ||
| Drug Interactions of Concern to Dentistry | 617 | ||
| Serious Reactions | 617 | ||
| Dental Considerations | 617 | ||
| General: | 617 | ||
| Consultations: | 617 | ||
| Teach Patient/Family to: | 617 | ||
| glipizide | 618 | ||
| Category and Schedule | 618 | ||
| Drug Class: | 618 | ||
| Mechanism of Action | 618 | ||
| Uses | 618 | ||
| Pharmacokinetics | 618 | ||
| Indications and Dosages | 618 | ||
| ► Diabetes Mellitus | 618 | ||
| PO | 618 | ||
| Adults. | 618 | ||
| Elderly. | 618 | ||
| Side Effects/Adverse Reactions | 618 | ||
| Frequent | 618 | ||
| Occasional | 618 | ||
| Precautions and Contraindications | 618 | ||
| Caution: | 618 | ||
| Drug Interactions of Concern to Dentistry | 618 | ||
| Serious Reactions | 618 | ||
| Dental Considerations | 619 | ||
| General: | 619 | ||
| Consultations: | 619 | ||
| Teach Patient/Family to: | 619 | ||
| glucagon hydrochloride | 619 | ||
| Category and Schedule | 619 | ||
| Drug Class: | 619 | ||
| Mechanism of Action | 619 | ||
| Uses | 619 | ||
| Pharmacokinetics | 619 | ||
| Indications and Dosages | 620 | ||
| ► Hypoglycemia | 620 | ||
| IV, IM, Subcutaneous | 620 | ||
| Adults, Elderly, Children weighing more than 20 kg. | 620 | ||
| Children weighing 20 kg or less. | 620 | ||
| ► Diagnostic Aid | 620 | ||
| IV, IM | 620 | ||
| Adults, Elderly. | 620 | ||
| Side Effects/Adverse Reactions | 620 | ||
| Occasional | 620 | ||
| Rare | 620 | ||
| Precautions and Contraindications | 620 | ||
| Caution: | 620 | ||
| Drug Interactions of Concern to Dentistry | 620 | ||
| Serious Reactions | 620 | ||
| Dental Considerations | 620 | ||
| General: | 620 | ||
| glyburide | 620 | ||
| Category and Schedule | 620 | ||
| Drug Class: | 620 | ||
| Mechanism of Action | 620 | ||
| Uses | 620 | ||
| Pharmacokinetics | 620 | ||
| Indications and Dosages | 621 | ||
| ► Diabetes Mellitus | 621 | ||
| PO | 621 | ||
| Adults. | 621 | ||
| Elderly. | 621 | ||
| PO (Micronized Tablets [Glynase]) | 621 | ||
| Adults, Elderly. | 621 | ||
| ► Dosage in Renal Impairment | 621 | ||
| Side Effects/Adverse Reactions | 621 | ||
| Frequent | 621 | ||
| Occasional | 621 | ||
| Precautions and Contraindications | 621 | ||
| Caution: | 621 | ||
| Drug Interactions of Concern to Dentistry | 621 | ||
| Serious Reactions | 621 | ||
| Dental Considerations | 621 | ||
| General: | 621 | ||
| Consultations: | 622 | ||
| Teach Patient/Family to: | 622 | ||
| glycerol phenylbutyrate | 622 | ||
| Category and Schedule | 622 | ||
| Drug Class: | 622 | ||
| Mechanism of Action | 622 | ||
| Uses | 622 | ||
| Pharmacokinetics | 622 | ||
| Indications and Dosages | 622 | ||
| ► Urea Cycle Disorders | 622 | ||
| PO | 622 | ||
| Adults. | 622 | ||
| Side Effects/Adverse Reactions | 622 | ||
| Frequent | 622 | ||
| Occasional | 622 | ||
| Precautions and Contraindications | 623 | ||
| Drug Interactions of Concern to Dentistry | 623 | ||
| Serious Reactions | 623 | ||
| Dental Considerations | 623 | ||
| General: | 623 | ||
| Consultations: | 623 | ||
| Teach Patient/Family to: | 623 | ||
| glycopyrrolate | 623 | ||
| Category and Schedule | 623 | ||
| Drug Class: | 623 | ||
| Mechanism of Action | 623 | ||
| Uses | 623 | ||
| Pharmacokinetics | 623 | ||
| Indications and Dosages | 623 | ||
| ► Preoperative Inhibition of Salivation and Excessive Respiratory Tract Secretions | 623 | ||
| IM | 623 | ||
| Adults, Elderly. | 623 | ||
| Children 2 yr and older. | 623 | ||
| Children younger than 2 yr. | 623 | ||
| ► To Block Effects of Anticholinesterase Agents | 624 | ||
| IV | 624 | ||
| goserelin acetate | 625 | ||
| Category and Schedule | 625 | ||
| Drug Class: | 625 | ||
| Mechanism of Action | 625 | ||
| Uses | 625 | ||
| Pharmacokinetics | 625 | ||
| Indications and Dosages | 625 | ||
| ► Prostatic Carcinoma | 625 | ||
| granisetron | 626 | ||
| Category and Schedule | 626 | ||
| Drug Class: | 626 | ||
| Mechanism of Action | 626 | ||
| Uses | 627 | ||
| Pharmacokinetics | 627 | ||
| Indications and Dosages | 627 | ||
| ► Prevention of Chemotherapy-Induced Nausea and Vomiting | 627 | ||
| griseofulvin | 628 | ||
| Category and Schedule | 628 | ||
| Drug Class: | 628 | ||
| Mechanism of Action | 628 | ||
| Uses | 628 | ||
| Pharmacokinetics | 628 | ||
| Indications and Dosages | 628 | ||
| ► Tinea Capitis, Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Unguium | 628 | ||
| PO (Microsize Tablets, Oral Suspension) | 628 | ||
| guaifenesin | 629 | ||
| Category and Schedule | 629 | ||
| Drug Class: | 629 | ||
| Mechanism of Action | 629 | ||
| Uses | 629 | ||
| Pharmacokinetics | 629 | ||
| guanabenz | 630 | ||
| Category and Schedule | 630 | ||
| Drug Class: | 630 | ||
| Mechanism of Action | 630 | ||
| Uses | 630 | ||
| Pharmacokinetics | 630 | ||
| Indications and Dosages | 630 | ||
| ► Expectorant | 630 | ||
| ► Hypertension | 630 | ||
| PO | 630 | ||
| Adults. | 630 | ||
| Elderly. | 630 | ||
| Side Effects/Adverse Reactions | 630 | ||
| Rare | 630 | ||
| Precautions and Contraindications | 630 | ||
| Serious Reactions | 630 | ||
| Dental Considerations | 630 | ||
| General: | 630 | ||
| Frequent | 630 | ||
| Occasional | 631 | ||
| Rare | 631 | ||
| Precautions and Contraindications | 631 | ||
| Caution: | 631 | ||
| Drug Interactions of Concern to Dentistry | 631 | ||
| Serious Reactions | 631 | ||
| Dental Considerations | 631 | ||
| General: | 631 | ||
| Consultations: | 631 | ||
| Teach Patient/Family: | 631 | ||
| guanadrel sulfate | 631 | ||
| Category and Schedule | 631 | ||
| Drug Class: | 631 | ||
| Mechanism of Action | 631 | ||
| Uses | 631 | ||
| Pharmacokinetics | 632 | ||
| Indications and Dosages | 632 | ||
| ► Hypertension | 632 | ||
| PO | 632 | ||
| Adults. | 632 | ||
| Elderly. | 632 | ||
| Side Effects/Adverse Reactions | 632 | ||
| Frequent | 632 | ||
| Occasional | 632 | ||
| Rare | 632 | ||
| Precautions and Contraindications | 632 | ||
| Caution: | 632 | ||
| Drug Interactions of Concern to Dentistry | 632 | ||
| Serious Reactions | 632 | ||
| Dental Considerations | 632 | ||
| General: | 632 | ||
| Consultations: | 632 | ||
| Teach Patient/Family: | 632 | ||
| guanethidine monosulfate | 633 | ||
| Category and Schedule | 633 | ||
| Drug Class: | 633 | ||
| Mechanism of Action | 633 | ||
| Uses | 633 | ||
| Pharmacokinetics | 633 | ||
| Indications and Dosages | 633 | ||
| ► Hypertension | 633 | ||
| PO | 633 | ||
| Adults. | 633 | ||
| Side Effects/Adverse Reactions | 633 | ||
| Frequent | 633 | ||
| Occasional | 633 | ||
| Rare | 633 | ||
| Precautions and Contraindications | 633 | ||
| Caution: | 633 | ||
| Drug Interactions of Concern to Dentistry | 633 | ||
| Serious Reactions | 633 | ||
| Dental Considerations | 633 | ||
| General: | 633 | ||
| Consultations: | 634 | ||
| Teach Patient/Family to: | 634 | ||
| guanfacine | 634 | ||
| Category and Schedule | 634 | ||
| Drug Class: | 634 | ||
| Mechanism of Action | 634 | ||
| Uses | 634 | ||
| Pharmacokinetics | 634 | ||
| Indications and Dosages | 634 | ||
| ► Hypertension | 634 | ||
| PO | 634 | ||
| Adults, Elderly. | 634 | ||
| Side Effects/Adverse Reactions | 635 | ||
| Frequent | 635 | ||
| Occasional | 635 | ||
| Precautions and Contraindications | 635 | ||
| Drug Interactions of Concern to Dentistry | 635 | ||
| Serious Reactions | 635 | ||
| Dental Considerations | 635 | ||
| General: | 635 | ||
| Consultations: | 635 | ||
| Teach Patient/Family to: | 635 | ||
| halcinonide | 636 | ||
| Category and Schedule | 636 | ||
| Drug Class: | 636 | ||
| Mechanism of Action | 636 | ||
| Uses | 636 | ||
| Pharmacokinetics | 636 | ||
| Indications and Dosages | 636 | ||
| ► Dermatoses | 636 | ||
| Topical | 636 | ||
| Adults, Elderly. | 636 | ||
| Side Effects/Adverse Reactions | 636 | ||
| Occasional | 636 | ||
| Rare | 636 | ||
| Precautions and Contraindications | 636 | ||
| Serious Reactions | 636 | ||
| Dental Considerations | 636 | ||
| General: | 636 | ||
| Teach Patient/Family to: | 636 | ||
| Mechanism of Action | 637 | ||
| Uses | 637 | ||
| Pharmacokinetics | 637 | ||
| Indications and Dosages | 637 | ||
| ► Treatment of Psychotic Disorders | 637 | ||
| haloperidol | 636 | ||
| histrelin | 639 | ||
| Category and Schedule | 639 | ||
| Drug Class: | 639 | ||
| Mechanism of Action | 639 | ||
| Uses | 639 | ||
| Pharmacokinetics | 639 | ||
| Indications and Dosages | 639 | ||
| Adult. | 639 | ||
| Pediatric. | 639 | ||
| Side Effects/Adverse Reactions | 639 | ||
| Frequent | 639 | ||
| Occasional | 639 | ||
| Precautions and Contraindications | 639 | ||
| Drug Interactions of Concern to Dentistry | 639 | ||
| Serious Reactions | 639 | ||
| Dental Considerations | 640 | ||
| Consultations: | 640 | ||
| Teach Patient/Family to: | 640 | ||
| homatropine hydrobromide | 640 | ||
| Category and Schedule | 640 | ||
| Drug Class: | 640 | ||
| Mechanism of Action | 640 | ||
| Uses | 640 | ||
| Pharmacokinetics | 640 | ||
| Indications and Dosages | 640 | ||
| ► Mydriasis and Cycloplegia for Refraction | 640 | ||
| hydralazine hydrochloride | 641 | ||
| Category and Schedule | 641 | ||
| Drug Class: | 641 | ||
| Mechanism of Action | 641 | ||
| Uses | 641 | ||
| Pharmacokinetics | 641 | ||
| Indications and Dosages | 641 | ||
| ► Moderate to Severe Hypertension | 641 | ||
| PO | 641 | ||
| Adults. | 641 | ||
| hydrochlorothiazide | 642 | ||
| Category and Schedule | 642 | ||
| Drug Class: | 642 | ||
| Mechanism of Action | 643 | ||
| Uses | 643 | ||
| Pharmacokinetics | 643 | ||
| Indications and Dosages | 643 | ||
| ► Edema, Hypertension | 643 | ||
| hydrocodone bitartrate | 644 | ||
| Category and Schedule | 644 | ||
| Drug Class: | 644 | ||
| Mechanism of Action | 644 | ||
| Uses | 644 | ||
| Pharmacokinetics | 644 | ||
| Indications and Dosages | 645 | ||
| ► Analgesia | 645 | ||
| hydrocodone | 646 | ||
| Category and Schedule | 646 | ||
| Drug Class: | 646 | ||
| Mechanism of Action | 646 | ||
| Uses | 646 | ||
| Pharmacokinetics | 646 | ||
| Indications and Dosages | 646 | ||
| Analgesia | 646 | ||
| ► Hydrocodone and Acetaminophen | 646 | ||
| hydrocortisone | 648 | ||
| Category and Schedule | 648 | ||
| Drug Class: | 648 | ||
| Mechanism of Action | 648 | ||
| Uses | 648 | ||
| Pharmacokinetics | 648 | ||
| Indications and Dosages | 648 | ||
| ► Acute Adrenal Insufficiency | 648 | ||
| hydroflumethiazide | 650 | ||
| Category and Schedule | 650 | ||
| Drug Class: | 650 | ||
| Mechanism of Action | 650 | ||
| Uses | 650 | ||
| Pharmacokinetics | 650 | ||
| Indications and Dosages | 650 | ||
| ► Edema | 650 | ||
| PO | 650 | ||
| Adults, Elderly. | 650 | ||
| ► Hypertension | 650 | ||
| Adults, Elderly, Children. | 650 | ||
| Side Effects/Adverse Reactions | 650 | ||
| Expected | 650 | ||
| Frequent | 650 | ||
| Occasional | 650 | ||
| Precautions and Contraindications | 650 | ||
| Drug Interactions of Concern to Dentistry | 650 | ||
| Serious Reactions | 650 | ||
| Dental Considerations | 651 | ||
| General: | 651 | ||
| Consultations: | 651 | ||
| Teach Patient/Family to: | 651 | ||
| hydromorphone hydrochloride | 651 | ||
| Category and Schedule | 651 | ||
| Drug Class: | 651 | ||
| Mechanism of Action | 652 | ||
| Uses | 652 | ||
| Pharmacokinetics | 652 | ||
| Indications and Dosages | 652 | ||
| ► Analgesia | 652 | ||
| hydroxychloroquine sulfate | 653 | ||
| Category and Schedule | 653 | ||
| Drug Class: | 653 | ||
| Mechanism of Action | 653 | ||
| Uses | 653 | ||
| Pharmacokinetics | 653 | ||
| Indications and Dosages | 654 | ||
| ► Treatment of Acute Attack of Malaria (Dosage in mg Base) | 654 | ||
| hydroxyurea | 655 | ||
| Category and Schedule | 655 | ||
| Drug Class: | 655 | ||
| Mechanism of Action | 655 | ||
| Uses | 655 | ||
| Pharmacokinetics | 655 | ||
| Indications and Dosages | 655 | ||
| ► Melanoma; Recurrent, Metastatic, or Inoperable Ovarian Carcinoma | 655 | ||
| hydroxyzine | 656 | ||
| Category and Schedule | 656 | ||
| Drug Class: | 656 | ||
| Mechanism of Action | 656 | ||
| Uses | 656 | ||
| Pharmacokinetics | 657 | ||
| Indications and Dosages | 657 | ||
| ► Anxiety | 657 | ||
| hyoscyamine | 658 | ||
| Category and Schedule | 658 | ||
| Drug Class: | 658 | ||
| Mechanism of Action | 658 | ||
| Uses | 658 | ||
| Pharmacokinetics | 658 | ||
| Indications and Dosages | 658 | ||
| ► GI Tract Disorders | 658 | ||
| ibandronate sodium | 660 | ||
| Category and Schedule | 660 | ||
| Drug Class: | 660 | ||
| Mechanism of Action | 660 | ||
| Uses | 660 | ||
| PharmacoKinetics | 660 | ||
| Indications and Dosages | 660 | ||
| ► Osteoporosis | 660 | ||
| PO | 660 | ||
| Adults, Elderly. | 660 | ||
| Side Effects/Adverse Reactions | 660 | ||
| Frequent | 660 | ||
| Occasional | 660 | ||
| Rare | 660 | ||
| Precautions and Contraindications | 660 | ||
| Drug Interactions of Concern to Dentistry | 660 | ||
| Serious Reactions | 660 | ||
| Dental Considerations | 660 | ||
| General: | 660 | ||
| Consultations: | 661 | ||
| Teach Patient/Family to: | 661 | ||
| ibuprofen | 661 | ||
| Category and Schedule | 661 | ||
| Drug Class: | 661 | ||
| Mechanism of Action | 661 | ||
| Uses | 661 | ||
| Pharmacokinetics | 661 | ||
| Indications and Dosages | 661 | ||
| ► Acute or Chronic Rheumatoid Arthritis, Osteoarthritis, Migraine Pain, Gouty Arthritis | 661 | ||
| ibuprofen + famotidine | 663 | ||
| Category and Schedule | 663 | ||
| Drug Class: | 663 | ||
| Mechanism of Action | 663 | ||
| Uses | 663 | ||
| Pharmacokinetics | 663 | ||
| Indications and Dosages | 663 | ||
| ► NSAID-Associated Ulcer Prophylaxis During Treatment for Osteoarthritis/Rheumatoid Arthritis | 663 | ||
| PO | 663 | ||
| Adults. | 663 | ||
| Side Effects/Adverse Reactions | 663 | ||
| Frequent | 663 | ||
| Occasional | 663 | ||
| Precautions and Contraindications | 663 | ||
| Drug Interactions of Concern to Dentistry | 664 | ||
| Serious Reactions | 664 | ||
| Dental Considerations | 664 | ||
| General: | 664 | ||
| Consultations: | 664 | ||
| Teach Patient/Family to: | 664 | ||
| ibutilide fumarate | 664 | ||
| Category and Schedule | 664 | ||
| Drug Class: | 664 | ||
| Mechanism of Action | 664 | ||
| Uses | 665 | ||
| Pharmacokinetics | 665 | ||
| Indications and Dosages | 665 | ||
| ► Rapid Conversion of Atrial Fibrillation or Flutter of Recent Onset to Normal Sinus Rhythm | 665 | ||
| IV Infusion | 665 | ||
| Adults, Elderly weighing 60 kg and more. | 665 | ||
| Adults, Elderly weighing less than 60 kg. | 665 | ||
| Side Effects/Adverse Reactions | 665 | ||
| Occasional | 665 | ||
| Rare | 665 | ||
| Precautions and Contraindications | 665 | ||
| Drug Interactions of Concern to Dentistry | 665 | ||
| Serious Reactions | 665 | ||
| Dental Considerations | 665 | ||
| General: | 665 | ||
| Consultations: | 665 | ||
| Teach Patient/Family to: | 665 | ||
| idarubicin hydrochloride | 666 | ||
| Category and Schedule | 666 | ||
| Drug Class: | 666 | ||
| Mechanism of Action | 666 | ||
| Uses | 666 | ||
| Pharmacokinetics | 666 | ||
| Indications and Dosages | 666 | ||
| ► AML | 666 | ||
| IV | 666 | ||
| Adults. | 666 | ||
| Children (solid tumor). | 666 | ||
| Children (leukemia). | 666 | ||
| ► Dosage in Hepatic or Renal Impairment | 666 | ||
| Side Effects/Adverse Reactions | 666 | ||
| Frequent | 666 | ||
| Occasional | 666 | ||
| Rare | 666 | ||
| Precautions and Contraindications | 666 | ||
| Drug Interactions of Concern to Dentistry | 666 | ||
| Serious Reactions | 666 | ||
| Dental Considerations | 667 | ||
| General: | 667 | ||
| Consultations: | 667 | ||
| Teach Patient/Family to: | 667 | ||
| idelalisib | 667 | ||
| Category and Schedule | 667 | ||
| Drug Class: | 667 | ||
| Mechanism of Action | 667 | ||
| Uses | 667 | ||
| Pharmacokinetics | 668 | ||
| Indications and Dosages | 668 | ||
| ► Chronic Lymphocytic Leukemia, Relapsed | 668 | ||
| idursulfase | 669 | ||
| Category and Schedule | 669 | ||
| Drug Class: | 669 | ||
| Mechanism of Action | 669 | ||
| Uses | 669 | ||
| Pharmacokinetics | 669 | ||
| Indications and Dosages | 669 | ||
| ► Hunter Syndrome | 669 | ||
| IV | 669 | ||
| Adults. | 669 | ||
| Children (5 yr and older). | 669 | ||
| Side Effects/Adverse Reactions | 669 | ||
| Frequent | 669 | ||
| Rare | 669 | ||
| Precautions and Contraindications | 669 | ||
| Caution: | 669 | ||
| Drug Interactions of Concern to Dentistry | 669 | ||
| Serious Reactions | 669 | ||
| Dental Considerations | 669 | ||
| General: | 669 | ||
| Consultations: | 669 | ||
| Teach Patient/Family to: | 669 | ||
| ifosfamide | 670 | ||
| Category and Schedule | 670 | ||
| Drug Class: | 670 | ||
| Mechanism of Action | 670 | ||
| Uses | 670 | ||
| Pharmacokinetics | 670 | ||
| Indications and Dosages | 670 | ||
| ► Germ Cell Testicular Carcinoma | 670 | ||
| IV | 670 | ||
| Adults. | 670 | ||
| Children. | 670 | ||
| Side Effects/Adverse Reactions | 670 | ||
| Frequent | 670 | ||
| Occasional | 670 | ||
| Rare | 670 | ||
| Precautions and Contraindications | 670 | ||
| Drug Interactions of Concern to Dentistry | 670 | ||
| Serious Reactions | 670 | ||
| Dental Considerations | 670 | ||
| General: | 670 | ||
| Consultations: | 671 | ||
| Teach Patient/Family to: | 671 | ||
| iloperidone | 671 | ||
| Category and Schedule | 671 | ||
| Drug Class: | 671 | ||
| Mechanism of Action | 671 | ||
| Uses | 671 | ||
| Pharmacokinetics | 671 | ||
| Indications and Dosages | 672 | ||
| ► Schizophrenia | 672 | ||
| PO | 672 | ||
| Adults. | 672 | ||
| Side Effects/Adverse Reactions | 672 | ||
| Frequent | 672 | ||
| Occasional | 672 | ||
| Rare | 672 | ||
| Precautions and Contraindications | 672 | ||
| Caution: | 672 | ||
| Drug Interactions of Concern to Dentistry | 672 | ||
| Serious Reactions | 672 | ||
| Dental Considerations | 672 | ||
| General: | 672 | ||
| Consultations: | 673 | ||
| Teach Patient/Family to: | 673 | ||
| iloprost | 673 | ||
| Category and Schedule | 673 | ||
| Drug Class: | 673 | ||
| Mechanism of Action | 673 | ||
| Uses | 673 | ||
| Pharmacokinetics | 673 | ||
| Indications and Dosages | 673 | ||
| ► Pulmonary Hypertension in Patients with NYHA Class III or IV Symptoms | 673 | ||
| Oral Inhalation | 673 | ||
| Adults, Elderly. | 673 | ||
| Side Effects/Adverse Reactions | 674 | ||
| Frequent | 674 | ||
| Occasional | 674 | ||
| Rare | 674 | ||
| Precautions and Contraindications | 674 | ||
| Caution: | 674 | ||
| Drug Interactions of Concern to Dentistry | 674 | ||
| Serious Reactions | 674 | ||
| Dental Considerations | 674 | ||
| General: | 674 | ||
| Consultations: | 674 | ||
| Teach Patient/Family to: | 674 | ||
| imatinib mesylate | 674 | ||
| Category and Schedule | 674 | ||
| Drug Class: | 674 | ||
| Mechanism of Action | 674 | ||
| Uses | 675 | ||
| Pharmacokinetics | 675 | ||
| Indications and Dosages | 675 | ||
| ► CML | 675 | ||
| PO | 675 | ||
| Adults, Elderly. | 675 | ||
| Children. | 675 | ||
| Side Effects/Adverse Reactions | 675 | ||
| Frequent | 675 | ||
| Occasional | 675 | ||
| Rare | 675 | ||
| Precautions and Contraindications | 675 | ||
| Caution: | 675 | ||
| Drug Interactions of Concern to Dentistry | 675 | ||
| Serious Reactions | 675 | ||
| Dental Considerations | 676 | ||
| General: | 676 | ||
| Consultations: | 676 | ||
| Teach Patient/Family to: | 676 | ||
| imipramine | 676 | ||
| Category and Schedule | 676 | ||
| Drug Class: | 676 | ||
| Mechanism of Action | 676 | ||
| Uses | 676 | ||
| Pharmacokinetics | 676 | ||
| Indications and Dosages | 676 | ||
| ► Depression | 676 | ||
| PO | 676 | ||
| Adults. | 676 | ||
| Elderly. | 677 | ||
| Children. | 677 | ||
| ► Enuresis | 677 | ||
| PO | 677 | ||
| Children older than 6 yr. | 677 | ||
| Side Effects/Adverse Reactions | 677 | ||
| Frequent | 677 | ||
| Occasional | 677 | ||
| Rare | 677 | ||
| Precautions and Contraindications | 677 | ||
| Caution: | 677 | ||
| Drug Interactions of Concern to Dentistry | 677 | ||
| Serious Reactions | 677 | ||
| Dental Considerations | 677 | ||
| General: | 677 | ||
| Consultations: | 678 | ||
| Teach Patient/Family to: | 678 | ||
| imiquimod | 678 | ||
| Category and Schedule | 678 | ||
| Drug Class: | 678 | ||
| Mechanism of Action | 678 | ||
| Uses | 678 | ||
| Pharmacokinetics | 678 | ||
| Indications and Dosages | 678 | ||
| ► Warts/Condyloma Acuminata | 678 | ||
| Topical | 678 | ||
| Adults, Elderly, Children 12 yr and older. | 678 | ||
| Side Effects/Adverse Reactions | 678 | ||
| Frequent | 678 | ||
| Occasional | 678 | ||
| indacaterol | 679 | ||
| Category and Schedule | 679 | ||
| Drug Class: | 679 | ||
| Mechanism of Action | 679 | ||
| Uses | 679 | ||
| Pharmacokinetics | 679 | ||
| Indications and Dosages | 679 | ||
| ► COPD, Maintenance | 679 | ||
| Oral inhalation | 679 | ||
| Adults. | 679 | ||
| Side Effects/Adverse Reactions | 679 | ||
| Frequent | 679 | ||
| Occasional | 679 | ||
| Precautions and Contraindications | 679 | ||
| Caution: | 679 | ||
| Drug Interactions of Concern to Dentistry | 679 | ||
| Serious Reactions | 679 | ||
| Dental Considerations | 679 | ||
| General: | 679 | ||
| Consultations: | 679 | ||
| Teach Patient/Family to: | 679 | ||
| Drug Interactions of Concern to Dentistry | 680 | ||
| Serious Reactions | 680 | ||
| Dental Considerations | 680 | ||
| General: | 680 | ||
| Consultations: | 680 | ||
| Teach Patient/Family to: | 680 | ||
| indapamide | 680 | ||
| Category and Schedule | 680 | ||
| Drug Class: | 680 | ||
| Mechanism of Action | 680 | ||
| Uses | 680 | ||
| Pharmacokinetics | 680 | ||
| Indications and Dosages | 681 | ||
| ► Edema | 681 | ||
| indinavir | 682 | ||
| Category and Schedule | 682 | ||
| Drug Class: | 682 | ||
| Mechanism of Action | 682 | ||
| Uses | 682 | ||
| PharmacoKinetics | 682 | ||
| Indications and Dosages | 682 | ||
| ► HIV Infection (in Combination with Other Antiretrovirals) | 682 | ||
| indomethacin | 683 | ||
| Category and Schedule | 683 | ||
| Drug Class: | 683 | ||
| Mechanism of Action | 683 | ||
| Uses | 683 | ||
| PharmacoKinetics | 683 | ||
| Indications and Dosages | 684 | ||
| ► Moderate-to-Severe Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis | 684 | ||
| infliximab | 685 | ||
| Category and Schedule | 685 | ||
| Drug Class: | 685 | ||
| Mechanism of Action | 685 | ||
| Uses | 685 | ||
| PharmacoKinetics | 686 | ||
| Indications and Dosages | 686 | ||
| ► Moderate-to-Severe Crohn’s Disease | 686 | ||
| ingenol mebutate | 687 | ||
| Category and Schedule | 687 | ||
| Drug Class: | 687 | ||
| Mechanism of Action | 687 | ||
| Uses | 687 | ||
| Pharmacokinetics | 687 | ||
| Indications and Dosages | 687 | ||
| ► Actinic Keratoses | 687 | ||
| Topical | 687 | ||
| Adults. | 687 | ||
| Side Effects/Adverse Reactions | 687 | ||
| Frequent | 687 | ||
| Occasional | 687 | ||
| Precautions and Contraindications | 687 | ||
| Drug Interactions of Concern to Dentistry | 687 | ||
| Serious Reactions | 687 | ||
| Dental Considerations | 687 | ||
| General: | 687 | ||
| Teach Patient/Family to: | 687 | ||
| insulin | 688 | ||
| Category and Schedule | 688 | ||
| Drug Class: | 688 | ||
| Mechanism of Action | 688 | ||
| Uses | 688 | ||
| PharmacoKinetics | 688 | ||
| Indications and Dosages | 688 | ||
| ► Treatment of Insulin-Dependent Type 1 Diabetes Mellitus and Non–Insulin-Dependent Type 2 Diabetes Mellitus When Diet or Weight Control Has Failed to Maintain Satisfactory Blood Glucose Levels or in Event of Fever, Infection, Pregnancy, Surgery, or Trauma, or Severe Endocrine, Hepatic or Renal Dysfunction; Emergency Treatment of Ketoacidosis (Regular Insulin); to Promote Passage of Glucose Across Cell Membrane in Hyperalimentation (Regular Insulin): to Facilitate Intracellular Shift of Potassium in Hyperkalemia (Regular Insulin) | 688 | ||
| Subcutaneous | 688 | ||
| Adults, Elderly, Children. | 688 | ||
| Adolescents (during growth spurt). | 688 | ||
| Side Effects/Adverse Reactions | 688 | ||
| Occasional | 688 | ||
| Infrequent | 689 | ||
| Rare | 689 | ||
| Precautions and Contraindications | 689 | ||
| Drug Interactions of Concern to Dentistry | 689 | ||
| Serious Reactions | 689 | ||
| Dental Considerations | 689 | ||
| General: | 689 | ||
| Consultations: | 689 | ||
| Teach Patient/Family to: | 689 | ||
| insulin glargine | 689 | ||
| Category and Schedule | 689 | ||
| Drug Class: | 689 | ||
| Mechanism of Action | 690 | ||
| Uses | 690 | ||
| PharmacoKinetics | 690 | ||
| Indications and Dosages | 690 | ||
| ► Treatment of Insulin-Dependent Type 1 Diabetes Mellitus, Non–Insulin-Dependent Type 2 Diabetes Mellitus When Diet or Weight Control Therapy Has Failed to Maintain Satisfactory Blood Glucose Levels or in Event of Fever, Infection, Pregnancy, Severe Endocrine, Liver or Renal Dysfunction, Surgery, or Trauma, Regular Insulin Used in Emergency Treatment of Ketoacidosis, to Promote Passage of Glucose Across Cell Membrane in Hyperalimentation, to Facilitate Intracellular Shift of Potassium in Hyperkalemia | 690 | ||
| Subcutaneous | 690 | ||
| Adults, Elderly, Children. | 690 | ||
| Side Effects/Adverse Reactions | 690 | ||
| Frequent | 690 | ||
| Occasional | 690 | ||
| Infrequent | 690 | ||
| Rare | 690 | ||
| Precautions and Contraindications | 690 | ||
| Drug Interactions of Concern to Dentistry | 690 | ||
| Serious Reactions | 691 | ||
| Dental Considerations | 691 | ||
| General: | 691 | ||
| Consultations: | 691 | ||
| Teach Patient/Family to: | 691 | ||
| insulin glulisine | 691 | ||
| Category and Schedule | 691 | ||
| Drug Class: | 691 | ||
| Mechanism of Action | 691 | ||
| Uses | 691 | ||
| PharmacoKinetics | 691 | ||
| Indications and Dosages | 692 | ||
| ► Diabetes Mellitus (Type 1 and Type 2) | 692 | ||
| Subcutaneous, Infusion Pump | 692 | ||
| Adults, Elderly, Children. | 692 | ||
| Side Effects/Adverse Reactions | 692 | ||
| Occasional | 692 | ||
| Infrequent | 692 | ||
| Rare | 692 | ||
| Precautions and Contraindications | 692 | ||
| Drug Interactions of Concern to Dentistry | 692 | ||
| Serious Reactions | 692 | ||
| Dental Considerations | 692 | ||
| General: | 692 | ||
| Consultations: | 692 | ||
| Teach Patient/Family to: | 692 | ||
| interferon alfa-2a | 693 | ||
| Category and Schedule | 693 | ||
| Drug Class: | 693 | ||
| Mechanism of Action | 693 | ||
| Uses | 693 | ||
| PharmacoKinetics | 693 | ||
| Indications and Dosages | 693 | ||
| ► Hairy Cell Leukemia | 693 | ||
| interferon alfa-2a/2b | 694 | ||
| Category and Schedule | 694 | ||
| Drug Class: | 694 | ||
| Mechanism of Action | 695 | ||
| Uses | 695 | ||
| PharmacoKinetics | 695 | ||
| interferon alfa-2b | 697 | ||
| Category and Schedule | 697 | ||
| Drug Class: | 697 | ||
| Mechanism of Action | 697 | ||
| Uses | 697 | ||
| PharmacoKinetics | 697 | ||
| Indications and Dosages | 697 | ||
| ► Hairy-Cell Leukemia | 697 | ||
| IM, Subcutaneous | 697 | ||
| Adults. | 697 | ||
| ► Condyloma Acuminatum | 698 | ||
| Intralesional | 698 | ||
| interferon alfa-n3 | 699 | ||
| Category and Schedule | 699 | ||
| Drug Class: | 699 | ||
| Mechanism of Action | 699 | ||
| Uses | 699 | ||
| PharmacoKinetics | 699 | ||
| Indications and Dosages | 699 | ||
| ► Condyloma Acuminatum | 699 | ||
| Intralesional | 699 | ||
| Adults, Children 18 yr and older. | 699 | ||
| Side Effects/Adverse Reactions | 699 | ||
| Frequent | 699 | ||
| Occasional | 700 | ||
| Rare | 700 | ||
| Precautions and Contraindications | 700 | ||
| Caution: | 700 | ||
| Drug Interactions of Concern to Dentistry | 700 | ||
| Serious Reactions | 700 | ||
| Dental Considerations | 700 | ||
| General: | 700 | ||
| Consultations: | 700 | ||
| Teach Patient/Family to: | 700 | ||
| interferon gamma-1b | 700 | ||
| Category and Schedule | 700 | ||
| Drug Class: | 700 | ||
| Mechanism of Action | 700 | ||
| Uses | 700 | ||
| PharmacoKinetics | 700 | ||
| Indications and Dosages | 701 | ||
| ► Chronic Granulomatous Disease; Severe, Malignant Osteoporosis | 701 | ||
| Subcutaneous | 701 | ||
| Adults, Children older than 1 yr. | 701 | ||
| Side Effects/Adverse Reactions | 701 | ||
| Frequent | 701 | ||
| Occasional | 701 | ||
| Rare | 701 | ||
| Precautions and Contraindications | 701 | ||
| Caution: | 701 | ||
| Drug Interactions of Concern to Dentistry | 701 | ||
| Serious Reactions | 701 | ||
| Dental Considerations | 701 | ||
| General: | 701 | ||
| Consultations: | 701 | ||
| Teach Patient/Family to: | 701 | ||
| ipratropium bromide | 702 | ||
| Category and Schedule | 702 | ||
| Drug Class: | 702 | ||
| Mechanism of Action | 702 | ||
| Uses | 702 | ||
| PharmacoKinetics | 702 | ||
| Indications and Dosages | 702 | ||
| ► Bronchospasm, Acute Treatment | 702 | ||
| irbesartan | 703 | ||
| Category and Schedule | 703 | ||
| Drug Class: | 703 | ||
| Mechanism of Action | 703 | ||
| Uses | 703 | ||
| PharmacoKinetics | 703 | ||
| Indications and Dosages | 704 | ||
| ► Hypertension Alone or in Combination with Other Antihypertensives | 704 | ||
| isavuconazonium sulfate | 704 | ||
| Category and Schedule | 704 | ||
| Drug Class: | 704 | ||
| Mechanism of Action | 705 | ||
| Uses | 705 | ||
| Pharmacokinetics | 705 | ||
| Indications and Dosages | 705 | ||
| ► Aspergillosis, Invasive | 705 | ||
| isocarboxazid | 706 | ||
| Category and Schedule | 706 | ||
| Drug Class: | 706 | ||
| Mechanism of Action | 706 | ||
| Uses | 706 | ||
| PharmacoKinetics | 706 | ||
| Indications and Dosages | 706 | ||
| ► Depression Refractory to Other Antidepressants or Electroconvulsive Therapy | 706 | ||
| PO | 706 | ||
| Adults, Elderly. | 706 | ||
| Side Effects/Adverse Reactions | 706 | ||
| Frequent | 706 | ||
| Occasional | 707 | ||
| Rare | 707 | ||
| Precautions and Contraindications | 707 | ||
| Caution: | 707 | ||
| Drug Interactions of Concern to Dentistry | 707 | ||
| Serious Reactions | 707 | ||
| Dental Considerations | 707 | ||
| General: | 707 | ||
| Consultations: | 707 | ||
| Teach Patient/Family: | 707 | ||
| isoetharine hydrochloride | 708 | ||
| Category and Schedule | 708 | ||
| Drug Class: | 708 | ||
| Mechanism of Action | 708 | ||
| Uses | 708 | ||
| PharmacoKinetics | 708 | ||
| Indications and Dosages | 708 | ||
| ► Bronchospasm | 708 | ||
| Hand-Bulb Nebulizer | 708 | ||
| isoniazid | 709 | ||
| Category and Schedule | 709 | ||
| Drug Class: | 709 | ||
| Mechanism of Action | 709 | ||
| Uses | 709 | ||
| PharmacoKinetics | 709 | ||
| Indications and Dosages | 709 | ||
| ► TB (in Combination with One or More Antituberculars) | 709 | ||
| isosorbide | 710 | ||
| Category and Schedule | 710 | ||
| Drug Class: | 710 | ||
| Mechanism of Action | 710 | ||
| Uses | 710 | ||
| PharmacoKinetics | 710 | ||
| Indications and Dosages | 711 | ||
| ► Acute Angina, Prophylactic Management in Situations Likely to Provoke Attack | 711 | ||
| isosorbide dinitrate/isosorbide mononitrate | 712 | ||
| Category and Schedule | 712 | ||
| Drug Class: | 712 | ||
| Mechanism of Action | 712 | ||
| Uses | 712 | ||
| PharmacoKinetics | 712 | ||
| Indications and Dosages | 713 | ||
| ► Angina | 713 | ||
| PO (Isosorbide Dinitrate) | 713 | ||
| isoxsuprine hydrochloride | 714 | ||
| Category and Schedule | 714 | ||
| Drug Class: | 714 | ||
| Mechanism of Action | 714 | ||
| Uses | 714 | ||
| PharmacoKinetics | 714 | ||
| Indications and Dosages | 714 | ||
| ► Raynaud’s Syndrome | 714 | ||
| IV Infusion | 714 | ||
| Adults, Elderly. | 714 | ||
| Side Effects/Adverse Reactions | 714 | ||
| Rare | 714 | ||
| Precautions and Contraindications | 714 | ||
| Caution: | 714 | ||
| Drug Interactions of Concern to Dentistry | 714 | ||
| Serious Reactions | 714 | ||
| Dental Considerations | 714 | ||
| General: | 714 | ||
| Consultations: | 715 | ||
| isradipine | 715 | ||
| Category and Schedule | 715 | ||
| Drug Class: | 715 | ||
| Mechanism of Action | 715 | ||
| Uses | 715 | ||
| PharmacoKinetics | 715 | ||
| Indications and Dosages | 715 | ||
| ► Hypertension | 715 | ||
| PO | 715 | ||
| Adults, Elderly. | 715 | ||
| Side Effects/Adverse Reactions | 715 | ||
| Frequent | 715 | ||
| Occasional | 715 | ||
| Rare | 715 | ||
| Precautions and Contraindications | 715 | ||
| Caution: | 715 | ||
| Drug Interactions of Concern to Dentistry | 716 | ||
| Serious Reactions | 716 | ||
| Dental Considerations | 716 | ||
| General: | 716 | ||
| Consultations: | 716 | ||
| Teach Patient/Family to: | 716 | ||
| itraconazole | 716 | ||
| Category and Schedule | 716 | ||
| Drug Class: | 716 | ||
| Mechanism of Action | 716 | ||
| Uses | 717 | ||
| PharmacoKinetics | 717 | ||
| Indications and Dosages | 717 | ||
| ► Blastomycosis, Histoplasmosis | 717 | ||
| ivabradine | 718 | ||
| Category and Schedule | 718 | ||
| Drug Class: | 718 | ||
| Mechanism of Action | 718 | ||
| Uses | 718 | ||
| Pharmacokinetics | 718 | ||
| Indications and Dosages | 718 | ||
| ► Heart Failure | 718 | ||
| PO | 718 | ||
| Adults. | 718 | ||
| Side Effects/Adverse Reactions | 719 | ||
| Frequent | 719 | ||
| Occasional | 719 | ||
| Precautions and Contraindications | 719 | ||
| Drug Interactions of Concern to Dentistry | 719 | ||
| Serious Reactions | 719 | ||
| Dental Considerations | 719 | ||
| General: | 719 | ||
| Consultations: | 719 | ||
| Teach Patient/Family to: | 719 | ||
| ivacaftor | 720 | ||
| Category and Schedule | 720 | ||
| Drug Class: | 720 | ||
| Mechanism of Action | 720 | ||
| Uses | 720 | ||
| Pharmacokinetics | 720 | ||
| Indications and Dosages | 720 | ||
| ► Cystic Fibrosis | 720 | ||
| Oral | 720 | ||
| Adults. | 720 | ||
| Children older than 6 yr. | 720 | ||
| ► Dosage in Hepatic Impairment | 720 | ||
| Side Effects/Adverse Reactions | 720 | ||
| Frequent | 720 | ||
| Occasional | 720 | ||
| Precautions and Contraindications | 720 | ||
| Drug Interactions of Concern to Dentistry | 720 | ||
| Serious Reactions | 720 | ||
| Dental Considerations | 720 | ||
| General: | 720 | ||
| Consultations: | 721 | ||
| ivermectin | 721 | ||
| Category and Schedule | 721 | ||
| Drug Class: | 721 | ||
| Mechanism of Action | 721 | ||
| Uses | 721 | ||
| Pharmacokinetics | 721 | ||
| Indications and Dosages | 721 | ||
| ► Rosacea | 721 | ||
| Adults. | 721 | ||
| Side Effects/Adverse Reactions | 721 | ||
| Frequent | 721 | ||
| Occasional | 721 | ||
| Precautions and Contraindications | 721 | ||
| Drug Interactions of Concern to Dentistry | 721 | ||
| Serious Reactions | 721 | ||
| Dental Considerations | 721 | ||
| General: | 721 | ||
| Teach Patient/Family to: | 721 | ||
| Mechanism of Action | 722 | ||
| Uses | 722 | ||
| PharmacoKinetics | 722 | ||
| Indications and Dosages | 722 | ||
| Adult. | 722 | ||
| Pediatric. | 722 | ||
| Dose Adjustment | 722 | ||
| Side Effects/Adverse Reactions | 722 | ||
| Frequent | 722 | ||
| Occasional | 722 | ||
| Precautions and Contraindications | 722 | ||
| Drug Interactions of Concern to Dentistry | 723 | ||
| Serious Reactions | 723 | ||
| Dental Considerations | 723 | ||
| General: | 723 | ||
| Consultations: | 723 | ||
| Teach Patient/Family to: | 723 | ||
| ixabepilone | 721 | ||
| kanamycin sulfate | 724 | ||
| Category and Schedule | 724 | ||
| Drug Class: | 724 | ||
| Mechanism of Action | 724 | ||
| Uses | 724 | ||
| Indications and Dosages | 724 | ||
| Wound and Surgical Site Irrigation | 724 | ||
| Adults, Elderly. | 724 | ||
| Side Effects/Adverse Reactions | 724 | ||
| Occasional | 724 | ||
| Rare | 724 | ||
| Precautions and Contraindications | 724 | ||
| Drug Interactions of Concern to Dentistry | 724 | ||
| Serious Reactions | 724 | ||
| Dental Considerations | 724 | ||
| General: | 724 | ||
| Consultations: | 724 | ||
| Teach Patient/Family to: | 724 | ||
| Mechanism of Action | 725 | ||
| Uses | 725 | ||
| Pharmacokinetics | 725 | ||
| Indications and Dosages | 725 | ||
| ► Sole Anesthetic for Short Diagnostic and Surgical Procedures That Do Not Require Skeletal Muscle Relaxation, Induction of Anesthesia Before Administering Other General Anesthetics, Supplement to Low-Potency Agents | 725 | ||
| IV | 725 | ||
| ketamine | 724 | ||
| ketoconazole | 726 | ||
| Category and Schedule | 726 | ||
| Drug Class: | 726 | ||
| Mechanism of Action | 726 | ||
| Uses | 726 | ||
| Pharmacokinetics | 726 | ||
| Indications and Dosages | 726 | ||
| ► Histoplasmosis, Blastomycosis, Systemic Candidiasis, Chronic Mucocutaneous Candidiasis, Coccidioidomycosis, Paracoccidioidomycosis, Chromomycosis, Seborrheic Dermatitis, Tinea Corporis, Tinea Capitis, Tinea Manus, Tinea Cruris, Tinea Pedis, Tinea Unguium (Onychomycosis), Oral Thrush, Candiduria | 726 | ||
| PO | 726 | ||
| ketoprofen | 727 | ||
| Category and Schedule | 727 | ||
| Drug Class: | 727 | ||
| Mechanism of Action | 728 | ||
| Uses | 728 | ||
| Pharmacokinetics | 728 | ||
| Indications and Dosages | 728 | ||
| ► Acute or Chronic Rheumatoid Arthritis and Osteoarthritis | 728 | ||
| ketorolac tromethamine | 729 | ||
| Category and Schedule | 729 | ||
| Drug Class: | 729 | ||
| Mechanism of Action | 729 | ||
| Uses | 729 | ||
| Pharmacokinetics | 729 | ||
| Indications and Dosages | 730 | ||
| ► Short-Term Relief of Mild-to-Moderate Pain (Multiple Doses) | 730 | ||
| PO | 730 | ||
| labetalol hydrochloride | 732 | ||
| Category and Schedule | 732 | ||
| Drug Class: | 732 | ||
| Mechanism of Action | 732 | ||
| Uses | 732 | ||
| Pharmacokinetics | 732 | ||
| Indications and Dosages | 732 | ||
| ► Hypertension | 732 | ||
| PO | 732 | ||
| Side Effects/Adverse Reactions | 732 | ||
| Frequent | 732 | ||
| Occasional | 732 | ||
| Rare | 732 | ||
| Precautions and Contraindications | 732 | ||
| Caution: | 733 | ||
| Drug Interactions of Concern to Dentistry | 733 | ||
| Serious Reactions | 733 | ||
| Dental Considerations | 733 | ||
| General: | 733 | ||
| Consultations: | 733 | ||
| Teach Patient/Family to: | 733 | ||
| lacosamide | 733 | ||
| Category and Schedule | 733 | ||
| Drug Class: | 733 | ||
| Mechanism of Action | 734 | ||
| Uses | 734 | ||
| Pharmacokinetics | 734 | ||
| Indications and Dosages | 734 | ||
| ► Partial-Onset Seizures | 734 | ||
| Adult. | 734 | ||
| Side Effects/AdversE Reactions | 734 | ||
| Frequent | 734 | ||
| Occasional | 734 | ||
| Precautions and Contraindications | 734 | ||
| Drug Interactions of Concern to Dentistry | 734 | ||
| Serious Reactions | 734 | ||
| Dental Considerations | 734 | ||
| General: | 734 | ||
| Consultations: | 734 | ||
| Teach Patient/Family: | 734 | ||
| lamivudine | 735 | ||
| Category and Schedule | 735 | ||
| Drug Class: | 735 | ||
| Mechanism of Action | 735 | ||
| Uses | 735 | ||
| Pharmacokinetics | 735 | ||
| Indications and Dosages | 735 | ||
| ► HIV Infection (in Combination with Other Antiretrovirals) | 735 | ||
| Side Effects/Adverse Reactions | 735 | ||
| Frequent | 735 | ||
| Occasional | 735 | ||
| Precautions and Contraindications | 735 | ||
| Caution: | 736 | ||
| Drug Interactions of Concern to Dentistry | 736 | ||
| Serious Reactions | 736 | ||
| Dental Considerations | 736 | ||
| General: | 736 | ||
| Consultations: | 736 | ||
| Teach Patient/Family to: | 736 | ||
| lamotrigine | 736 | ||
| Category and Schedule | 736 | ||
| Drug Class: | 736 | ||
| Mechanism of Action | 736 | ||
| Uses | 736 | ||
| Pharmacokinetics | 736 | ||
| Indications and Dosages | 736 | ||
| ► Seizure Control in Patients Receiving Enzyme-Inducing Antiepileptic Drug (EIAEDS), But Not Valproic Acid | 736 | ||
| PO | 736 | ||
| Adults, Elderly, Children older than 12 yr. | 736 | ||
| Side Effects/Adverse Reactions | 737 | ||
| Frequent | 737 | ||
| Occasional | 737 | ||
| Rare | 737 | ||
| Precautions and Contraindications | 737 | ||
| Caution: | 737 | ||
| Drug Interactions of Concern to Dentistry | 738 | ||
| Serious Reactions | 738 | ||
| Dental Considerations | 738 | ||
| General: | 738 | ||
| Consultations: | 738 | ||
| Teach Patient/Family to: | 738 | ||
| lanreotide | 738 | ||
| Category and Schedule | 738 | ||
| Drug Class: | 738 | ||
| Mechanism of Action | 738 | ||
| Uses | 739 | ||
| Pharmacokinetics | 739 | ||
| Indications and Dosages | 739 | ||
| SC Injection | 739 | ||
| Adult. | 739 | ||
| Dose Adjustments | 739 | ||
| Side Effects/Adverse Reactions | 739 | ||
| Frequent | 739 | ||
| Precautions and Contraindications | 739 | ||
| Drug Interactions of Concern to Dentistry | 739 | ||
| Serious Reactions | 739 | ||
| Dental Considerations | 739 | ||
| General: | 739 | ||
| Consultations: | 739 | ||
| Teach Patient/Family to: | 740 | ||
| lansoprazole | 740 | ||
| Category and Schedule | 740 | ||
| Drug Class: | 740 | ||
| Mechanism of Action | 740 | ||
| Uses | 740 | ||
| Pharmacokinetics | 740 | ||
| Indications and Dosages | 740 | ||
| ► Duodenal Ulcer | 740 | ||
| Side Effects/Adverse Reactions | 741 | ||
| Occasional | 741 | ||
| Rare | 741 | ||
| Precautions and Contraindications | 741 | ||
| Caution: | 741 | ||
| Drug Interactions of Concern to Dentistry | 741 | ||
| Serious Reactions | 741 | ||
| Dental Considerations | 741 | ||
| General: | 741 | ||
| Teach Patient/Family to: | 741 | ||
| lanthanum carbonate | 741 | ||
| Category and Schedule | 741 | ||
| Drug Class: | 741 | ||
| Mechanism of Action | 741 | ||
| Uses | 742 | ||
| Pharmacokinetics | 742 | ||
| Indications and Dosages | 742 | ||
| ► Reduce Serum Phosphate in End-Stage Renal Disease | 742 | ||
| PO | 742 | ||
| Adults, Elderly. | 742 | ||
| Side Effects/Adverse Reactions | 742 | ||
| Frequent | 742 | ||
| Precautions and Contraindications | 742 | ||
| Drug Interactions of Concern to Dentistry | 742 | ||
| Serious Reactions | 742 | ||
| Dental Considerations | 742 | ||
| General: | 742 | ||
| Consultations: | 742 | ||
| Teach Patient/Family to: | 742 | ||
| lapatinib | 743 | ||
| Category and Schedule | 743 | ||
| Drug Class: | 743 | ||
| Mechanism of Action | 743 | ||
| Uses | 743 | ||
| Pharmacokinetics | 743 | ||
| Indications and Dosages | 743 | ||
| ► Breast Cancer | 743 | ||
| PO | 743 | ||
| Adults. | 743 | ||
| Side Effects/Adverse Reactions | 743 | ||
| Frequent | 743 | ||
| Occasional | 743 | ||
| Precautions and Contraindications | 743 | ||
| Drug Interactions of Concern to Dentistry | 744 | ||
| Serious Reactions | 744 | ||
| Dental Considerations | 744 | ||
| General: | 744 | ||
| Consultations: | 744 | ||
| Teach Patient/Family to: | 744 | ||
| latanoprost | 744 | ||
| Category and Schedule | 744 | ||
| Drug Class: | 744 | ||
| Mechanism of Action | 744 | ||
| Uses | 744 | ||
| Pharmacokinetics | 745 | ||
| Indications and Dosages | 745 | ||
| ► Glaucoma, Ocular Hypertension | 745 | ||
| Ophthalmic | 745 | ||
| Adults, Elderly. | 745 | ||
| Side Effects/Adverse Reactions | 745 | ||
| Frequent | 745 | ||
| Occasional | 745 | ||
| Rare | 745 | ||
| Precautions and Contraindications | 745 | ||
| Caution: | 745 | ||
| Drug Interactions of Concern to Dentistry | 745 | ||
| Serious Reactions | 745 | ||
| Dental Considerations | 745 | ||
| General: | 745 | ||
| Consultations: | 745 | ||
| ledipasvir + sofosbuvir | 746 | ||
| Category and Schedule | 746 | ||
| Drug Class: | 746 | ||
| Mechanism of Action | 746 | ||
| Uses | 746 | ||
| Pharmacokinetics | 746 | ||
| Indications and Dosages | 746 | ||
| ► Chronic Hepatitis C (CHC) Infection in Monoinfected (HCV) or Coinfected (HCV/HIV-1) Genotype 1 Patients | 746 | ||
| leflunomide | 747 | ||
| Category and Schedule | 747 | ||
| Drug Class: | 747 | ||
| Mechanism of Action | 747 | ||
| Uses | 747 | ||
| Pharmacokinetics | 747 | ||
| Indications and Dosages | 748 | ||
| ► Rheumatoid Arthritis | 748 | ||
| PO | 748 | ||
| Adults, Elderly. | 748 | ||
| Side Effects/Adverse Reactions | 748 | ||
| Frequent | 748 | ||
| Precautions and Contraindications | 748 | ||
| Caution: | 748 | ||
| Drug Interactions of Concern to Dentistry | 748 | ||
| Serious Reactions | 748 | ||
| Dental Considerations | 748 | ||
| General: | 748 | ||
| Consultations: | 748 | ||
| Teach Patient/Family to: | 748 | ||
| letrozole | 748 | ||
| Category and Schedule | 748 | ||
| Drug Class: | 748 | ||
| Mechanism of Action | 748 | ||
| Uses | 748 | ||
| Pharmacokinetics | 749 | ||
| Indications and Dosages | 749 | ||
| ► Breast Cancer | 749 | ||
| PO | 749 | ||
| Adults, Elderly. | 749 | ||
| Side Effects/Adverse Reactions | 749 | ||
| Frequent | 749 | ||
| Occasional | 749 | ||
| Rare | 749 | ||
| Precautions and Contraindications | 749 | ||
| Caution: | 749 | ||
| Drug Interactions of Concern to Dentistry | 749 | ||
| Serious Reactions | 749 | ||
| Dental Considerations | 749 | ||
| General: | 749 | ||
| Consultations: | 749 | ||
| Teach Patient/Family to: | 749 | ||
| leucovorin calcium (folinic acid, citrovorum factor) | 749 | ||
| Category and Schedule | 749 | ||
| Drug Class: | 749 | ||
| Mechanism of Action | 750 | ||
| Uses | 750 | ||
| Pharmacokinetics | 750 | ||
| Indications and Dosages | 750 | ||
| ► Conventional Rescue Dosage in Methotrexate Rescue | 750 | ||
| PO, IV, IM | 750 | ||
| Side Effects/Adverse Reactions | 750 | ||
| Frequent | 750 | ||
| Occasional | 750 | ||
| Precautions and Contraindications | 750 | ||
| Drug Interactions of Concern to Dentistry | 750 | ||
| Serious Reactions | 750 | ||
| Dental Considerations | 751 | ||
| General: | 751 | ||
| Consultations: | 751 | ||
| Teach Patient/Family to: | 751 | ||
| leuprolide acetate | 751 | ||
| Category and Schedule | 751 | ||
| Drug Class: | 751 | ||
| Mechanism of Action | 751 | ||
| Uses | 751 | ||
| Pharmacokinetics | 751 | ||
| Indications and Dosages | 751 | ||
| ► Advanced Prostatic Carcinoma | 751 | ||
| Side Effects/Adverse Reactions | 752 | ||
| Frequent | 752 | ||
| Occasional | 752 | ||
| Rare | 752 | ||
| Precautions and Contraindications | 752 | ||
| Drug Interactions of Concern to Dentistry | 752 | ||
| Serious Reactions | 752 | ||
| Dental Considerations | 752 | ||
| General: | 752 | ||
| Consultations: | 752 | ||
| Teach Patient/Family to: | 753 | ||
| levalbuterol | 753 | ||
| Category and Schedule | 753 | ||
| Drug Class: | 753 | ||
| Mechanism of Action | 753 | ||
| Uses | 753 | ||
| Pharmacokinetics | 753 | ||
| Indications and Dosages | 753 | ||
| ► Treatment and Prevention of Bronchospasm | 753 | ||
| Nebulization | 753 | ||
| Adults, Elderly, Children 12 yr and older. | 753 | ||
| Children 3–11 yr. | 753 | ||
| Side Effects/Adverse Reactions | 753 | ||
| Frequent | 753 | ||
| Occasional | 753 | ||
| Rare | 753 | ||
| Precautions and Contraindications | 753 | ||
| Caution: | 753 | ||
| Drug Interactions of Concern to Dentistry | 754 | ||
| Serious Reactions | 754 | ||
| Dental Considerations | 754 | ||
| General: | 754 | ||
| Consultations: | 754 | ||
| Teach Patient/Family to: | 754 | ||
| levetiracetam | 754 | ||
| Category and Schedule | 754 | ||
| Drug Class: | 754 | ||
| Mechanism of Action | 754 | ||
| Uses | 754 | ||
| Pharmacokinetics | 754 | ||
| Indications and Dosages | 755 | ||
| ► Partial-Onset Seizures | 755 | ||
| PO | 755 | ||
| Adults, Elderly. | 755 | ||
| Children 4–16 yr. | 755 | ||
| ► Dosage in Renal Impairment | 755 | ||
| Side Effects/Adverse Reactions | 755 | ||
| Frequent | 755 | ||
| Occasional | 755 | ||
| Rare | 755 | ||
| Precautions and Contraindications | 755 | ||
| Caution: | 755 | ||
| Drug Interactions of Concern to Dentistry | 755 | ||
| Serious Reactions | 755 | ||
| Dental Considerations | 755 | ||
| General: | 755 | ||
| Consultation: | 755 | ||
| Teach Patient/Family to: | 755 | ||
| levobetaxolol hydrochloride | 755 | ||
| Category and Schedule | 755 | ||
| Drug Class: | 755 | ||
| Mechanism of Action | 756 | ||
| Uses | 756 | ||
| Pharmacokinetics | 756 | ||
| Indications and Dosages | 756 | ||
| ► Glaucoma, Ocular Hypertension | 756 | ||
| Ophthalmic | 756 | ||
| Adults, Elderly. | 756 | ||
| Side Effects/Adverse Reactions | 756 | ||
| Frequent | 756 | ||
| Occasional | 756 | ||
| Rare | 756 | ||
| Precautions and Contraindications | 756 | ||
| Drug Interactions of Concern to Dentistry | 756 | ||
| Serious Reactions | 756 | ||
| Dental Considerations | 756 | ||
| General: | 756 | ||
| Consultations: | 756 | ||
| Teach Patient/Family to: | 756 | ||
| levobunolol hydrochloride | 757 | ||
| Category and Schedule | 757 | ||
| Drug Class: | 757 | ||
| Mechanism of Action | 757 | ||
| Uses | 757 | ||
| Pharmacokinetics | 757 | ||
| Indications and Dosages | 757 | ||
| ► Glaucoma, Ocular Hypertension | 757 | ||
| Ophthalmic | 757 | ||
| Adults, Elderly. | 757 | ||
| Side Effects/ Adverse Reactions | 757 | ||
| Frequent | 757 | ||
| Occasional | 757 | ||
| Rare | 757 | ||
| Precautions and Contraindications | 757 | ||
| Drug Interactions of Concern to Dentistry | 757 | ||
| Serious Reactions | 757 | ||
| Dental Considerations | 757 | ||
| General: | 757 | ||
| Consultations: | 757 | ||
| levocabastine | 758 | ||
| Category and Schedule | 758 | ||
| Drug Class: | 758 | ||
| Mechanism of Action | 758 | ||
| Uses | 758 | ||
| Pharmacokinetics | 758 | ||
| Indications and Dosages | 758 | ||
| ► Allergic Conjunctivitis | 758 | ||
| Ophthalmic | 758 | ||
| Adults, Elderly, Children 12 yr or older. | 758 | ||
| Side Effects/Adverse Reactions | 758 | ||
| Frequent | 758 | ||
| Occasional | 758 | ||
| Rare | 758 | ||
| Precautions and Contraindications | 758 | ||
| Caution: | 758 | ||
| Drug Interactions of Concern to Dentistry | 758 | ||
| Serious Reactions | 758 | ||
| Dental Considerations | 758 | ||
| General: | 758 | ||
| Teach Patient/Family to: | 758 | ||
| levocetirizine | 759 | ||
| Category and Schedule | 759 | ||
| Drug Class: | 759 | ||
| Mechanism of Action | 759 | ||
| Uses | 759 | ||
| Pharmacokinetics | 759 | ||
| Indications and Dosages | 759 | ||
| ► Seasonal Rhinitis | 759 | ||
| Adults and Children 12 yr. | 759 | ||
| Children 6 to 11 yr. | 759 | ||
| Side Effects/Adverse Reactions | 759 | ||
| Frequent | 759 | ||
| Occasional | 759 | ||
| Rare | 759 | ||
| Precautions and Contraindications | 759 | ||
| Drug Interactions of Concern to Dentistry | 759 | ||
| Serious Reactions | 759 | ||
| Dental Considerations | 759 | ||
| General: | 759 | ||
| Consultations: | 760 | ||
| Teach Patient/Family: | 760 | ||
| levodopa | 760 | ||
| Category and Schedule | 760 | ||
| Drug Class: | 760 | ||
| Mechanism of Action | 760 | ||
| Uses | 760 | ||
| Pharmacokinetics | 760 | ||
| Indications and Dosages | 760 | ||
| ► Parkinsonism | 760 | ||
| Adults, Elderly. | 760 | ||
| Side Effects/Adverse Reactions | 760 | ||
| Frequent | 760 | ||
| Occasional | 760 | ||
| Rare | 760 | ||
| Precautions and Contraindications | 760 | ||
| Caution: | 760 | ||
| Drug Interactions of Concern to Dentistry | 761 | ||
| Serious Reactions | 761 | ||
| Dental Considerations | 761 | ||
| General: | 761 | ||
| Consultations: | 761 | ||
| Teach Patient/Family to: | 761 | ||
| levofloxacin | 761 | ||
| Category and Schedule | 761 | ||
| Drug Class: | 761 | ||
| Mechanism of Action | 761 | ||
| Uses | 761 | ||
| Pharmacokinetics | 762 | ||
| Indications and Dosages | 762 | ||
| ► Bronchitis | 762 | ||
| Side Effects/Adverse Reactions | 762 | ||
| Occasional | 762 | ||
| Rare | 762 | ||
| Precautions and Contraindications | 763 | ||
| Caution: | 763 | ||
| Drug Interactions of Concern to Dentistry | 763 | ||
| Serious Reactions | 763 | ||
| Dental Considerations | 763 | ||
| General: | 763 | ||
| Consultations: | 763 | ||
| Teach Patient/Family to: | 763 | ||
| levothyroxine | 763 | ||
| Category and Schedule | 763 | ||
| Drug Class: | 763 | ||
| Mechanism of Action | 763 | ||
| Uses | 763 | ||
| Pharmacokinetics | 764 | ||
| Indications and Dosages | 764 | ||
| ► Hypothyroidism | 764 | ||
| Side Effects/Adverse Reactions | 764 | ||
| Occasional | 764 | ||
| Rare | 764 | ||
| Precautions and Contraindications | 764 | ||
| Caution: | 764 | ||
| Drug Interactions of Concern to Dentistry | 764 | ||
| Serious Reactions | 764 | ||
| Dental Considerations | 764 | ||
| General: | 764 | ||
| Consultations: | 765 | ||
| lidocaine hydrochloride | 765 | ||
| Category and Schedule | 765 | ||
| Drug Class: | 765 | ||
| Mechanism of Action | 765 | ||
| Uses | 765 | ||
| Pharmacokinetics | 765 | ||
| Indications and Dosages | 765 | ||
| ► Rapid Control of Acute Ventricular Arrhythmias after an MI, Cardiac Catheterization, Cardiac Surgery, or Digitalis-Induced Ventricular Arrhythmias | 765 | ||
| IM | 765 | ||
| Side Effects/Adverse Reactions | 766 | ||
| Occasional | 766 | ||
| Rare | 766 | ||
| Precautions and Contraindications | 766 | ||
| Caution: | 766 | ||
| Drug Interactions of Concern to Dentistry | 766 | ||
| Patch Form | 766 | ||
| Injectable Form | 766 | ||
| Serious Reactions | 766 | ||
| Dental Considerations | 766 | ||
| ► Patch Form | 766 | ||
| General: | 766 | ||
| Teach Patient/Family to: | 766 | ||
| lidocaine transoral delivery system | 767 | ||
| Category and Schedule | 767 | ||
| Drug Class: | 767 | ||
| Mechanism of Action | 767 | ||
| Uses | 767 | ||
| Pharmacokinetics | 767 | ||
| Indications and Dosages | 767 | ||
| Topical | 767 | ||
| Adult. | 767 | ||
| Side Effects/Adverse Reactions | 767 | ||
| Precautions and Contraindications | 767 | ||
| Caution: | 767 | ||
| Drug Interactions of Concern to Dentistry | 767 | ||
| Serious Reactions | 767 | ||
| Dental Considerations | 767 | ||
| General: | 767 | ||
| Teach Patient/Family to: | 767 | ||
| linaclotide | 768 | ||
| Category and Schedule | 768 | ||
| Drug Class: | 768 | ||
| Mechanism of Action | 768 | ||
| Uses | 768 | ||
| Pharmacokinetics | 768 | ||
| Indications and Dosages | 768 | ||
| ► Chronic Idiopathic Constipation (CIC) | 768 | ||
| linagliptin + metformin hydrochloride | 769 | ||
| Category and Schedule | 769 | ||
| Drug Class: | 769 | ||
| Mechanism of Action | 769 | ||
| Uses | 769 | ||
| Pharmacokinetics | 769 | ||
| Indications and Dosages | 769 | ||
| ► Type 2 Diabetes Mellitus | 769 | ||
| PO | 769 | ||
| Adults. | 769 | ||
| Elderly. | 770 | ||
| Side Effects/Adverse Reactions | 770 | ||
| Frequent | 770 | ||
| Occasional | 770 | ||
| Precautions and Contraindications | 770 | ||
| Drug Interactions of Concern to Dentistry | 770 | ||
| Serious Reactions | 770 | ||
| Dental Considerations | 770 | ||
| General: | 770 | ||
| Consultations: | 770 | ||
| Teach Patient/Family to: | 770 | ||
| lincomycin HCl | 771 | ||
| Category and Schedule | 771 | ||
| Drug Class: | 771 | ||
| Mechanism of Action | 771 | ||
| Uses | 771 | ||
| Pharmacokinetics | 771 | ||
| Indications and Dosages | 771 | ||
| Side Effects/Adverse Reactions | 772 | ||
| Frequent | 772 | ||
| Occasional | 772 | ||
| Rare | 772 | ||
| Precautions and Contraindications | 772 | ||
| Caution: | 772 | ||
| Drug Interactions of Concern to Dentistry | 772 | ||
| Serious Reactions | 772 | ||
| Alert | 772 | ||
| Dental Considerations | 772 | ||
| General: | 772 | ||
| Consultations: | 772 | ||
| Teach Patient/Family to: | 772 | ||
| linezolid | 772 | ||
| Category and Schedule | 772 | ||
| Drug Class: | 772 | ||
| Mechanism of Action | 772 | ||
| Uses | 773 | ||
| Pharmacokinetics | 773 | ||
| Indications and Dosages | 773 | ||
| ► Vancomycin-Resistant Infections | 773 | ||
| Side Effects/Adverse Reactions | 773 | ||
| Occasional | 773 | ||
| Rare | 773 | ||
| Precautions and Contraindications | 773 | ||
| Caution: | 773 | ||
| Drug Interactions of Concern to Dentistry | 773 | ||
| Serious Reactions | 773 | ||
| Dental Considerations | 774 | ||
| General: | 774 | ||
| Consultations: | 774 | ||
| Teach Patient/Family to: | 774 | ||
| liothyronine (T3) | 774 | ||
| Category and Schedule | 774 | ||
| Drug Class: | 774 | ||
| Mechanism of Action | 774 | ||
| Uses | 774 | ||
| Pharmacokinetics | 774 | ||
| Indications and Dosages | 774 | ||
| ► Hypothyroidism | 774 | ||
| PO | 774 | ||
| Adults, Elderly. | 774 | ||
| Children. | 774 | ||
| ► Myxedema | 775 | ||
| Side Effects/Adverse Reactions | 775 | ||
| Occasional | 775 | ||
| Rare | 775 | ||
| Precautions and Contraindications | 775 | ||
| Caution: | 775 | ||
| Drug Interactions of Concern to Dentistry | 775 | ||
| Serious Reactions | 775 | ||
| Dental Considerations | 775 | ||
| General: | 775 | ||
| Consultations: | 775 | ||
| liraglutide | 776 | ||
| Category and Schedule | 776 | ||
| Drug Class: | 776 | ||
| Mechanism of Action | 776 | ||
| Uses | 776 | ||
| Pharmacokinetics | 776 | ||
| Indications and Dosages | 776 | ||
| ► Treatment of Type 2 Diabetes | 776 | ||
| Subcutaneous injection | 776 | ||
| Adults. | 776 | ||
| Side Effects/Adverse Reactions | 776 | ||
| Frequent | 776 | ||
| Occasional | 776 | ||
| Precautions and Contraindications | 776 | ||
| Drug Interactions of Concern to Dentistry | 776 | ||
| Serious Reactions | 776 | ||
| Dental Considerations | 776 | ||
| General: | 776 | ||
| Consultations: | 777 | ||
| Teach Patient/Family to: | 777 | ||
| liotrix | 777 | ||
| Category and Schedule | 777 | ||
| Drug Class: | 777 | ||
| Mechanism of Action | 777 | ||
| Uses | 777 | ||
| Pharmacokinetics | 777 | ||
| Indications and Dosages | 777 | ||
| ► Hypothyroidism | 777 | ||
| Side Effects/Adverse Reactions | 778 | ||
| Occasional | 778 | ||
| Rare | 778 | ||
| Precautions and Contraindications | 778 | ||
| Caution: | 778 | ||
| Drug Interactions of Concern to Dentistry | 778 | ||
| Serious Reactions | 778 | ||
| Dental Considerations | 778 | ||
| General: | 778 | ||
| Consultations: | 778 | ||
| Teach Patient/Family to: | 778 | ||
| lisdexamfetamine dimesylate | 778 | ||
| Category and Schedule | 778 | ||
| Drug Class: | 778 | ||
| Mechanism of Action | 779 | ||
| Uses | 779 | ||
| Pharmacokinetics | 779 | ||
| Indications and Dosages | 779 | ||
| ► ADHD | 779 | ||
| PO | 779 | ||
| Adults. | 779 | ||
| Children (6–12 yr). | 779 | ||
| Side Effects/Adverse Reactions | 779 | ||
| Adult | 779 | ||
| Precautions and Contraindications | 779 | ||
| Drug Interactions of Concern to Dentistry | 779 | ||
| Serious Reactions | 780 | ||
| Dental Considerations | 780 | ||
| General: | 780 | ||
| Teach Patient/Family to: | 780 | ||
| lisinopril | 780 | ||
| Category and Schedule | 780 | ||
| Drug Class: | 780 | ||
| Mechanism of Action | 780 | ||
| Uses | 780 | ||
| Pharmacokinetics | 781 | ||
| Indications and Dosages | 781 | ||
| ► Hypertension (Used Alone) | 781 | ||
| Side Effects/Adverse Reactions | 781 | ||
| Frequent | 781 | ||
| Occasional | 781 | ||
| Rare | 781 | ||
| Precautions and Contraindications | 781 | ||
| Caution: | 781 | ||
| Drug Interactions of Concern to Dentistry | 781 | ||
| Serious Reactions | 781 | ||
| Dental Considerations | 782 | ||
| General: | 782 | ||
| Consultations: | 782 | ||
| Teach Patient/Family to: | 782 | ||
| lithium carbonate/lithium citrate | 782 | ||
| Category and Schedule | 782 | ||
| Drug Class: | 782 | ||
| Mechanism of Action | 782 | ||
| Uses | 783 | ||
| Pharmacokinetics | 783 | ||
| Indications and Dosages | 783 | ||
| Alert | 783 | ||
| ► Prevention or Treatment of Acute Mania, Manic Phase of Bipolar Disorder (Manic-Depressive Illness) | 783 | ||
| PO | 783 | ||
| Adults. | 783 | ||
| Elderly. | 783 | ||
| Children 12 yr and older. | 783 | ||
| Children younger than 12 yr. | 783 | ||
| Side Effects/Adverse Reactions | 783 | ||
| Occasional | 783 | ||
| Rare | 783 | ||
| Precautions and Contraindications | 783 | ||
| Caution: | 783 | ||
| Drug Interactions of Concern to Dentistry | 783 | ||
| Serious Reactions | 783 | ||
| Dental Considerations | 783 | ||
| General: | 783 | ||
| Consultations: | 784 | ||
| Teach Patient/Family to: | 784 | ||
| lixisenatide | 784 | ||
| Category and Schedule | 784 | ||
| Drug Class: | 784 | ||
| Mechanism of Action | 784 | ||
| Uses | 784 | ||
| Pharmacokinetics | 784 | ||
| Indications and Dosages | 784 | ||
| ► Diabetes Mellitus, Type 2 | 784 | ||
| Adults. | 784 | ||
| Side Effects/Adverse Reactions | 784 | ||
| Frequent | 784 | ||
| Occasional | 784 | ||
| Precautions and Contraindications | 784 | ||
| Drug Interactions of Concern to Dentistry | 785 | ||
| Serious Reactions | 785 | ||
| Dental Considerations | 785 | ||
| General: | 785 | ||
| Consultations: | 785 | ||
| Teach Patient/Family to: | 785 | ||
| lodoxamide | 785 | ||
| Category and Schedule | 785 | ||
| Drug Class: | 785 | ||
| Mechanism of Action | 785 | ||
| Uses | 785 | ||
| Pharmacokinetics | 785 | ||
| Indications and Dosages | 785 | ||
| ► Treatment of Vernal Keratoconjunctivitis, Conjunctivitis, and Keratitis | 785 | ||
| Ophthalmic | 785 | ||
| Adults, Elderly, Children 2 yr or older. | 785 | ||
| Side Effects/Adverse Reactions | 785 | ||
| Frequent | 785 | ||
| Occasional | 786 | ||
| Rare | 786 | ||
| Precautions and Contraindications | 786 | ||
| Caution: | 786 | ||
| Drug Interactions of Concern to Dentistry | 786 | ||
| Serious Reactions | 786 | ||
| Dental Considerations | 786 | ||
| General: | 786 | ||
| Teach Patient/Family to: | 786 | ||
| lomefloxacin hydrochloride | 786 | ||
| Category and Schedule | 786 | ||
| Drug Class: | 786 | ||
| Mechanism of Action | 786 | ||
| Uses | 786 | ||
| Pharmacokinetics | 786 | ||
| Indications and Dosages | 786 | ||
| ► Complicated UTIs | 786 | ||
| PO | 786 | ||
| Adults, Elderly. | 786 | ||
| ► Uncomplicated UTIs | 787 | ||
| Side Effects/Adverse Reactions | 787 | ||
| Occasional | 787 | ||
| Rare | 787 | ||
| Precautions and Contraindications | 787 | ||
| Caution: | 787 | ||
| Drug Interactions of Concern to Dentistry | 787 | ||
| Serious Reactions | 787 | ||
| Dental Considerations | 787 | ||
| General: | 787 | ||
| Consultations: | 787 | ||
| Teach Patient/Family to: | 787 | ||
| lomustine | 788 | ||
| Category and Schedule | 788 | ||
| Drug Class: | 788 | ||
| Mechanism of Action | 788 | ||
| Uses | 788 | ||
| Pharmacokinetics | 788 | ||
| Indications and Dosages | 788 | ||
| ► Disseminated Hodgkin’s Disease, Primary and Metastatic Brain Tumors | 788 | ||
| PO | 788 | ||
| Adults, Elderly. | 788 | ||
| Children. | 788 | ||
| Side Effects/Adverse Reactions | 788 | ||
| Frequent | 788 | ||
| Occasional | 788 | ||
| Precautions and Contraindications | 788 | ||
| Caution: | 788 | ||
| Drug Interactions of Concern to Dentistry | 788 | ||
| Serious Reactions | 788 | ||
| Dental Considerations | 789 | ||
| General: | 789 | ||
| Consultations: | 789 | ||
| Teach Patient/Family to: | 789 | ||
| loperamide hydrochloride | 789 | ||
| Category and Schedule | 789 | ||
| Drug Class: | 789 | ||
| Mechanism of Action | 789 | ||
| Uses | 789 | ||
| Pharmacokinetics | 789 | ||
| Indications and Dosages | 790 | ||
| ► Acute Diarrhea | 790 | ||
| PO (Capsules) | 790 | ||
| Side Effects/Adverse Reactions | 790 | ||
| Frequent | 790 | ||
| Rare | 790 | ||
| Precautions and Contraindications | 790 | ||
| Caution: | 790 | ||
| Drug Interactions of Concern to Dentistry | 790 | ||
| Serious Reactions | 790 | ||
| Dental Considerations | 790 | ||
| General: | 790 | ||
| Teach Patient/Family: | 790 | ||
| loracarbef | 791 | ||
| Category and Schedule | 791 | ||
| Drug Class: | 791 | ||
| Mechanism of Action | 791 | ||
| Uses | 791 | ||
| Pharmacokinetics | 791 | ||
| Indications and Dosages | 791 | ||
| ► Bronchitis | 791 | ||
| Side Effects/Adverse Reactions | 791 | ||
| Frequent | 791 | ||
| Occasional | 791 | ||
| Rare | 791 | ||
| Precautions and Contraindications | 791 | ||
| Caution: | 791 | ||
| Drug Interactions of Concern to Dentistry | 792 | ||
| Serious Reactions | 792 | ||
| Dental Considerations | 792 | ||
| General: | 792 | ||
| Consultations: | 792 | ||
| Teach Patient/Family to: | 792 | ||
| loratadine | 792 | ||
| Category and Schedule | 792 | ||
| Drug Class: | 792 | ||
| Mechanism of Action | 792 | ||
| Uses | 792 | ||
| Pharmacokinetics | 792 | ||
| Indications and Dosages | 793 | ||
| ► Allergic Rhinitis, Urticaria | 793 | ||
| PO | 793 | ||
| Adults, Elderly, Children 6 yr and older. | 793 | ||
| Children 2–5 yr. | 793 | ||
| ► Dosage in Hepatic Impairment | 793 | ||
| Side Effects/Adverse Reactions | 793 | ||
| Frequent | 793 | ||
| Occasional | 793 | ||
| Rare | 793 | ||
| Precautions and Contraindications | 793 | ||
| Caution: | 793 | ||
| Drug Interactions of Concern to Dentistry | 793 | ||
| Serious Reactions | 793 | ||
| Dental Considerations | 793 | ||
| General: | 793 | ||
| Teach Patient/Family to: | 793 | ||
| lorazepam | 793 | ||
| Category and Schedule | 793 | ||
| Drug Class: | 793 | ||
| Mechanism of Action | 793 | ||
| Uses | 794 | ||
| Pharmacokinetics | 794 | ||
| Indications and Dosages | 794 | ||
| ► Anxiety | 794 | ||
| Side Effects/Adverse Reactions | 794 | ||
| Frequent | 794 | ||
| Occasional | 794 | ||
| Rare | 794 | ||
| Precautions and Contraindications | 794 | ||
| Caution: | 794 | ||
| Drug Interactions of Concern to Dentistry | 794 | ||
| Serious Reactions | 794 | ||
| Dental Considerations | 795 | ||
| General: | 795 | ||
| Consultations: | 795 | ||
| Teach Patient/Family to: | 795 | ||
| lorcaserin | 795 | ||
| Category and Schedule | 795 | ||
| Drug Class: | 795 | ||
| Mechanism of Action | 795 | ||
| Uses | 795 | ||
| Pharmacokinetics | 795 | ||
| Indications and Dosages | 795 | ||
| ► Weight management | 795 | ||
| PO | 795 | ||
| Adults. | 795 | ||
| Side Effects/Adverse Reactions | 795 | ||
| Frequent | 795 | ||
| Occasional | 795 | ||
| Precautions and Contraindications | 796 | ||
| Drug Interactions of Concern to Dentistry | 796 | ||
| Serious Reactions | 796 | ||
| Dental Considerations | 796 | ||
| General: | 796 | ||
| Consultations: | 796 | ||
| Teach Patient/Family to: | 796 | ||
| losartan | 797 | ||
| Category and Schedule | 797 | ||
| Drug Class: | 797 | ||
| Mechanism of Action | 797 | ||
| Uses | 797 | ||
| Pharmacokinetics | 797 | ||
| Indications and Dosages | 797 | ||
| ► Hypertension | 797 | ||
| Side Effects/Adverse Reactions | 797 | ||
| Frequent | 797 | ||
| Occasional | 797 | ||
| Rare | 797 | ||
| Precautions and Contraindications | 797 | ||
| Caution: | 797 | ||
| Drug Interactions of Concern to Dentistry | 797 | ||
| Serious Reactions | 798 | ||
| Dental Considerations | 798 | ||
| General: | 798 | ||
| Consultations: | 798 | ||
| Teach Patient/Family to: | 798 | ||
| loteprednol etabonate; tobramycin | 798 | ||
| Category and Schedule | 798 | ||
| Drug Class: | 798 | ||
| Mechanism of Action | 798 | ||
| Uses | 798 | ||
| Pharmacokinetics | 798 | ||
| Indications and Dosages | 799 | ||
| ► Steroid-Responsive Inflammatory Ocular Conditions for Which a Corticosteroid is Indicated and Where Superficial Bacterial Ocular Infection or a Risk of Bacterial Ocular Infection Exists | 799 | ||
| Ophthalmic | 799 | ||
| Adults, Elderly. | 799 | ||
| Side Effects/Adverse Reactions | 799 | ||
| Frequent | 799 | ||
| Occasional | 799 | ||
| Rare | 799 | ||
| Precautions and Contraindications | 799 | ||
| Drug Interactions of Concern to Dentistry | 799 | ||
| Serious Reactions | 799 | ||
| Dental Considerations | 799 | ||
| General: | 799 | ||
| lovastatin | 799 | ||
| Category and Schedule | 799 | ||
| Drug Class: | 799 | ||
| Mechanism of Action | 799 | ||
| Uses | 800 | ||
| Pharmacokinetics | 800 | ||
| Indications and Dosages | 800 | ||
| ► Hyperlipoproteinemia, Primary Prevention of Coronary Artery Disease | 800 | ||
| Side Effects/Adverse Reactions | 800 | ||
| Frequent | 800 | ||
| Occasional | 800 | ||
| Rare | 800 | ||
| Precautions and Contraindications | 800 | ||
| Caution: | 800 | ||
| Drug Interactions of Concern to Dentistry | 800 | ||
| Serious Reactions | 800 | ||
| Dental Considerations | 800 | ||
| General: | 800 | ||
| Teach Patient/Family to: | 800 | ||
| loxapine | 801 | ||
| Category and Schedule | 801 | ||
| Drug Class: | 801 | ||
| Mechanism of Action | 801 | ||
| Uses | 801 | ||
| Pharmacokinetics | 801 | ||
| Indications and Dosages | 801 | ||
| ► Psychotic Disorders | 801 | ||
| PO | 801 | ||
| Adults. | 801 | ||
| Side Effects/Adverse Reactions | 801 | ||
| Frequent | 801 | ||
| Occasional | 801 | ||
| Precautions and Contraindications | 801 | ||
| Caution: | 801 | ||
| Drug Interactions of Concern to Dentistry | 801 | ||
| Serious Reactions | 801 | ||
| Dental Considerations | 802 | ||
| General: | 802 | ||
| Consultations: | 802 | ||
| Teach Patient/Family to: | 802 | ||
| lucinactant | 802 | ||
| Category and Schedule | 802 | ||
| Drug Class: | 802 | ||
| Mechanism of Action | 802 | ||
| Uses | 802 | ||
| Pharmacokinetics | 802 | ||
| lurasidone | 803 | ||
| Category and Schedule | 803 | ||
| Drug Class: | 803 | ||
| Mechanism of Action | 803 | ||
| Uses | 803 | ||
| Pharmacokinetics | 803 | ||
| Indications and Dosages | 803 | ||
| ► Respiratory Distress Prophylaxis | 803 | ||
| Endotracheal | 803 | ||
| Premature infants. | 803 | ||
| Side Effects/Adverse Reactions | 803 | ||
| Frequent | 803 | ||
| Occasional | 803 | ||
| Precautions and Contraindications | 803 | ||
| Drug Interactions of Concern to Dentistry | 803 | ||
| Serious Reactions | 803 | ||
| Dental Considerations | 803 | ||
| General: | 803 | ||
| Consultations: | 803 | ||
| ► Schizophrenia | 803 | ||
| PO | 803 | ||
| Adults. | 803 | ||
| ► Dosage in Renal Impairment | 803 | ||
| ► Dosage in Hepatic Impairment | 804 | ||
| Side Effects/Adverse Reactions | 804 | ||
| Frequent | 804 | ||
| Occasional | 804 | ||
| Precautions and Contraindications | 804 | ||
| Drug Interactions of Concern to Dentistry | 804 | ||
| Serious Reactions | 804 | ||
| Dental Considerations | 804 | ||
| General: | 804 | ||
| Consultations: | 804 | ||
| Teach Patient/Family to: | 804 | ||
| mafenide | 805 | ||
| Category and Schedule | 805 | ||
| Drug Class: | 805 | ||
| Mechanism of Action | 805 | ||
| Uses | 805 | ||
| Pharmacokinetics | 805 | ||
| Indications and Dosages | 805 | ||
| ► Burns | 805 | ||
| Topical | 805 | ||
| Adults, Elderly, Children. | 805 | ||
| Side Effects/Adverse Reactions | 805 | ||
| Frequent | 805 | ||
| Occasional | 805 | ||
| Rare | 805 | ||
| Precautions and Contraindications | 805 | ||
| Drug Interactions of Concern to Dentistry | 805 | ||
| Serious Reactions | 805 | ||
| Dental Considerations | 805 | ||
| General: | 805 | ||
| Consultations: | 805 | ||
| Teach Patient/Family to: | 805 | ||
| magaldrate | 806 | ||
| Category and Schedule | 806 | ||
| Drug Class: | 806 | ||
| Mechanism of Action | 806 | ||
| Uses | 806 | ||
| Pharmacokinetics | 806 | ||
| Indications and Dosages | 806 | ||
| ► Hyperacidity and Gas | 806 | ||
| PO | 806 | ||
| Adults, Elderly. | 806 | ||
| Side Effects/Adverse Reactions | 806 | ||
| Rare | 806 | ||
| Precautions and Contraindications | 806 | ||
| Caution: | 806 | ||
| Drug Interactions of Concern to Dentistry | 806 | ||
| Serious Reactions | 806 | ||
| Dental Considerations | 806 | ||
| General: | 806 | ||
| Uses | 807 | ||
| Pharmacokinetics | 807 | ||
| Indications and Dosages | 807 | ||
| ► Mild-to-Moderate Depression | 807 | ||
| maprotiline | 806 | ||
| mebendazole | 808 | ||
| Category and Schedule | 808 | ||
| Drug Class: | 808 | ||
| Mechanism of Action | 808 | ||
| Uses | 808 | ||
| Pharmacokinetics | 809 | ||
| Indications and Dosages | 809 | ||
| ► Trichuriasis, Ascariasis, Hookworm | 809 | ||
| mecasermin | 809 | ||
| Category and Schedule | 809 | ||
| Drug Class: | 809 | ||
| Mechanism of Action | 809 | ||
| Uses | 809 | ||
| Pharmacokinetics | 810 | ||
| Indications and Dosages | 810 | ||
| ► Primary IGF-1 Deficiency (Severe) | 810 | ||
| SC | 810 | ||
| Children. | 810 | ||
| Side Effects/Adverse Reactions | 810 | ||
| Occasional | 810 | ||
| Rare | 810 | ||
| Precautions and Contraindications | 810 | ||
| Caution: | 810 | ||
| Drug Interactions of Concern to Dentistry | 810 | ||
| Serious Reactions | 810 | ||
| Dental Considerations | 810 | ||
| General: | 810 | ||
| meclizine | 810 | ||
| Category and Schedule | 810 | ||
| Drug Class: | 810 | ||
| Mechanism of Action | 810 | ||
| Uses | 811 | ||
| Pharmacokinetics | 811 | ||
| Indications and Dosages | 811 | ||
| ► Motion Sickness | 811 | ||
| meclofenamate sodium | 812 | ||
| Category and Schedule | 812 | ||
| Drug Class: | 812 | ||
| Mechanism of Action | 812 | ||
| Uses | 812 | ||
| Pharmacokinetics | 812 | ||
| Indications and Dosages | 812 | ||
| ► Mild-to-Moderate Pain | 812 | ||
| medroxyprogesterone acetate | 813 | ||
| Category and Schedule | 813 | ||
| Drug Class: | 813 | ||
| Mechanism of Action | 814 | ||
| Uses | 814 | ||
| Pharmacokinetics | 814 | ||
| Indications and Dosages | 814 | ||
| ► Endometrial Hyperplasia | 814 | ||
| medrysone | 815 | ||
| Category and Schedule | 815 | ||
| Drug Class: | 815 | ||
| Mechanism of Action | 815 | ||
| Uses | 815 | ||
| Pharmacokinetics | 815 | ||
| Indications and Dosages | 815 | ||
| ► Ophthalmic Disorders | 815 | ||
| Ophthalmic | 815 | ||
| Adults, Elderly, Children 3 yr and older. | 815 | ||
| Side Effects/Adverse Reactions | 815 | ||
| Frequent | 815 | ||
| Occasional | 815 | ||
| Precautions and Contraindications | 815 | ||
| Drug Interactions of Concern to Dentistry | 815 | ||
| Serious Reactions | 815 | ||
| Dental Considerations | 815 | ||
| General: | 815 | ||
| Teach Patient/Family to: | 815 | ||
| mefenamic acid | 816 | ||
| Category and Schedule | 816 | ||
| Drug Class: | 816 | ||
| Mechanism of Action | 816 | ||
| Uses | 816 | ||
| Pharmacokinetics | 816 | ||
| Indications and Dosages | 816 | ||
| ► Mild-to-Moderate Pain, Lower Back Pain, Dysmenorrhea | 816 | ||
| PO | 816 | ||
| Adults, Elderly, Children 14 yr and older. | 816 | ||
| Side Effects/Adverse Reactions | 816 | ||
| Occasional | 816 | ||
| Rare | 816 | ||
| Precautions and Contraindications | 816 | ||
| Caution: | 816 | ||
| Drug Interactions of Concern to Dentistry | 816 | ||
| Serious Reactions | 816 | ||
| Dental Considerations | 817 | ||
| General: | 817 | ||
| Consultations: | 817 | ||
| Teach Patient/Family to: | 817 | ||
| mefloquine | 817 | ||
| Category and Schedule | 817 | ||
| Drug Class: | 817 | ||
| Mechanism of Action | 817 | ||
| Uses | 817 | ||
| Pharmacokinetics | 817 | ||
| Indications and Dosages | 817 | ||
| ► Suppression of Malaria | 817 | ||
| PO | 817 | ||
| Adults. | 817 | ||
| Children more than 45 kg. | 817 | ||
| Children 30–45 kg. | 817 | ||
| Children 20–30 kg. | 817 | ||
| Children 10–20 kg. | 817 | ||
| ► Treatment of Malaria | 818 | ||
| PO | 818 | ||
| Adults. | 818 | ||
| Children. | 818 | ||
| Side Effects/Adverse Reactions | 818 | ||
| Occasional | 818 | ||
| Rare | 818 | ||
| Precautions and Contraindications | 818 | ||
| Drug Interactions of Concern to Dentistry | 818 | ||
| Serious Reactions | 818 | ||
| Dental Considerations | 818 | ||
| General: | 818 | ||
| Consultations: | 818 | ||
| Teach Patient/Family to: | 818 | ||
| megestrol acetate | 818 | ||
| Category and Schedule | 818 | ||
| Drug Class: | 818 | ||
| Mechanism of Action | 818 | ||
| Uses | 818 | ||
| meloxicam | 819 | ||
| Category and Schedule | 819 | ||
| Drug Class: | 819 | ||
| Mechanism of Action | 819 | ||
| Uses | 819 | ||
| Pharmacokinetics | 819 | ||
| Indications and Dosages | 819 | ||
| ► Palliative Treatment of Advanced Breast Cancer | 819 | ||
| ► Osteoarthritis, Rheumatoid Arthritis | 819 | ||
| PO | 819 | ||
| Adults, Elderly. | 819 | ||
| ► Palliative Treatment of Advanced Endometrial Carcinoma | 819 | ||
| ► Anorexia, Cachexia, Weight Loss | 819 | ||
| Side Effects/Adverse Reactions | 819 | ||
| Frequent | 819 | ||
| Occasional | 819 | ||
| Rare | 819 | ||
| Precautions and Contraindications | 819 | ||
| Serious Reactions | 819 | ||
| Dental Considerations | 819 | ||
| General: | 819 | ||
| Teach Patient/Family to: | 819 | ||
| Adults. | 819 | ||
| Side Effects/Adverse Reactions | 820 | ||
| Frequent | 820 | ||
| Occasional | 820 | ||
| Rare | 820 | ||
| Precautions and Contraindications | 820 | ||
| Caution: | 820 | ||
| Drug Interactions of Concern to Dentistry | 820 | ||
| Serious Reactions | 820 | ||
| Dental Considerations | 820 | ||
| General: | 820 | ||
| Consultations: | 820 | ||
| Teach Patient/Family to: | 820 | ||
| melphalan | 821 | ||
| Category and Schedule | 821 | ||
| Drug Class: | 821 | ||
| Mechanism of Action | 821 | ||
| Uses | 821 | ||
| Pharmacokinetics | 821 | ||
| Indications and Dosages | 821 | ||
| ► Ovarian Carcinoma | 821 | ||
| memantine + donepezil | 822 | ||
| Category and Schedule | 822 | ||
| Drug Class: | 822 | ||
| Mechanism of Action | 822 | ||
| Uses | 822 | ||
| Pharmacokinetics | 823 | ||
| Indications and Dosages | 823 | ||
| ► Alzheimer Dementia (Moderate to Severe) | 823 | ||
| PO | 823 | ||
| Adults. | 823 | ||
| Side Effects/Adverse Reactions | 823 | ||
| Frequent | 823 | ||
| Occasional | 823 | ||
| Precautions and Contraindications | 823 | ||
| Drug Interactions of Concern to Dentistry | 823 | ||
| Serious Reactions | 823 | ||
| Dental Considerations | 823 | ||
| General: | 823 | ||
| Consultations: | 824 | ||
| Teach Patient/Family to: | 824 | ||
| memantine hydrochloride | 824 | ||
| Category and Schedule | 824 | ||
| Drug Class: | 824 | ||
| Mechanism of Action | 824 | ||
| Uses | 824 | ||
| Pharmacokinetics | 824 | ||
| Indications and Dosages | 824 | ||
| ► Alzheimer’s Disease | 824 | ||
| PO | 824 | ||
| Adults, Elderly. | 824 | ||
| Side Effects/Adverse Reactions | 824 | ||
| Occasional | 824 | ||
| Rare | 824 | ||
| Precautions and Contraindications | 824 | ||
| Caution: | 824 | ||
| Drug Interactions of Concern to Dentistry | 825 | ||
| Serious Reactions | 825 | ||
| Dental Considerations | 825 | ||
| General: | 825 | ||
| Consultations: | 825 | ||
| Teach Patient/Family to: | 825 | ||
| meperidine hydrochloride | 825 | ||
| Category and Schedule | 825 | ||
| Drug Class: | 825 | ||
| Mechanism of Action | 825 | ||
| Uses | 825 | ||
| Pharmacokinetics | 825 | ||
| Indications and Dosages | 826 | ||
| ► Analgesia | 826 | ||
| PO, IM, Subcutaneous | 826 | ||
| Adults, Elderly. | 826 | ||
| Children. | 826 | ||
| ► Patient-Controlled Analgesia | 826 | ||
| IV | 826 | ||
| Adults. | 826 | ||
| ► Dosage in Renal Impairment | 826 | ||
| Side Effects/Adverse Reactions | 826 | ||
| Frequent | 826 | ||
| Occasional | 826 | ||
| Rare | 826 | ||
| Precautions and Contraindications | 826 | ||
| Caution: | 826 | ||
| Drug Interactions of Concern to Dentistry | 826 | ||
| Serious Reactions | 826 | ||
| Dental Considerations | 826 | ||
| General: | 826 | ||
| Teach Patient/Family to: | 826 | ||
| mephentermine sulfate | 827 | ||
| Category and Schedule | 827 | ||
| Drug Class: | 827 | ||
| Mechanism of Action | 827 | ||
| Uses | 827 | ||
| Pharmacokinetics | 827 | ||
| Indications and Dosages | 827 | ||
| ► Hypotension (Secondary to Spinal Anesthesia) | 827 | ||
| Uses | 828 | ||
| Pharmacokinetics | 828 | ||
| Indications and Dosages | 828 | ||
| ► Epilepsy | 828 | ||
| mephobarbital | 827 | ||
| mepivacaine HCl | 829 | ||
| Category and Schedule | 829 | ||
| Drug Class: | 829 | ||
| Mechanism of Action | 829 | ||
| Uses | 829 | ||
| Pharmacokinetics | 829 | ||
| Indications and Dosages | 829 | ||
| ► Regional Anesthesia | 829 | ||
| Side Effects/Adverse Reactions | 830 | ||
| Occasional | 830 | ||
| Rare | 830 | ||
| Precautions and Contraindications | 830 | ||
| Caution: | 830 | ||
| Drug Interactions of Concern to Dentistry | 830 | ||
| Serious Reactions | 830 | ||
| Dental Considerations | 830 | ||
| General: | 830 | ||
| Teach Patient/Family to: | 830 | ||
| meprobamate | 831 | ||
| Category and Schedule | 831 | ||
| Drug Class: | 831 | ||
| Mechanism of Action | 831 | ||
| Uses | 831 | ||
| Pharmacokinetics | 831 | ||
| Indications and Dosages | 831 | ||
| ► Anxiety Disorders | 831 | ||
| PO | 831 | ||
| Adults, Children 12 yr and older. | 831 | ||
| Children 6–12 yr. | 831 | ||
| Elderly. | 831 | ||
| ► Dosage in Renal Impairment | 831 | ||
| Side Effects/Adverse Reactions | 831 | ||
| Frequent | 831 | ||
| Occasional | 831 | ||
| Precautions and Contraindications | 831 | ||
| Caution: | 831 | ||
| Drug Interactions of Concern to Dentistry | 831 | ||
| Serious Reactions | 831 | ||
| Dental Considerations | 831 | ||
| General: | 831 | ||
| Consultations: | 832 | ||
| Teach Patient/Family to: | 832 | ||
| mercaptopurine (6-MP) | 832 | ||
| Category and Schedule | 832 | ||
| Drug Class: | 832 | ||
| Mechanism of Action | 832 | ||
| Uses | 832 | ||
| Pharmacokinetics | 832 | ||
| Indications and Dosages | 832 | ||
| ► ALL | 832 | ||
| PO | 832 | ||
| Adults, Elderly, Children. | 832 | ||
| ► Dosage in Renal Impairment | 832 | ||
| Side Effects/Adverse Reactions | 832 | ||
| Frequent | 832 | ||
| Occasional | 832 | ||
| Precautions and Contraindications | 832 | ||
| Caution: | 832 | ||
| Drug Interactions of Concern to Dentistry | 833 | ||
| Serious Reactions | 833 | ||
| Dental Considerations | 833 | ||
| General: | 833 | ||
| Consultations: | 833 | ||
| Teach Patient/Family to: | 833 | ||
| meropenem | 833 | ||
| Category and Schedule | 833 | ||
| Drug Class: | 833 | ||
| Mechanism of Action | 833 | ||
| Uses | 833 | ||
| Pharmacokinetics | 833 | ||
| Indications and Dosages | 833 | ||
| ► Mild-to-Moderate Infections | 833 | ||
| mesalamine/ 5-aminosalicylic acid (5-ASA) | 834 | ||
| Category and Schedule | 834 | ||
| Drug Class: | 834 | ||
| Mechanism of Action | 834 | ||
| Uses | 834 | ||
| Pharmacokinetics | 835 | ||
| Indications and Dosages | 835 | ||
| ► Ulcerative Colitis (Induction of Remission), Proctosigmoiditis, Proctitis | 835 | ||
| mesna | 836 | ||
| Category and Schedule | 836 | ||
| Drug Class: | 836 | ||
| Mechanism of Action | 836 | ||
| Uses | 836 | ||
| Pharmacokinetics | 836 | ||
| Indications and Dosages | 836 | ||
| ► Prevention of Hemorrhagic Cystitis in Patients Receiving Ifosfamide | 836 | ||
| IV | 836 | ||
| Adults, Elderly. | 836 | ||
| ► Prevention of Hemorrhagic Cystitis in Patients Receiving Cyclophosphamide | 837 | ||
| PO | 837 | ||
| mesoridazine besylate | 837 | ||
| Category and Schedule | 837 | ||
| Drug Class: | 837 | ||
| Mechanism of Action | 837 | ||
| Uses | 838 | ||
| Pharmacokinetics | 838 | ||
| Indications and Dosages | 838 | ||
| ► Schizophrenia | 838 | ||
| metaproterenol sulfate | 839 | ||
| Category and Schedule | 839 | ||
| Drug Class: | 839 | ||
| Mechanism of Action | 839 | ||
| Uses | 840 | ||
| Pharmacokinetics | 840 | ||
| Indications and Dosages | 840 | ||
| ► Treatment of Bronchospasm | 840 | ||
| PO | 840 | ||
| Adults, Children 10 yr and older. | 840 | ||
| Elderly. | 840 | ||
| Children 6–9 yr. | 840 | ||
| Children 2–5 yr. | 840 | ||
| Children younger than 2 yr. | 840 | ||
| Inhalation | 840 | ||
| metaraminol | 841 | ||
| Category and Schedule | 841 | ||
| Drug Class: | 841 | ||
| Mechanism of Action | 841 | ||
| Uses | 841 | ||
| Pharmacokinetics | 841 | ||
| Indications and Dosages | 841 | ||
| ► Prevention of Hypotension | 841 | ||
| IM/Subcutaneous | 841 | ||
| metaxalone | 842 | ||
| Category and Schedule | 842 | ||
| Drug Class: | 842 | ||
| Mechanism of Action | 842 | ||
| Uses | 842 | ||
| Pharmacokinetics | 842 | ||
| Indications and Dosages | 842 | ||
| ► Muscle Relaxant | 842 | ||
| PO | 842 | ||
| Adults, Elderly, Children older than 12 yr. | 842 | ||
| Side Effects/Adverse Reactions | 842 | ||
| Occasional | 842 | ||
| Precautions and Contraindications | 842 | ||
| Caution: | 842 | ||
| Drug Interactions of Concern to Dentistry | 842 | ||
| Serious Reactions | 842 | ||
| Dental Considerations | 842 | ||
| General: | 842 | ||
| Consultations: | 843 | ||
| Teach Patient/Family to: | 843 | ||
| metformin hydrochloride | 843 | ||
| Category and Schedule | 843 | ||
| Drug Class: | 843 | ||
| Mechanism of Action | 843 | ||
| Uses | 843 | ||
| Pharmacokinetics | 843 | ||
| Indications and Dosages | 843 | ||
| ► Diabetes Mellitus | 843 | ||
| PO (500-mg, 1000-mg Tablet) | 843 | ||
| methadone hydrochloride | 845 | ||
| Category and Schedule | 845 | ||
| Drug Class: | 845 | ||
| Mechanism of Action | 845 | ||
| Uses | 845 | ||
| Pharmacokinetics | 845 | ||
| Indications and Dosages | 845 | ||
| ► Analgesia | 845 | ||
| PO | 845 | ||
| methamphetamine | 846 | ||
| Category and Schedule | 846 | ||
| Drug Class: | 846 | ||
| Mechanism of Action | 846 | ||
| Uses | 846 | ||
| Pharmacokinetics | 846 | ||
| Indications and Dosages | 846 | ||
| ► ADHD | 846 | ||
| PO | 846 | ||
| Adults, Children 6 yr and older. | 846 | ||
| ► Appetite Suppressant | 847 | ||
| PO | 847 | ||
| Adults, Children 12 yr and older. | 847 | ||
| Side Effects/Adverse Reactions | 847 | ||
| Frequent | 847 | ||
| Occasional | 847 | ||
| Precautions and Contraindications | 847 | ||
| Caution: | 847 | ||
| Drug Interactions of Concern to Dentistry | 847 | ||
| Serious Reactions | 847 | ||
| Dental Considerations | 847 | ||
| General: | 847 | ||
| Consultations: | 847 | ||
| Teach Patient/Family to: | 847 | ||
| methazolamide | 848 | ||
| Category and Schedule | 848 | ||
| Drug Class: | 848 | ||
| Mechanism of Action | 848 | ||
| Uses | 848 | ||
| Pharmacokinetics | 848 | ||
| Indications and Dosages | 848 | ||
| ► Glaucoma | 848 | ||
| PO | 848 | ||
| Adults, Elderly. | 848 | ||
| Side Effects/Adverse Reactions | 848 | ||
| Occasional | 848 | ||
| Rare | 848 | ||
| Precautions and Contraindications | 848 | ||
| Caution: | 848 | ||
| Drug Interactions of Concern to Dentistry | 848 | ||
| Methazolamide (Neptazane, GlaucTabs) | 848 | ||
| Serious Reactions | 848 | ||
| Dental Considerations | 849 | ||
| General: | 849 | ||
| Consultations: | 849 | ||
| Teach Patient/Family to: | 849 | ||
| methenamine | 849 | ||
| Category and Schedule | 849 | ||
| Drug Class: | 849 | ||
| Mechanism of Action | 849 | ||
| Uses | 849 | ||
| Pharmacokinetics | 849 | ||
| Indications and Dosages | 849 | ||
| ► UTI | 849 | ||
| PO | 849 | ||
| Adults, Elderly. | 849 | ||
| Children 6–12 yr. | 849 | ||
| Side Effects/Adverse Reactions | 849 | ||
| Occasional | 849 | ||
| Rare | 849 | ||
| Precautions and Contraindications | 849 | ||
| Caution: | 849 | ||
| methimazole | 850 | ||
| Category and Schedule | 850 | ||
| Drug Class: | 850 | ||
| Mechanism of Action | 850 | ||
| Uses | 850 | ||
| Pharmacokinetics | 850 | ||
| Indications and Dosages | 850 | ||
| ► Hyperthyroidism | 850 | ||
| PO | 850 | ||
| Adults, Elderly. | 850 | ||
| Children. | 850 | ||
| Side Effects/Adverse Reactions | 850 | ||
| Frequent | 850 | ||
| Occasional | 850 | ||
| Rare | 850 | ||
| Precautions and Contraindications | 850 | ||
| Caution: | 850 | ||
| Drug Interactions of Concern to Dentistry | 850 | ||
| Serious Reactions | 850 | ||
| Dental Considerations | 850 | ||
| General: | 850 | ||
| Teach Patient/Family to: | 850 | ||
| Serious Reactions | 851 | ||
| Dental Considerations | 851 | ||
| General: | 851 | ||
| Consultations: | 851 | ||
| Teach Patient/Family to: | 851 | ||
| methocarbamol | 851 | ||
| Category and Schedule | 851 | ||
| Drug Class: | 851 | ||
| Mechanism of Action | 851 | ||
| Uses | 851 | ||
| Pharmacokinetics | 851 | ||
| Indications and Dosages | 851 | ||
| ► Musculoskeletal Spasm | 851 | ||
| IM/IV | 851 | ||
| methotrexate sodium | 852 | ||
| Category and Schedule | 852 | ||
| Drug Class: | 852 | ||
| Mechanism of Action | 852 | ||
| Uses | 853 | ||
| Pharmacokinetics | 853 | ||
| Indications and Dosages | 853 | ||
| ► Trophoblastic Neoplasms | 853 | ||
| methoxy polyethylene glycol-epoetin beta | 855 | ||
| Category and Schedule | 855 | ||
| Drug Class: | 855 | ||
| Mechanism of Action | 855 | ||
| Uses | 855 | ||
| Pharmacokinetics | 855 | ||
| Indications and Dosages | 855 | ||
| ► Patients Not Currently Treated with an Erythropoiesis Stimulating Agent (ESA) | 855 | ||
| methsuximide | 856 | ||
| Category and Schedule | 856 | ||
| Drug Class: | 856 | ||
| Mechanism of Action | 856 | ||
| Uses | 856 | ||
| Pharmacokinetics | 856 | ||
| Indications and Dosages | 857 | ||
| ► Absence Seizures | 857 | ||
| PO | 857 | ||
| Adults, Elderly. | 857 | ||
| Children. | 857 | ||
| Side Effects/Adverse Reactions | 857 | ||
| Frequent | 857 | ||
| Occasional | 857 | ||
| Precautions and Contraindications | 857 | ||
| Caution: | 857 | ||
| Drug Interactions of Concern to Dentistry | 857 | ||
| Serious Reactions | 857 | ||
| Dental Considerations | 857 | ||
| General: | 857 | ||
| Consultations: | 857 | ||
| Teach Patient/Family to: | 857 | ||
| methyldopa/methyldopate | 858 | ||
| Category and Schedule | 858 | ||
| Drug Class: | 858 | ||
| Mechanism of Action | 858 | ||
| Uses | 858 | ||
| Pharmacokinetics | 858 | ||
| Indications and Dosages | 858 | ||
| ► Moderate-to-Severe Hypertension | 858 | ||
| PO | 858 | ||
| methylergonovine | 859 | ||
| Category and Schedule | 859 | ||
| Drug Class: | 859 | ||
| Mechanism of Action | 859 | ||
| Uses | 859 | ||
| Pharmacokinetics | 859 | ||
| Indications and Dosages | 860 | ||
| ► Prevention and Treatment of Postpartum and Postabortion Hemorrhage Caused by Atony or Involution | 860 | ||
| PO | 860 | ||
| methylphenidate hydrochloride | 860 | ||
| Category and Schedule | 860 | ||
| Drug Class: | 860 | ||
| Mechanism of Action | 860 | ||
| Uses | 861 | ||
| Pharmacokinetics | 861 | ||
| Indications and Dosages | 861 | ||
| ► ADHD | 861 | ||
| methylprednisolone | 862 | ||
| Category and Schedule | 862 | ||
| Drug Class: | 862 | ||
| Mechanism of Action | 862 | ||
| Uses | 862 | ||
| Pharmacokinetics | 862 | ||
| Indications and Dosages | 863 | ||
| ► Substitution Therapy for Deficiency States: Acute or Chronic Adrenal Insufficiency, Adrenal Insufficiency Secondary to Pituitary Insufficiency, and Congenital Adrenal Hyperplasia; Nonendocrine Disorders: Allergic, Collagen, Hepatic, Intestinal Tract, Ocular, Renal, and Skin Diseases; Arthritis; Bronchial Asthma; Cerebral Edema; Malignancies; and Rheumatic Carditis | 863 | ||
| PO | 863 | ||
| methyltestosterone | 864 | ||
| Category and Schedule | 864 | ||
| Drug Class: | 864 | ||
| Mechanism of Action | 864 | ||
| Uses | 864 | ||
| Pharmacokinetics | 864 | ||
| Indications and Dosages | 865 | ||
| ► Breast Cancer | 865 | ||
| metipranolol hydrochloride | 865 | ||
| Category and Schedule | 865 | ||
| Drug Class: | 865 | ||
| Mechanism of Action | 865 | ||
| Uses | 866 | ||
| Pharmacokinetics | 866 | ||
| Indications and Dosages | 866 | ||
| ► Glaucoma, Ocular Hypertension | 866 | ||
| Ophthalmic | 866 | ||
| Adults, Elderly. | 866 | ||
| Side Effects/Adverse Reactions | 866 | ||
| Frequent | 866 | ||
| Occasional | 866 | ||
| Rare | 866 | ||
| Precautions and Contraindications | 866 | ||
| Drug Interactions of Concern to Dentistry | 866 | ||
| Serious Reactions | 866 | ||
| Dental Considerations | 866 | ||
| General: | 866 | ||
| Consultations: | 866 | ||
| Teach Patient/Family to: | 866 | ||
| metoclopramide | 866 | ||
| Category and Schedule | 866 | ||
| Drug Class: | 866 | ||
| Mechanism of Action | 867 | ||
| Uses | 867 | ||
| Pharmacokinetics | 867 | ||
| Indications and Dosages | 867 | ||
| ► Prevention of Chemotherapy-Induced Nausea and Vomiting | 867 | ||
| metolazone | 868 | ||
| Category and Schedule | 868 | ||
| Drug Class: | 868 | ||
| Mechanism of Action | 868 | ||
| Uses | 869 | ||
| Pharmacokinetics | 869 | ||
| Indications and Dosages | 869 | ||
| ► Edema | 869 | ||
| metoprolol tartrate | 870 | ||
| Category and Schedule | 870 | ||
| Drug Class: | 870 | ||
| Mechanism of Action | 870 | ||
| Uses | 870 | ||
| Pharmacokinetics | 870 | ||
| Indications and Dosages | 871 | ||
| ► Mild-to-Moderate Hypertension | 871 | ||
| metronidazole hydrochloride | 873 | ||
| Category and Schedule | 873 | ||
| Drug Class: | 873 | ||
| Mechanism of Action | 873 | ||
| Uses | 873 | ||
| Pharmacokinetics | 873 | ||
| Indications and Dosages | 873 | ||
| ► Amebiasis | 873 | ||
| metyrosine | 875 | ||
| Category and Schedule | 875 | ||
| Drug Class: | 875 | ||
| Mechanism of Action | 875 | ||
| Uses | 875 | ||
| Pharmacokinetics | 875 | ||
| Indications and Dosages | 875 | ||
| ► Pheochromocytoma (Preoperative) | 875 | ||
| PO | 875 | ||
| Adults, Elderly. | 875 | ||
| Side Effects/Adverse Reactions | 875 | ||
| Frequent | 875 | ||
| Occasional | 875 | ||
| Rare | 875 | ||
| Precautions and Contraindications | 875 | ||
| Drug Interactions of Concern to Dentistry | 875 | ||
| Serious Reactions | 875 | ||
| Dental Considerations | 875 | ||
| General: | 875 | ||
| Consultations: | 876 | ||
| Teach Patient/Family to: | 876 | ||
| mexiletine hydrochloride | 876 | ||
| Category and Schedule | 876 | ||
| Drug Class: | 876 | ||
| Mechanism of Action | 876 | ||
| Uses | 876 | ||
| Pharmacokinetics | 876 | ||
| Indications and Dosages | 876 | ||
| ► Arrhythmia | 876 | ||
| PO | 876 | ||
| Adults, Elderly. | 876 | ||
| Side Effects/Adverse Reactions | 876 | ||
| Frequent | 876 | ||
| Occasional | 876 | ||
| Precautions and Contraindications | 876 | ||
| Caution: | 876 | ||
| Drug Interactions of Concern to Dentistry | 876 | ||
| Serious Reactions | 877 | ||
| Dental Considerations | 877 | ||
| General: | 877 | ||
| Consultations: | 877 | ||
| Teach Patient/Family to: | 877 | ||
| miconazole | 877 | ||
| Category and Schedule | 877 | ||
| Drug Class: | 877 | ||
| Mechanism of Action | 877 | ||
| Uses | 877 | ||
| Pharmacokinetics | 877 | ||
| Indications and Dosages | 878 | ||
| ► Coccidioidomycosis | 878 | ||
| midazolam hydrochloride | 879 | ||
| Category and Schedule | 879 | ||
| Drug Class: | 879 | ||
| Mechanism of Action | 879 | ||
| Uses | 879 | ||
| Pharmacokinetics | 879 | ||
| Indications and Dosages | 879 | ||
| ► Preoperative Sedation | 879 | ||
| PO | 879 | ||
| midodrine | 881 | ||
| Category and Schedule | 881 | ||
| Drug Class: | 881 | ||
| Mechanism of Action | 881 | ||
| Uses | 881 | ||
| Pharmacokinetics | 881 | ||
| Indications and Dosages | 881 | ||
| ► Orthostatic Hypotension | 881 | ||
| PO | 881 | ||
| mifepristone | 882 | ||
| Category and Schedule | 882 | ||
| Drug Class: | 882 | ||
| Mechanism of Action | 882 | ||
| Uses | 882 | ||
| Pharmacokinetics | 882 | ||
| Indications and Dosages | 882 | ||
| ► Hyperglycemia in Patients with Cushing’s Syndrome | 882 | ||
| PO | 882 | ||
| Adults. | 882 | ||
| Dosage in Renal Impairment. | 882 | ||
| Dosage in Hepatic Impairment. | 883 | ||
| Side Effects/Adverse Reactions | 883 | ||
| Frequent | 883 | ||
| Occasional | 883 | ||
| Precautions and Contraindications | 883 | ||
| Drug Interactions of Concern to Dentistry | 883 | ||
| Serious Reactions | 883 | ||
| Dental Considerations | 883 | ||
| General: | 883 | ||
| Consultations: | 883 | ||
| Teach Patient/Family to: | 884 | ||
| miglitol | 884 | ||
| Category and Schedule | 884 | ||
| Drug Class: | 884 | ||
| Mechanism of Action | 884 | ||
| Uses | 884 | ||
| Pharmacokinetics | 884 | ||
| Indications and Dosages | 884 | ||
| ► Diabetes Mellitus | 884 | ||
| PO | 884 | ||
| Adults, Elderly. | 884 | ||
| Side Effects/Adverse Reactions | 884 | ||
| Frequent | 884 | ||
| Occasional | 884 | ||
| Precautions and Contraindications | 884 | ||
| Caution: | 884 | ||
| Drug Interactions of Concern to Dentistry | 884 | ||
| Dental Considerations | 884 | ||
| General: | 884 | ||
| Consultations: | 885 | ||
| Teach Patient/Family to: | 885 | ||
| miglustat | 885 | ||
| Category and Schedule | 885 | ||
| Drug Class: | 885 | ||
| Mechanism of Action | 885 | ||
| Uses | 885 | ||
| Pharmacokinetics | 885 | ||
| Indications and Dosages | 885 | ||
| ► Gaucher’s Disease | 885 | ||
| PO | 885 | ||
| Adults, Elderly. | 885 | ||
| ► Dosage in Renal Impairment | 885 | ||
| Patients with creatinine clearance of 50–70 ml/min. | 885 | ||
| Patients with creatinine clearance of 30–49 ml/min. | 885 | ||
| Side Effects/Adverse Reactions | 885 | ||
| Expected | 885 | ||
| Frequent | 885 | ||
| Occasional | 885 | ||
| Precautions and Contraindications | 885 | ||
| Caution: | 885 | ||
| Drug Interactions of Concern to Dentistry | 886 | ||
| Serious Reactions | 886 | ||
| Dental Considerations | 886 | ||
| General: | 886 | ||
| Consultations: | 886 | ||
| Teach Patient/Family to: | 886 | ||
| milnacipran | 886 | ||
| Category and Schedule | 886 | ||
| Drug Class: | 886 | ||
| Mechanism of Action | 886 | ||
| Uses | 886 | ||
| Pharmacokinetics | 886 | ||
| Indications and Dosages | 886 | ||
| ► Fibromyalgia | 886 | ||
| PO | 886 | ||
| Adults, Elderly. | 886 | ||
| Side Effects/Adverse Reactions | 887 | ||
| Frequent | 887 | ||
| Occasional | 887 | ||
| Rare | 887 | ||
| Precautions and Contraindications | 887 | ||
| Caution: | 887 | ||
| Drug Interactions of Concern to Dentistry | 887 | ||
| Serious Reactions | 887 | ||
| Dental Considerations | 887 | ||
| General: | 887 | ||
| Teach Patient/Family: | 887 | ||
| minocycline hydrochloride | 888 | ||
| Category and Schedule | 888 | ||
| Drug Class: | 888 | ||
| Mechanism of Action | 888 | ||
| Uses | 888 | ||
| Pharmacokinetics | 888 | ||
| Indications and Dosages | 888 | ||
| ► Mild, Moderate, or Severe Prostate, Urinary Tract, and CNS Infections (excluding meningitis); Uncomplicated Gonorrhea; Inflammatory Acne; Brucellosis; Skin Granulomas; Cholera; Trachoma; Nocardiasis; Yaws; and Syphilis When Penicillins Are Contraindicated | 888 | ||
| PO | 888 | ||
| minoxidil | 890 | ||
| Category and Schedule | 890 | ||
| Drug Class: | 890 | ||
| Mechanism of Action | 890 | ||
| Uses | 890 | ||
| Pharmacokinetics | 890 | ||
| Indications and Dosages | 890 | ||
| ► Severe Symptomatic Hypertension, Hypertension Associated with Organ Damage, Hypertension That Has Failed to Respond to Maximal Therapeutic Dosages of a Diuretic or Two Other Antihypertensives | 890 | ||
| PO | 890 | ||
| mipomersen | 891 | ||
| Category and Schedule | 891 | ||
| Drug Class: | 891 | ||
| Mechanism of Action | 891 | ||
| Uses | 892 | ||
| Pharmacokinetics | 892 | ||
| Indications and Dosages | 892 | ||
| ► Homozygous Familial Hypercholesterolemia (HoFH) | 892 | ||
| Adults. | 892 | ||
| Side Effects/Adverse Reactions | 892 | ||
| Frequent | 892 | ||
| Occasional | 892 | ||
| Precautions and Contraindications | 892 | ||
| Drug Interactions of Concern to Dentistry | 892 | ||
| Serious Reactions | 892 | ||
| Dental Considerations | 892 | ||
| General: | 892 | ||
| Consultations: | 892 | ||
| Teach Patient/Family to: | 892 | ||
| mirtazapine | 893 | ||
| Category and Schedule | 893 | ||
| Drug Class: | 893 | ||
| Mechanism of Action | 893 | ||
| Uses | 893 | ||
| Pharmacokinetics | 893 | ||
| Indications and Dosages | 893 | ||
| ► Depression | 893 | ||
| PO | 893 | ||
| Adults. | 893 | ||
| Elderly. | 893 | ||
| Side Effects/Adverse Reactions | 893 | ||
| Frequent | 893 | ||
| Occasional | 893 | ||
| Rare | 893 | ||
| Precautions and Contraindications | 893 | ||
| Caution: | 893 | ||
| Drug Interactions of Concern to Dentistry | 893 | ||
| Serious Reactions | 893 | ||
| Dental Considerations | 894 | ||
| General: | 894 | ||
| Consultations: | 894 | ||
| Teach Patient/Family to: | 894 | ||
| misoprostol | 894 | ||
| Category and Schedule | 894 | ||
| Drug Class: | 894 | ||
| Mechanism of Action | 894 | ||
| Uses | 894 | ||
| Pharmacokinetics | 894 | ||
| mitotane | 895 | ||
| Category and Schedule | 895 | ||
| Drug Class: | 895 | ||
| Mechanism of Action | 895 | ||
| Uses | 895 | ||
| Pharmacokinetics | 895 | ||
| Indications and Dosages | 895 | ||
| ► Prevention of NSAID-Induced Gastric Ulcer | 895 | ||
| ► Adrenocortical Carcinomas | 895 | ||
| PO | 895 | ||
| Adults. | 895 | ||
| Elderly. | 895 | ||
| Adults, Elderly. | 895 | ||
| Side Effects/Adverse Reactions | 895 | ||
| Frequent | 895 | ||
| Occasional | 895 | ||
| Rare | 895 | ||
| Precautions and Contraindications | 895 | ||
| Caution: | 895 | ||
| Serious Reactions | 895 | ||
| Dental Considerations | 895 | ||
| General: | 895 | ||
| Consultations: | 895 | ||
| Precautions and Contraindications | 896 | ||
| Caution: | 896 | ||
| Drug Interactions of Concern to Dentistry | 896 | ||
| Serious Reactions | 896 | ||
| Dental Considerations | 896 | ||
| General: | 896 | ||
| Consultations: | 896 | ||
| Teach Patient/Family to: | 896 | ||
| mitoxantrone | 896 | ||
| Category and Schedule | 896 | ||
| Drug Class: | 896 | ||
| Mechanism of Action | 896 | ||
| modafinil | 898 | ||
| Category and Schedule | 898 | ||
| Drug Class: | 898 | ||
| Mechanism of Action | 898 | ||
| Uses | 898 | ||
| Pharmacokinetics | 898 | ||
| Indications and Dosages | 898 | ||
| ► Narcolepsy, Other Sleep Disorders | 898 | ||
| PO | 898 | ||
| Adults, Elderly. | 898 | ||
| Side Effects/Adverse Reactions | 898 | ||
| Frequent | 898 | ||
| Occasional | 899 | ||
| Precautions and Contraindications | 899 | ||
| Caution: | 899 | ||
| Drug Interactions of Concern to Dentistry | 899 | ||
| Serious Reactions | 899 | ||
| Dental Considerations | 899 | ||
| General: | 899 | ||
| Teach Patient/Family to: | 899 | ||
| moexipril hydrochloride | 899 | ||
| Category and Schedule | 899 | ||
| Drug Class: | 899 | ||
| Mechanism of Action | 899 | ||
| Uses | 899 | ||
| Pharmacokinetics | 899 | ||
| Indications and Dosages | 900 | ||
| ► Hypertension | 900 | ||
| molindone | 901 | ||
| Category and Schedule | 901 | ||
| Drug Class: | 901 | ||
| Mechanism of Action | 901 | ||
| Uses | 901 | ||
| Pharmacokinetics | 901 | ||
| Indications and Dosages | 901 | ||
| ► Schizophrenia | 901 | ||
| PO | 901 | ||
| Adults, Children 12 yr and older. | 901 | ||
| Elderly. | 901 | ||
| Side Effects/Adverse Reactions | 901 | ||
| Frequent | 901 | ||
| Occasional | 901 | ||
| Rare | 901 | ||
| Precautions and Contraindications | 902 | ||
| Caution: | 902 | ||
| Drug Interactions of Concern to Dentistry | 902 | ||
| Serious Reactions | 902 | ||
| Dental Considerations | 902 | ||
| General: | 902 | ||
| Consultations: | 902 | ||
| Teach Patient/Family to: | 902 | ||
| mometasone furoate monohydrate | 902 | ||
| Category and Schedule | 902 | ||
| Drug Class: | 902 | ||
| Mechanism of Action | 903 | ||
| Uses | 903 | ||
| Pharmacokinetics | 903 | ||
| Indications and Dosages | 903 | ||
| ► Allergic Rhinitis | 903 | ||
| mometasone furoate + formoterol fumarate | 904 | ||
| Category and Schedule | 904 | ||
| Drug Class: | 904 | ||
| Mechanism of Action | 904 | ||
| Uses | 904 | ||
| Pharmacokinetics | 904 | ||
| Indications and Dosages | 904 | ||
| ► Asthma | 904 | ||
| Oral Inhalation | 904 | ||
| Adults, Children 12 yr and older. | 904 | ||
| Side Effects/Adverse Reactions | 904 | ||
| Frequent | 904 | ||
| Occasional | 904 | ||
| Precautions and Contraindications | 904 | ||
| Drug Interactions of Concern to Dentistry | 905 | ||
| Serious Reactions | 905 | ||
| Dental Considerations | 905 | ||
| General: | 905 | ||
| Consultations: | 905 | ||
| Teach Patient/Family to: | 905 | ||
| montelukast | 905 | ||
| Category and Schedule | 905 | ||
| Drug Class: | 905 | ||
| Mechanism of Action | 905 | ||
| Uses | 905 | ||
| Pharmacokinetics | 906 | ||
| Indications and Dosages | 906 | ||
| ► Bronchial Asthma | 906 | ||
| PO | 906 | ||
| Adults, Elderly, Adolescents older than 14 yr. | 906 | ||
| Children 6–14 yr. | 906 | ||
| Children 1–5 yr. | 906 | ||
| Side Effects/Adverse Reactions | 906 | ||
| Adults, Adolescents 15 yr and older | 906 | ||
| Frequent | 906 | ||
| Occasional | 906 | ||
| moricizine hydrochloride | 907 | ||
| Category and Schedule | 907 | ||
| Drug Class: | 907 | ||
| Mechanism of Action | 907 | ||
| Uses | 907 | ||
| Pharmacokinetics | 907 | ||
| Indications and Dosages | 907 | ||
| ► Arrhythmias | 907 | ||
| PO | 907 | ||
| Adults, Elderly. | 907 | ||
| Side Effects/Adverse Reactions | 907 | ||
| Frequent | 907 | ||
| Occasional | 907 | ||
| Precautions and Contraindications | 907 | ||
| Caution: | 907 | ||
| Drug Interactions of Concern to Dentistry | 907 | ||
| Serious Reactions | 907 | ||
| Dental Considerations | 907 | ||
| General: | 907 | ||
| Consultations: | 908 | ||
| Teach Patient/Family to: | 908 | ||
| morphine sulfate | 908 | ||
| Category and Schedule | 908 | ||
| Drug Class: | 908 | ||
| Mechanism of Action | 908 | ||
| Uses | 908 | ||
| Pharmacokinetics | 908 | ||
| Indications and Dosages | 908 | ||
| moxifloxacin hydrochloride | 910 | ||
| Category and Schedule | 910 | ||
| Drug Class: | 910 | ||
| Mechanism of Action | 910 | ||
| Uses | 910 | ||
| Pharmacokinetics | 911 | ||
| Indications and Dosages | 911 | ||
| ► Acute Bacterial Sinusitis, Community-Acquired Pneumonia | 911 | ||
| mupirocin | 912 | ||
| Category and Schedule | 912 | ||
| Drug Class: | 912 | ||
| Mechanism of Action | 912 | ||
| Uses | 912 | ||
| Pharmacokinetics | 912 | ||
| Indications and Dosages | 912 | ||
| ► Impetigo, Infected Traumatic Skin Lesions | 912 | ||
| Topical | 912 | ||
| Adults, Elderly, Children. | 912 | ||
| ► Nasal Colonization of Resistant Staphylococcus Aureus | 912 | ||
| Intranasal | 912 | ||
| Adults, Elderly, Children 12 yr and older. | 912 | ||
| Side Effects/Adverse Reactions | 913 | ||
| Frequent | 913 | ||
| Occasional | 913 | ||
| Rare | 913 | ||
| Precautions and Contraindications | 913 | ||
| Caution: | 913 | ||
| Drug Interactions of Concern to Dentistry | 913 | ||
| Serious Reactions | 913 | ||
| Dental Considerations | 913 | ||
| General: | 913 | ||
| mycophenolate mofetil | 913 | ||
| Category and Schedule | 913 | ||
| Drug Class: | 913 | ||
| Mechanism of Action | 913 | ||
| Uses | 913 | ||
| Pharmacokinetics | 913 | ||
| Indications and Dosages | 913 | ||
| ► Prevention of Renal Transplant Rejection | 913 | ||
| PO, IV | 913 | ||
| Adults, Elderly. | 913 | ||
| ► Prevention of Heart Transplant Rejection | 914 | ||
| PO, IV | 914 | ||
| nabumetone | 916 | ||
| Category and Schedule | 916 | ||
| Drug Class: | 916 | ||
| Mechanism of Action | 916 | ||
| Uses | 916 | ||
| Pharmacokinetics | 916 | ||
| Indications and Dosages | 916 | ||
| ► Acute or Chronic Rheumatoid Arthritis and Osteoarthritis | 916 | ||
| PO | 916 | ||
| Adults, Elderly. | 916 | ||
| Side Effects/Adverse Reactions | 916 | ||
| Frequent | 916 | ||
| Occasional | 916 | ||
| Rare | 916 | ||
| Precautions and Contraindications | 916 | ||
| Caution: | 916 | ||
| Drug Interactions of Concern to Dentistry | 916 | ||
| Serious Reactions | 916 | ||
| Dental Considerations | 917 | ||
| General: | 917 | ||
| Consultations: | 917 | ||
| Teach Patient/Family to: | 917 | ||
| nadolol | 917 | ||
| Category and Schedule | 917 | ||
| Drug Class: | 917 | ||
| Mechanism of Action | 917 | ||
| Uses | 917 | ||
| Pharmacokinetics | 917 | ||
| Indications and Dosages | 918 | ||
| ► Mild-to-Moderate Hypertension, Angina | 918 | ||
| PO | 918 | ||
| Adults. | 918 | ||
| Elderly. | 918 | ||
| ► Dosage in Renal Impairment | 918 | ||
| Side Effects/Adverse Reactions | 918 | ||
| Frequent | 918 | ||
| Occasional | 918 | ||
| Rare | 918 | ||
| Precautions and Contraindications | 918 | ||
| Caution: | 918 | ||
| Drug Interactions of Concern to Dentistry | 918 | ||
| Serious Reactions | 918 | ||
| Dental Considerations | 918 | ||
| General: | 918 | ||
| Consultations: | 919 | ||
| Teach Patient/Family to: | 919 | ||
| nafarelin | 919 | ||
| Category and Schedule | 919 | ||
| Drug Class: | 919 | ||
| Mechanism of Action | 919 | ||
| Uses | 919 | ||
| Pharmacokinetics | 919 | ||
| Indications and Dosages | 919 | ||
| ► Endometriosis | 919 | ||
| Intranasal | 919 | ||
| Adults. | 919 | ||
| ► Central Precocious Puberty | 920 | ||
| Intranasal | 920 | ||
| Children. | 920 | ||
| naftifine | 920 | ||
| Category and Schedule | 920 | ||
| Drug Class: | 920 | ||
| Mechanism of Action | 920 | ||
| Uses | 920 | ||
| Pharmacokinetics | 920 | ||
| Indications and Dosages | 920 | ||
| ► Tinea Pedis, Tinea Cruris, Tinea Corporis | 920 | ||
| Topical | 920 | ||
| Adults, Elderly, Children 12 yr and older. | 920 | ||
| Side Effects/Adverse Reactions | 920 | ||
| Frequent | 920 | ||
| Occasional | 920 | ||
| Rare | 920 | ||
| Precautions and Contraindications | 920 | ||
| Drug Interactions of Concern to Dentistry | 920 | ||
| Serious Reactions | 920 | ||
| Dental Considerations | 920 | ||
| General: | 920 | ||
| nalbuphine hydrochloride | 921 | ||
| Category and Schedule | 921 | ||
| Drug Class: | 921 | ||
| Mechanism of Action | 921 | ||
| Uses | 921 | ||
| Pharmacokinetics | 921 | ||
| Indications and Dosages | 921 | ||
| ► Analgesia | 921 | ||
| IV, IM, Subcutaneous | 921 | ||
| nalmefene hydrochloride | 922 | ||
| Category and Schedule | 922 | ||
| Drug Class: | 922 | ||
| Mechanism of Action | 922 | ||
| Uses | 923 | ||
| Pharmacokinetics | 923 | ||
| Indications and Dosages | 923 | ||
| ► Reversal of Opioid Depression | 923 | ||
| naloxegol | 924 | ||
| Category and Schedule | 924 | ||
| Drug Class: | 924 | ||
| Mechanism of Action | 924 | ||
| Uses | 924 | ||
| Pharmacokinetics | 924 | ||
| Indications and Dosages | 924 | ||
| ► Opioid-Induced Constipation | 924 | ||
| PO | 924 | ||
| Adults. | 924 | ||
| Side Effects/Adverse Reactions | 924 | ||
| Frequent | 924 | ||
| Occasional | 924 | ||
| Precautions and Contraindications | 924 | ||
| Drug Interactions of Concern to Dentistry | 924 | ||
| Serious Reactions | 925 | ||
| Dental Considerations | 925 | ||
| General: | 925 | ||
| Consultations: | 925 | ||
| Teach Patient/Family to: | 925 | ||
| naloxone hydrochloride | 925 | ||
| Category and Schedule | 925 | ||
| Drug Class: | 925 | ||
| Mechanism of Action | 925 | ||
| Uses | 925 | ||
| Pharmacokinetics | 925 | ||
| Indications and Dosages | 926 | ||
| ► Opioid Toxicity | 926 | ||
| IV, IM, Subcutaneous | 926 | ||
| Adults, Elderly. | 926 | ||
| Children 5 yr and older and weighing 22 kg or more. | 926 | ||
| Children younger than 5 yr and weighing less than 22 kg. | 926 | ||
| ► Postanesthesia Narcotic Reversal | 926 | ||
| naltrexone + bupropion | 927 | ||
| Category and Schedule | 927 | ||
| Drug Class: | 927 | ||
| Mechanism of Action | 927 | ||
| Uses | 927 | ||
| Pharmacokinetics | 927 | ||
| Indications and Dosages | 927 | ||
| ► Chronic Weight Management | 927 | ||
| PO | 927 | ||
| Adults. | 927 | ||
| Side Effects/Adverse Reactions | 927 | ||
| Frequent | 927 | ||
| Occasional | 928 | ||
| Precautions and Contraindications | 928 | ||
| Drug Interactions of Concern to Dentistry | 928 | ||
| Serious Reactions | 928 | ||
| Dental Considerations | 928 | ||
| General: | 928 | ||
| Consultations: | 928 | ||
| Teach Patient/Family to: | 928 | ||
| naltrexone hydrochloride | 929 | ||
| Category and Schedule | 929 | ||
| Drug Class: | 929 | ||
| Mechanism of Action | 929 | ||
| Uses | 929 | ||
| Pharmacokinetics | 929 | ||
| Indications and Dosages | 929 | ||
| ► Naloxone Challenge Test to Determine if Patient is Opioid Dependent | 929 | ||
| Alert | 929 | ||
| IV | 929 | ||
| naproxen/naproxen sodium | 930 | ||
| Category and Schedule | 930 | ||
| Drug Class: | 930 | ||
| Mechanism of Action | 930 | ||
| Uses | 931 | ||
| Pharmacokinetics | 931 | ||
| Indications and Dosages | 931 | ||
| ► Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis | 931 | ||
| naproxen + esomeprazole | 932 | ||
| Category and Schedule | 932 | ||
| Drug Class: | 932 | ||
| Mechanism of Action | 933 | ||
| Uses | 933 | ||
| Pharmacokinetics | 933 | ||
| Indications and Dosages | 933 | ||
| Reduce NSAID-Associated Gastric Ulcers During Treatment for Arthritis | 933 | ||
| PO | 933 | ||
| Adults. | 933 | ||
| Side Effects/Adverse Reactions | 933 | ||
| Frequent | 933 | ||
| Occasional | 933 | ||
| Precautions and Contraindications | 933 | ||
| Drug Interactions of Concern to Dentistry | 933 | ||
| Serious Reactions | 934 | ||
| Dental Considerations | 934 | ||
| General: | 934 | ||
| Consultations: | 934 | ||
| Teach Patient/Family to: | 934 | ||
| naratriptan | 934 | ||
| Category and Schedule | 934 | ||
| Drug Class: | 934 | ||
| Mechanism of Action | 934 | ||
| Uses | 934 | ||
| Pharmacokinetics | 935 | ||
| Indications and Dosages | 935 | ||
| ► Acute Migraine Attack | 935 | ||
| PO | 935 | ||
| Adults. | 935 | ||
| ► Dosage in Mild-to-Moderate Hepatic or Renal Impairment | 935 | ||
| Side Effects/Adverse Reactions | 935 | ||
| Occasional | 935 | ||
| Rare | 935 | ||
| Precautions and Contraindications | 935 | ||
| Caution: | 935 | ||
| Drug Interactions of Concern to Dentistry | 935 | ||
| Serious Reactions | 935 | ||
| Dental Considerations | 935 | ||
| General: | 935 | ||
| Consultations: | 935 | ||
| Teach Patient/Family to: | 935 | ||
| nateglinide | 936 | ||
| Category and Schedule | 936 | ||
| Drug Class: | 936 | ||
| Mechanism of Action | 936 | ||
| Uses | 936 | ||
| Pharmacokinetics | 936 | ||
| Indications and Dosages | 936 | ||
| ► Diabetes Mellitus | 936 | ||
| PO | 936 | ||
| Adult, Elderly. | 936 | ||
| Side Effects/Adverse Reactions | 936 | ||
| Frequent | 936 | ||
| Occasional | 936 | ||
| Rare | 936 | ||
| Precautions and Contraindications | 936 | ||
| Caution: | 936 | ||
| Drug Interactions of Concern to Dentistry | 936 | ||
| Serious Reactions | 936 | ||
| Dental Considerations | 937 | ||
| General: | 937 | ||
| Consultations: | 937 | ||
| Teach Patient/Family to: | 937 | ||
| nebivolol | 937 | ||
| Category and Schedule | 937 | ||
| Drug Class: | 937 | ||
| Mechanism of Action | 937 | ||
| Uses | 937 | ||
| Pharmacokinetics | 937 | ||
| Indications and Dosages | 937 | ||
| ► Hypertension | 937 | ||
| PO | 937 | ||
| Adults, Elderly. | 937 | ||
| ► Dosage in Renal Impairment | 937 | ||
| Adults (creatinine clearance less than 30 ml/min). | 937 | ||
| ► Dosage in Hepatic Impairment (Moderate) | 937 | ||
| Adults. | 937 | ||
| Side Effects/Adverse Reactions | 938 | ||
| Adults | 938 | ||
| Frequent | 938 | ||
| Occasional | 938 | ||
| Rare | 938 | ||
| Precautions and Contraindications | 938 | ||
| Caution: | 938 | ||
| Drug Interactions of Concern to Dentistry | 938 | ||
| Serious Reactions | 938 | ||
| Dental Considerations | 938 | ||
| General: | 938 | ||
| Consultations: | 939 | ||
| Teach Patient/Family to: | 939 | ||
| nebivolol + valsartan | 939 | ||
| Category and Schedule | 939 | ||
| Drug Class: | 939 | ||
| Mechanism of Action | 939 | ||
| Uses | 939 | ||
| Pharmacokinetics | 939 | ||
| Indications and Dosages | 939 | ||
| ► Hypertension | 939 | ||
| PO | 939 | ||
| Adults. | 939 | ||
| Side Effects/Adverse Reactions | 940 | ||
| Frequent | 940 | ||
| Occasional | 940 | ||
| Precautions and Contraindications | 940 | ||
| Drug Interactions of Concern to Dentistry | 940 | ||
| Serious Reactions | 940 | ||
| Dental Considerations | 940 | ||
| General: | 940 | ||
| Consultations: | 940 | ||
| Teach Patient/Family to: | 940 | ||
| nedocromil sodium | 940 | ||
| Category and Schedule | 940 | ||
| Drug Class: | 940 | ||
| Mechanism of Action | 941 | ||
| Uses | 941 | ||
| Pharmacokinetics | 941 | ||
| Indications and Dosages | 941 | ||
| ► Mild-to-Moderate Asthma | 941 | ||
| Oral Inhalation | 941 | ||
| Adults, Elderly, Children 6 yr and older. | 941 | ||
| ► Allergic Conjunctivitis | 941 | ||
| Ophthalmic | 941 | ||
| Adults, Elderly, Children 3 yr and older. | 941 | ||
| Side Effects/Adverse Reactions | 941 | ||
| Frequent | 941 | ||
| Occasional | 941 | ||
| Rare | 941 | ||
| Precautions and Contraindications | 941 | ||
| Caution: | 941 | ||
| Drug Interactions of Concern to Dentistry | 941 | ||
| Serious Reactions | 941 | ||
| Dental Considerations | 941 | ||
| Nedocromil Sodium (Alocril) | 941 | ||
| nefazodone hydrochloride | 942 | ||
| Category and Schedule | 942 | ||
| Drug Class: | 942 | ||
| Mechanism of Action | 942 | ||
| Uses | 942 | ||
| Pharmacokinetics | 942 | ||
| Indications and Dosages | 942 | ||
| ► Depression, Prevention of Relapse of Acute Depressive Episode | 942 | ||
| PO | 942 | ||
| Adults. | 942 | ||
| Elderly. | 942 | ||
| Children. | 942 | ||
| Side Effects/Adverse Reactions | 942 | ||
| Frequent | 942 | ||
| Occasional | 942 | ||
| Precautions and Contraindications | 942 | ||
| Caution: | 942 | ||
| Drug Interactions of Concern to Dentistry | 942 | ||
| Serious Reactions | 942 | ||
| Dental Considerations | 943 | ||
| General: | 943 | ||
| Consultations: | 943 | ||
| Teach Patient/Family to: | 943 | ||
| nelarabine | 943 | ||
| Category and Schedule | 943 | ||
| Drug Class: | 943 | ||
| Mechanism of Action | 943 | ||
| Uses | 943 | ||
| Pharmacokinetics | 943 | ||
| Indications and Dosages | 943 | ||
| ► T-cell ALL (Relapsed or Refractory) | 943 | ||
| IV | 943 | ||
| Adults. | 943 | ||
| nelfinavir | 945 | ||
| Category and Schedule | 945 | ||
| Drug Class: | 945 | ||
| Mechanism of Action | 945 | ||
| Uses | 945 | ||
| Pharmacokinetics | 945 | ||
| Indications and Dosages | 945 | ||
| ► HIV Infection | 945 | ||
| PO | 945 | ||
| Adults. | 945 | ||
| Children 2–13 yr. | 946 | ||
| Side Effects/Adverse Reactions | 946 | ||
| Frequent | 946 | ||
| Occasional | 946 | ||
| Rare | 946 | ||
| Precautions and Contraindications | 946 | ||
| Caution: | 946 | ||
| Drug Interactions of Concern to Dentistry | 946 | ||
| Serious Reactions | 946 | ||
| Dental Considerations | 946 | ||
| General: | 946 | ||
| Consultations: | 946 | ||
| Teach Patient/Family to: | 946 | ||
| neostigmine | 946 | ||
| Category and Schedule | 946 | ||
| Drug Class: | 946 | ||
| Mechanism of Action | 947 | ||
| Uses | 947 | ||
| Pharmacokinetics | 947 | ||
| Indications and Dosages | 947 | ||
| ► Myasthenia Gravis | 947 | ||
| PO | 947 | ||
| netupitant + palonosetron | 948 | ||
| Category and Schedule | 948 | ||
| Drug Class: | 948 | ||
| Mechanism of Action | 948 | ||
| Uses | 948 | ||
| Pharmacokinetics | 948 | ||
| Indications and Dosages | 949 | ||
| ► Prevention of Acute and Delayed Cancer Chemotherapy–Induced Nausea and Vomiting | 949 | ||
| PO | 949 | ||
| Adults. | 949 | ||
| Side Effects/Adverse Reactions | 949 | ||
| Frequent | 949 | ||
| Occasional | 949 | ||
| Precautions and Contraindications | 949 | ||
| Drug Interactions of Concern to Dentistry | 949 | ||
| Serious Reactions | 949 | ||
| Dental Considerations | 949 | ||
| General: | 949 | ||
| Consultations: | 949 | ||
| Teach Patient/Family to: | 949 | ||
| nevirapine | 949 | ||
| Category and Schedule | 949 | ||
| Drug Class: | 949 | ||
| Mechanism of Action | 950 | ||
| Uses | 950 | ||
| Pharmacokinetics | 950 | ||
| Indications and Dosages | 950 | ||
| ► HIV Infection | 950 | ||
| PO | 950 | ||
| Adults. | 950 | ||
| Children older than 8 yr. | 950 | ||
| Children 2 mo–8 yr. | 950 | ||
| Side Effects/Adverse Reactions | 950 | ||
| Frequent | 950 | ||
| Occasional | 950 | ||
| Rare | 950 | ||
| Precautions and Contraindications | 950 | ||
| Caution: | 950 | ||
| Drug Interactions of Concern to Dentistry | 950 | ||
| Serious Reactions | 950 | ||
| Dental Considerations | 950 | ||
| General: | 950 | ||
| Consultations: | 950 | ||
| Teach Patient/Family to: | 950 | ||
| niacin, nicotinic acid | 951 | ||
| Category and Schedule | 951 | ||
| Drug Class: | 951 | ||
| Mechanism of Action | 951 | ||
| Uses | 951 | ||
| Pharmacokinetics | 951 | ||
| Indications and Dosages | 951 | ||
| ► Hyperlipidemia | 951 | ||
| PO (Immediate-Release) | 951 | ||
| nicardipine hydrochloride | 952 | ||
| Category and Schedule | 952 | ||
| Drug Class: | 952 | ||
| Mechanism of Action | 952 | ||
| Uses | 952 | ||
| Pharmacokinetics | 952 | ||
| Indications and Dosages | 953 | ||
| ► Chronic Stable (Effort-Associated) Angina | 953 | ||
| nicotine | 954 | ||
| Category and Schedule | 954 | ||
| Drug Class: | 954 | ||
| Mechanism of Action | 954 | ||
| Uses | 954 | ||
| Pharmacokinetics | 954 | ||
| Indications and Dosages | 955 | ||
| ► Smoking Cessation Aid to Relieve Nicotine Withdrawal Symptoms | 955 | ||
| PO (Chewing Gum) | 955 | ||
| nifedipine | 956 | ||
| Category and Schedule | 956 | ||
| Drug Class: | 956 | ||
| Mechanism of Action | 957 | ||
| Uses | 957 | ||
| Pharmacokinetics | 957 | ||
| Indications and Dosages | 957 | ||
| ► Prinzmetal’s Variant Angina, Chronic Stable (Effort-Associated) Angina | 957 | ||
| PO | 957 | ||
| nilotinib | 958 | ||
| Category and Schedule | 958 | ||
| Drug Class: | 958 | ||
| Mechanism of Action | 958 | ||
| Uses | 958 | ||
| Pharmacokinetics | 958 | ||
| Indications and Dosages | 958 | ||
| PO | 958 | ||
| Adults. | 958 | ||
| Side Effects/Adverse Reactions | 959 | ||
| Adult | 959 | ||
| Frequent | 959 | ||
| Occasional | 959 | ||
| Precautions and Contraindications | 959 | ||
| Drug Interactions of Concern to Dentistry | 960 | ||
| Serious Reactions | 960 | ||
| Dental Considerations | 960 | ||
| General: | 960 | ||
| Consultations: | 960 | ||
| Teach Patient/Family to: | 960 | ||
| nilutamide | 960 | ||
| Category and Schedule | 960 | ||
| Drug Class: | 960 | ||
| Mechanism of Action | 960 | ||
| Uses | 960 | ||
| Pharmacokinetics | 960 | ||
| Indications and Dosages | 960 | ||
| ► Prostatic Carcinoma | 960 | ||
| PO | 960 | ||
| Adults, Elderly. | 960 | ||
| Side Effects/Adverse Reactions | 960 | ||
| Frequent | 960 | ||
| Occasional | 961 | ||
| Precautions and Contraindications | 961 | ||
| Drug Interactions of Concern to Dentistry | 961 | ||
| Serious Reactions | 961 | ||
| Dental Considerations | 961 | ||
| General: | 961 | ||
| Consultations: | 961 | ||
| Teach Patient/Family to: | 961 | ||
| nimodipine | 961 | ||
| Category and Schedule | 961 | ||
| Drug Class: | 961 | ||
| Mechanism of Action | 961 | ||
| Uses | 961 | ||
| Pharmacokinetics | 962 | ||
| Indications and Dosages | 962 | ||
| ► Improvement in Neurologic Deficits after Subarachnoid Hemorrhage from Ruptured Congenital Aneurysms | 962 | ||
| PO | 962 | ||
| Adults, Elderly. | 962 | ||
| Side Effects/Adverse Reactions | 962 | ||
| Occasional | 962 | ||
| Rare | 962 | ||
| Precautions and Contraindications | 962 | ||
| Drug Interactions of Concern to Dentistry | 962 | ||
| Serious Reactions | 962 | ||
| Dental Considerations | 962 | ||
| General: | 962 | ||
| Consultations: | 962 | ||
| Teach Patient/Family to: | 962 | ||
| nintedanib | 962 | ||
| Category and Schedule | 962 | ||
| Drug Class: | 962 | ||
| Mechanism of Action | 963 | ||
| Uses | 963 | ||
| Pharmacokinetics | 963 | ||
| Indications and Dosages | 963 | ||
| ► Idiopathic Pulmonary Fibrosis (IPF) | 963 | ||
| PO | 963 | ||
| Adults. | 963 | ||
| Side Effects/Adverse Reactions | 963 | ||
| Frequent | 963 | ||
| Occasional | 963 | ||
| Precautions and Contraindications | 963 | ||
| Drug Interactions of Concern to Dentistry | 963 | ||
| Serious Reactions | 963 | ||
| Dental Considerations | 963 | ||
| General: | 963 | ||
| Consultations: | 964 | ||
| Teach Patient/Family to: | 964 | ||
| nipradilol | 964 | ||
| Category and Schedule | 964 | ||
| Drug Class: | 964 | ||
| Mechanism of Action | 964 | ||
| Uses | 964 | ||
| Pharmacokinetics | 964 | ||
| Indications and Dosages | 964 | ||
| ► Hypertension, Essential | 964 | ||
| nisoldipine | 965 | ||
| Category and Schedule | 965 | ||
| Drug Class: | 965 | ||
| Mechanism of Action | 965 | ||
| Uses | 966 | ||
| Pharmacokinetics | 966 | ||
| Indications and Dosages | 966 | ||
| ► Hypertension | 966 | ||
| PO | 966 | ||
| Adults. | 966 | ||
| Side Effects/Adverse Reactions | 966 | ||
| Frequent | 966 | ||
| Occasional | 966 | ||
| Rare | 966 | ||
| Precautions and Contraindications | 966 | ||
| Caution: | 966 | ||
| Serious Reactions | 966 | ||
| Dental Considerations | 966 | ||
| General: | 966 | ||
| Consultations: | 966 | ||
| nitazoxanide | 967 | ||
| Category and Schedule | 967 | ||
| Drug Class: | 967 | ||
| Mechanism of Action | 967 | ||
| Uses | 967 | ||
| Pharmacokinetics | 967 | ||
| Indications and Dosages | 967 | ||
| ► Diarrhea | 967 | ||
| PO | 967 | ||
| Children 12 yr and older. | 967 | ||
| Children 4–11 yr. | 967 | ||
| Children 12–47 mo. | 967 | ||
| Side Effects/Adverse Reactions | 967 | ||
| Occasional | 967 | ||
| Rare | 967 | ||
| Precautions and Contraindications | 967 | ||
| Drug Interactions of Concern to Dentistry | 967 | ||
| Serious Reactions | 967 | ||
| Dental Considerations | 967 | ||
| General: | 967 | ||
| Consultations: | 967 | ||
| Teach Patient/Family to: | 967 | ||
| nitrofurantoin sodium | 968 | ||
| Category and Schedule | 968 | ||
| Drug Class: | 968 | ||
| Mechanism of Action | 968 | ||
| Uses | 968 | ||
| Pharmacokinetics | 968 | ||
| Indications and Dosages | 968 | ||
| ► UTIs | 968 | ||
| PO (Furadantin, Macrodantin) | 968 | ||
| nitrofurazone | 969 | ||
| Category and Schedule | 969 | ||
| Drug Class: | 969 | ||
| Mechanism of Action | 969 | ||
| Uses | 969 | ||
| Pharmacokinetics | 969 | ||
| Indications and Dosages | 969 | ||
| ► Burns, Catheter-Related UTI, Skin Grafts | 969 | ||
| Topical | 969 | ||
| Adults. | 969 | ||
| Side Effects/Adverse Reactions | 969 | ||
| Occasional | 969 | ||
| Precautions and Contraindications | 969 | ||
| Drug Interactions of Concern to Dentistry | 969 | ||
| Serious Reactions | 969 | ||
| Dental Considerations | 969 | ||
| General: | 969 | ||
| Consultations: | 969 | ||
| Teach Patient/Family to: | 969 | ||
| nitroglycerin | 970 | ||
| Category and Schedule | 970 | ||
| Drug Class: | 970 | ||
| Mechanism of Action | 970 | ||
| Uses | 970 | ||
| Pharmacokinetics | 970 | ||
| Indications and Dosages | 970 | ||
| ► Acute Relief of Angina Pectoris, Acute Prophylaxis | 970 | ||
| Lingual Spray | 970 | ||
| nizatidine | 972 | ||
| Category and Schedule | 972 | ||
| Drug Class: | 972 | ||
| Mechanism of Action | 972 | ||
| Uses | 972 | ||
| Pharmacokinetics | 972 | ||
| Indications and Dosages | 972 | ||
| ► Active Duodenal Ulcer | 972 | ||
| PO | 972 | ||
| Adults, Elderly. | 972 | ||
| ► Prevention of Duodenal Ulcer Recurrence | 973 | ||
| norethindrone | 973 | ||
| Category and Schedule | 973 | ||
| Drug Class: | 973 | ||
| Mechanism of Action | 973 | ||
| Uses | 974 | ||
| Pharmacokinetics | 974 | ||
| Indications and Dosages | 974 | ||
| ► Contraception | 974 | ||
| norfloxacin | 975 | ||
| Category and Schedule | 975 | ||
| Drug Class: | 975 | ||
| Mechanism of Action | 975 | ||
| Uses | 975 | ||
| Pharmacokinetics | 975 | ||
| Indications and Dosages | 975 | ||
| ► UTIs | 975 | ||
| norgestrel | 976 | ||
| Category and Schedule | 976 | ||
| Drug Class: | 976 | ||
| Mechanism of Action | 976 | ||
| Uses | 976 | ||
| Pharmacokinetics | 976 | ||
| Indications and Dosages | 976 | ||
| ► Contraception, Female | 976 | ||
| PO | 976 | ||
| Adults. | 976 | ||
| Side Effects/Adverse Reactions | 976 | ||
| Frequent | 976 | ||
| Occasional | 977 | ||
| Rare | 977 | ||
| Precautions and Contraindications | 977 | ||
| Caution: | 977 | ||
| Drug Interactions of Concern to Dentistry | 977 | ||
| Serious Reactions | 977 | ||
| Dental Considerations | 977 | ||
| General: | 977 | ||
| Teach Patient/Family to: | 977 | ||
| nortriptyline hydrochloride | 977 | ||
| Category and Schedule | 977 | ||
| Drug Class: | 977 | ||
| Mechanism of Action | 977 | ||
| Uses | 977 | ||
| Pharmacokinetics | 977 | ||
| Indications and Dosages | 978 | ||
| ► Depression | 978 | ||
| nystatin | 979 | ||
| Category and Schedule | 979 | ||
| Drug Class: | 979 | ||
| Mechanism of Action | 979 | ||
| Uses | 979 | ||
| Pharmacokinetics | 979 | ||
| Indications and Dosages | 979 | ||
| Intestinal Infections | 979 | ||
| obeticholic acid | 981 | ||
| Category and Schedule | 981 | ||
| Drug Class: | 981 | ||
| Mechanism of Action | 981 | ||
| Uses | 981 | ||
| Pharmacokinetics | 981 | ||
| Indications and Dosages | 981 | ||
| ► Primary Biliary Cholangitis | 981 | ||
| PO | 981 | ||
| Adults. | 981 | ||
| Side Effects/Adverse Reactions | 981 | ||
| Frequent | 981 | ||
| Occasional | 981 | ||
| Precautions and Contraindications | 981 | ||
| Drug Interactions of Concern to Dentistry | 981 | ||
| Serious Reactions | 981 | ||
| Dental Considerations | 981 | ||
| General: | 981 | ||
| Consultations: | 982 | ||
| Teach Patient/Family to: | 982 | ||
| octreotide acetate | 982 | ||
| Category and Schedule | 982 | ||
| Drug Class: | 982 | ||
| Mechanism of Action | 982 | ||
| Uses | 982 | ||
| Pharmacokinetics | 982 | ||
| Indications and Dosages | 982 | ||
| ► Diarrhea | 982 | ||
| olanzapine | 983 | ||
| Category and Schedule | 983 | ||
| Drug Class: | 983 | ||
| Mechanism of Action | 983 | ||
| Uses | 984 | ||
| Pharmacokinetics | 984 | ||
| Indications and Dosages | 984 | ||
| ► Schizophrenia | 984 | ||
| olaparib | 985 | ||
| Category and Schedule | 985 | ||
| Drug Class: | 985 | ||
| Mechanism of Action | 986 | ||
| Uses | 986 | ||
| Pharmacokinetics | 986 | ||
| Indications and Dosages | 986 | ||
| ► Ovarian Cancer, Advanced | 986 | ||
| PO | 986 | ||
| Adults. | 986 | ||
| Side Effects/Adverse Reactions | 986 | ||
| Frequent | 986 | ||
| Occasional | 986 | ||
| Precautions and Contraindications | 986 | ||
| Drug Interactions of Concern to Dentistry | 986 | ||
| Serious Reactions | 986 | ||
| Dental Considerations | 987 | ||
| General: | 987 | ||
| Consultations: | 987 | ||
| Teach Patient/Family to: | 987 | ||
| olmesartan | 987 | ||
| Category and Schedule | 987 | ||
| Drug Class: | 987 | ||
| Mechanism of Action | 987 | ||
| Uses | 987 | ||
| Pharmacokinetics | 987 | ||
| Indications and Dosages | 987 | ||
| ► Hypertension (with or without Other Antihypertensive Agents) | 987 | ||
| PO | 987 | ||
| Adults. | 987 | ||
| Elderly. | 988 | ||
| Side Effects/Adverse Reactions | 988 | ||
| Adults | 988 | ||
| Frequent | 988 | ||
| Occasional | 988 | ||
| Children | 988 | ||
| Precautions and Contraindications | 988 | ||
| Drug Interactions of Concern to Dentistry | 988 | ||
| Serious Reactions | 988 | ||
| Dental Considerations | 988 | ||
| General: | 988 | ||
| Consultations: | 988 | ||
| Teach Patient/Family to: | 988 | ||
| olmesartan medoxomil | 988 | ||
| Category and Schedule | 988 | ||
| Drug Class: | 988 | ||
| Mechanism of Action | 988 | ||
| Uses | 989 | ||
| Pharmacokinetics | 989 | ||
| Indications and Dosages | 989 | ||
| ► Hypertension | 989 | ||
| PO | 989 | ||
| Adults, Elderly, Patients with mildly impaired hepatic or renal function. | 989 | ||
| Side Effects/Adverse Reactions | 989 | ||
| Occasional | 989 | ||
| Rare | 989 | ||
| Precautions and Contraindications | 989 | ||
| Caution: | 989 | ||
| Drug Interactions of Concern to Dentistry | 989 | ||
| Serious Reactions | 989 | ||
| Dental Considerations | 989 | ||
| General: | 989 | ||
| Consultations: | 989 | ||
| Teach Patient/Family to: | 990 | ||
| olodaterol | 990 | ||
| Category and Schedule | 990 | ||
| Drug Class: | 990 | ||
| Mechanism of Action | 990 | ||
| Uses | 990 | ||
| Pharmacokinetics | 990 | ||
| Indications and Dosages | 990 | ||
| Dosage and Routes: | 990 | ||
| ► Chronic Obstructive Pulmonary Disease | 990 | ||
| Adults. | 990 | ||
| PO | 990 | ||
| Side Effects/Adverse Reactions | 990 | ||
| Frequent | 990 | ||
| Occasional | 990 | ||
| Precautions and Contraindications | 990 | ||
| Drug Interactions of Concern to Dentistry | 991 | ||
| Serious Reactions | 991 | ||
| Dental Considerations | 991 | ||
| General: | 991 | ||
| Consultations: | 991 | ||
| Teach Patient/Family to: | 991 | ||
| olopatadine | 991 | ||
| Category and Schedule | 991 | ||
| Drug Class: | 991 | ||
| Mechanism of Action | 991 | ||
| Uses | 991 | ||
| Pharmacokinetics | 991 | ||
| Indications and Dosages | 991 | ||
| ► Allergic Conjunctivitis | 991 | ||
| Topical, Ophthalmic/Intranasal | 991 | ||
| Adult. | 991 | ||
| olsalazine sodium | 992 | ||
| Category and Schedule | 992 | ||
| Drug Class: | 992 | ||
| Mechanism of Action | 992 | ||
| Uses | 992 | ||
| Pharmacokinetics | 992 | ||
| Indications and Dosages | 992 | ||
| ► Maintenance of Controlled Ulcerative Colitis | 992 | ||
| PO | 992 | ||
| Adults, Elderly. | 992 | ||
| Side Effects/Adverse Reactions | 992 | ||
| Frequent | 992 | ||
| Occasional | 992 | ||
| Precautions and Contraindications | 992 | ||
| Drug Interactions of Concern to Dentistry | 992 | ||
| Serious Reactions | 992 | ||
| Dental Considerations | 992 | ||
| General: | 992 | ||
| Consultations: | 992 | ||
| Teach Patient/Family to: | 992 | ||
| Occasional | 993 | ||
| Rare | 993 | ||
| Precautions and Contraindications | 993 | ||
| Caution: | 993 | ||
| Serious Reactions | 993 | ||
| Dental Considerations | 993 | ||
| General: | 993 | ||
| Consultations: | 993 | ||
| Teach Patient/Family to: | 993 | ||
| omalizumab | 993 | ||
| Category and Schedule | 993 | ||
| Drug Class: | 993 | ||
| Mechanism of Action | 993 | ||
| Uses | 993 | ||
| Pharmacokinetics | 993 | ||
| Indications and Dosages | 993 | ||
| ► Moderate-to-Severe Persistent Asthma in Patients Who Are Reactive to a Perennial Allergen and Whose Asthma Symptoms Have Been Inadequately Controlled with Inhaled Corticosteroids | 993 | ||
| Subcutaneous | 993 | ||
| Adults, Elderly, Children 12 yr and older. | 993 | ||
| Side Effects/Adverse Reactions | 994 | ||
| Frequent | 994 | ||
| Occasional | 994 | ||
| Rare | 994 | ||
| Precautions and Contraindications | 994 | ||
| Caution: | 994 | ||
| Drug Interactions of Concern to Dentistry | 994 | ||
| Serious Reactions | 994 | ||
| Dental Considerations | 994 | ||
| General: | 994 | ||
| Consultations: | 995 | ||
| Teach Patient/Family to: | 995 | ||
| ombitasvir, paritaprevir, ritonavir, and dasabuvir | 995 | ||
| Category and Schedule | 995 | ||
| Drug Class: | 995 | ||
| Mechanism of Action | 995 | ||
| Uses | 995 | ||
| Pharmacokinetics | 995 | ||
| Indications and Dosages | 996 | ||
| ► Chronic Hepatitis C: | 996 | ||
| PO | 996 | ||
| Adults. | 996 | ||
| Side Effects/Adverse Reactions | 996 | ||
| Frequent | 996 | ||
| Occasional | 996 | ||
| Precautions and Contraindications | 996 | ||
| Drug Interactions of Concern to Dentistry | 996 | ||
| Serious Reactions | 997 | ||
| Dental Considerations | 997 | ||
| General: | 997 | ||
| Consultations: | 997 | ||
| Teach Patient/Family to: | 997 | ||
| omega-3-carboxylic acids | 997 | ||
| Category and Schedule | 997 | ||
| Drug Class: | 997 | ||
| Mechanism of Action | 997 | ||
| Uses | 997 | ||
| Pharmacokinetics | 997 | ||
| Indications and Dosages | 997 | ||
| ► Severe Hypertriglyceridemia (TGL ≥500 mg/dl) | 997 | ||
| PO | 997 | ||
| Adults. | 997 | ||
| omega-3 fatty acids | 998 | ||
| Category and Schedule | 998 | ||
| Drug Class: | 998 | ||
| Mechanism of Action | 998 | ||
| Uses | 998 | ||
| Pharmacokinetics | 998 | ||
| Indications and Dosages | 998 | ||
| ► Hypertriglyceridemia, Severe (≥500 mg/dl), Adjunct to Diet | 998 | ||
| PO | 998 | ||
| Adults. | 998 | ||
| Side Effects/Adverse Reactions | 998 | ||
| Frequent | 998 | ||
| Occasional | 998 | ||
| Rare | 998 | ||
| Precautions and Contraindications | 998 | ||
| Drug Interactions of Concern to Dentistry | 998 | ||
| Serious Reactions | 998 | ||
| Dental Considerations | 998 | ||
| General: | 998 | ||
| Consultations: | 998 | ||
| Teach Patient/Family to: | 998 | ||
| Caution: | 999 | ||
| Drug Interactions of Concern to Dentistry | 999 | ||
| Serious Reactions | 999 | ||
| Dental Considerations | 999 | ||
| General: | 999 | ||
| Consultations: | 999 | ||
| Teach Patient/Family to: | 999 | ||
| omeprazole | 999 | ||
| Category and Schedule | 999 | ||
| Drug Class: | 999 | ||
| Mechanism of Action | 999 | ||
| Uses | 999 | ||
| Pharmacokinetics | 1000 | ||
| Indications and Dosages | 1000 | ||
| ► Erosive Esophagitis, Poorly Responsive GERD, Active Duodenal Ulcer, Prevention and Treatment of NSAID-Induced Ulcers | 1000 | ||
| ondansetron, oral soluble film | 1001 | ||
| Category and Schedule | 1001 | ||
| Drug Class: | 1001 | ||
| Mechanism of Action | 1001 | ||
| Uses | 1001 | ||
| Pharmacokinetics | 1001 | ||
| Indications and Dosages | 1001 | ||
| ► Prevention of Chemotherapy-Induced Nausea and Vomiting | 1001 | ||
| oprelvekin (interleukin-2, IL-2) | 1002 | ||
| Category and Schedule | 1002 | ||
| Drug Class: | 1002 | ||
| Mechanism of Action | 1002 | ||
| Uses | 1002 | ||
| Pharmacokinetics | 1002 | ||
| Indications and Dosages | 1002 | ||
| ► Prevention of Thrombocytopenia | 1002 | ||
| Subcutaneous | 1002 | ||
| Adults. | 1002 | ||
| Children. | 1002 | ||
| Side Effects/Adverse Reactions | 1002 | ||
| Frequent | 1002 | ||
| Precautions and Contraindications | 1002 | ||
| Drug Interactions of Concern to Dentistry | 1002 | ||
| Serious Reactions | 1002 | ||
| Dental Considerations | 1002 | ||
| General: | 1002 | ||
| Teach Patient/Family: | 1002 | ||
| Dental Considerations | 1003 | ||
| General: | 1003 | ||
| Consultations: | 1003 | ||
| Teach Patient/Family to: | 1003 | ||
| orlistat | 1003 | ||
| Category and Schedule | 1003 | ||
| Drug Class: | 1003 | ||
| Mechanism of Action | 1003 | ||
| Uses | 1003 | ||
| Pharmacokinetics | 1004 | ||
| Indications and Dosages | 1004 | ||
| ► Weight Reduction | 1004 | ||
| PO | 1004 | ||
| Adults, Elderly, Children 12–16 yr. | 1004 | ||
| Side Effects/Adverse Reactions | 1004 | ||
| Frequent | 1004 | ||
| Occasional | 1004 | ||
| Rare | 1004 | ||
| Precautions and Contraindications | 1004 | ||
| Caution: | 1004 | ||
| Drug Interactions of Concern to Dentistry | 1004 | ||
| Serious Reactions | 1004 | ||
| Dental Considerations | 1004 | ||
| General: | 1004 | ||
| Consultations: | 1004 | ||
| Teach Patient/Family to: | 1004 | ||
| orphenadrine | 1004 | ||
| Category and Schedule | 1004 | ||
| Drug Class: | 1004 | ||
| Mechanism of Action | 1004 | ||
| Uses | 1005 | ||
| Pharmacokinetics | 1005 | ||
| Indications and Dosages | 1005 | ||
| ► Musculoskeletal Pain | 1005 | ||
| IM/IV | 1005 | ||
| oseltamivir | 1006 | ||
| Category and Schedule | 1006 | ||
| Drug Class: | 1006 | ||
| Mechanism of Action | 1006 | ||
| Uses | 1006 | ||
| Pharmacokinetics | 1006 | ||
| Indications and Dosages | 1006 | ||
| ► Influenza | 1006 | ||
| ospemifene | 1007 | ||
| Category and Schedule | 1007 | ||
| Drug Class: | 1007 | ||
| Mechanism of Action | 1007 | ||
| Uses | 1007 | ||
| Pharmacokinetics | 1007 | ||
| Indications and Dosages | 1007 | ||
| ► Adult Dyspareunia, Moderate to Severe | 1007 | ||
| PO | 1007 | ||
| Adults. | 1007 | ||
| Side Effects/Adverse Reactions | 1007 | ||
| Frequent | 1007 | ||
| Occasional | 1007 | ||
| Precautions and Contraindications | 1007 | ||
| Drug Interactions of Concern to Dentistry | 1007 | ||
| Serious Reactions | 1007 | ||
| Dental Considerations | 1008 | ||
| General: | 1008 | ||
| Teach Patient/Family to: | 1008 | ||
| oxacillin | 1008 | ||
| Category and Schedule | 1008 | ||
| Drug Class: | 1008 | ||
| Mechanism of Action | 1008 | ||
| Uses | 1008 | ||
| Pharmacokinetics | 1008 | ||
| Indications and Dosages | 1008 | ||
| ► Upper Respiratory Tract, Skin, and Skin-Structure Infections | 1008 | ||
| oxaliplatin | 1009 | ||
| Category and Schedule | 1009 | ||
| Drug Class: | 1009 | ||
| Mechanism of Action | 1009 | ||
| Uses | 1009 | ||
| Pharmacokinetics | 1009 | ||
| Indications and Dosages | 1009 | ||
| ► Metastatic Colon or Rectal Cancer in Patients Whose Disease Has Recurred or Progressed During or Within 6 Mo of Completing First-Line Therapy with Bolus 5-Fluorouracil (5-FU), Leucovorin, and Irinotecan | 1009 | ||
| oxandrolone | 1011 | ||
| Category and Schedule | 1011 | ||
| Drug Class: | 1011 | ||
| Mechanism of Action | 1011 | ||
| Uses | 1011 | ||
| Pharmacokinetics | 1011 | ||
| Indications and Dosages | 1011 | ||
| ► Weight Gain | 1011 | ||
| Adults, Elderly. | 1011 | ||
| Children. | 1011 | ||
| Side Effects/Adverse Reactions | 1011 | ||
| Frequent | 1011 | ||
| Occasional | 1011 | ||
| Rare | 1011 | ||
| Precautions and Contraindications | 1011 | ||
| Caution: | 1012 | ||
| Drug Interactions of Concern to Dentistry | 1012 | ||
| Serious Reactions | 1012 | ||
| Dental Considerations | 1012 | ||
| General: | 1012 | ||
| Consultations: | 1012 | ||
| Teach Patient/Family to: | 1012 | ||
| oxaprozin | 1012 | ||
| Category and Schedule | 1012 | ||
| Drug Class: | 1012 | ||
| Mechanism of Action | 1012 | ||
| Uses | 1012 | ||
| Pharmacokinetics | 1012 | ||
| Indications and Dosages | 1012 | ||
| ► Osteoarthritis | 1012 | ||
| PO | 1012 | ||
| Adults, Elderly. | 1012 | ||
| ► Rheumatoid Arthritis | 1013 | ||
| PO | 1013 | ||
| Adults, Elderly. | 1013 | ||
| ► Juvenile Rheumatoid Arthritis | 1013 | ||
| Children weighing more than 54 kg. | 1013 | ||
| Children weighing 32–54 kg. | 1013 | ||
| Children weighing 22–31 kg. | 1013 | ||
| ► Dosage in Renal Impairment | 1013 | ||
| Side Effects/Adverse Reactions | 1013 | ||
| Occasional | 1013 | ||
| Rare | 1013 | ||
| Precautions and Contraindications | 1013 | ||
| Caution: | 1013 | ||
| Drug Interactions of Concern to Dentistry | 1013 | ||
| Serious Reactions | 1013 | ||
| Dental Considerations | 1013 | ||
| General: | 1013 | ||
| Consultations: | 1013 | ||
| Teach Patient/Family to: | 1014 | ||
| oxazepam | 1014 | ||
| Category and Schedule | 1014 | ||
| Drug Class: | 1014 | ||
| Mechanism of Action | 1014 | ||
| Uses | 1014 | ||
| Pharmacokinetics | 1014 | ||
| Indications and Dosages | 1014 | ||
| ► Mild-to-Moderate Anxiety | 1014 | ||
| oxcarbazepine | 1015 | ||
| Category and Schedule | 1015 | ||
| Drug Class: | 1015 | ||
| Mechanism of Action | 1015 | ||
| Uses | 1015 | ||
| Pharmacokinetics | 1015 | ||
| Indications and Dosages | 1015 | ||
| ► Adjunctive Treatment of Seizures | 1015 | ||
| PO | 1015 | ||
| Adults, Elderly. | 1015 | ||
| Children 4–16 yr. | 1015 | ||
| ► Conversion to Monotherapy | 1016 | ||
| oxiconazole | 1017 | ||
| Category and Schedule | 1017 | ||
| Drug Class: | 1017 | ||
| Mechanism of Action | 1017 | ||
| Uses | 1017 | ||
| Pharmacokinetics | 1017 | ||
| Indications and Dosages | 1017 | ||
| ► Tinea pedis | 1017 | ||
| oxidized cellulose | 1018 | ||
| Category and Schedule | 1018 | ||
| Drug Class: | 1018 | ||
| Mechanism of Action | 1018 | ||
| Uses | 1018 | ||
| Pharmacokinetics | 1018 | ||
| Indications and Dosages | 1018 | ||
| ► Surgical Procedures to Assist in the Control of Capillary, Venous, and Small Arterial Hemorrhage When Ligation or Other Conventional Methods of Control Are Impractical or Ineffective | 1018 | ||
| Topical | 1018 | ||
| Adults. | 1018 | ||
| Side Effects/Adverse Reactions | 1018 | ||
| Frequency Not Defined | 1018 | ||
| Precautions and Contraindications | 1018 | ||
| Caution: | 1018 | ||
| Serious Reactions | 1018 | ||
| Dental Considerations | 1018 | ||
| General: | 1018 | ||
| oxybutynin | 1019 | ||
| Category and Schedule | 1019 | ||
| Drug Class: | 1019 | ||
| Mechanism of Action | 1019 | ||
| Uses | 1019 | ||
| Pharmacokinetics | 1019 | ||
| Indications and Dosages | 1019 | ||
| ► Neurogenic Bladder | 1019 | ||
| PO | 1019 | ||
| oxycodone | 1020 | ||
| Category and Schedule | 1020 | ||
| Drug Class: | 1020 | ||
| Mechanism of Action | 1020 | ||
| Uses | 1020 | ||
| Pharmacokinetics | 1020 | ||
| Indications and Dosages | 1021 | ||
| ► Analgesia | 1021 | ||
| PO (Controlled-Release) | 1021 | ||
| oxycodone + naltrexone | 1022 | ||
| Category and Schedule | 1022 | ||
| Drug Class: | 1022 | ||
| Mechanism of Action | 1022 | ||
| Uses | 1022 | ||
| Pharmacokinetics | 1022 | ||
| Indications and Dosages | 1022 | ||
| ► Pain Management | 1022 | ||
| PO | 1022 | ||
| Adults. | 1022 | ||
| Side Effects/Adverse Reactions | 1023 | ||
| Frequent | 1023 | ||
| Occasional | 1023 | ||
| Precautions and Contraindications | 1023 | ||
| Drug Interactions of Concern to Dentistry | 1024 | ||
| Serious Reactions | 1024 | ||
| Dental Considerations | 1024 | ||
| General: | 1024 | ||
| Consultations: | 1024 | ||
| Teach Patient/Family to: | 1024 | ||
| oxymetazoline | 1024 | ||
| Category and Schedule | 1024 | ||
| Drug Class: | 1024 | ||
| Mechanism of Action | 1025 | ||
| Uses | 1025 | ||
| Pharmacokinetics | 1025 | ||
| Indications and Dosages | 1025 | ||
| ► Rhinitis | 1025 | ||
| Intranasal | 1025 | ||
| oxymetholone | 1025 | ||
| Category and Schedule | 1025 | ||
| Drug Class: | 1025 | ||
| Mechanism of Action | 1026 | ||
| Uses | 1026 | ||
| Pharmacokinetics | 1026 | ||
| Indications and Dosages | 1026 | ||
| ► Anemia, Chronic Renal Failure, Acquired Aplastic Anemia, Chemotherapy-Induced Myelosuppression, Fanconi’s Anemia, Red Cell Aplasia | 1026 | ||
| PO | 1026 | ||
| Adults, Elderly, Children. | 1026 | ||
| Side Effects/Adverse Reactions | 1026 | ||
| Frequent | 1026 | ||
| Occasional | 1026 | ||
| Rare | 1026 | ||
| Precautions and Contraindications | 1026 | ||
| Caution: | 1026 | ||
| Drug Interactions of Concern to Dentistry | 1026 | ||
| Serious Reactions | 1026 | ||
| Dental Considerations | 1027 | ||
| General: | 1027 | ||
| Consultations: | 1027 | ||
| Teach Patient/Family to: | 1027 | ||
| paclitaxel | 1028 | ||
| Category and Schedule | 1028 | ||
| Drug Class: | 1028 | ||
| Mechanism of Action | 1028 | ||
| Uses | 1028 | ||
| Pharmacokinetics | 1028 | ||
| Indications and Dosages | 1028 | ||
| ► Ovarian Cancer | 1028 | ||
| paliperidone | 1029 | ||
| Category and Schedule | 1029 | ||
| Drug Class: | 1029 | ||
| Mechanism Of Action | 1029 | ||
| Uses | 1029 | ||
| Pharmacokinetics | 1029 | ||
| Indications and Dosages | 1029 | ||
| ► Schizophrenia | 1029 | ||
| PO (Extended-Release) | 1029 | ||
| Adults. | 1029 | ||
| ► Renal Impairment | 1030 | ||
| PO (Extended-Release) | 1030 | ||
| Side Effects/Adverse Reactions | 1030 | ||
| Frequent | 1030 | ||
| Occasional | 1030 | ||
| Rare | 1030 | ||
| Precautions and Contraindications | 1030 | ||
| Caution: | 1030 | ||
| Drug Interactions of Concern to Dentistry | 1030 | ||
| Serious Reactions | 1030 | ||
| Dental Considerations | 1030 | ||
| General: | 1030 | ||
| Consultations: | 1031 | ||
| Teach Patient/Family to: | 1031 | ||
| palonosetron hydrochloride | 1031 | ||
| Category and Schedule | 1031 | ||
| Drug Class: | 1031 | ||
| Mechanism of Action | 1031 | ||
| Uses | 1031 | ||
| Pharmacokinetics | 1031 | ||
| Indications and Dosages | 1031 | ||
| ► Chemotherapy-Induced Nausea and Vomiting | 1031 | ||
| IV | 1031 | ||
| Adults, Elderly. | 1031 | ||
| Side Effects/Adverse Reactions | 1031 | ||
| Occasional | 1031 | ||
| Rare | 1031 | ||
| Precautions and Contraindications | 1031 | ||
| Drug Interactions of Concern to Dentistry | 1032 | ||
| Serious Reactions | 1032 | ||
| Dental Considerations | 1032 | ||
| General: | 1032 | ||
| Teach Patient/Family to: | 1032 | ||
| pamidronate disodium | 1032 | ||
| Category and Schedule | 1032 | ||
| Drug Class: | 1032 | ||
| Mechanism of Action | 1032 | ||
| Uses | 1032 | ||
| Pharmacokinetics | 1032 | ||
| Indications and Dosages | 1032 | ||
| ► Hypercalcemia | 1032 | ||
| pancreatin/pancrelipase | 1033 | ||
| Category and Schedule | 1033 | ||
| Drug Class: | 1033 | ||
| Mechanism of Action | 1033 | ||
| Uses | 1033 | ||
| Pharmacokinetics | 1034 | ||
| Indications and Dosages | 1034 | ||
| ► Pancreatic Insufficiency | 1034 | ||
| Adult. | 1034 | ||
| Children 7–12 yr. | 1034 | ||
| Children 1–6 yr. | 1034 | ||
| Side Effects/Adverse Reactions | 1034 | ||
| Frequent | 1034 | ||
| Occasional | 1034 | ||
| Rare | 1034 | ||
| Precautions and Contraindications | 1034 | ||
| Drug Interactions of Concern to Dentistry | 1034 | ||
| Serious Reactions | 1034 | ||
| Dental Considerations | 1034 | ||
| General: | 1034 | ||
| Consultations: | 1034 | ||
| Teach Patient/Family to: | 1034 | ||
| panitumumab | 1034 | ||
| Category and Schedule | 1034 | ||
| Drug Class: | 1034 | ||
| Mechanism of Action | 1034 | ||
| Uses | 1034 | ||
| Pharmacokinetics | 1035 | ||
| Indications and Dosages | 1035 | ||
| ► EGFR-Positive Metastatic Colorectal Cancer | 1035 | ||
| IV Infusion | 1035 | ||
| Adults. | 1035 | ||
| ► Dosing Adjustments | 1035 | ||
| Infusion Reactions | 1035 | ||
| ► Dermatologic Toxicity | 1035 | ||
| Dermatologic toxicity (grade 3 or 4). | 1035 | ||
| Dermatologic toxicity (grade 2 or lower), and the patient is symptomatically improved after withholding no more than 2 doses of panitumumab. | 1035 | ||
| Side Effects/Adverse Reactions | 1035 | ||
| Frequent | 1035 | ||
| Occasional | 1035 | ||
| Rare | 1035 | ||
| Precautions and Contraindications | 1035 | ||
| Drug Interactions of Concern to Dentistry | 1035 | ||
| Serious Reactions | 1035 | ||
| Dental Considerations | 1035 | ||
| General: | 1035 | ||
| Consultations: | 1035 | ||
| Teach Patient/Family to: | 1035 | ||
| panobinostat | 1036 | ||
| Category and Schedule | 1036 | ||
| Drug Class: | 1036 | ||
| Mechanism of Action | 1036 | ||
| Uses | 1036 | ||
| Pharmacokinetics | 1036 | ||
| Indications and Dosages | 1036 | ||
| ► Multiple Myeloma | 1036 | ||
| PO | 1036 | ||
| Adults. | 1036 | ||
| Side Effects/Adverse Reactions | 1036 | ||
| Frequent | 1036 | ||
| Occasional | 1036 | ||
| Precautions and Contraindications | 1036 | ||
| Drug Interactions of Concern to Dentistry | 1037 | ||
| Serious Reactions | 1037 | ||
| Dental Considerations | 1037 | ||
| General: | 1037 | ||
| Consultations: | 1037 | ||
| Teach Patient/Family to: | 1037 | ||
| pantoprazole | 1038 | ||
| Category and Schedule | 1038 | ||
| Drug Class: | 1038 | ||
| Mechanism of Action | 1038 | ||
| Uses | 1038 | ||
| Pharmacokinetics | 1038 | ||
| Indications and Dosages | 1038 | ||
| ► Erosive Esophagitis | 1038 | ||
| papaverine hydrochloride | 1039 | ||
| Category and Schedule | 1039 | ||
| Drug Class: | 1039 | ||
| Mechanism of Action | 1039 | ||
| Uses | 1039 | ||
| Pharmacokinetics | 1039 | ||
| Indications and Dosages | 1039 | ||
| ► Vascular Spasm | 1039 | ||
| IV/IM | 1039 | ||
| paregoric | 1040 | ||
| Category and Schedule | 1040 | ||
| Drug Class: | 1040 | ||
| Mechanism of Action | 1040 | ||
| Uses | 1040 | ||
| Pharmacokinetics | 1040 | ||
| Indications and Dosages | 1040 | ||
| ► Antidiarrheal | 1040 | ||
| PO | 1040 | ||
| Adults, Elderly. | 1040 | ||
| Children. | 1040 | ||
| Side Effects/Adverse Reactions | 1040 | ||
| Frequent | 1040 | ||
| Occasional | 1040 | ||
| Rare | 1040 | ||
| Precautions and Contraindications | 1041 | ||
| Caution: | 1041 | ||
| Drug Interactions of Concern to Dentistry | 1041 | ||
| Serious Reactions | 1041 | ||
| Dental Considerations | 1041 | ||
| General: | 1041 | ||
| Teach Patient/Family to: | 1041 | ||
| pargyline | 1041 | ||
| Category and Schedule | 1041 | ||
| Drug Class: | 1041 | ||
| Mechanism of Action | 1041 | ||
| Uses | 1041 | ||
| Pharmacokinetics | 1041 | ||
| Indications and Dosages | 1041 | ||
| ► Hypertension | 1041 | ||
| PO | 1041 | ||
| Adults. | 1041 | ||
| Side Effects/Adverse Reactions | 1041 | ||
| Frequent | 1041 | ||
| Occasional | 1041 | ||
| Rare | 1041 | ||
| Precautions and Contraindications | 1042 | ||
| Caution: | 1042 | ||
| Drug Interactions of Concern to Dentistry | 1042 | ||
| Serious Reactions | 1042 | ||
| Dental Considerations | 1042 | ||
| General: | 1042 | ||
| Consultations: | 1042 | ||
| Teach Patient/Family to: | 1042 | ||
| paromomycin | 1042 | ||
| Category and Schedule | 1042 | ||
| Drug Class: | 1042 | ||
| Mechanism of Action | 1042 | ||
| Uses | 1042 | ||
| Pharmacokinetics | 1042 | ||
| Indications and Dosages | 1042 | ||
| ► Intestinal Amebiasis | 1042 | ||
| PO | 1042 | ||
| Adults, Elderly, Children. | 1042 | ||
| ► Hepatic Coma | 1043 | ||
| PO | 1043 | ||
| Adults, Elderly. | 1043 | ||
| Side Effects/Adverse Reactions | 1043 | ||
| Occasional | 1043 | ||
| Rare | 1043 | ||
| Precautions and Contraindications | 1043 | ||
| Drug Interactions of Concern to Dentistry | 1043 | ||
| Serious Reactions | 1043 | ||
| Dental Considerations | 1043 | ||
| General: | 1043 | ||
| Consultations: | 1043 | ||
| Teach Patient/Family to: | 1043 | ||
| paroxetine hydrochloride | 1043 | ||
| Category and Schedule | 1043 | ||
| Drug Class: | 1043 | ||
| Mechanism of Action | 1043 | ||
| Uses | 1043 | ||
| Pharmacokinetics | 1044 | ||
| Indications and Dosages | 1044 | ||
| ► Depression | 1044 | ||
| pazopanib | 1045 | ||
| Category and Schedule | 1045 | ||
| Drug Class: | 1045 | ||
| Mechanism of Action | 1045 | ||
| Uses | 1045 | ||
| Pharmacokinetics | 1045 | ||
| Indications and Dosages | 1045 | ||
| ► Advanced Renal Cell Cancer | 1045 | ||
| PO | 1045 | ||
| Adults, Elderly. | 1045 | ||
| ► Dosage Adjustment for Moderate Hepatic Impairment | 1046 | ||
| Side Effects/Adverse Reactions | 1046 | ||
| Frequent | 1046 | ||
| Occasional | 1046 | ||
| Precautions and Contraindications | 1046 | ||
| Drug Interactions of Concern to Dentistry | 1046 | ||
| Serious Reactions | 1046 | ||
| Dental Considerations | 1046 | ||
| General: | 1046 | ||
| Consultations: | 1046 | ||
| Teach Patient/Family to: | 1046 | ||
| pegfilgrastim | 1047 | ||
| Category and Schedule | 1047 | ||
| Drug Class: | 1047 | ||
| Mechanism of Action | 1047 | ||
| Uses | 1047 | ||
| Pharmacokinetics | 1047 | ||
| Indications and Dosages | 1047 | ||
| ► Myelosuppression | 1047 | ||
| Subcutaneous | 1047 | ||
| Adults, Elderly. | 1047 | ||
| Side Effects/Adverse Reactions | 1047 | ||
| Frequent | 1047 | ||
| Precautions and Contraindications | 1047 | ||
| Drug Interactions of Concern to Dentistry | 1047 | ||
| Serious Reactions | 1047 | ||
| Dental Considerations | 1047 | ||
| General: | 1047 | ||
| Consultations: | 1048 | ||
| Teach Patient/Family to: | 1048 | ||
| peginterferon alfa-2a | 1048 | ||
| Category and Schedule | 1048 | ||
| Drug Class: | 1048 | ||
| Mechanism of Action | 1048 | ||
| Uses | 1048 | ||
| Pharmacokinetics | 1048 | ||
| Indications and Dosages | 1048 | ||
| ► Hepatitis C | 1048 | ||
| Subcutaneous | 1048 | ||
| Adults 18 yr and older, Elderly. | 1048 | ||
| ► Dosage in Renal Impairment | 1048 | ||
| ► Dosage in Hepatic Impairment | 1048 | ||
| Side Effects/Adverse Reactions | 1048 | ||
| Frequent | 1048 | ||
| Occasional | 1048 | ||
| Precautions and Contraindications | 1048 | ||
| Caution: | 1048 | ||
| Drug Interactions of Concern to Dentistry | 1049 | ||
| Serious Reactions | 1049 | ||
| Dental Considerations | 1049 | ||
| General: | 1049 | ||
| Consultations: | 1049 | ||
| Teach Patient/Family to: | 1049 | ||
| peginterferon alfa-2b | 1049 | ||
| Category and Schedule | 1049 | ||
| Drug Class: | 1049 | ||
| Mechanism of Action | 1049 | ||
| Uses | 1050 | ||
| Pharmacokinetics | 1050 | ||
| Indications and Dosages | 1050 | ||
| ► Chronic Hepatitis C, Monotherapy | 1050 | ||
| Subcutaneous | 1050 | ||
| Adults 18 yr and older, Elderly. | 1050 | ||
| ► Chronic Hepatitis C | 1050 | ||
| Side Effects/Adverse Reactions | 1050 | ||
| Frequent | 1050 | ||
| Occasional | 1050 | ||
| Rare | 1050 | ||
| Precautions and Contraindications | 1050 | ||
| Caution: | 1050 | ||
| Drug Interactions of Concern to Dentistry | 1050 | ||
| Serious Reactions | 1050 | ||
| Dental Considerations | 1051 | ||
| General: | 1051 | ||
| Consultations: | 1051 | ||
| Teach Patient/Family to: | 1051 | ||
| pegvisomant | 1051 | ||
| Category and Schedule | 1051 | ||
| Drug Class: | 1051 | ||
| Mechanism of Action | 1051 | ||
| Uses | 1051 | ||
| Pharmacokinetics | 1051 | ||
| Indications and Dosages | 1052 | ||
| ► Acromegaly | 1052 | ||
| Subcutaneous | 1052 | ||
| Adults, Elderly. | 1052 | ||
| Side Effects/Adverse Reactions | 1052 | ||
| Frequent | 1052 | ||
| Occasional | 1052 | ||
| Rare | 1052 | ||
| Precautions and Contraindications | 1052 | ||
| Drug Interactions of Concern to Dentistry | 1052 | ||
| Serious Reactions | 1052 | ||
| Dental Considerations | 1052 | ||
| General: | 1052 | ||
| Consultations: | 1052 | ||
| Teach Patient/Family to: | 1052 | ||
| penbutolol | 1052 | ||
| Category and Schedule | 1052 | ||
| Drug Class: | 1052 | ||
| Mechanism of Action | 1052 | ||
| Uses | 1052 | ||
| Pharmacokinetics | 1053 | ||
| Indications and Dosages | 1053 | ||
| ► Hypertension | 1053 | ||
| PO | 1053 | ||
| Adults. | 1053 | ||
| Elderly. | 1053 | ||
| Side Effects/Adverse Reactions | 1053 | ||
| Frequent | 1053 | ||
| Occasional | 1053 | ||
| Rare | 1053 | ||
| Precautions and Contraindications | 1053 | ||
| Caution: | 1053 | ||
| Drug Interactions of Concern to Dentistry | 1053 | ||
| Serious Reactions | 1053 | ||
| Dental Considerations | 1053 | ||
| General: | 1053 | ||
| Consultations: | 1054 | ||
| Teach Patient/Family to: | 1054 | ||
| penciclovir | 1054 | ||
| Category and Schedule | 1054 | ||
| Drug Class: | 1054 | ||
| Mechanism of Action | 1054 | ||
| Uses | 1054 | ||
| Pharmacokinetics | 1054 | ||
| Indications and Dosages | 1054 | ||
| ► Herpes Labialis (Cold Sores) | 1054 | ||
| Topical | 1054 | ||
| Adolescents, Adults. | 1054 | ||
| Side Effects/Adverse Reactions | 1054 | ||
| Frequent | 1054 | ||
| Occasional | 1054 | ||
| Rare | 1055 | ||
| Precautions and Contraindications | 1055 | ||
| Caution: | 1055 | ||
| Drug Interactions of Concern to Dentistry | 1055 | ||
| Serious Reactions | 1055 | ||
| Dental Considerations | 1055 | ||
| General: | 1055 | ||
| Teach Patient/Family to: | 1055 | ||
| penicillin G benzathine | 1055 | ||
| Category and Schedule | 1055 | ||
| Drug Class: | 1055 | ||
| Mechanism of Action | 1055 | ||
| Uses | 1055 | ||
| Pharmacokinetics | 1055 | ||
| Indications and Dosages | 1056 | ||
| ► Group A Streptococcal Infections | 1056 | ||
| penicillin G potassium | 1057 | ||
| Category and Schedule | 1057 | ||
| Drug Class: | 1057 | ||
| Mechanism of Action | 1057 | ||
| Uses | 1057 | ||
| Pharmacokinetics | 1057 | ||
| Indications and Dosages | 1057 | ||
| ► Sepsis, Meningitis, Pericarditis, Endocarditis, Pneumonia Caused by Susceptible Gram-Positive Organisms (Not Staphylococcus aureus) and Some Gram-Negative Organisms | 1057 | ||
| IV, IM | 1057 | ||
| Adults, Elderly. | 1057 | ||
| Children. | 1057 | ||
| ► Dosage in Renal Impairment | 1057 | ||
| Side Effects/Adverse Reactions | 1057 | ||
| Occasional | 1057 | ||
| Rare | 1057 | ||
| Precautions and Contraindications | 1057 | ||
| Drug Interactions of Concern to Dentistry | 1057 | ||
| Serious Reactions | 1057 | ||
| Dental Considerations | 1058 | ||
| General: | 1058 | ||
| Consultations: | 1058 | ||
| Teach Patient/Family to: | 1058 | ||
| penicillin V potassium | 1058 | ||
| Category and Schedule | 1058 | ||
| Drug Class: | 1058 | ||
| Mechanism of Action | 1058 | ||
| Uses | 1058 | ||
| Pharmacokinetics | 1058 | ||
| Indications and Dosages | 1058 | ||
| ► Mild-to-Moderate Respiratory Tract or Skin or Skin-Structure Infections, Otitis Media, Necrotizing Ulcerative Gingivitis | 1058 | ||
| pentamidine isethionate | 1059 | ||
| Category and Schedule | 1059 | ||
| Drug Class: | 1059 | ||
| Mechanism of Action | 1059 | ||
| Uses | 1059 | ||
| Pharmacokinetics | 1059 | ||
| Indications and Dosages | 1059 | ||
| ► Pneumocystis carinii Pneumonia (PCP) | 1059 | ||
| IV, IM | 1059 | ||
| Adults, Elderly. | 1059 | ||
| Children. | 1060 | ||
| ► Prevention of PCP | 1060 | ||
| Inhalation | 1060 | ||
| Adults, Elderly. | 1060 | ||
| Children 5 yr and older. | 1060 | ||
| Children younger than 5 yr. | 1060 | ||
| Side Effects/Adverse Reactions | 1060 | ||
| Frequent | 1060 | ||
| Occasional | 1060 | ||
| Rare | 1060 | ||
| Precautions and Contraindications | 1060 | ||
| Caution: | 1060 | ||
| Drug Interactions of Concern to Dentistry | 1060 | ||
| Serious Reactions | 1060 | ||
| Dental Considerations | 1060 | ||
| General: | 1060 | ||
| Consultations: | 1060 | ||
| Teach Patient/Family to: | 1060 | ||
| pentazocine hydrochloride; naloxone hydrochloride | 1061 | ||
| Category and Schedule | 1061 | ||
| Drug Class: | 1061 | ||
| Mechanism of Action | 1061 | ||
| Uses | 1061 | ||
| Pharmacokinetics | 1061 | ||
| Indications and Dosages | 1061 | ||
| ► Pain, Moderate-to-Severe | 1061 | ||
| PO | 1061 | ||
| Adults, Elderly, Children 12 yr and older. | 1061 | ||
| Side Effects/Adverse Reactions | 1061 | ||
| Occasional | 1061 | ||
| Precautions and Contraindications | 1061 | ||
| Caution: | 1061 | ||
| Drug Interactions of Concern to Dentistry | 1061 | ||
| Serious Reactions | 1062 | ||
| Dental Considerations | 1062 | ||
| General: | 1062 | ||
| Teach Patient/Family: | 1062 | ||
| pentazocine | 1062 | ||
| Combination Products | 1062 | ||
| Category and Schedule | 1062 | ||
| Drug Class: | 1062 | ||
| Mechanism of Action | 1062 | ||
| Uses | 1062 | ||
| Pharmacokinetics | 1062 | ||
| Indications and Dosages | 1062 | ||
| ► Analgesia | 1062 | ||
| PO (with Naloxone) | 1062 | ||
| Adults. | 1062 | ||
| Elderly. | 1062 | ||
| ► Subcutaneous/IM/IV (without Naloxone) | 1063 | ||
| pentobarbital | 1064 | ||
| Category and Schedule | 1064 | ||
| Drug Class: | 1064 | ||
| Mechanism of Action | 1064 | ||
| Uses | 1064 | ||
| Pharmacokinetics | 1064 | ||
| Indications and Dosages | 1064 | ||
| ► Preanesthetic | 1064 | ||
| pentosan polysulfate | 1066 | ||
| Category and Schedule | 1066 | ||
| Drug Class: | 1066 | ||
| Mechanism of Action | 1066 | ||
| Uses | 1066 | ||
| Pharmacokinetics | 1066 | ||
| Indications and Dosages | 1066 | ||
| ► Interstitial Cystitis | 1066 | ||
| PO | 1066 | ||
| Adults, Elderly. | 1066 | ||
| Side Effects/Adverse Reactions | 1066 | ||
| Frequent | 1066 | ||
| Occasional | 1066 | ||
| Precautions and Contraindications | 1066 | ||
| Drug Interactions of Concern to Dentistry | 1066 | ||
| Serious Reactions | 1066 | ||
| Dental Considerations | 1066 | ||
| General: | 1066 | ||
| Consultations: | 1067 | ||
| Teach Patient/Family to: | 1067 | ||
| pentostatin | 1067 | ||
| Category and Schedule | 1067 | ||
| Drug Class: | 1067 | ||
| Mechanism of Action | 1067 | ||
| Uses | 1067 | ||
| Pharmacokinetics | 1067 | ||
| Indications and Dosages | 1067 | ||
| ► Hairy Cell Leukemia | 1067 | ||
| IV | 1067 | ||
| Adults, Elderly. | 1067 | ||
| ► Dosage in Renal Impairment | 1067 | ||
| Side Effects/Adverse Reactions | 1067 | ||
| Frequent | 1067 | ||
| Occasional | 1067 | ||
| Precautions and Contraindications | 1067 | ||
| Serious Reactions | 1067 | ||
| Dental Considerations | 1068 | ||
| pentoxifylline | 1068 | ||
| Category and Schedule | 1068 | ||
| Drug Class: | 1068 | ||
| Mechanism of Action | 1068 | ||
| Uses | 1068 | ||
| Pharmacokinetics | 1068 | ||
| Indications and Dosages | 1068 | ||
| ► Intermittent Claudication | 1068 | ||
| PO | 1068 | ||
| Adults, Elderly. | 1068 | ||
| Side Effects/Adverse Reactions | 1068 | ||
| Occasional | 1068 | ||
| Rare | 1068 | ||
| Precautions and Contraindications | 1068 | ||
| Caution: | 1068 | ||
| Drug Interactions of Concern to Dentistry | 1068 | ||
| Serious Reactions | 1068 | ||
| Dental Considerations | 1069 | ||
| General: | 1069 | ||
| Consultations: | 1069 | ||
| Teach Patient/Family to: | 1069 | ||
| perindopril | 1069 | ||
| Category and Schedule | 1069 | ||
| Drug Class: | 1069 | ||
| Mechanism of Action | 1069 | ||
| Uses | 1069 | ||
| Pharmacokinetics | 1069 | ||
| Indications and Dosages | 1069 | ||
| ► Hypertension | 1069 | ||
| PO | 1069 | ||
| Adults, Elderly. | 1069 | ||
| Side Effects/Adverse Reactions | 1070 | ||
| Occasional | 1070 | ||
| Precautions and Contraindications | 1070 | ||
| Caution: | 1070 | ||
| Drug Interactions of Concern to Dentistry | 1070 | ||
| Serious Reactions | 1070 | ||
| Dental Considerations | 1070 | ||
| General: | 1070 | ||
| Consultations: | 1070 | ||
| Teach Patient/Family to: | 1070 | ||
| perindopril arginine + amlodipine | 1071 | ||
| Category and Schedule | 1071 | ||
| Drug Class: | 1071 | ||
| Mechanism of Action | 1071 | ||
| Uses | 1071 | ||
| Pharmacokinetics | 1071 | ||
| Indications and Dosages | 1071 | ||
| ► Hypertension | 1071 | ||
| PO | 1071 | ||
| Adults. | 1071 | ||
| Side Effects/Adverse Reactions | 1071 | ||
| Frequent | 1071 | ||
| Occasional | 1071 | ||
| Precautions and Contraindications | 1072 | ||
| Drug Interactions of Concern to Dentistry | 1072 | ||
| Serious Reactions | 1072 | ||
| Dental Considerations | 1072 | ||
| General: | 1072 | ||
| Consultations: | 1072 | ||
| Teach Patient/Family to: | 1072 | ||
| perphenazine | 1072 | ||
| Category and Schedule | 1072 | ||
| Drug Class: | 1072 | ||
| Mechanism of Action | 1073 | ||
| Uses | 1073 | ||
| Pharmacokinetics | 1073 | ||
| Indications and Dosages | 1073 | ||
| ► Severe Schizophrenia | 1073 | ||
| phenazopyridine hydrochloride | 1074 | ||
| Category and Schedule | 1074 | ||
| Drug Class: | 1074 | ||
| Mechanism of Action | 1074 | ||
| Uses | 1074 | ||
| Pharmacokinetics | 1075 | ||
| Indications and Dosages | 1075 | ||
| ► Urinary Analgesic | 1075 | ||
| PO | 1075 | ||
| Adults. | 1075 | ||
| Children 6 yr and older. | 1075 | ||
| ► Dosage in Renal Impairment | 1075 | ||
| Side Effects/Adverse Reactions | 1075 | ||
| Occasional | 1075 | ||
| Precautions and Contraindications | 1075 | ||
| Caution: | 1075 | ||
| Drug Interactions of Concern to Dentistry | 1075 | ||
| Serious Reactions | 1075 | ||
| Dental Considerations | 1075 | ||
| General: | 1075 | ||
| phendimetrazine | 1075 | ||
| Category and Schedule | 1075 | ||
| Drug Class: | 1075 | ||
| Mechanism of Action | 1075 | ||
| Uses | 1075 | ||
| Pharmacokinetics | 1076 | ||
| Indications and Dosages | 1076 | ||
| ► Obesity | 1076 | ||
| PO | 1076 | ||
| Adults, Elderly. | 1076 | ||
| Side Effects/Adverse Reactions | 1076 | ||
| Occasional | 1076 | ||
| Precautions and Contraindications | 1076 | ||
| Caution: | 1076 | ||
| Drug Interactions of Concern to Dentistry | 1076 | ||
| Serious Reactions | 1076 | ||
| Dental Considerations | 1076 | ||
| General: | 1076 | ||
| Consultations: | 1076 | ||
| Teach Patient/Family to: | 1076 | ||
| phenelzine sulfate | 1077 | ||
| Category and Schedule | 1077 | ||
| Drug Class: | 1077 | ||
| Mechanism of Action | 1077 | ||
| Uses | 1077 | ||
| Pharmacokinetics | 1077 | ||
| Indications and Dosages | 1077 | ||
| ► Depression Refractory to Other Antidepressants or Electroconvulsive Therapy | 1077 | ||
| PO | 1077 | ||
| Adults. | 1077 | ||
| Elderly. | 1077 | ||
| Side Effects/Adverse Reactions | 1077 | ||
| Frequent | 1077 | ||
| Occasional | 1077 | ||
| Rare | 1077 | ||
| Precautions and Contraindications | 1077 | ||
| Caution: | 1077 | ||
| Drug Interactions of Concern to Dentistry | 1077 | ||
| Serious Reactions | 1078 | ||
| Dental Considerations | 1078 | ||
| General: | 1078 | ||
| Consultations: | 1078 | ||
| Teach Patient/Family to: | 1078 | ||
| phenobarbital | 1078 | ||
| Category and Schedule | 1078 | ||
| Drug Class: | 1078 | ||
| Mechanism of Action | 1078 | ||
| Uses | 1078 | ||
| Pharmacokinetics | 1079 | ||
| Indications and Dosages | 1079 | ||
| ► Status Epilepticus | 1079 | ||
| IV | 1079 | ||
| Adults, Elderly, Children, Neonates. | 1079 | ||
| ► Seizure Control | 1079 | ||
| PO, IV | 1079 | ||
| Adults, Elderly, Children older than 12 yr. | 1079 | ||
| Children 6–12 yr. | 1079 | ||
| Children 1–5 yr. | 1079 | ||
| Children younger than 1 yr. | 1079 | ||
| Neonates. | 1079 | ||
| ► Sedation | 1079 | ||
| PO, IM | 1079 | ||
| phenoxybenzamine | 1080 | ||
| Category and Schedule | 1080 | ||
| Drug Class: | 1080 | ||
| Mechanism of Action | 1080 | ||
| Uses | 1080 | ||
| Pharmacokinetics | 1080 | ||
| Indications and Dosages | 1080 | ||
| ► Pheochromocytoma | 1080 | ||
| PO | 1080 | ||
| Adults. | 1080 | ||
| Children. | 1080 | ||
| Side Effects/Adverse Reactions | 1081 | ||
| Frequent | 1081 | ||
| Occasional | 1081 | ||
| Rare | 1081 | ||
| Precautions and Contraindications | 1081 | ||
| Drug Interactions of Concern to Dentistry | 1081 | ||
| Serious Reactions | 1081 | ||
| Dental Considerations | 1081 | ||
| General: | 1081 | ||
| Consultations: | 1081 | ||
| Teach Patient/Family to: | 1081 | ||
| phentermine | 1081 | ||
| Category and Schedule | 1081 | ||
| Drug Class: | 1081 | ||
| Mechanism of Action | 1081 | ||
| Uses | 1082 | ||
| Pharmacokinetics | 1082 | ||
| Indications and Dosages | 1082 | ||
| ► Obesity | 1082 | ||
| PO | 1082 | ||
| Adults, Children older than 16 yr. | 1082 | ||
| Side Effects/Adverse Reactions | 1082 | ||
| Occasional | 1082 | ||
| Precautions and Contraindications | 1082 | ||
| Caution: | 1082 | ||
| Drug Interactions of Concern to Dentistry | 1082 | ||
| Serious Reactions | 1082 | ||
| Dental Considerations | 1082 | ||
| General: | 1082 | ||
| Consultations: | 1082 | ||
| Teach Patient/Family to: | 1082 | ||
| phentolamine | 1083 | ||
| Category and Schedule | 1083 | ||
| Drug Class: | 1083 | ||
| Mechanism of Action | 1083 | ||
| Uses | 1083 | ||
| Pharmacokinetics | 1083 | ||
| Indications and Dosages | 1083 | ||
| ► Extravasation of Norepinephrine | 1083 | ||
| Subcutaneous | 1083 | ||
| phenylephrine hydrochloride | 1085 | ||
| Category and Schedule | 1085 | ||
| Drug Class: | 1085 | ||
| Mechanism of Action | 1085 | ||
| Uses | 1085 | ||
| Pharmacokinetics | 1085 | ||
| Indications and Dosages | 1085 | ||
| ► Nasal Decongestant | 1085 | ||
| Nasal Spray, Nasal Solution | 1085 | ||
| phenylephrine hydrochloride; sulfacetamide sodium | 1086 | ||
| Category and Schedule | 1086 | ||
| Drug Class: | 1086 | ||
| Mechanism of Action | 1086 | ||
| Uses | 1086 | ||
| phenytoin | 1087 | ||
| Category and Schedule | 1087 | ||
| Drug Class: | 1087 | ||
| Mechanism of Action | 1087 | ||
| Uses | 1087 | ||
| Pharmacokinetics | 1087 | ||
| Indications and Dosages | 1087 | ||
| ► Topical Application to Conjunctiva That Relieves Congestion, Itching, Minor Irritation; Whitens Sclera of Eye | 1087 | ||
| Ophthalmic | 1087 | ||
| Adults, Elderly, Children 12 yr and older. | 1087 | ||
| Side Effects/Adverse Reactions | 1087 | ||
| Occasional | 1087 | ||
| Precautions and Contraindications | 1087 | ||
| Drug Interactions of Concern to Dentistry | 1087 | ||
| Serious Reactions | 1087 | ||
| Dental Considerations | 1087 | ||
| General: | 1087 | ||
| Teach Patient/Family: | 1087 | ||
| Indications and Dosages | 1088 | ||
| physostigmine | 1090 | ||
| Category and Schedule | 1090 | ||
| Drug Class: | 1090 | ||
| Mechanism of Action | 1090 | ||
| Uses | 1090 | ||
| Indications and Dosages | 1090 | ||
| ► To Reverse CNS Effects of Anticholinergic Drugs and Tricyclic Antidepressants | 1090 | ||
| IV, IM | 1090 | ||
| Adults, Elderly. | 1090 | ||
| Children. | 1090 | ||
| Side Effects/Adverse Reactions | 1090 | ||
| Expected | 1090 | ||
| Occasional | 1090 | ||
| Rare | 1090 | ||
| Precautions and Contraindications | 1090 | ||
| Drug Interactions of Concern to Dentistry | 1090 | ||
| Serious Reactions | 1090 | ||
| Dental Considerations | 1091 | ||
| General: | 1091 | ||
| Teach Patient/Family to: | 1091 | ||
| phytonadione | 1091 | ||
| Category and Schedule | 1091 | ||
| Drug Class: | 1091 | ||
| Mechanism of Action | 1091 | ||
| Uses | 1091 | ||
| Pharmacokinetics | 1091 | ||
| Indications and Dosages | 1091 | ||
| ► Hypoprothrombinemia Caused by Vitamin K Malabsorption | 1091 | ||
| PO/IM | 1091 | ||
| pilocarpine hydrochloride | 1092 | ||
| Category and Schedule | 1092 | ||
| Drug Class: | 1092 | ||
| Mechanism of Action | 1092 | ||
| Uses | 1092 | ||
| Pharmacokinetics | 1092 | ||
| Indications and Dosages | 1092 | ||
| ► Dry Mouth Associated with Radiation Treatment for Head and Neck Cancer | 1092 | ||
| pimecrolimus | 1093 | ||
| Category and Schedule | 1093 | ||
| Drug Class: | 1093 | ||
| Mechanism of Action | 1093 | ||
| Uses | 1093 | ||
| pimozide | 1094 | ||
| Category and Schedule | 1094 | ||
| Drug Class: | 1094 | ||
| Mechanism of Action | 1094 | ||
| Uses | 1094 | ||
| Pharmacokinetics | 1094 | ||
| Indications and Dosages | 1094 | ||
| ► Atopic Dermatitis (Eczema) | 1094 | ||
| Topical | 1094 | ||
| Adults, Elderly, Children 2–17 yr. | 1094 | ||
| ► Tourette’s Disorder | 1094 | ||
| PO | 1094 | ||
| Adults, Elderly. | 1094 | ||
| Children older than 12 yr. | 1094 | ||
| Side Effects/Adverse Reactions | 1094 | ||
| Rare | 1094 | ||
| Precautions and Contraindications | 1094 | ||
| Caution: | 1094 | ||
| Drug Interactions of Concern to Dentistry | 1094 | ||
| Serious Reactions | 1094 | ||
| Dental Considerations | 1094 | ||
| General: | 1094 | ||
| Occasional | 1094 | ||
| Rare | 1095 | ||
| Precautions and Contraindications | 1095 | ||
| Caution: | 1095 | ||
| Drug Interactions of Concern to Dentistry | 1095 | ||
| Serious Reactions | 1095 | ||
| Dental Considerations | 1095 | ||
| General: | 1095 | ||
| Consultations: | 1096 | ||
| Teach Patient/Family to: | 1096 | ||
| pindolol | 1096 | ||
| Category and Schedule | 1096 | ||
| Drug Class: | 1096 | ||
| Mechanism of Action | 1096 | ||
| Uses | 1096 | ||
| Pharmacokinetics | 1096 | ||
| Indications and Dosages | 1096 | ||
| ► Mild-to-Moderate Hypertension | 1096 | ||
| pioglitazone | 1098 | ||
| Category and Schedule | 1098 | ||
| Drug Class: | 1098 | ||
| Mechanism of Action | 1098 | ||
| Uses | 1098 | ||
| Pharmacokinetics | 1098 | ||
| Indications and Dosages | 1098 | ||
| ► Diabetes Mellitus, Combination Therapy | 1098 | ||
| PO | 1098 | ||
| Adult, Elderly. | 1098 | ||
| Side Effects/Adverse Reactions | 1098 | ||
| Frequent | 1098 | ||
| Occasional | 1098 | ||
| Precautions and Contraindications | 1098 | ||
| Caution: | 1098 | ||
| Drug Interactions of Concern to Dentistry | 1098 | ||
| Serious Reactions | 1098 | ||
| Dental Considerations | 1098 | ||
| General: | 1098 | ||
| Consultations: | 1099 | ||
| Teach Patient/Family to: | 1099 | ||
| pirbuterol | 1099 | ||
| Category and Schedule | 1099 | ||
| Drug Class: | 1099 | ||
| Mechanism of Action | 1099 | ||
| Uses | 1099 | ||
| Pharmacokinetics | 1099 | ||
| Indications and Dosages | 1099 | ||
| ► Prevention of Bronchospasm | 1099 | ||
| pirfenidone | 1100 | ||
| Category and Schedule | 1100 | ||
| Drug Class: | 1100 | ||
| Mechanism of Action | 1100 | ||
| Uses | 1100 | ||
| Pharmacokinetics | 1100 | ||
| Indications and Dosages | 1100 | ||
| ► Idiopathic pulmonary fibrosis | 1100 | ||
| PO | 1100 | ||
| Adults. | 1100 | ||
| Side Effects/Adverse Reactions | 1101 | ||
| Frequent | 1101 | ||
| Occasional | 1101 | ||
| Precautions and Contraindications | 1101 | ||
| Drug Interactions of Concern to Dentistry | 1101 | ||
| Serious Reactions | 1101 | ||
| Dental Considerations | 1101 | ||
| General: | 1101 | ||
| Consultations: | 1101 | ||
| Teach Patient/Family to: | 1101 | ||
| piroxicam | 1102 | ||
| Category and Schedule | 1102 | ||
| Drug Class: | 1102 | ||
| Mechanism of Action | 1102 | ||
| Uses | 1102 | ||
| Pharmacokinetics | 1102 | ||
| Indications and Dosages | 1102 | ||
| ► Acute or Chronic Rheumatoid Arthritis and Osteoarthritis | 1102 | ||
| PO | 1102 | ||
| Adults, Elderly. | 1102 | ||
| Children. | 1102 | ||
| Side Effects/Adverse Reactions | 1102 | ||
| Frequent | 1102 | ||
| Occasional | 1102 | ||
| Rare | 1102 | ||
| Precautions and Contraindications | 1102 | ||
| Caution: | 1102 | ||
| Drug Interactions of Concern to Dentistry | 1102 | ||
| Serious Reactions | 1102 | ||
| Dental Considerations | 1103 | ||
| General: | 1103 | ||
| Consultations: | 1103 | ||
| Teach Patient/Family to: | 1103 | ||
| pitavastatin | 1103 | ||
| Category and Schedule | 1103 | ||
| Drug Class: | 1103 | ||
| Mechanism of Action | 1103 | ||
| Uses | 1103 | ||
| Pharmacokinetics | 1103 | ||
| Indications and Dosages | 1104 | ||
| ► Hypercholesterolemia, Mixed Dyslipidemia | 1104 | ||
| PO | 1104 | ||
| Adults. | 1104 | ||
| ► Dosage in Renal Impairment | 1104 | ||
| Mild to moderate impairment (CrCl 30 to less than 60 ml/min or ESRD on hemodialysis). | 1104 | ||
| Moderate to severe impairment (CrCl less than 30 ml/min and not on hemodialysis). | 1104 | ||
| Side Effects/Adverse Reactions | 1104 | ||
| Occasional | 1104 | ||
| Rare | 1104 | ||
| Precautions and Contraindications | 1104 | ||
| Caution: | 1104 | ||
| Drug Interactions of Concern to Dentistry | 1104 | ||
| Serious Reactions | 1104 | ||
| Dental Considerations | 1104 | ||
| General: | 1104 | ||
| Consultations: | 1104 | ||
| Teach Patient/Family to: | 1105 | ||
| podofilox | 1105 | ||
| Category and Schedule | 1105 | ||
| Drug Class: | 1105 | ||
| Mechanism of Action | 1105 | ||
| Uses | 1105 | ||
| Pharmacokinetics | 1105 | ||
| Indications and Dosages | 1105 | ||
| ► Anogenital Warts | 1105 | ||
| podophyllum resin | 1106 | ||
| Category and Schedule | 1106 | ||
| Drug Class: | 1106 | ||
| Mechanism of Action | 1106 | ||
| Uses | 1106 | ||
| Pharmacokinetics | 1106 | ||
| Indications and Dosages | 1106 | ||
| ► Genital Warts (Condylomata Acuminate) | 1106 | ||
| Topical | 1106 | ||
| Adults, Elderly, Children. | 1106 | ||
| Side Effects/Adverse Reactions | 1106 | ||
| Occasional | 1106 | ||
| Precautions and Contraindications | 1106 | ||
| Drug Interactions of Concern to Dentistry | 1106 | ||
| Serious Reactions | 1106 | ||
| Dental Considerations | 1106 | ||
| General: | 1106 | ||
| Consultations: | 1107 | ||
| Teach Patient/Family to: | 1107 | ||
| polymyxin B | 1107 | ||
| Category and Schedule | 1107 | ||
| Drug Class: | 1107 | ||
| Mechanism of Action | 1107 | ||
| Uses | 1107 | ||
| Pharmacokinetics | 1107 | ||
| Indications and Dosages | 1107 | ||
| ► Mild-to-Moderate Infections | 1107 | ||
| IV | 1107 | ||
| polymyxin B sulfate; trimethoprim sulfate | 1108 | ||
| Category and Schedule | 1108 | ||
| Drug Class: | 1108 | ||
| Mechanism of Action | 1108 | ||
| Uses | 1108 | ||
| Pharmacokinetics | 1108 | ||
| Indications and Dosages | 1108 | ||
| ► Treatment of Surface Ocular Bacterial Conjunctivitis and Blepharoconjunctivitis | 1108 | ||
| Ophthalmic | 1108 | ||
| Adults, Elderly, Children. | 1108 | ||
| Side Effects/Adverse Reactions | 1108 | ||
| Occasional | 1108 | ||
| Precautions and Contraindications | 1108 | ||
| Drug Interactions of Concern to Dentistry | 1108 | ||
| Serious Reactions | 1108 | ||
| Dental Considerations | 1108 | ||
| General: | 1108 | ||
| pomalidomide | 1109 | ||
| Category and Schedule | 1109 | ||
| Drug Class: | 1109 | ||
| Mechanism of Action | 1109 | ||
| Uses | 1109 | ||
| Pharmacokinetics | 1109 | ||
| Indications and Dosages | 1109 | ||
| ► Multiple Myeloma, Relapsed/Refractory | 1109 | ||
| PO | 1109 | ||
| Adults. | 1109 | ||
| Side Effects/Adverse Reactions | 1109 | ||
| Frequent | 1109 | ||
| Occasional | 1109 | ||
| Precautions and Contraindications | 1109 | ||
| Drug Interactions of Concern to Dentistry | 1110 | ||
| Serious Reactions | 1110 | ||
| Dental Considerations | 1110 | ||
| General: | 1110 | ||
| Consultations: | 1110 | ||
| Teach Patient/Family to: | 1110 | ||
| posaconazole | 1110 | ||
| Category and Schedule | 1110 | ||
| Drug Class: | 1110 | ||
| Mechanism of Action | 1110 | ||
| Uses | 1110 | ||
| Pharmacokinetics | 1111 | ||
| Indications and Dosages | 1111 | ||
| ► Prophylaxis of Invasive Fungal Infections | 1111 | ||
| potassium chloride | 1112 | ||
| Category and Schedule | 1112 | ||
| Drug Class: | 1112 | ||
| Mechanism of Action | 1112 | ||
| Uses | 1112 | ||
| Pharmacokinetics | 1112 | ||
| Indications and Dosages | 1113 | ||
| ► Prevention of Hypokalemia (on Diuretic Therapy) | 1113 | ||
| potassium acetate/potassium bicarbonate-citrate/potassium chloride/potassium gluconate | 1114 | ||
| Category and Schedule | 1114 | ||
| Drug Class: | 1114 | ||
| Mechanism of Action | 1114 | ||
| Uses | 1114 | ||
| Pharmacokinetics | 1114 | ||
| Indications and Dosages | 1114 | ||
| ► Prevention of Hypokalemia (in Patients on Diuretic Therapy) | 1114 | ||
| povidone iodine | 1115 | ||
| Category and Schedule | 1115 | ||
| Drug Class: | 1115 | ||
| Mechanism of Action | 1115 | ||
| Uses | 1115 | ||
| Indications and Dosages | 1115 | ||
| Topical | 1115 | ||
| Adults, Children. | 1115 | ||
| Side Effects/Adverse Reactions | 1115 | ||
| Frequent | 1115 | ||
| Precautions and Contraindications | 1115 | ||
| Caution: | 1115 | ||
| Drug Interactions of Concern to Dentistry | 1115 | ||
| Serious Reactions | 1115 | ||
| Dental Considerations | 1115 | ||
| General: | 1115 | ||
| Teach Patient/Family to: | 1115 | ||
| pramipexole | 1116 | ||
| Category and Schedule | 1116 | ||
| Drug Class: | 1116 | ||
| Mechanism of Action | 1116 | ||
| Uses | 1116 | ||
| Pharmacokinetics | 1116 | ||
| Indications and Dosages | 1116 | ||
| ► Parkinson’s Disease | 1116 | ||
| PO | 1116 | ||
| Adults, Elderly. | 1116 | ||
| ► Dosage in Renal Impairment | 1116 | ||
| Side Effects/Adverse Reactions | 1116 | ||
| Frequent | 1116 | ||
| Occasional | 1116 | ||
| Rare | 1116 | ||
| Precautions and Contraindications | 1116 | ||
| Caution: | 1116 | ||
| Drug Interactions of Concern to Dentistry | 1117 | ||
| Serious Reactions | 1117 | ||
| Dental Considerations | 1117 | ||
| General: | 1117 | ||
| Consultations: | 1117 | ||
| Teach Patient/Family to: | 1117 | ||
| prasugrel | 1117 | ||
| Category and Schedule | 1117 | ||
| Drug Class: | 1117 | ||
| Mechanisn of Action | 1117 | ||
| Uses | 1117 | ||
| Pharmacokinetics | 1117 | ||
| Indications and Dosages | 1118 | ||
| ► Antiplatelet Therapy | 1118 | ||
| PO | 1118 | ||
| Adult, Elderly (under the age of 75). | 1118 | ||
| Side Effects/Adverse Reactions | 1118 | ||
| Frequent | 1118 | ||
| Occasional | 1118 | ||
| Rare | 1118 | ||
| Precautions and Contraindications | 1118 | ||
| Drug Interactions of Concern to Dentistry | 1118 | ||
| Serious Reactions | 1118 | ||
| Dental Considerations | 1118 | ||
| General: | 1118 | ||
| Consultations: | 1118 | ||
| Teach Patient/Family to: | 1118 | ||
| pravastatin | 1119 | ||
| Category and Schedule | 1119 | ||
| Drug Class: | 1119 | ||
| Mechanism of Action | 1119 | ||
| Uses | 1119 | ||
| Pharmacokinetics | 1119 | ||
| Indications and Dosages | 1119 | ||
| ► Hyperlipidemia, Primary and Secondary Prevention of Cardiovascular Events in Patients with Elevated Cholesterol Levels | 1119 | ||
| PO | 1119 | ||
| Adults, Elderly. | 1119 | ||
| Children 14–18 yr. | 1119 | ||
| Children 8–13 yr. | 1119 | ||
| ► Dosage in Hepatic and Renal Impairment | 1119 | ||
| Side Effects/Adverse Reactions | 1119 | ||
| Occasional | 1119 | ||
| Rare | 1119 | ||
| Precautions and Contraindications | 1119 | ||
| Caution: | 1119 | ||
| Drug Interactions of Concern to Dentistry | 1119 | ||
| prazosin hydrochloride | 1120 | ||
| Category and Schedule | 1120 | ||
| Drug Class: | 1120 | ||
| Mechanism of Action | 1120 | ||
| Uses | 1120 | ||
| Pharmacokinetics | 1120 | ||
| Indications and Dosages | 1120 | ||
| ► Mild-to-Moderate Hypertension | 1120 | ||
| PO | 1120 | ||
| Adults, Elderly. | 1120 | ||
| Children. | 1120 | ||
| Side Effects/Adverse Reactions | 1120 | ||
| Frequent | 1120 | ||
| Occasional | 1120 | ||
| Rare | 1120 | ||
| Precautions and Contraindications | 1120 | ||
| Caution: | 1120 | ||
| Drug Interactions of Concern to Dentistry | 1120 | ||
| Serious Reactions | 1120 | ||
| Dental Considerations | 1120 | ||
| General: | 1120 | ||
| Dental Considerations | 1121 | ||
| General: | 1121 | ||
| Consultations: | 1121 | ||
| Teach Patient/Family to: | 1121 | ||
| prednisolone | 1121 | ||
| Category and Schedule | 1121 | ||
| Drug Class: | 1121 | ||
| Mechanism of Action | 1121 | ||
| Uses | 1121 | ||
| Pharmacokinetics | 1121 | ||
| Indications and Dosages | 1122 | ||
| ► Substitution Therapy for Deficiency States: Acute or Chronic Adrenal Insufficiency, Congenital Adrenal Hyperplasia, and Adrenal Insufficiency Secondary to Pituitary Insufficiency; Nonendocrine Disorders: Arthritis; Rheumatic Carditis; Allergic, Collagen, Intestinal Tract, Liver, Ocular, Renal, Skin Diseases; Bronchial Asthma; Cerebral Edema; Malignancies | 1122 | ||
| PO | 1122 | ||
| prednisolone acetate | 1123 | ||
| Category and Schedule | 1123 | ||
| Drug Class: | 1123 | ||
| Mechanism of Action | 1123 | ||
| Uses | 1123 | ||
| Pharmacokinetics | 1123 | ||
| Indications and Dosages | 1123 | ||
| ► Conjunctivitis | 1123 | ||
| Ophthalmic | 1123 | ||
| Adults, Elderly, Children. | 1123 | ||
| Side Effects/Adverse Reactions | 1124 | ||
| Occasional | 1124 | ||
| Precautions and Contraindications | 1124 | ||
| Caution: | 1124 | ||
| Drug Interactions of Concern to Dentistry | 1124 | ||
| Serious Reactions | 1124 | ||
| Dental Considerations | 1124 | ||
| General: | 1124 | ||
| Consultations: | 1124 | ||
| Teach Patient/Family to: | 1125 | ||
| prednisolone acetate; sulfacetamide sodium | 1125 | ||
| Category and Schedule | 1125 | ||
| Drug Class: | 1125 | ||
| Mechanism of Action | 1125 | ||
| Uses | 1125 | ||
| Pharmacokinetics | 1125 | ||
| Indications and Dosages | 1125 | ||
| ► Steroid-Responsive Inflammatory Ocular Conditions for Which a Corticosteroid is Indicated and Where Superficial Bacterial Ocular Infection or a Risk of Bacterial Ocular Infection Exists | 1125 | ||
| Ophthalmic Ointment | 1125 | ||
| prednisolone sodium phosphate | 1127 | ||
| Category and Schedule | 1127 | ||
| Drug Class: | 1127 | ||
| Mechanism of Action | 1127 | ||
| Uses | 1127 | ||
| Pharmacokinetics | 1127 | ||
| Indications and Dosages | 1127 | ||
| ► Asthma | 1127 | ||
| prednisone | 1129 | ||
| Category and Schedule | 1129 | ||
| Drug Class: | 1129 | ||
| Mechanism of Action | 1129 | ||
| Uses | 1129 | ||
| Pharmacokinetics | 1129 | ||
| Indications and Dosages | 1129 | ||
| ► Substitution Therapy in Deficiency States: Acute or Chronic Adrenal Insufficiency, Congenital Adrenal Hyperplasia, and Adrenal Insufficiency Secondary to Pituitary Insufficiency; Nonendocrine Disorders: Arthritis; Rheumatic Carditis; Allergic, Collagen, Intestinal Tract, Liver, Ocular, Renal, Skin Diseases; Bronchial Asthma; Cerebral Edema; Malignancies | 1129 | ||
| PO | 1129 | ||
| Adults, Elderly. | 1129 | ||
| Children. | 1129 | ||
| Side Effects/Adverse Reactions | 1129 | ||
| Frequent | 1129 | ||
| Occasional | 1130 | ||
| Rare | 1130 | ||
| Precautions and Contraindications | 1130 | ||
| Caution: | 1130 | ||
| Drug Interactions of Concern to Dentistry | 1130 | ||
| Serious Reactions | 1130 | ||
| Dental Considerations | 1130 | ||
| General: | 1130 | ||
| Consultations: | 1130 | ||
| Teach Patient/Family to: | 1131 | ||
| pregabalin | 1131 | ||
| Category and Schedule | 1131 | ||
| Drug Class: | 1131 | ||
| Mechanism of Action | 1131 | ||
| Uses | 1131 | ||
| Pharmacokinetics | 1131 | ||
| Indications and Dosages | 1131 | ||
| ► Partial-Onset Seizures | 1131 | ||
| prilocaine hydrochloride (local) | 1132 | ||
| Category and Schedule | 1132 | ||
| Drug Class: | 1132 | ||
| Mechanism of Action | 1132 | ||
| Uses | 1132 | ||
| Pharmacokinetics | 1132 | ||
| Indications and Dosages | 1132 | ||
| ► Dental Injection: Infiltration or Conduction Block | 1132 | ||
| primaquine | 1134 | ||
| Category and Schedule | 1134 | ||
| Drug Class: | 1134 | ||
| Mechanism of Action | 1134 | ||
| Uses | 1134 | ||
| Pharmacokinetics | 1134 | ||
| Indications and Dosages | 1134 | ||
| ► Treatment of Malaria | 1134 | ||
| primidone | 1135 | ||
| Category and Schedule | 1135 | ||
| Drug Class: | 1135 | ||
| Mechanism of Action | 1135 | ||
| Uses | 1135 | ||
| Pharmacokinetics | 1135 | ||
| Indications and Dosages | 1135 | ||
| ► Seizure Control | 1135 | ||
| PO | 1135 | ||
| Adults, Elderly, Children 8 yr and older. | 1135 | ||
| Children younger than 8 yr. | 1135 | ||
| Neonates. | 1135 | ||
| Side Effects/Adverse Reactions | 1136 | ||
| Frequent | 1136 | ||
| Occasional | 1136 | ||
| Rare | 1136 | ||
| Precautions and Contraindications | 1136 | ||
| Caution: | 1136 | ||
| Drug Interactions of Concern to Dentistry | 1136 | ||
| Serious Reactions | 1136 | ||
| Dental Considerations | 1136 | ||
| General: | 1136 | ||
| Consultations: | 1136 | ||
| Teach Patient/Family to: | 1136 | ||
| probenecid | 1137 | ||
| Category and Schedule | 1137 | ||
| Drug Class: | 1137 | ||
| Mechanism of Action | 1137 | ||
| Uses | 1137 | ||
| Pharmacokinetics | 1137 | ||
| Indications and Dosages | 1137 | ||
| ► Gout | 1137 | ||
| procaine | 1138 | ||
| Category and Schedule | 1138 | ||
| Drug Class: | 1138 | ||
| Mechanism of Action | 1138 | ||
| Uses | 1138 | ||
| Pharmacokinetics | 1138 | ||
| Indications and Dosages | 1138 | ||
| ► Spinal Anesthesia | 1138 | ||
| Intrathecal | 1138 | ||
| procarbazine hydrochloride | 1140 | ||
| Category and Schedule | 1140 | ||
| Drug Class: | 1140 | ||
| Mechanism of Action | 1140 | ||
| Uses | 1140 | ||
| Pharmacokinetics | 1140 | ||
| Indications and Dosages | 1140 | ||
| ► Advanced Hodgkin’s Disease | 1140 | ||
| PO | 1140 | ||
| Adults, Elderly. | 1140 | ||
| Children. | 1140 | ||
| Side Effects/Adverse Reactions | 1140 | ||
| Frequent | 1140 | ||
| Occasional | 1140 | ||
| Rare | 1140 | ||
| Precautions and Contraindications | 1140 | ||
| Caution: | 1140 | ||
| Drug Interactions of Concern to Dentistry | 1140 | ||
| Serious Reactions | 1141 | ||
| Dental Considerations | 1141 | ||
| General: | 1141 | ||
| Consultations: | 1141 | ||
| Teach Patient/Family to: | 1141 | ||
| prochlorperazine | 1141 | ||
| Category and Schedule | 1141 | ||
| Drug Class: | 1141 | ||
| Mechanism of Action | 1141 | ||
| Pharmacokinetics | 1142 | ||
| Indications and Dosages | 1142 | ||
| ► Nausea and Vomiting | 1142 | ||
| procyclidine | 1143 | ||
| Category and Schedule | 1143 | ||
| Drug Class: | 1143 | ||
| Mechanism of Action | 1144 | ||
| Uses | 1144 | ||
| Pharmacokinetics | 1144 | ||
| Indications and Dosages | 1144 | ||
| ► Drug-Induced Extrapyramidal Reactions | 1144 | ||
| progesterone | 1145 | ||
| Category and Schedule | 1145 | ||
| Drug Class: | 1145 | ||
| Mechanism of Action | 1145 | ||
| Uses | 1145 | ||
| Pharmacokinetics | 1145 | ||
| Indications and Dosages | 1145 | ||
| ► Amenorrhea | 1145 | ||
| promethazine hydrochloride | 1146 | ||
| Category and Schedule | 1146 | ||
| Drug Class: | 1146 | ||
| Mechanism of Action | 1146 | ||
| Uses | 1147 | ||
| Pharmacokinetics | 1147 | ||
| Indications and Dosages | 1147 | ||
| ► Allergic Symptoms | 1147 | ||
| propafenone hydrochloride | 1148 | ||
| Category and Schedule | 1148 | ||
| Drug Class: | 1148 | ||
| Mechanism of Action | 1148 | ||
| Uses | 1148 | ||
| Pharmacokinetics | 1148 | ||
| Indications and Dosages | 1149 | ||
| ► Documented, Life-Threatening Ventricular Arrhythmias, such as Sustained Ventricular Tachycardia | 1149 | ||
| PO (Prompt-Release) | 1149 | ||
| propantheline | 1150 | ||
| Category and Schedule | 1150 | ||
| Drug Class: | 1150 | ||
| Mechanism of Action | 1150 | ||
| Uses | 1150 | ||
| Pharmacokinetics | 1150 | ||
| Indications and Dosages | 1150 | ||
| ► Peptic Ulcer | 1150 | ||
| PO | 1150 | ||
| Adults, Elderly. | 1150 | ||
| Children. | 1150 | ||
| Side Effects/Adverse Reactions | 1150 | ||
| Frequent | 1150 | ||
| Occasional | 1150 | ||
| Rare | 1150 | ||
| Precautions and Contraindications | 1150 | ||
| Caution: | 1150 | ||
| Drug Interactions of Concern to Dentistry | 1150 | ||
| Serious Reactions | 1151 | ||
| Dental Considerations | 1151 | ||
| General: | 1151 | ||
| Consultations: | 1151 | ||
| Teach Patient/Family to: | 1151 | ||
| propofol | 1151 | ||
| Category and Schedule | 1151 | ||
| Drug Class: | 1151 | ||
| Mechanism of Action | 1151 | ||
| Uses | 1151 | ||
| Pharmacokinetics | 1151 | ||
| Indications and Dosages | 1151 | ||
| ► Intensive Care Unit Sedation | 1151 | ||
| IV | 1151 | ||
| Adults, Elderly. | 1151 | ||
| ► Anesthesia | 1152 | ||
| IV | 1152 | ||
| Adults, American Society of Anesthesiologists (ASA) I and II patients. | 1152 | ||
| Elderly, Debilitated, Hypovolemic, ASA III or IV patients. | 1152 | ||
| Children 3 yr and older, ASA I or II patients. | 1152 | ||
| Children 2 mo–16 yr. | 1152 | ||
| Side Effects/Adverse Reactions | 1152 | ||
| Frequent | 1152 | ||
| Occasional | 1152 | ||
| Rare | 1152 | ||
| Precautions and Contraindications | 1152 | ||
| Caution: | 1152 | ||
| Drug Interactions of Concern to Dentistry | 1152 | ||
| Serious Reactions | 1152 | ||
| Dental Considerations | 1152 | ||
| General: | 1152 | ||
| propranolol hydrochloride | 1153 | ||
| Category and Schedule | 1153 | ||
| Drug Class: | 1153 | ||
| Mechanism of Action | 1153 | ||
| Uses | 1153 | ||
| Pharmacokinetics | 1153 | ||
| Indications and Dosages | 1153 | ||
| ► Hypertension | 1153 | ||
| PO | 1153 | ||
| Adults, Elderly. | 1153 | ||
| Children. | 1153 | ||
| ► Angina | 1154 | ||
| propylthiouracil | 1156 | ||
| Category and Schedule | 1156 | ||
| Drug Class: | 1156 | ||
| Mechanism of Action | 1156 | ||
| Uses | 1156 | ||
| Pharmacokinetics | 1156 | ||
| Indications and Dosages | 1156 | ||
| ► Hyperthyroidism | 1156 | ||
| PO | 1156 | ||
| Adults, Elderly. | 1156 | ||
| Children. | 1156 | ||
| Neonates. | 1156 | ||
| Side Effects/Adverse Reactions | 1156 | ||
| Frequent | 1156 | ||
| Occasional | 1156 | ||
| Rare | 1156 | ||
| Precautions and Contraindications | 1156 | ||
| Caution: | 1156 | ||
| Drug Interactions of Concern to Dentistry | 1156 | ||
| Serious Reactions | 1156 | ||
| Dental Considerations | 1156 | ||
| General: | 1156 | ||
| Consultations: | 1157 | ||
| protein C, human | 1157 | ||
| Category and Schedule | 1157 | ||
| Drug Class: | 1157 | ||
| Mechanism of Action | 1157 | ||
| Uses | 1157 | ||
| Pharmacokinetics | 1157 | ||
| Indications and Dosages | 1157 | ||
| ► Severe Congenital Protein C Deficiency for the Prevention and Treatment of Venous Thrombosis and Purpura Fulminans, Replacement Therapy for Pediatric and Adult Patients | 1157 | ||
| Injection, Powder for Reconstitution | 1157 | ||
| Adults. | 1157 | ||
| Side Effects/Adverse Reactions | 1157 | ||
| Occasional | 1157 | ||
| Precautions and Contraindications | 1157 | ||
| Caution: | 1157 | ||
| Drug Interactions of Concern to Dentistry | 1157 | ||
| Serious Reactions | 1158 | ||
| Dental Considerations | 1158 | ||
| General: | 1158 | ||
| Consultations: | 1158 | ||
| Teach Patient/Family to: | 1158 | ||
| protriptyline | 1158 | ||
| Category and Schedule | 1158 | ||
| Drug Class: | 1158 | ||
| Mechanism of Action | 1158 | ||
| Uses | 1158 | ||
| Pharmacokinetics | 1158 | ||
| Indications and Dosages | 1158 | ||
| ► Depression | 1158 | ||
| PO | 1158 | ||
| Adults. | 1158 | ||
| Elderly. | 1158 | ||
| Side Effects/Adverse Reactions | 1158 | ||
| Frequent | 1158 | ||
| Occasional | 1158 | ||
| Rare | 1158 | ||
| Precautions and Contraindications | 1159 | ||
| Caution: | 1159 | ||
| Drug Interactions of Concern to Dentistry | 1159 | ||
| Serious Reactions | 1159 | ||
| Dental Considerations | 1159 | ||
| General: | 1159 | ||
| Consultations: | 1159 | ||
| Teach Patient/Family to: | 1159 | ||
| pseudoephedrine | 1160 | ||
| Category and Schedule | 1160 | ||
| Drug Class: | 1160 | ||
| Mechanism of Action | 1160 | ||
| Uses | 1160 | ||
| Pharmacokinetics | 1160 | ||
| Indications and Dosages | 1160 | ||
| ► Decongestant | 1160 | ||
| PO | 1160 | ||
| pyrazinamide | 1161 | ||
| Category and Schedule | 1161 | ||
| Drug Class: | 1161 | ||
| Mechanism of Action | 1161 | ||
| Uses | 1161 | ||
| Pharmacokinetics | 1161 | ||
| Indications and Dosages | 1161 | ||
| ► TB (in Combination with Other Antituberculars) | 1161 | ||
| PO | 1161 | ||
| Adults. | 1161 | ||
| Children. | 1161 | ||
| Side Effects/Adverse Reactions | 1161 | ||
| Frequent | 1161 | ||
| Rare | 1161 | ||
| Precautions and Contraindications | 1162 | ||
| Caution: | 1162 | ||
| Drug Interactions of Concern to Dentistry | 1162 | ||
| Serious Reactions | 1162 | ||
| Dental Considerations | 1162 | ||
| General: | 1162 | ||
| Consultations: | 1162 | ||
| Teach Patient/Family to: | 1162 | ||
| pyridostigmine bromide | 1162 | ||
| Category and Schedule | 1162 | ||
| Drug Class: | 1162 | ||
| Mechanism of Action | 1162 | ||
| Uses | 1162 | ||
| Pharmacokinetics | 1162 | ||
| Indications and Dosages | 1162 | ||
| ► Myasthenia Gravis | 1162 | ||
| PO | 1162 | ||
| Adults, Elderly. | 1162 | ||
| PO (Extended-Release) | 1162 | ||
| pyridoxine hydrochloride (vitamin B6) | 1164 | ||
| Category and Schedule | 1164 | ||
| Drug Class: | 1164 | ||
| Mechanism of Action | 1164 | ||
| Uses | 1164 | ||
| Pharmacokinetics | 1164 | ||
| Indications and Dosages | 1164 | ||
| ► Pyridoxine Deficiency | 1164 | ||
| PO | 1164 | ||
| pyrimethamine | 1165 | ||
| Category and Schedule | 1165 | ||
| Drug Class: | 1165 | ||
| Mechanism of Action | 1165 | ||
| Uses | 1165 | ||
| Pharmacokinetics | 1165 | ||
| Indications and Dosages | 1165 | ||
| ► Toxoplasmosis | 1165 | ||
| quazepam | 1167 | ||
| Category and Schedule | 1167 | ||
| Drug Class: | 1167 | ||
| Mechanism of Action | 1167 | ||
| Uses | 1167 | ||
| Pharmacokinetics | 1167 | ||
| Indications and Dosages | 1167 | ||
| ► Insomnia | 1167 | ||
| PO | 1167 | ||
| Adults (older than 18 yr). | 1167 | ||
| Elderly, debilitated, liver disease. | 1167 | ||
| Side Effects/Adverse Reactions | 1167 | ||
| Frequent | 1167 | ||
| Occasional | 1167 | ||
| Rare | 1167 | ||
| Precautions and Contraindications | 1167 | ||
| Caution: | 1167 | ||
| Drug Interactions of Concern to Dentistry | 1167 | ||
| Serious Reactions | 1167 | ||
| Dental Considerations | 1168 | ||
| General: | 1168 | ||
| Consultations: | 1168 | ||
| Teach Patient/Family to: | 1168 | ||
| quetiapine | 1168 | ||
| Category and Schedule | 1168 | ||
| Drug Class: | 1168 | ||
| Mechanism of Action | 1168 | ||
| Uses | 1168 | ||
| Pharmacokinetics | 1168 | ||
| Indications and Dosages | 1168 | ||
| ► To Manage Manifestations of Psychotic Disorders, Bipolar Disorder | 1168 | ||
| PO | 1168 | ||
| Adults, Elderly. | 1168 | ||
| ► Dosage in Hepatic Impairment, Elderly or Debilitated Patients, and Those Predisposed to Hypotensive Reactions | 1168 | ||
| Side Effects/Adverse Reactions | 1169 | ||
| Frequent | 1169 | ||
| Occasional | 1169 | ||
| Rare | 1169 | ||
| Precautions and Contraindications | 1169 | ||
| Drug Interactions of Concern to Dentistry | 1169 | ||
| Serious Reactions | 1169 | ||
| Dental Considerations | 1169 | ||
| General: | 1169 | ||
| Consultations: | 1169 | ||
| Teach Patient/Family to: | 1169 | ||
| quinapril | 1170 | ||
| Category and Schedule | 1170 | ||
| Drug Class: | 1170 | ||
| Mechanism of Action | 1170 | ||
| Uses | 1170 | ||
| Pharmacokinetics | 1170 | ||
| Indications and Dosages | 1170 | ||
| ► Hypertension (Monotherapy) | 1170 | ||
| quinidine | 1172 | ||
| Category and Schedule | 1172 | ||
| Drug Class: | 1172 | ||
| Mechanism of Action | 1172 | ||
| Uses | 1172 | ||
| Pharmacokinetics | 1172 | ||
| Indications and Dosages | 1172 | ||
| ► Maintenance of Normal Sinus Rhythm after Conversion of Atrial Fibrillation or Flutter; Prevention of Premature Atrial, AV, and Ventricular Contractions; Paroxysmal Atrial Tachycardia; Paroxysmal AV Junctional Rhythm; Atrial Fibrillation; Atrial Flutter; Paroxysmal Ventricular Tachycardia Not Associated with Complete Heart Block | 1172 | ||
| PO | 1172 | ||
| quinine | 1174 | ||
| Category and Schedule | 1174 | ||
| Drug Class: | 1174 | ||
| Mechanism of Action | 1174 | ||
| Uses | 1174 | ||
| Pharmacokinetics | 1174 | ||
| Indications and Dosages | 1174 | ||
| ► Nocturnal Leg Cramps | 1174 | ||
| rabeprazole sodium | 1176 | ||
| Category And Schedule | 1176 | ||
| Drug Class: | 1176 | ||
| Mechanism Of Action | 1176 | ||
| Uses | 1176 | ||
| Pharmacokinetics | 1176 | ||
| Indications And Dosages | 1176 | ||
| ► GERD | 1176 | ||
| raloxifene | 1177 | ||
| Category And Schedule | 1177 | ||
| Drug Class: | 1177 | ||
| Mechanism Of Action | 1177 | ||
| Uses | 1177 | ||
| Pharmacokinetics | 1177 | ||
| Indications And Dosages | 1177 | ||
| ► Prevention or Treatment of Osteoporosis | 1177 | ||
| PO | 1177 | ||
| Adults, Elderly. | 1177 | ||
| Side Effects/Adverse Reactions | 1177 | ||
| Frequent | 1177 | ||
| Occasional | 1177 | ||
| Rare | 1177 | ||
| Precautions And Contraindications | 1177 | ||
| Caution: | 1178 | ||
| Drug Interactions Of Concern To Dentistry | 1178 | ||
| Serious Reactions | 1178 | ||
| Dental Considerations | 1178 | ||
| General: | 1178 | ||
| Consultations: | 1178 | ||
| raltegravir | 1178 | ||
| Category And Schedule | 1178 | ||
| Drug Class: | 1178 | ||
| Mechanism Of Action | 1178 | ||
| Uses | 1178 | ||
| Pharmacokinetics | 1178 | ||
| Indications And Dosages | 1178 | ||
| ► HIV Infection | 1178 | ||
| PO | 1178 | ||
| Adults. | 1178 | ||
| Adolescents (16 yr). | 1178 | ||
| Side Effects/Adverse Reactions | 1178 | ||
| ► Adult | 1178 | ||
| Frequent | 1178 | ||
| Occasional | 1178 | ||
| Precautions And Contraindications | 1178 | ||
| Drug Interactions Of Concern To Dentistry | 1179 | ||
| Serious Reactions | 1179 | ||
| Dental Considerations | 1179 | ||
| General: | 1179 | ||
| Consultations: | 1179 | ||
| Teach Patient/Family to: | 1179 | ||
| ramipril | 1179 | ||
| Category And Schedule | 1179 | ||
| Drug Class: | 1179 | ||
| Mechanism Of Action | 1179 | ||
| Uses | 1179 | ||
| Pharmacokinetics | 1179 | ||
| Indications And Dosages | 1180 | ||
| ► Hypertension (Monotherapy) | 1180 | ||
| ranitidine hydrochloride/ranitidine bismuth citrate | 1181 | ||
| Category And Schedule | 1181 | ||
| Drug Class: | 1181 | ||
| Mechanism Of Action | 1181 | ||
| Uses | 1181 | ||
| Pharmacokinetics | 1182 | ||
| Indications And Dosages | 1182 | ||
| ► Duodenal Ulcers, Gastric Ulcers, Gastroesophageal Reflux Disease | 1182 | ||
| rasagiline | 1183 | ||
| Category And Schedule | 1183 | ||
| Drug Class: | 1183 | ||
| Mechanism Of Action | 1183 | ||
| Uses | 1183 | ||
| Pharmacokinetics | 1183 | ||
| Indications And Dosages | 1183 | ||
| ► Parkinson’s Disease, Monotherapy | 1183 | ||
| regorafenib | 1184 | ||
| Category and Schedule | 1184 | ||
| Drug Class: | 1184 | ||
| Mechanism of Action | 1185 | ||
| Uses | 1185 | ||
| Pharmacokinetics | 1185 | ||
| Indications and Dosages | 1185 | ||
| ► Colorectal Cancer, Metastatic | 1185 | ||
| repaglinide | 1186 | ||
| Category And Schedule | 1186 | ||
| Drug Class: | 1186 | ||
| Mechanism Of Action | 1186 | ||
| Uses | 1186 | ||
| Pharmacokinetics | 1186 | ||
| Indications And Dosages | 1186 | ||
| ► Diabetes Mellitus | 1186 | ||
| PO | 1186 | ||
| Adults, Elderly. | 1186 | ||
| Side Effects/Adverse Reactions | 1187 | ||
| Frequent | 1187 | ||
| Occasional | 1187 | ||
| Rare | 1187 | ||
| Precautions And Contraindications | 1187 | ||
| Caution: | 1187 | ||
| Drug Interactions Of Concern To Dentistry | 1187 | ||
| Serious Reactions | 1187 | ||
| Dental Considerations | 1187 | ||
| General: | 1187 | ||
| Consultations: | 1187 | ||
| Teach Patient/Family to: | 1187 | ||
| reserpine | 1187 | ||
| Category And Schedule | 1187 | ||
| Drug Class: | 1187 | ||
| Mechanism Of Action | 1188 | ||
| Uses | 1188 | ||
| Pharmacokinetics | 1188 | ||
| Indications And Dosages | 1188 | ||
| ► Hypertension | 1188 | ||
| retapamulin | 1189 | ||
| Category And Schedule | 1189 | ||
| Drug Class: | 1189 | ||
| Mechanism Of Action | 1189 | ||
| Uses | 1189 | ||
| Pharmacokinetics | 1189 | ||
| Indications And Dosages | 1189 | ||
| ► Impetigo Caused by Staphylococcus aureus or Streptococcus pyogenes | 1189 | ||
| Topical | 1189 | ||
| Adults. | 1189 | ||
| Children (9 mo or older). | 1189 | ||
| Side Effects/Adverse Reactions | 1189 | ||
| Occasional | 1189 | ||
| ► Adults | 1189 | ||
| ► Children | 1189 | ||
| Precautions And Contraindications | 1189 | ||
| reteplase, recombinant | 1190 | ||
| Category And Schedule | 1190 | ||
| Drug Class: | 1190 | ||
| Mechanism Of Action | 1190 | ||
| Uses | 1190 | ||
| Pharmacokinetics | 1190 | ||
| Indications And Dosages | 1190 | ||
| ► Acute MI, CHF | 1190 | ||
| IV Bolus | 1190 | ||
| Adults, Elderly. | 1190 | ||
| Side Effects/Adverse Reactions | 1190 | ||
| Frequent | 1190 | ||
| Precautions And Contraindications | 1190 | ||
| Drug Interactions Of Concern To Dentistry | 1190 | ||
| Serious Reactions | 1190 | ||
| Dental Considerations | 1190 | ||
| General: | 1190 | ||
| Consultations: | 1190 | ||
| Teach Patient/Family to: | 1190 | ||
| Dental Considerations | 1191 | ||
| General: | 1191 | ||
| Consultations: | 1191 | ||
| Teach Patient/Family to: | 1191 | ||
| ribavirin | 1191 | ||
| Category And Schedule | 1191 | ||
| Drug Class: | 1191 | ||
| Mechanism Of Action | 1191 | ||
| Uses | 1191 | ||
| Pharmacokinetics | 1191 | ||
| Indications And Dosages | 1192 | ||
| ► Chronic Hepatitis C | 1192 | ||
| PO (Capsule or Oral Solution in Combination with Interferon Alfa-2b) | 1192 | ||
| rifabutin | 1193 | ||
| Category And Schedule | 1193 | ||
| Drug Class: | 1193 | ||
| Mechanism Of Action | 1193 | ||
| Uses | 1193 | ||
| Pharmacokinetics | 1193 | ||
| Indications And Dosages | 1193 | ||
| ► Prevention of MAC Disease (First Episode) | 1193 | ||
| PO | 1193 | ||
| Adults, Elderly. | 1193 | ||
| ► Prevention of Recurrent MAC Disease | 1194 | ||
| PO | 1194 | ||
| Adults, Elderly. | 1194 | ||
| ► Dosage in Renal Impairment | 1194 | ||
| Side Effects/Adverse Reactions | 1194 | ||
| Frequent | 1194 | ||
| Occasional | 1194 | ||
| Rare | 1194 | ||
| Precautions And Contraindications | 1194 | ||
| Caution: | 1194 | ||
| Drug Interactions Of Concern To Dentistry | 1194 | ||
| Serious Reactions | 1194 | ||
| Dental Considerations | 1194 | ||
| General: | 1194 | ||
| Consultations: | 1194 | ||
| Teach Patient/Family to: | 1194 | ||
| rifampin | 1194 | ||
| Category And Schedule | 1194 | ||
| Drug Class: | 1194 | ||
| Mechanism Of Action | 1194 | ||
| Uses | 1195 | ||
| Pharmacokinetics | 1195 | ||
| Indications And Dosages | 1195 | ||
| ► Tuberculosis | 1195 | ||
| rifapentine | 1196 | ||
| Category And Schedule | 1196 | ||
| Drug Class: | 1196 | ||
| Mechanism Of Action | 1196 | ||
| Uses | 1197 | ||
| Pharmacokinetics | 1197 | ||
| Indications And Dosages | 1197 | ||
| ► TB | 1197 | ||
| PO | 1197 | ||
| Adults, Elderly. | 1197 | ||
| Side Effects/Adverse Reactions | 1197 | ||
| Rare | 1197 | ||
| Precautions And Contraindications | 1197 | ||
| Caution: | 1197 | ||
| Drug Interactions Of Concern To Dentistry | 1197 | ||
| Serious Reactions | 1197 | ||
| Dental Considerations | 1197 | ||
| General: | 1197 | ||
| Consultations: | 1197 | ||
| Teach Patient/Family to: | 1198 | ||
| rifaximin | 1198 | ||
| Category and Schedule | 1198 | ||
| Drug Class: | 1198 | ||
| Mechanism of Action | 1198 | ||
| Uses | 1198 | ||
| Pharmacokinetics | 1198 | ||
| Indications and Dosages | 1198 | ||
| ► Reduction of Overt Hepatic Encephalopathy Recurrence | 1198 | ||
| rilpivirine | 1199 | ||
| Category and Schedule | 1199 | ||
| Drug Class: | 1199 | ||
| Mechanism of Action | 1199 | ||
| Uses | 1199 | ||
| Pharmacokinetics | 1199 | ||
| Indications and Dosages | 1199 | ||
| ► Treatment of HIV-1 Infection | 1199 | ||
| PO | 1199 | ||
| Adults. | 1199 | ||
| Side Effects/Adverse Reactions | 1199 | ||
| Frequent | 1199 | ||
| Occasional | 1199 | ||
| Precautions and Contraindications | 1200 | ||
| Drug Interactions of Concern to Dentistry | 1200 | ||
| Serious Reactions | 1200 | ||
| Dental Considerations | 1200 | ||
| General: | 1200 | ||
| Consultations: | 1200 | ||
| Teach Patient/Family to: | 1200 | ||
| riluzole | 1200 | ||
| Category And Schedule | 1200 | ||
| Drug Class: | 1200 | ||
| Mechanism Of Action | 1200 | ||
| Uses | 1200 | ||
| Pharmacokinetics | 1200 | ||
| Indications And Dosages | 1200 | ||
| ► ALS | 1200 | ||
| PO | 1200 | ||
| Adults, Elderly. | 1200 | ||
| Side Effects/Adverse Reactions | 1200 | ||
| Frequent | 1200 | ||
| Occasional | 1200 | ||
| Precautions And Contraindications | 1201 | ||
| Drug Interactions Of Concern To Dentistry | 1201 | ||
| Serious Reactions | 1201 | ||
| Dental Considerations | 1201 | ||
| General: | 1201 | ||
| Consultations: | 1201 | ||
| Teach Patient/Family to: | 1201 | ||
| rimantadine hydrochloride | 1201 | ||
| Category And Schedule | 1201 | ||
| Drug Class: | 1201 | ||
| Mechanism Of Action | 1201 | ||
| Uses | 1202 | ||
| Pharmacokinetics | 1202 | ||
| Indications And Dosages | 1202 | ||
| ► Influenza A Virus | 1202 | ||
| rimexolone | 1202 | ||
| Category And Schedule | 1202 | ||
| Drug Class: | 1202 | ||
| risedronate sodium | 1203 | ||
| Category And Schedule | 1203 | ||
| Drug Class: | 1203 | ||
| Mechanism Of Action | 1203 | ||
| Uses | 1203 | ||
| Pharmacokinetics | 1203 | ||
| Indications And Dosages | 1203 | ||
| ► Inflammation after Ocular Surgery, Treatment of Anterior Uveitis | 1203 | ||
| Ophthalmic | 1203 | ||
| Adults, Elderly. | 1203 | ||
| Side Effects/Adverse Reactions | 1203 | ||
| Occasional | 1203 | ||
| Precautions And Contraindications | 1203 | ||
| Caution: | 1203 | ||
| Drug Interactions Of Concern To Dentistry | 1203 | ||
| Serious Reactions | 1203 | ||
| Dental Considerations | 1203 | ||
| General: | 1203 | ||
| Indications And Dosages | 1204 | ||
| ► Paget’s Disease | 1204 | ||
| risperidone | 1204 | ||
| Category And Schedule | 1204 | ||
| Drug Class: | 1204 | ||
| Mechanism Of Action | 1204 | ||
| Uses | 1205 | ||
| Pharmacokinetics | 1205 | ||
| Indications And Dosages | 1205 | ||
| ► Psychotic Disorder | 1205 | ||
| ritonavir | 1206 | ||
| Category And Schedule | 1206 | ||
| Drug Class: | 1206 | ||
| Mechanism Of Action | 1206 | ||
| Uses | 1207 | ||
| Pharmacokinetics | 1207 | ||
| Indications And Dosages | 1207 | ||
| ► HIV Infection | 1207 | ||
| PO | 1207 | ||
| Adults, Children 12 yr and older. | 1207 | ||
| Children younger than 12 yr. | 1207 | ||
| Side Effects/Adverse Reactions | 1207 | ||
| Frequent | 1207 | ||
| Occasional | 1207 | ||
| Rare | 1207 | ||
| Precautions And Contraindications | 1207 | ||
| Caution: | 1207 | ||
| Drug Interactions Of Concern To Dentistry | 1207 | ||
| Serious Reactions | 1207 | ||
| Dental Considerations | 1208 | ||
| General: | 1208 | ||
| Consultations: | 1208 | ||
| Teach Patient/Family to: | 1208 | ||
| rituximab | 1208 | ||
| Category And Schedule | 1208 | ||
| Drug Class: | 1208 | ||
| Mechanism Of Action | 1208 | ||
| Uses | 1208 | ||
| Pharmacokinetics | 1208 | ||
| Indications And Dosages | 1208 | ||
| ► Non-Hodgkin’s Lymphoma | 1208 | ||
| IV | 1208 | ||
| Adults. | 1208 | ||
| Side Effects/Adverse Reactions | 1208 | ||
| Frequent | 1208 | ||
| Occasional | 1208 | ||
| Precautions And Contraindications | 1208 | ||
| Drug Interactions Of Concern To Dentistry | 1208 | ||
| Serious Reactions | 1208 | ||
| Dental Considerations | 1209 | ||
| General: | 1209 | ||
| Consultations: | 1209 | ||
| Teach Patient/Family to: | 1209 | ||
| rivaroxaban | 1209 | ||
| Category and Schedule | 1209 | ||
| Drug Class: | 1209 | ||
| Mechanism of Action | 1209 | ||
| Uses | 1209 | ||
| Pharmacokinetics | 1209 | ||
| Indications and Dosages | 1210 | ||
| ► Nonvalvular Atrial Fibrillation (to Prevent Stroke and Systemic Embolism) | 1210 | ||
| rivastigmine tartrate | 1211 | ||
| Category And Schedule | 1211 | ||
| Drug Class: | 1211 | ||
| Mechanism Of Action | 1211 | ||
| Pharmacokinetics | 1211 | ||
| Indications And Dosages | 1211 | ||
| ► Alzheimer’s Disease | 1211 | ||
| PO | 1211 | ||
| Adults, Elderly. | 1211 | ||
| Side Effects/Adverse Reactions | 1211 | ||
| Frequent | 1211 | ||
| Occasional | 1211 | ||
| Rare | 1211 | ||
| Precautions And Contraindications | 1211 | ||
| Caution: | 1211 | ||
| Drug Interactions Of Concern To Dentistry | 1211 | ||
| Serious Reactions | 1211 | ||
| Dental Considerations | 1211 | ||
| General: | 1211 | ||
| Consultations: | 1212 | ||
| Teach Patient/Family to: | 1212 | ||
| rizatriptan benzoate | 1212 | ||
| Category And Schedule | 1212 | ||
| Drug Class: | 1212 | ||
| Mechanism Of Action | 1212 | ||
| Uses | 1212 | ||
| Pharmacokinetics | 1212 | ||
| Indications And Dosages | 1212 | ||
| ► Acute Migraine Attack | 1212 | ||
| PO | 1212 | ||
| Adults older than 18 yr, Elderly. | 1212 | ||
| Side Effects/Adverse Reactions | 1212 | ||
| Frequent | 1212 | ||
| Occasional | 1212 | ||
| Rare | 1213 | ||
| Precautions And Contraindications | 1213 | ||
| Caution: | 1213 | ||
| Drug Interactions Of Concern To Dentistry | 1213 | ||
| Serious Reactions | 1213 | ||
| Dental Considerations | 1213 | ||
| General: | 1213 | ||
| Consultations: | 1213 | ||
| Teach Patient/Family to: | 1213 | ||
| roflumilast | 1213 | ||
| Category and Schedule | 1213 | ||
| Drug Class: | 1213 | ||
| Mechanism of Action | 1213 | ||
| ropinirole hydrochloride | 1214 | ||
| Category And Schedule | 1214 | ||
| Drug Class: | 1214 | ||
| Mechanism Of Action | 1214 | ||
| Uses | 1214 | ||
| Pharmacokinetics | 1214 | ||
| Indications and Dosages | 1214 | ||
| ► COPD | 1214 | ||
| PO | 1214 | ||
| Adults. | 1214 | ||
| Side Effects/Adverse Reactions | 1214 | ||
| Frequent | 1214 | ||
| Occasional | 1214 | ||
| Precautions and Contraindications | 1214 | ||
| Drug Interactions of Concern to Dentistry | 1214 | ||
| Serious Reactions | 1214 | ||
| Dental Considerations | 1214 | ||
| General: | 1214 | ||
| Teach Patient/Family to: | 1214 | ||
| Pharmacokinetics | 1215 | ||
| Indications And Dosages | 1215 | ||
| ► Parkinson’s Disease | 1215 | ||
| PO | 1215 | ||
| Adults, Elderly. | 1215 | ||
| Side Effects/Adverse Reactions | 1215 | ||
| Frequent | 1215 | ||
| Occasional | 1215 | ||
| Rare | 1215 | ||
| Precautions And Contraindications: Hypersensitivity | 1215 | ||
| Drug Interactions Of Concern To Dentistry | 1215 | ||
| Serious Reactions | 1215 | ||
| Dental Considerations | 1215 | ||
| General: | 1215 | ||
| Consultations: | 1215 | ||
| Teach Patient/Family to: | 1215 | ||
| rosiglitazone maleate | 1216 | ||
| Category And Schedule | 1216 | ||
| Drug Class: | 1216 | ||
| Mechanism Of Action | 1216 | ||
| Uses | 1216 | ||
| Pharmacokinetics | 1216 | ||
| Indications And Dosages | 1216 | ||
| ► Diabetes Mellitus, Combination Therapy | 1216 | ||
| PO | 1216 | ||
| rosuvastatin calcium | 1217 | ||
| Category And Schedule | 1217 | ||
| Drug Class: | 1217 | ||
| Mechanism Of Action | 1217 | ||
| Uses | 1217 | ||
| Pharmacokinetics | 1217 | ||
| Indications And Dosages | 1217 | ||
| ► Hyperlipidemia, Dyslipidemia | 1217 | ||
| rotigotine | 1218 | ||
| Category and Schedule | 1218 | ||
| Drug Class: | 1218 | ||
| Mechanism of Action | 1218 | ||
| Uses | 1218 | ||
| Pharmacokinetics | 1218 | ||
| Indications and Dosages | 1219 | ||
| ► Parkinson’s Disease | 1219 | ||
| sacubitril + valsartan | 1220 | ||
| Category and Schedule | 1220 | ||
| Drug Class: | 1220 | ||
| Mechanism of Action | 1220 | ||
| Uses | 1220 | ||
| Pharmacokinetics | 1220 | ||
| Indications and Dosages | 1220 | ||
| ► Heart Failure | 1220 | ||
| PO | 1220 | ||
| Adults. | 1220 | ||
| Side Effects/Adverse Reactions | 1220 | ||
| Frequent | 1220 | ||
| Occasional | 1220 | ||
| Precautions and Contraindications | 1220 | ||
| Drug Interactions of Concern to Dentistry | 1221 | ||
| Serious Reactions | 1221 | ||
| Dental Considerations | 1221 | ||
| General: | 1221 | ||
| Consultations: | 1221 | ||
| Teach Patient/Family to: | 1221 | ||
| salmeterol | 1221 | ||
| Category And Schedule | 1221 | ||
| Drug Class: | 1221 | ||
| Mechanism Of Action | 1221 | ||
| Uses | 1221 | ||
| Pharmacokinetics | 1221 | ||
| Indications And Dosages | 1221 | ||
| ► Prevention and Maintenance Treatment of Asthma | 1221 | ||
| Inhalation (Diskus) | 1221 | ||
| Adults, Elderly, Children 4 yr and older. | 1221 | ||
| ► Prevention of Exercise-Induced Bronchospasm | 1222 | ||
| salsalate | 1222 | ||
| Category And Schedule | 1222 | ||
| Drug Class: | 1222 | ||
| Mechanism Of Action | 1222 | ||
| Uses | 1223 | ||
| Pharmacokinetics | 1223 | ||
| Indications And Dosages | 1223 | ||
| ► Rheumatoid Arthritis, Osteoarthritis Pain | 1223 | ||
| PO | 1223 | ||
| Adults, Elderly. | 1223 | ||
| Side Effects/Adverse Reactions | 1223 | ||
| Occasional | 1223 | ||
| Precautions And Contraindications | 1223 | ||
| Caution: | 1223 | ||
| Drug Interactions Of Concern To Dentistry | 1223 | ||
| Serious Reactions | 1223 | ||
| Dental Considerations | 1223 | ||
| General: | 1223 | ||
| Consultations: | 1224 | ||
| Teach Patient/Family to: | 1224 | ||
| sapropterin | 1224 | ||
| Category And Schedule | 1224 | ||
| Drug Class: | 1224 | ||
| Mechanism Of Action | 1224 | ||
| Uses | 1224 | ||
| Pharmacokinetics | 1224 | ||
| Indications And Dosages | 1224 | ||
| ► Management of Phenylketonuria | 1224 | ||
| Adult. | 1224 | ||
| Side Effects/Adverse Reactions | 1224 | ||
| Frequent | 1224 | ||
| Occasional | 1225 | ||
| Precautions And Contraindications | 1225 | ||
| Drug Interactions Of Concern To Dentistry | 1225 | ||
| Serious Reactions | 1225 | ||
| Dental Considerations | 1225 | ||
| General: | 1225 | ||
| Consultations: | 1225 | ||
| Teach Patient/Family to: | 1225 | ||
| saquinavir | 1225 | ||
| Category And Schedule | 1225 | ||
| Drug Class: | 1225 | ||
| Mechanism Of Action | 1225 | ||
| Uses | 1226 | ||
| Pharmacokinetics | 1226 | ||
| Indications And Dosages | 1226 | ||
| ► HIV Infection in Combination with Other Antiretrovirals | 1226 | ||
| PO | 1226 | ||
| Adults, Elderly. | 1226 | ||
| ► Dosage Adjustments When Given in Combination Therapy | 1226 | ||
| Side Effects/Adverse Reactions | 1226 | ||
| Occasional | 1226 | ||
| Rare | 1226 | ||
| Precautions And Contraindications | 1226 | ||
| Caution: | 1226 | ||
| Drug Interactions Of Concern To Dentistry | 1226 | ||
| Serious Reactions | 1226 | ||
| Dental Considerations | 1226 | ||
| General: | 1226 | ||
| Consultations: | 1226 | ||
| Teach Patient/Family to: | 1226 | ||
| sargramostim (granulocyte macrophage colony-stimulating factor, GM-CSF) | 1227 | ||
| Category And Schedule | 1227 | ||
| Drug Class: | 1227 | ||
| Mechanism Of Action | 1227 | ||
| Uses | 1227 | ||
| Pharmacokinetics | 1227 | ||
| Indications And Dosages | 1227 | ||
| ► Myeloid Recovery Following Bone Marrow Transplant (BMT) | 1227 | ||
| saxagliptin | 1228 | ||
| Category And Schedule | 1228 | ||
| Drug Class: | 1228 | ||
| Mechanism Of Action | 1229 | ||
| Uses | 1229 | ||
| Pharmacokinetics | 1229 | ||
| Indications And Dosages | 1229 | ||
| ► Type 2 Diabetes Mellitus | 1229 | ||
| PO | 1229 | ||
| Adults. | 1229 | ||
| Concurrent use with strong CYP3A4/5 inhibitors. | 1229 | ||
| ► Dosage in Renal Impairment | 1229 | ||
| Mild impairment (CrCl greater than 50 ml/min). | 1229 | ||
| Moderate to severe impairment (CrCl 50 ml/min or less). | 1229 | ||
| ESRD requiring dialysis. | 1229 | ||
| Side Effects/Adverse Reactions | 1229 | ||
| Frequent | 1229 | ||
| Occasional | 1229 | ||
| Rare | 1229 | ||
| Precautions And Contraindications | 1229 | ||
| Caution: | 1229 | ||
| Drug Interactions Of Concern To Dentistry | 1229 | ||
| Serious Reactions | 1229 | ||
| Dental Considerations | 1229 | ||
| General: | 1229 | ||
| Consultations: | 1230 | ||
| Teach Patient/Family to: | 1230 | ||
| scopolamine | 1230 | ||
| Category And Schedule | 1230 | ||
| Drug Class: | 1230 | ||
| Mechanism Of Action | 1230 | ||
| Uses | 1230 | ||
| Pharmacokinetics | 1230 | ||
| Indications And Dosages | 1230 | ||
| ► Prevention of Motion Sickness | 1230 | ||
| secobarbital | 1231 | ||
| Category And Schedule | 1231 | ||
| Drug Class: | 1231 | ||
| Mechanism Of Action | 1231 | ||
| Uses | 1231 | ||
| Pharmacokinetics | 1231 | ||
| Indications And Dosages | 1231 | ||
| ► Insomnia | 1231 | ||
| selegiline hydrochloride | 1233 | ||
| Category And Schedule | 1233 | ||
| Drug Class: | 1233 | ||
| Mechanism Of Action | 1233 | ||
| Uses | 1233 | ||
| Pharmacokinetics | 1233 | ||
| Indications And Dosages | 1233 | ||
| ► Adjunctive Treatment for Parkinsonism | 1233 | ||
| PO | 1233 | ||
| Adults. | 1233 | ||
| Elderly. | 1233 | ||
| Side Effects/Adverse Reactions | 1233 | ||
| Frequent | 1233 | ||
| Occasional | 1233 | ||
| Rare | 1233 | ||
| Precautions And Contraindications | 1233 | ||
| Caution: | 1233 | ||
| Drug Interactions Of Concern To Dentistry | 1233 | ||
| Serious Reactions | 1233 | ||
| Dental Considerations | 1234 | ||
| General: | 1234 | ||
| Consultations: | 1234 | ||
| Teach Patient/Family to: | 1234 | ||
| sertaconazole | 1234 | ||
| Category And Schedule | 1234 | ||
| Drug Class: | 1234 | ||
| Mechanism Of Action | 1234 | ||
| Uses | 1234 | ||
| Pharmacokinetics | 1234 | ||
| Indications And Dosages | 1234 | ||
| ► Tinea Pedis | 1234 | ||
| Topical | 1234 | ||
| Adults, Elderly, Children 12 yr and older. | 1234 | ||
| Side Effects/Adverse Reactions | 1234 | ||
| Rare | 1234 | ||
| Precautions And Contraindications | 1234 | ||
| Drug Interactions Of Concern To Dentistry | 1234 | ||
| Serious Reactions | 1235 | ||
| Dental Considerations | 1235 | ||
| General: | 1235 | ||
| sertraline | 1235 | ||
| Category And Schedule | 1235 | ||
| Drug Class: | 1235 | ||
| Mechanism Of Action | 1235 | ||
| Uses | 1235 | ||
| Pharmacokinetics | 1235 | ||
| Indications And Dosages | 1235 | ||
| ► Depression | 1235 | ||
| sevelamer hydrochloride | 1237 | ||
| Category And Schedule | 1237 | ||
| Drug Class: | 1237 | ||
| Mechanism Of Action | 1237 | ||
| Uses | 1237 | ||
| Pharmacokinetics | 1237 | ||
| Indications And Dosages | 1237 | ||
| ► Hyperphosphatemia | 1237 | ||
| PO | 1237 | ||
| Adults, Elderly. | 1237 | ||
| Side Effects/Adverse Reactions | 1237 | ||
| Frequent | 1237 | ||
| Occasional | 1237 | ||
| Precautions And Contraindications | 1237 | ||
| Drug Interactions Of Concern To Dentistry | 1237 | ||
| Serious Reactions | 1237 | ||
| Dental Considerations | 1237 | ||
| General: | 1237 | ||
| Consultations: | 1237 | ||
| Teach Patient/Family to: | 1238 | ||
| sildenafil citrate | 1238 | ||
| Category And Schedule | 1238 | ||
| Drug Class: | 1238 | ||
| Mechanism Of Action | 1238 | ||
| Uses | 1238 | ||
| Pharmacokinetics | 1238 | ||
| Indications And Dosages | 1238 | ||
| ► Erectile Dysfunction | 1238 | ||
| PO | 1238 | ||
| Adults. | 1238 | ||
| Elderly older than 65 yr. | 1238 | ||
| Side Effects/Adverse Reactions | 1238 | ||
| Frequent | 1238 | ||
| Occasional | 1238 | ||
| Rare | 1238 | ||
| Precautions And Contraindications | 1238 | ||
| Caution: | 1238 | ||
| Drug Interactions Of Concern To Dentistry | 1239 | ||
| Serious Reactions | 1239 | ||
| Dental Considerations | 1239 | ||
| General: | 1239 | ||
| silodosin | 1239 | ||
| Category and Schedule | 1239 | ||
| Drug Class: | 1239 | ||
| Mechanism of Action | 1239 | ||
| Uses | 1239 | ||
| Pharmacokinetics | 1239 | ||
| Indications and Dosages | 1239 | ||
| ► Benign Prostatic Hyperplasia | 1239 | ||
| PO | 1239 | ||
| Adults. | 1239 | ||
| ► Renal Impairment | 1239 | ||
| Side Effects/Adverse Reactions | 1239 | ||
| Frequent | 1239 | ||
| Occasional | 1239 | ||
| Precautions and Contraindications | 1239 | ||
| Drug Interactions of Concern to Dentistry | 1240 | ||
| Serious Reactions | 1240 | ||
| Dental Considerations | 1240 | ||
| General: | 1240 | ||
| Teach Patient/Family to: | 1240 | ||
| simethicone | 1240 | ||
| Category And Schedule | 1240 | ||
| Drug Class: | 1240 | ||
| Mechanism Of Action | 1240 | ||
| Uses | 1240 | ||
| Pharmacokinetics | 1240 | ||
| Indications And Dosages | 1240 | ||
| ► Antiflatulent | 1240 | ||
| PO | 1240 | ||
| Adults, Elderly, Children 12 yr and older. | 1240 | ||
| Children 2–11 yr. | 1240 | ||
| Children younger than 2 yr. | 1240 | ||
| Side Effects/Adverse Reactions | 1240 | ||
| Precautions And Contraindications | 1241 | ||
| Drug Interactions Of Concern To Dentistry | 1241 | ||
| Serious Reactions | 1241 | ||
| Dental Considerations | 1241 | ||
| General: | 1241 | ||
| Teach Patient/Family to: | 1241 | ||
| simvastatin | 1241 | ||
| Category And Schedule | 1241 | ||
| Drug Class: | 1241 | ||
| Mechanism Of Action | 1241 | ||
| Uses | 1241 | ||
| Pharmacokinetics | 1241 | ||
| Indications And Dosages | 1242 | ||
| ► Adjunct to Diet to Decrease Heterozygous Familial Hypercholesterolemia in Adolescents 10–17 Yr of Age (Girls at Least 1-Yr Post-menarche) | 1242 | ||
| Heterozygous Familial Hypercholesterolemia | 1242 | ||
| tacrine hydrochloride | 1275 | ||
| Category And Schedule | 1275 | ||
| Drug Class: | 1275 | ||
| Cholinesterase Inhibitor | 1275 | ||
| Mechanism Of Action | 1275 | ||
| Uses | 1275 | ||
| Pharmacokinetics | 1275 | ||
| Indications And Dosages | 1275 | ||
| ► Alzheimer’s Disease | 1275 | ||
| PO | 1275 | ||
| Adults, Elderly. | 1275 | ||
| ► Dosage in Hepatic Impairment | 1275 | ||
| Side Effects/Adverse Reactions | 1275 | ||
| Frequent | 1275 | ||
| Occasional | 1275 | ||
| Rare | 1275 | ||
| Precautions And Contraindications | 1275 | ||
| Caution: | 1275 | ||
| Drug Interactions Of Concern To Dentistry | 1275 | ||
| Serious Reactions | 1275 | ||
| Dental Considerations | 1276 | ||
| General: | 1276 | ||
| Consultations: | 1276 | ||
| Teach Patient/Family to: | 1276 | ||
| tacrolimus | 1276 | ||
| Category And Schedule | 1276 | ||
| Drug Class: | 1276 | ||
| Mechanism Of Action | 1276 | ||
| Uses | 1276 | ||
| Pharmacokinetics | 1276 | ||
| Indications And Dosages | 1277 | ||
| ► Prevention of Liver Transplant Rejection | 1277 | ||
| ulipristal | 1393 | ||
| Category and Schedule | 1393 | ||
| Drug Class: | 1393 | ||
| Mechanism of Action | 1393 | ||
| Uses | 1393 | ||
| Pharmacokinetics | 1393 | ||
| Indications and Dosages | 1393 | ||
| ► Emergency Contraception | 1393 | ||
| PO | 1393 | ||
| Adults (females). | 1393 | ||
| Side Effects/Adverse Reactions | 1393 | ||
| Frequent | 1393 | ||
| Occasional | 1393 | ||
| Precautions and Contraindications | 1393 | ||
| Drug Interactions of Concern to Dentistry | 1393 | ||
| Serious Reactions | 1393 | ||
| Dental Considerations | 1393 | ||
| General: | 1393 | ||
| Teach Patient/Family to: | 1393 | ||
| Uses | 1394 | ||
| Pharmacokinetics | 1394 | ||
| Indications and Dosages | 1394 | ||
| ► Chronic Obstructive Pulmonary Disease (COPD) | 1394 | ||
| Adults. | 1394 | ||
| Side Effects/Adverse Reactions | 1394 | ||
| Frequent | 1394 | ||
| Occasional | 1394 | ||
| Precautions and Contraindications | 1394 | ||
| Drug Interactions of Concern to Dentistry | 1394 | ||
| Serious Reactions | 1394 | ||
| Dental Considerations | 1394 | ||
| General: | 1394 | ||
| Consultations: | 1395 | ||
| Teach Patient/Family to: | 1395 | ||
| umeclidinium + vilanterol | 1393 | ||
| unoprostone isopropyl | 1395 | ||
| Category And Schedule | 1395 | ||
| Drug Class: | 1395 | ||
| Mechanism Of Action | 1395 | ||
| Uses | 1395 | ||
| Pharmacokinetics | 1395 | ||
| Indications And Dosages | 1395 | ||
| ► Glaucoma, Ocular Hypertension | 1395 | ||
| Ophthalmic | 1395 | ||
| Adults, Elderly. | 1395 | ||
| Side Effects/Adverse Reactions | 1395 | ||
| Frequent | 1395 | ||
| Occasional | 1395 | ||
| Precautions And Contraindications | 1395 | ||
| Caution: | 1395 | ||
| ursodiol | 1396 | ||
| Category And Schedule | 1396 | ||
| Drug Class: | 1396 | ||
| Mechanism Of Action | 1396 | ||
| Uses | 1396 | ||
| Indications And Dosages | 1396 | ||
| ► Dissolution of Radiolucent, Noncalcified Gallstones When Cholecystectomy Is Not Recommended; Treatment of Biliary Cirrhosis | 1396 | ||
| valacyclovir | 1398 | ||
| Category and Schedule | 1398 | ||
| Drug Class: | 1398 | ||
| Mechanism of Action | 1398 | ||
| Uses | 1398 | ||
| Pharmacokinetics | 1398 | ||
| Indications and Dosages | 1398 | ||
| ► Herpes Zoster (shingles) | 1398 | ||
| valganciclovir hydrochloride | 1399 | ||
| Category and Schedule | 1399 | ||
| Drug Class: | 1399 | ||
| Mechanism of Action | 1399 | ||
| Uses | 1399 | ||
| Pharmacokinetics | 1399 | ||
| Indications and Dosages | 1399 | ||
| ► CMV Retinitis in Patients with Normal Renal Function | 1399 | ||
| valproic acid/valproate sodium/divalproex sodium | 1401 | ||
| Category and Schedule | 1401 | ||
| Drug Class: | 1401 | ||
| Mechanism of Action | 1401 | ||
| Uses | 1401 | ||
| Pharmacokinetics | 1401 | ||
| Indications and Dosages | 1401 | ||
| ► Seizures | 1401 | ||
| valrubicin | 1402 | ||
| Category and Schedule | 1402 | ||
| Drug Class: | 1402 | ||
| Mechanism of Action | 1402 | ||
| Uses | 1403 | ||
| Pharmacokinetics | 1403 | ||
| Indications and Dosages | 1403 | ||
| ► Bladder Cancer | 1403 | ||
| Intravesical | 1403 | ||
| Adults, Elderly. | 1403 | ||
| Side Effects/Adverse Reactions | 1403 | ||
| Frequent | 1403 | ||
| Occasional | 1403 | ||
| Rare | 1403 | ||
| Precautions and Contraindications | 1403 | ||
| Drug Interactions of Concern to Dentistry | 1403 | ||
| Serious Reactions | 1403 | ||
| Dental Considerations | 1403 | ||
| General: | 1403 | ||
| Consultations: | 1403 | ||
| Teach Patient/Family to: | 1403 | ||
| valsartan | 1404 | ||
| Category and Schedule | 1404 | ||
| Drug Class: | 1404 | ||
| Mechanism of Action | 1404 | ||
| Uses | 1404 | ||
| Pharmacokinetics | 1404 | ||
| Indications and Dosages | 1404 | ||
| ► Hypertension | 1404 | ||
| vancomycin hydrochloride | 1405 | ||
| Category and Schedule | 1405 | ||
| Drug Class: | 1405 | ||
| Mechanism of Action | 1405 | ||
| Uses | 1405 | ||
| Pharmacokinetics | 1405 | ||
| Indications and Dosages | 1405 | ||
| ► Treatment of Bone, Respiratory Tract, Skin, and Soft Tissue Infections; Endocarditis, Peritonitis, and Septicemia; Prevention of Bacterial Endocarditis in Those at Risk (If Penicillin Is Contraindicated) When Undergoing Biliary, Dental, GI, GU, or Respiratory Surgery or Invasive Procedures | 1405 | ||
| IV | 1405 | ||
| vardenafil | 1406 | ||
| Category and Schedule | 1406 | ||
| Drug Class: | 1406 | ||
| Mechanism of Action | 1406 | ||
| Uses | 1406 | ||
| Pharmacokinetics | 1406 | ||
| Indications and Dosages | 1406 | ||
| ► Erectile Dysfunction | 1406 | ||
| PO | 1406 | ||
| Adults. | 1406 | ||
| Elderly, older than 65 yr. | 1406 | ||
| ► Dosage in Moderate Hepatic Impairment | 1407 | ||
| varenicline | 1407 | ||
| Category and Schedule | 1407 | ||
| Drug Class: | 1407 | ||
| Mechanism of Action | 1408 | ||
| Uses | 1408 | ||
| Pharmacokinetics | 1408 | ||
| Indications and Dosages | 1408 | ||
| ► Aid to Smoking Cessation | 1408 | ||
| Adult. | 1408 | ||
| Side Effects/Adverse Reactions | 1408 | ||
| Frequent | 1408 | ||
| Occasional | 1408 | ||
| Rare | 1408 | ||
| Precautions and Contraindications | 1408 | ||
| Drug Interactions of Concern to Dentistry | 1408 | ||
| Dental Considerations | 1408 | ||
| General: | 1408 | ||
| Consultations: | 1408 | ||
| Teach Patient/Family: | 1408 | ||
| vasopressin | 1409 | ||
| Category and Schedule | 1409 | ||
| Drug Class: | 1409 | ||
| Mechanism of Action | 1409 | ||
| Uses | 1409 | ||
| Pharmacokinetics | 1409 | ||
| Indications and Dosages | 1409 | ||
| ► Cardiac Arrest | 1409 | ||
| venlafaxine | 1410 | ||
| Category and Schedule | 1410 | ||
| Drug Class: | 1410 | ||
| Mechanism of Action | 1410 | ||
| Uses | 1410 | ||
| Pharmacokinetics | 1410 | ||
| Indications and Dosages | 1410 | ||
| ► Depression | 1410 | ||
| PO | 1410 | ||
| verapamil hydrochloride | 1412 | ||
| Category and Schedule | 1412 | ||
| Drug Class: | 1412 | ||
| Mechanism of Action | 1412 | ||
| Uses | 1412 | ||
| Pharmacokinetics | 1412 | ||
| Indications and Dosages | 1412 | ||
| ► Supraventricular Tachyarrhythmias, Temporary Control of Rapid Ventricular Rate with Atrial Fibrillation or Flutter | 1412 | ||
| IV | 1412 | ||
| Adults, Elderly. | 1412 | ||
| Children 1–15 yr. | 1412 | ||
| ► Arrhythmias, Including Prevention of Recurrent Paroxysmal Supraventricular Tachycardia and Control of Ventricular Resting Rate in Chronic Atrial Fibrillation or Flutter (with Digoxin) | 1413 | ||
| vidarabine | 1414 | ||
| Category and Schedule | 1414 | ||
| Drug Class: | 1414 | ||
| Mechanism of Action | 1414 | ||
| Uses | 1414 | ||
| Pharmacokinetics | 1414 | ||
| Indications and Dosages | 1414 | ||
| ► Treatment of Keratitis, Keratoconjunctivitis Caused by Human Herpes Virus, Types 1 and 2 | 1414 | ||
| Ophthalmic | 1414 | ||
| Adults, Elderly. | 1414 | ||
| Side Effects/Adverse Reactions | 1414 | ||
| Frequent | 1414 | ||
| Occasional | 1414 | ||
| vigabatrin | 1415 | ||
| Category and Schedule | 1415 | ||
| Drug Class: | 1415 | ||
| Mechanism of Action | 1415 | ||
| Uses | 1415 | ||
| Pharmacokinetics | 1415 | ||
| Indications and Dosages | 1415 | ||
| ► Partial-Onset Seizures | 1415 | ||
| Adult. | 1415 | ||
| Side Effects/Adverse Reactions | 1415 | ||
| Frequent | 1415 | ||
| Occasional | 1415 | ||
| Precautions and Contraindications | 1415 | ||
| Caution: | 1415 | ||
| Drug Interactions of Concern to Dentistry | 1415 | ||
| Serious Reactions | 1415 | ||
| Dental Considerations | 1415 | ||
| General: | 1415 | ||
| Teach Patient/Family to: | 1415 | ||
| Dental Considerations | 1416 | ||
| General: | 1416 | ||
| Consultations: | 1416 | ||
| Teach Patient/Family to: | 1416 | ||
| vilazodone | 1416 | ||
| Category and Schedule | 1416 | ||
| Drug Class: | 1416 | ||
| Mechanism of Action | 1416 | ||
| Uses | 1416 | ||
| Pharmacokinetics | 1416 | ||
| Indications and Dosages | 1416 | ||
| ► Depression | 1416 | ||
| PO | 1416 | ||
| Adults. | 1416 | ||
| Side Effects/Adverse Reactions | 1416 | ||
| Frequent | 1416 | ||
| Occasional | 1416 | ||
| Precautions and Contraindications | 1416 | ||
| Drug Interactions of Concern to Dentistry | 1417 | ||
| Serious Reactions | 1417 | ||
| Dental Considerations | 1417 | ||
| General: | 1417 | ||
| Consultations: | 1417 | ||
| Teach Patient/Family to: | 1417 | ||
| vinblastine sulfate | 1417 | ||
| Category and Schedule | 1417 | ||
| Drug Class: | 1417 | ||
| Mechanism of Action | 1417 | ||
| Uses | 1417 | ||
| Pharmacokinetics | 1417 | ||
| Indications and Dosages | 1417 | ||
| ► Remission Induction in Advanced Testicular Carcinoma, Advanced Mycosis Fungoides, Breast Carcinoma, Choriocarcinoma, Disseminated Hodgkin’s Disease, Non-Hodgkin’s Lymphoma, Kaposi’s Sarcoma (KS), or Letterer-Siwe Disease | 1417 | ||
| IV | 1417 | ||
| Adults, Elderly. | 1417 | ||
| Children. | 1418 | ||
| ► Maintenance Dose for Treatment of Advanced Testicular Carcinoma, Advanced Mycosis Fungoides, Breast Carcinoma, Choriocarcinoma, Disseminated Hodgkin’s Disease, Non-Hodgkin’s Lymphoma, KS, or Letterer-Siwe Disease | 1418 | ||
| IV | 1418 | ||
| Adults, Elderly, Children. | 1418 | ||
| Side Effects/Adverse Reactions | 1418 | ||
| Frequent | 1418 | ||
| Occasional | 1418 | ||
| Rare | 1418 | ||
| Precautions and Contraindications | 1418 | ||
| Drug Interactions of Concern to Dentistry | 1418 | ||
| Serious Reactions | 1418 | ||
| Dental Considerations | 1418 | ||
| General: | 1418 | ||
| Consultations: | 1419 | ||
| Teach Patient/Family to: | 1419 | ||
| vincristine sulfate | 1419 | ||
| Category and Schedule | 1419 | ||
| Drug Class: | 1419 | ||
| Mechanism of Action | 1419 | ||
| Uses | 1419 | ||
| Pharmacokinetics | 1419 | ||
| Indications and Dosages | 1420 | ||
| ► Acute Leukemia, Advanced Non-Hodgkin’s Lymphoma, Disseminated Hodgkin’s Disease, Neuroblastoma, Rhabdomyosarcoma, Wilms’ Tumor | 1420 | ||
| IV | 1420 | ||
| Adults, Elderly. | 1420 | ||
| Children. | 1420 | ||
| Children weighing less than 10 kg or with a body surface area less than 1 m2 0.05 mg/kg. | 1420 | ||
| ► Dosage in Hepatic Impairment | 1420 | ||
| Side Effects/Adverse Reactions | 1420 | ||
| Expected | 1420 | ||
| Frequent | 1420 | ||
| Occasional | 1420 | ||
| Rare | 1420 | ||
| Precautions and Contraindications | 1420 | ||
| Drug Interactions of Concern to Dentistry | 1420 | ||
| Serious Reactions | 1420 | ||
| Dental Considerations | 1420 | ||
| General: | 1420 | ||
| Consultations: | 1421 | ||
| Teach Patient/Family to: | 1421 | ||
| vinorelbine | 1421 | ||
| Category and Schedule | 1421 | ||
| Drug Class: | 1421 | ||
| Mechanism of Action | 1421 | ||
| Uses | 1421 | ||
| Pharmacokinetics | 1421 | ||
| Indications and Dosages | 1421 | ||
| ► Unresectable, Advanced Non–Small-Cell Lung Cancer (as Monotherapy or in Combination with Cisplatin) | 1421 | ||
| IV | 1421 | ||
| Adults, Elderly. | 1421 | ||
| ► Dosage Adjustment Guidelines | 1421 | ||
| ► Combination Therapy (with Cisplatin) | 1422 | ||
| IV Injection | 1422 | ||
| Adults, Elderly. | 1422 | ||
| Side Effects/Adverse Reactions | 1422 | ||
| Frequent | 1422 | ||
| Occasional | 1422 | ||
| Rare | 1422 | ||
| Precautions and Contraindications | 1422 | ||
| Drug Interactions of Concern to Dentistry | 1422 | ||
| Serious Reactions | 1422 | ||
| Dental Considerations | 1422 | ||
| General: | 1422 | ||
| Consultations: | 1422 | ||
| Teach Patient/Family to: | 1423 | ||
| vismodegib | 1423 | ||
| Category and Schedule | 1423 | ||
| Drug Class: | 1423 | ||
| Mechanism of Action | 1423 | ||
| Uses | 1423 | ||
| Pharmacokinetics | 1423 | ||
| Indications and Dosages | 1423 | ||
| ► Basal Cell Cancer, Metastatic or Locally Advanced | 1423 | ||
| PO | 1423 | ||
| Adults. | 1423 | ||
| Side Effects/Adverse Reactions | 1423 | ||
| Frequent | 1423 | ||
| Occasional | 1423 | ||
| Precautions and Contraindications | 1423 | ||
| Drug Interactions of Concern to Dentistry | 1423 | ||
| Serious Reactions | 1423 | ||
| Dental Considerations | 1424 | ||
| General: | 1424 | ||
| Consultations: | 1424 | ||
| Teach Patient/Family to: | 1424 | ||
| vorapaxar | 1424 | ||
| Category and Schedule | 1424 | ||
| Drug Class: | 1424 | ||
| Mechanism of Action | 1424 | ||
| Uses | 1424 | ||
| Pharmacokinetics | 1424 | ||
| Indications and Dosages | 1424 | ||
| ► History of MI or PAD | 1424 | ||
| PO | 1424 | ||
| Adults. | 1424 | ||
| Side Effects/Adverse Reactions | 1424 | ||
| Frequent | 1424 | ||
| Occasional | 1424 | ||
| Precautions and Contraindications | 1424 | ||
| Drug Interactions of Concern to Dentistry | 1424 | ||
| Serious Reactions | 1424 | ||
| Dental Considerations | 1425 | ||
| General: | 1425 | ||
| Consultations: | 1425 | ||
| Teach Patient/Family to: | 1425 | ||
| vortioxetine | 1425 | ||
| Category and Schedule | 1425 | ||
| Drug Class: | 1425 | ||
| Mechanism of Action | 1425 | ||
| Uses | 1425 | ||
| Pharmacokinetics | 1425 | ||
| Indications and Dosages | 1425 | ||
| ► Major Depressive Disorder | 1425 | ||
| PO | 1425 | ||
| Adults. | 1425 | ||
| Side Effects/Adverse Reactions | 1425 | ||
| Frequent | 1425 | ||
| Occasional | 1426 | ||
| Precautions and Contraindications | 1426 | ||
| Drug Interactions of Concern to Dentistry | 1426 | ||
| Serious Reactions | 1426 | ||
| Dental Considerations | 1426 | ||
| General: | 1426 | ||
| Consultations: | 1426 | ||
| Teach Patient/Family to: | 1426 | ||
| warfarin sodium | 1427 | ||
| Category and Schedule | 1427 | ||
| Drug Class: | 1427 | ||
| Mechanism of Action | 1427 | ||
| Uses | 1427 | ||
| Pharmacokinetics | 1427 | ||
| Indications and Dosages | 1427 | ||
| Anticoagulant | 1427 | ||
| PO | 1427 | ||
| Adults, Elderly. | 1427 | ||
| Children. | 1427 | ||
| Usual Elderly Dosage (Maintenance) | 1427 | ||
| PO, IV | 1427 | ||
| Elderly. | 1427 | ||
| Side Effects/Adverse Reactions | 1427 | ||
| Occasional | 1427 | ||
| Rare | 1427 | ||
| Precautions and Contraindications | 1427 | ||
| Caution: | 1427 | ||
| Drug Interactions of Concern to Dentistry | 1427 | ||
| Serious Reactions | 1428 | ||
| Dental Considerations | 1428 | ||
| General: | 1428 | ||
| Consultations: | 1428 | ||
| Teach Patient/Family to: | 1428 | ||
| zafirlukast | 1429 | ||
| Category and Schedule | 1429 | ||
| Drug Class: | 1429 | ||
| Mechanism of Action | 1429 | ||
| Uses | 1429 | ||
| Pharmacokinetics | 1429 | ||
| Indications and Dosages | 1429 | ||
| ► Bronchial Asthma | 1429 | ||
| PO | 1429 | ||
| Adults, Elderly, Children 12 yr and older. | 1429 | ||
| Children 5–11 yr. | 1429 | ||
| Side Effects/Adverse Reactions | 1429 | ||
| Frequent | 1429 | ||
| Occasional | 1429 | ||
| Rare | 1429 | ||
| Precautions and Contraindications | 1429 | ||
| Caution: | 1429 | ||
| Drug Interactions of Concern to Dentistry | 1429 | ||
| Serious Reactions | 1429 | ||
| Dental Considerations | 1430 | ||
| General: | 1430 | ||
| Consultations: | 1430 | ||
| Teach Patient/Family to: | 1430 | ||
| zalcitabine | 1430 | ||
| Category and Schedule | 1430 | ||
| Drug Class: | 1430 | ||
| Mechanism of Action | 1430 | ||
| Uses | 1430 | ||
| Pharmacokinetics | 1430 | ||
| Indications and Dosages | 1430 | ||
| ► HIV Infection (in Combination with Other Antiretrovirals) | 1430 | ||
| PO | 1430 | ||
| Adults, Children 13 yr and older. | 1430 | ||
| Children younger than 13 yr. | 1430 | ||
| ► Dosage in Renal Impairment | 1430 | ||
| Side Effects/Adverse Reactions | 1430 | ||
| Frequent | 1430 | ||
| Occasional | 1431 | ||
| Rare | 1431 | ||
| Precautions and Contraindications | 1431 | ||
| Caution: | 1431 | ||
| Drug Interactions of Concern to Dentistry | 1431 | ||
| Serious Reactions | 1431 | ||
| Dental Considerations | 1431 | ||
| General: | 1431 | ||
| Consultations: | 1431 | ||
| Teach Patient/Family to: | 1431 | ||
| zaleplon | 1431 | ||
| Category and Schedule | 1431 | ||
| Drug Class: | 1431 | ||
| Mechanism of Action | 1432 | ||
| Uses | 1432 | ||
| Pharmacokinetics | 1432 | ||
| Indications and Dosages | 1432 | ||
| ► Insomnia | 1432 | ||
| PO | 1432 | ||
| Adults. | 1432 | ||
| Elderly. | 1432 | ||
| Side Effects/Adverse Reactions | 1432 | ||
| Expected | 1432 | ||
| Frequent | 1432 | ||
| Occasional | 1432 | ||
| Rare | 1432 | ||
| Precautions and Contraindications | 1432 | ||
| Caution: | 1432 | ||
| Drug Interactions of Concern to Dentistry | 1432 | ||
| Serious Reactions | 1432 | ||
| Dental Considerations | 1432 | ||
| General: | 1432 | ||
| Consultations: | 1432 | ||
| Teach Patient/Family to: | 1432 | ||
| zanamivir | 1433 | ||
| Category and Schedule | 1433 | ||
| Drug Class: | 1433 | ||
| Mechanism of Action | 1433 | ||
| Uses | 1433 | ||
| Pharmacokinetics | 1433 | ||
| Indications and Dosages | 1433 | ||
| ► Influenza Virus | 1433 | ||
| ziconotide | 1434 | ||
| Category and Schedule | 1434 | ||
| Drug Class: | 1434 | ||
| Mechanism of Action | 1434 | ||
| Uses | 1434 | ||
| Pharmacokinetics | 1434 | ||
| Indications and Dosages | 1434 | ||
| ► Pain Control | 1434 | ||
| Intrathecal | 1434 | ||
| Adults, Elderly. | 1434 | ||
| Side Effects/Adverse Reactions | 1434 | ||
| Frequent | 1434 | ||
| Occasional | 1434 | ||
| Rare | 1434 | ||
| Precautions and Contraindications | 1434 | ||
| Drug Interactions of Concern to Dentistry | 1434 | ||
| Serious Reactions | 1434 | ||
| Dental Considerations | 1434 | ||
| General: | 1434 | ||
| Consultations: | 1434 | ||
| Teach Patient/Family to: | 1434 | ||
| zidovudine | 1435 | ||
| Category and Schedule | 1435 | ||
| Drug Class: | 1435 | ||
| Mechanism of Action | 1435 | ||
| Uses | 1435 | ||
| Pharmacokinetics | 1435 | ||
| Indications and Dosages | 1435 | ||
| ► HIV Infection | 1435 | ||
| PO | 1435 | ||
| zileuton | 1436 | ||
| Category and Schedule | 1436 | ||
| Drug Class: | 1436 | ||
| Mechanism of Action | 1436 | ||
| Uses | 1436 | ||
| Pharmacokinetics | 1436 | ||
| Indications and Dosages | 1436 | ||
| ► Bronchial Asthma | 1436 | ||
| PO | 1436 | ||
| Adults, Elderly, Children 12 yr and older. | 1436 | ||
| Side Effects/Adverse Reactions | 1437 | ||
| Frequent | 1437 | ||
| Occasional | 1437 | ||
| Rare | 1437 | ||
| Precautions and Contraindications | 1437 | ||
| Caution: | 1437 | ||
| Drug Interactions of Concern to Dentistry | 1437 | ||
| Serious Reactions | 1437 | ||
| Dental Considerations | 1437 | ||
| General: | 1437 | ||
| Consultations: | 1437 | ||
| Teach Patient/Family to: | 1437 | ||
| ziprasidone | 1437 | ||
| Category and Schedule | 1437 | ||
| Drug Class: | 1437 | ||
| Mechanism of Action | 1437 | ||
| Uses | 1437 | ||
| Pharmacokinetics | 1437 | ||
| Indications and Dosages | 1438 | ||
| ► Schizophrenia | 1438 | ||
| zoledronic acid | 1439 | ||
| Category and Schedule | 1439 | ||
| Drug Class: | 1439 | ||
| Mechanism of Action | 1439 | ||
| Uses | 1439 | ||
| Pharmacokinetics | 1439 | ||
| Indications and Dosages | 1439 | ||
| ► Hypercalcemia | 1439 | ||
| IV Infusion | 1439 | ||
| zolmitriptan | 1440 | ||
| Category and Schedule | 1440 | ||
| Drug Class: | 1440 | ||
| Mechanism of Action | 1440 | ||
| Uses | 1440 | ||
| Pharmacokinetics | 1440 | ||
| Indications and Dosages | 1440 | ||
| ► Acute Migraine Attack | 1440 | ||
| PO | 1440 | ||
| Adults, Elderly, Children older than 18 yr. | 1440 | ||
| Intranasal | 1441 | ||
| Adults, Elderly. | 1441 | ||
| Side Effects/Adverse Reactions | 1441 | ||
| Frequent | 1441 | ||
| Occasional | 1441 | ||
| Rare | 1441 | ||
| Precautions and Contraindications | 1441 | ||
| Caution: | 1441 | ||
| Drug Interactions of Concern to Dentistry | 1441 | ||
| Serious Reactions | 1441 | ||
| Dental Considerations | 1441 | ||
| General: | 1441 | ||
| Consultations: | 1441 | ||
| Teach Patient/Family to: | 1441 | ||
| zolpidem tartrate | 1442 | ||
| Category and Schedule | 1442 | ||
| Drug Class: | 1442 | ||
| Mechanism of Action | 1442 | ||
| Uses | 1442 | ||
| Pharmacokinetics | 1442 | ||
| Indications and Dosages | 1442 | ||
| ► Insomnia | 1442 | ||
| PO | 1442 | ||
| Adults. | 1442 | ||
| Elderly, Debilitated. | 1442 | ||
| Side Effects/Adverse Reactions | 1442 | ||
| Occasional | 1442 | ||
| Rare | 1442 | ||
| Precautions and Contraindications | 1442 | ||
| Caution: | 1442 | ||
| Drug Interactions of Concern to Dentistry | 1442 | ||
| Serious Reactions | 1442 | ||
| Dental Considerations | 1442 | ||
| General: | 1442 | ||
| Consultations: | 1443 | ||
| Teach Patient/Family to: | 1443 | ||
| zonisamide | 1443 | ||
| Category and Schedule | 1443 | ||
| Drug Class: | 1443 | ||
| Mechanism of Action | 1443 | ||
| Uses | 1443 | ||
| Pharmacokinetics | 1443 | ||
| Indications and Dosages | 1443 | ||
| ► Partial Seizures | 1443 | ||
| PO | 1443 | ||
| Adults, Elderly, Children older than 16 yr. | 1443 | ||
| Side Effects/Adverse Reactions | 1443 | ||
| Frequent | 1443 | ||
| Occasional | 1443 | ||
| Rare | 1443 | ||
| Precautions and Contraindications | 1443 | ||
| Caution: | 1443 | ||
| Drug Interactions of Concern to Dentistry | 1443 | ||
| Serious Reactions | 1444 | ||
| Dental Considerations | 1444 | ||
| General: | 1444 | ||
| Consultations: | 1444 | ||
| Teach Patient/Family to: | 1444 | ||
| Appendix A Abbreviations | e1 | ||
| Appendix B Combination Drugs by Trade Name | e9 | ||
| Appendix C Drugs Associated With Dry Mouth | e17 | ||
| Appendix D Drugs That Affect Taste | e22 | ||
| Alcohol Detoxification | e22 | ||
| Alkalosis Agent | e22 | ||
| Alzheimer’s | e22 | ||
| Analgesics (NSAIDS) | e22 | ||
| Anesthetics (General) | e22 | ||
| Anesthetics (Local) | e22 | ||
| Anorexiants | e22 | ||
| Antacids | e22 | ||
| Antagonists | e22 | ||
| Antianemic | e22 | ||
| Antianxiety | e22 | ||
| Antiarthritic | e22 | ||
| Anticholinergics | e22 | ||
| Anticonvulsants | e22 | ||
| Antidepressants | e22 | ||
| Antidiabetics | e22 | ||
| Antidiarrheals | e22 | ||
| Antiemetics | e22 | ||
| Antifungals | e22 | ||
| Antigout | e22 | ||
| Antihyperlipidemics | e23 | ||
| Antiinfectives | e23 | ||
| Antiinflammatory/Antiarthritic | e23 | ||
| Antimigraine | e23 | ||
| Antineoplastic | e23 | ||
| Antiparkinson | e23 | ||
| Antiprotozoal | e23 | ||
| Antipsychotics | e23 | ||
| Antithyroid | e23 | ||
| Antivirals | e23 | ||
| Anxiolytic/Sedatives | e23 | ||
| Asthma Preventives | e23 | ||
| Bronchodilators | e23 | ||
| Calcium-Affecting Drugs | e23 | ||
| Cancer Chemotherapeutics | e24 | ||
| Cardiovascular | e24 | ||
| Cns Stimulants | e24 | ||
| Decongestant | e24 | ||
| Diuretics | e24 | ||
| Glucocorticoids | e24 | ||
| Gallstone Solubilization | e24 | ||
| Hemorheologic | e24 | ||
| Immunomodulators | e24 | ||
| Immunosuppressants | e24 | ||
| Irritable Bowel Syndrome | e24 | ||
| Hypnotic | e24 | ||
| Methylxanthines | e24 | ||
| Nicotine Cessation | e24 | ||
| Ophthalmics | e24 | ||
| Proton Pump Inhibitors | e24 | ||
| Retinoid, Systemic | e24 | ||
| Salivary Stimulant | e24 | ||
| Sedative-Hypnotic | e24 | ||
| Relaxants | e25 | ||
| Vitamins | e25 | ||
| Appendix E Complementary and Alternative Medications and Dietary Supplements | e26 | ||
| aloe vera | e26 | ||
| Other Names: | e26 | ||
| Class: | e26 | ||
| Major Ingredients | e26 | ||
| Claimed Actions | e26 | ||
| Uses | e26 | ||
| Administration | e26 | ||
| Side Effects | e26 | ||
| Appendix F Preventing Medication Errors and Improving Medication Safety | e72 | ||
| Communicating Prescription Information | e72 | ||
| Zeros and Decimal Points | e73 | ||
| Abbreviations | e73 | ||
| Ambiguous or Incomplete Orders | e73 | ||
| High-Alert Medications | e73 | ||
| Appendix G Oral Contraceptives | e75 | ||
| Category and Schedule | e75 | ||
| Drug Class: | e75 | ||
| Mechanism of Action | e75 | ||
| Uses | e75 | ||
| Pharmacokinetics | e75 | ||
| Indications and Dosages | e75 | ||
| ► Contraception | e75 | ||
| Generic and Trade Name Index | 1445 | ||
| A | 1445 | ||
| B | 1450 | ||
| C | 1452 | ||
| D | 1457 | ||
| E | 1460 | ||
| F | 1462 | ||
| G | 1463 | ||
| H | 1464 | ||
| I | 1467 | ||
| J | 1469 | ||
| K | 1469 | ||
| L | 1470 | ||
| M | 1471 | ||
| N | 1474 | ||
| O | 1476 | ||
| P | 1478 | ||
| Q | 1483 | ||
| R | 1483 | ||
| S | 1485 | ||
| T | 1488 | ||
| U | 1491 | ||
| V | 1491 | ||
| W | 1493 | ||
| X | 1493 | ||
| Y | 1493 | ||
| Z | 1493 | ||
| Weights and Equivalents | IBC1 | ||
| Metric System | IBC1 | ||
| Weight Conversion, Pounds to Kilograms | IBC1 | ||
| Household Equivalents—Approximate | IBC1 | ||
| Calculations for Determining the Amount of Local Anesthetic and/or Vasoconstrictor in Dental Cartridges | IBC2 | ||
| Typical Local Anesthetic Concentrations | IBC2 | ||
| Typical Vasoconstrictor Concentrations | IBC2 | ||
| General Calculation Guidelines | IBC2 |